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A Angstrom 
[a] Optical rotation 
Ac Acetate 
AIBN 2,2' -Azobisisobutyronitrile 








CAN Ceric ammonium nitrate 
CDI 1,1' -carbonyldiimdazole 
cm centimetre 
COSY COrrelation SpectroscopY 
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DAN 1 ,8-diaminonapthalene 
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EDCI 1 -(3-Dimethylaminopropyl)-3-ethylcarbodiimide 
Et Ethyl 
Ether Diethyl ether 
FAB Fast Atom Bombardment 
g 	 gram 
lv 
hr hour 
HRMS High Resolution Mass Spectrometry 
Hz Hertz 
IR Infra-red 
J Coupling Constant 
Lit Literature 
M Moles per litre 
M Multiplet 






mp melting point 
m/z mass to charge ratio 
nd not determined 
NMR Nuclear Magnetic Resonance 








TLC Thin Layer Chromatography 
TMS Trimethylsilyl 





1,3 -Nucleophilic  addition reactions of thiols and amines with pyranosylnitrile oxides 
have been employed in the synthesis of C-glycosides. The nitrile oxides were 
generated by base-induced dehydrochlori nation of the corresponding hydroximoyl 
chlorides 106 and 107. 
D-Glucose derived hydroximoyl chloride 107 was prepared in four steps from D-
glucose and employed in collaborative work toward the synthesis of glucosinol ate 
analogues. Reactions of alkyl and aryl thiols with D-xylose nitrile oxide 151 afforded 
a series of desulfoisoglucosinolates in 55-76% yields. 
Reactions of alkyl and aryl amines with the D-xylose and D-glucose derived nitrile 
oxides 151 and 115 under basic conditions afforded the corresponding Z-
amidoximes. For example, (Z)-N-benzyl-(2,3 ,4,6-tetra-O-acetyl--D-
glucopyranosyl)formamide oxime (137) was prepared from 107 and benzylamine in 
88% yield. 
The addition of amino acid derived nucleophiles was also investigated. Reaction of 
the D-xylose and D-glucose nitrile oxides 151 and 115 with L-cysteine derivative 
147 under basic conditions afforded thiohydroximates 148 and 150 in high yield. 
Reaction of the D-xylose nitrile oxide 151 with glycine, L-leucine and L-
phenylalanine esters initially afforded amidoximes 152, 155 and 161. Cyclisation of 
152, 155 and 161 to form 1,2,4-oxadiazin-6-ones occurred on exposure to silica or 
prolonged standing. Employing L-proline benzyl ester as the nucleophile led to the 
formation -of predominantly oxadiazinone 163. Attempts to synthesise pyranosyl-
1 ,2,4-oxathiazin-6-ones were not successful. 
6-Amino-6-deoxy- 1,2:3 ,4-di-O-isopropylidene-a-D-galactopyranose hydrochloride 
was prepared from D-galactose in 4 steps, and reaction with D-xylose and D-glucose 
derived nitrile oxides 151 and 115 afforded (1—+6) amidoxime linked pseudo-
disaccharides 178 (81%) and 181 (75%). D-Xylose and D-glucose amines 182 and 
183 were prepared from the parent aldoses in 5 steps. Reaction of these amines with 
vi 
D-xylose and D-glucose nitrile oxides 151 and 115 yielded a series of (1—+1) 
amidoxime linked pseudo-disaccharides (31-49% yields). Deprotection of 184 was 
achieved under basic conditions. 
Reaction of o-phenylenediamine, o-aninothiophenol, o-aminophenol with D-glucose 
nitrite oxide 115 gave access to the corresponding benzimidazole 218, benzothiazole 
215 and benzoxazole 221 in high yields (71-85%). Similarly, reaction with D-xylose 
nitrile oxide 151 afforded the corresponding xylose benzazoles (68-90%). 
Deprotection of the pyranosyl benzazoles was achieved under basic conditions. 2-
(2,3 ,5-Tri-O-benzoyl-3-D-ribopyranosy1)benzoxazole (241) and 2-(2,3 ,5-tri-O-
benzoyl-f3-D-ribopyranosyl) benzimidazole (242) were prepared similarly in 92 and 
90% yields respectively. Deprotection of 241 under Zemplen conditions led to an 
anomeric mixture (13 :a, 62:38) of products. Deprotection of 242 on the other hand, 
gave exclusively 2--D-Ribofuranosy1benzimidazole in 91% yield. 
Reaction of 1 ,8-diaminonapthalene with D-xylose derived nitrile oxide 151 at room 
temperature (16 hours) afforded perimidine 259 in 60% yield. Perimidines derived 
from D-glucose, D-mannose and D-galactose were prepared similarly (55-65%). 
Attempts to repeat the reaction at elevated temperature lead to the formation of 
glycal products 258 and 261. Glyceraldehyde derived hydroximoyl chloride 265 was 
prepared in 4 steps from D-mannitol and afforded perimidine 264 under the 
conditions described above in 61% yield. 
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The work presented in this thesis investigates the application of nitrile oxide 
chemistry as part of a route to novel C-glycosides. The synthesis of C-glycosides is 
of great interest due to their importance in biological systems. 1,2  The strategy exploits 
the ability of nitrile oxides to undergo 1,3-addition reactions with a range of 
nucleophiles. This introductory section briefly reviews general aspects of nitrile 
oxide chemistry, the remaining sections cover applications of 1 ,3-nucleophilic 
reactions of nitrile oxides in the synthesis of thiohydramates (specifically 
glucosinolates and their analogues), amidoximes and 5- and 6-membered 
heterocycles. 
1.2 Nitrile oxide chemistry overview 
1.2.1 Nitrile Oxides: Background 
Nitrile oxides are a member of the nitrilium betaine class of 1,3-dipoles. The 
existence of nitrile oxides has been known for over 200 years. Mercury and silver 
fulminate salts (formonitrile oxide salts) were described by Howard ca 1800 and 
benzonitrile oxide has been known since l894. The general nitrile oxide structure 
was first proposed by Ley in 1899, but not finally elucidated until IR experiments 
were conducted in the mid 1960s. 6 
1,3-Dipoles are three-atom, 4-2t electron systems, which have an overall neutral 
charge. They are divided into two, classes. 7 The allyl class have three sp 2-hybridised 
atoms, which allow a single 2t-bond and have a bent structure. The propargyl-allenyl 
class possess an additional orthogonal it-bond between two sp-hybridised atoms and 
are therefore linear. Both structural classes are further subdivided according to the 
nature of the X, Y and Z atoms. 
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1,3-Dipolar species such as nitrile oxides are normally represented as having a 
zwitterionic structure. They are more accurately represented by a resonance hybrid of 
octet, sextet, diradical and carbene forms (Scheme l).8.9  A great deal of work has 
been conducted in the field of nitrile oxide chemistry over the last 40 years; a number 
of texts that provide detailed discussions of nitrile oxide structure and reactivity are 
available. 8-12 
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Scheme 1 
1.2.2 Nitrile Oxides: Generation 
Like many 1,3-dipoles, nitrile oxides 1 are very reactive and are consequently rarely 
isolated; generation normally takes place in situ in the presence of the co-reactant. 
The key problem in the isolation of nitrile oxides is their ability to dimerise to form 
1,2,5-oxadiazole-2-oxides 2 13,14  (furoxans) (Scheme 2). It should be noted, however, 
that those with bulky substituents do not readily dimerise and are therefore isolable. 
Over the years a number of generation strategies have been devised,' 2" 5 the 
precursors are most frequently aldoxime derivatives 5-8 8,9,15  or nitro compounds 3 
8,9,16 (Scheme 2). 
The thermal cycloreversion of furoxans 2 also results in the formation of two nitrile 
oxide molecules. 13  This reaction is not frequently employed in synthetic strategies 
since high temperatures are usually required (200 0 C). Furoxans with bulky 
substituents' 8 and ring strained furoxans' 9 are observed to undergo cycloreversion at 
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Scheme 2 
One of the most widely employed strategies is the Mukaiyama dehydration  16  of 
primary nitro compounds 3. The reaction is base catalysed and usually employs an 
isocyanate as a dehydrating agent to generate the nitrile oxide. A variety of 
dehydrating agents have been. employed; these include t-Boc anhydride,  17  acid 
chlorides  ,20  phosphorous oxychloride, 2 ' p-toluenesulfonic acid 22 and DAST. 23 A 
recent publication has reported that Mukaiyama type dehydration takes place under 
microwave irradiation in the presence of 4-(4,6-dimethoxy[ 1,3 ,5]triazin-2-yl)-4- 
methylmorpholonium chloride (DMTMM). 24 Nitro substituted alkenes 4 are also 
known to afford nitrile oxides on treatment with organolithium compounds, Grignard 
reagents or titanium tetrachloride. 25,26 
A number of nitrile oxide generation strategies involve aldoximes 5 or their 
derivatives as precursors. The most widely used route proceeds via base  27 -30  or 
thermally  3 ' induced dehydrohalogenation of hydroximoyl halides 6. The 
hydroximoyl halide precurors are produced from the oxime by direct halogenation 32 
or treatment with N-chlorosuccinimide 33 or N-bromosuccinimide. 34 Hydroximoyl 
chlorides have also been reported to yield the corresponding nitrile oxide on 
treatment with silver(I) acetate.  35  Routes based on other aldoxime derivatives have 
3 
been reported, these include nitrolic acids 7 36,37  and a-hydroxyimino carboxylic 
acids 8.38 
Oxidation of aldoximes themselves can also yield the corresponding nitrile oxide. 
Employing alkaline sodium hypochlorite 39 or tBuOCl4° as the oxidising agent affords 
the respective hydroximoyl halide in situ, which may then spontaneously 
dehydrohalogenate under the basic conditions. A number of other agents are known 
to afford nitrile oxides from aldoximes; these include chloramine-T 4 ' manganese 
dioxide ,42  lead tetraacetate 43 and iodosylbenzene. 44 
A completely novel strategy, that employs O-silylated hydroxamic acid precursors 9 
has recently been reported by Carreira et al.45 Treatment of the O-silylated 
hydroxamic acid with triflic anhydride leads to an activated intermediate 10 which 
may undergo de-silylation and C-O bond scission to afford the nitrile oxide 1 
(Scheme 3). 
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Scheme 3 
1.2.3 Nitrile Oxides: Reactions 
The reactive character of nitrile oxides allows them to undergo a number of varied 
reactions (Scheme 4). Generation of nitrile oxides in the absence of any 
dipolarophile leads to the coupling of two molecules of nitrile oxide. The products of 
such reactions may be furoxans 2, 13,14 1,2,4-oxadiazole-4-oxides 11 or 1,4,2,5-
dioxazidines 12.14  The furoxan products are well known and are potential synthetic 
targets . 46  Furoxan formation is also found as a side reaction in cycloadditions of 
nitnle oxides with less reactive dipolarophiles.' 3 Nitrile oxide dimerisation is 2' 
order in [RCNO] whereas cycloaddition with dipolarophiles is 1 order. 47 
Dimensation may therefore be limited by in situ generation of nitrile oxides, since 
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The most frequently exploited reaction of nitrile oxides is the 1,3-dipolar 
cycloaddition with alkenes and alkynes (where X=Y=C). 8 ' 9 The products of such 
reactions are isoxazolines 13 and isoxazoles 14 respectively; the former are 
frequently employed in natural product synthesis 48,49  and the latter are currently 
important subjects in the emerging field of "click" chemistry. 50"5 ' 1,3-Dipolar 
cycloadditions with C=N, C=O, C=S and CEN dipolarophiles are also well known. 8 ' 9 
Nitrile oxides also rearrange to isocyanates 15 at temperatures in excess of 1 1O0C .s 9 
1.2.4 1,3-Addition reactions 
The 1,3-addition of nucleophiles to nitrile oxides to afford substituted oximes 16 is a 
less well-known, yet valuable reaction. 8 ' 9  A large variety of nucleophiles undergo 
1,3-additions to nitrile oxides (Scheme 5). Hydroximoyl chlorides are the most 
convenient nitrile oxide precursors in 1,3-additions since Mukaiyama type conditions 
do not tolerate nucleophiles 52  and the nitrile oxide concentration may be more readily 
5 
controlled to limit furoxan formation. Arguably the most studied adducts to date have 
been the thiohydroxamates 17 and amidoximes 54.55 
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1.2.5 Mechanism of 1,3-addition reactions 
The reactivity of nitrile oxides with nucleophiles stems from the electrophilicity of 
the nitrilic carbon atom, indeed nitrile oxides may be considered as analogous to 
nitrilium cations.  56  An interesting facet of the 1,3-addition reactions is that they are 
stereospecific for the Z-oxime 19 (kinetic) product in all cases, despite the fact that 
many of the E-products 20 are thermodynamically favoured  .54,56 -66 The formation of 
the Z-oxime is thought to be stereoelectronically favoured; the entering nucleophile 
and the nitrogen lone pair of electrons adopt a favourable antiperiplanar arrangement, 
which forces the OH group and nucleophile to be cis to each other. 
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The specificity of the reaction explains a number of observations that could 
previously not be fully rationalised. For example addition of carboxylates to nitrile 
oxides (Scheme 5) does not form the expected oxime derivative 22, instead as soon 
as the initial adduct is formed it undergoes a 1,4-acyl migration to form a 
57 hydroxamate ester 23.A second key observation is that addition of azide ion to a 
nitrile oxide affords exclusively Z-azidoxime 24; if any E-isomer was formed it 
would be expected to cyclise to the corresponding N-hydroxytetrazole, and a mixture 
of products should therefore be observed. 
Although the stereochemical outcome of nucleophilic additions is not in doubt there 
has been some debate as to the mechanistic origins of this specificity. The debate has 
centred on whether the reaction proceeds in a concerted or a stepwise manner. Work 
conducted in the mid-1980s by Sharma and Aggarwal 64 '65 concluded that the 
reactions of formonitrile oxide and acetonitrile oxide with methanol proceeded via a 
stepwise addition through two discrete transition states (TS1, TS2, Scheme 6). The 























Hegarty and co-workers 54 have proposed that the 1,3-addition reactions proceed via 
an asynchronous concerted process (Scheme 7). As the nucleophile approaches the 
nitrile oxide, the dipolar species undergoes heavy-atom rearrangement in a trans 
fashion, thus establishing the Z configuration. Proton transfer is then believed to 
occur without having to overcome any energy barrier. Hegarty's conclusions are 
based on ab initio calculations concerning the additions of water, ammonia and 
methanol to formonitrile oxide. At present, Hegarty's work appears to have been that 
accepted, and no subsequent report has so far challenged his findings. 
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Scheme 7 
It was stated above that additions of nucleophiles to nitrile oxides proceeded under 
kinetic control to afford exclusively Z-configured products. It is known, however, 
that amidoximes produced by such reactions can be obtained only as E-configured 
products. 5963 Z versus E specificity has been found to be dependent on the nature of 
the amine nucleophile. These observations appear to contrast with the theory 
described previously, and it is therefore necessary to account for this apparent 
exception. Addition of ammonia or primary amines leads to only Z-adducts as 
isomerisation of such adducts is difficult due to hydrogen bond stabilisation by the 
"amido" type N-H bond and the oxime oxygen. 62  X-Ray crystallographic studies 
clearly demonstrate such bonding in non and mono-N-substituted amidoximes due to 
the adoption of a Z-antiperiplanar (Zap) or "S-trans" configuration, where the amidic 
N-H bond faces the oxime OH. 62 ' 66' 67 In contrast, Z configured NN-di-substituted 
amidoximes cannot be stabilised as above, and over time isomerise to the 
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Z to E isomerisation is promoted by acid and indeed is >10 5 times faster6 ' than in 
neutral conditions, the proposed isomerisation mechanisms are illustrated in Scheme 
8. 
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1.3 Glucosinolates: A natural class of thiohydroximates 
1.3.1 Glucosinolates: Background 
Glucosinolates are a naturally occurring class of thiosaccharides that are isolated 
from all members of the botanical family Cruczferae.687 ' A number of familiar 
brassica crops such as oilseed rape, cabbage, Brussels sprouts and numerous 
mustards derive their characteristic flavours from the breakdown products of 
glucosinolates. Glucosinolates are broken down by the enzyme myrosinase (EC 
3.2.3.1) to produce a range of degradation products (refer to Scheme 9)6871  The 
most important of these are isothiocyanates (mustard oils). Glucosinolate-derived 
isothiocyanates possess a range of biological activities; these include toxic, anti-
nutritional, goitrogenic, anti-carcinogenic, anti-fungal and anti-bacterial effects in a 
wide range of mammals (including humans). 687 ' Some glucosinolates are also of 
interest themselves due to the role they play in host-plant recognition and as egg-
laying stimulants for bras sica-adapted insects. 72,73 
All glucosinolates conform to the general structure 27. The structure consists of three 
fragments: a 3-D-glucopyranose unit, an 0-sulfated thiohydroximate bridge and an 






Glucosinolate Occurrence Side chain (R) Biosynthesis from 
Sinigrin Black mustard 
seeds (Brassica 2-Propenyl- Homomethionine 
nigra) 
Sinalbin White mustard 
seeds (Sinapis p-Hydroxybenzyl- Tyrosine 
alba) 
Gluconapin Rapeseed 3-Butenyl- 
(Brassica napus) 
Glucobrassicanapin Rapeseed 4-Pentenyl 




(Nasturtium Phenylethyl- Homophenylalanine 
officinale) 
Table 1: Selected examples of naturally occurring glucosinolates 
1.3.2 Glucosinolate Hydrolysis 
Myrosinase is a naturally occurring 3-thioglucosidase enzyme that is found in all 
known Cruciferae.758 ' It is the only known enzyme that is capable of catalysing the 
hydrolysis and degradation of glucosinolates. Following hydrolysis, glucosinolates 
undergo spontaneous Lossen rearrangement to afford a number of degradation 
products (Scheme 9)•6870  The major products are isothiocyanates (28), nitnles (29), 
thiocyanates (30) (Path A) and oxazolidine-2-thiones (31) (where the aglycon 
contains a hydroxy group [Path B]). 68 ' 70 
11 
Path A 
0SO3K 	H20 	D-Gtc 	 1_SO3K 
N 	 C I 
D-GIc 
A 	s' 	Myrosinase 	 A 
R—N=C=S 	R—C=N 	R—S—C=N 






In Nature the myrosinase and the glucosinolate substrate only come together if plant 
cells are physically broken by chewing, cutting or grating etc. 7 ' This response is 
believed to be a plant defence mechanism against herbivores. The breakdown 
products can be toxic and therefore pose problems to commercial farming. 73 '74 
Humans do not normally show toxic effects on eating glucosinolate-rich vegetables 
since cooking destroys myrosinase. 
1.3.3 Myrosinase: Mechanism of Action 
The mechanism of myrosinase catalysed glucosinolate hydrolysis has been subject to 
extensive study in recent years. 75-81  The hydrolysis process is believed to resemble 
the well-established mechanism of (retaining) family 1 O-glycosidases (Scheme 
10),76 however there are significant differences. A study by Botting et al 75 
established that myrosinase is incapable of facilitating transglycosylation. This 
phenomenon was unexpected since analogous O-glycosidases have long been known 








The catalytic site in myrosinase differs from family 1 O-glycosidases by not having 
two glutamic acid residues, in myrosinase the upper residue is not present . 77 Work 
with 2-deoxyglucotropaeolin as a myrosinase inhibitor led to a 2-step/double-pocket 
active site hypothesis being initially put forward for the hydrolysis mechanism 
(Scheme 11).78  The first step was believed to be cleavage of the S-glycosidic bond to 
form a covalent intermediate; a histidyl cation was supposed to play the role of the 
absent glutamic acid residue. The cleavage step was thought to precede an enzyme-
independent Lossen rearrangement of the newly formed thiohydroximate-O-
sulfonate to afford degradation products. The covalent intermediate was then 
believed to undergo histidine-catalysed hydrolysis. 
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Subsequent studies with 2-deoxy-2-fluoroglucotropaeolin allowed the resulting 
glucosyl-enzyme intermediate to be studied by X-ray crystallography.  79  The results 
of this work have led to a revised mechanism (Scheme 12) . 79 The crystal structure 
showed that the myrosinase active site contains a glutamine residue in place of the 
glutamic acid found in family 1 O-glycosidases, this finding confirmed results 
obtained by Henrissat et al.77 The glutamine residue assists substrate binding by 
forming a hydrogen bond to the sulfate group. Its most crucial role, however, is to 
position an incoming water molecule via hydrogen bonding for hydrolysis of the 
enzyme-substrate intermediate.  79  The water molecule requires a base to initiate 
hydrolysis, a task normally performed by a glutamate residue.  76  In this case L-
ascorbate is found to enter the active site on loss of the aglycon and performs the 
glutamate role by abstracting a proton from the positioned water molecule, thus 
initiating the final hydrolysis step.  79  The presence of ascorbate as a co-factor leads to 
a significantly different hydrolysis process to those outlined in Schemes 10 and 11. 
The involvement of ascorbate is not entirely surprising since it has previously been 
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The function of the sulfate group is still a matter of debate. The previous studies 
concluded that the role of the anionic group was to facilitate enzyme-substrate 
binding. Withers et a180 have proposed that the sulfate acts as a substrate bound acid 
catalyst, thus removing the need for enzymatic acid catalysis (Scheme 13). 
According to their proposal, the pendant sulfate would be protonated on entry to the 
active site, which would then enable spontaneous formation of the enzyme/substrate 
intermediate and subsequent hydrolysis. Withers et al also suggest that the anionic 
sulfate would lead to poor glucosinolate binding to an O-glycosidase type active site, 
and Nature therefore has removed one of the glutamic acid residues in myrosinase to 















1.3.4 Synthesis of Glucosinolates 
1.3.4.1 Biosynthesis 
The biosynthesis of glucosinolates from amino acids has been studied since the early 
1970s, and the currently accepted sequence is outlined in Scheme 14.6870  The initial 
step involves P-450 mediated amine hydroxylation of an amino acid and subsequent 
decarboxylation to afford an aldoxime intermediate. The aldoxime then undergoes a 
poorly understood conversion to a transient thiohydroximic acid which is 
glycosylated with UDP-glucose; the resultant desulfoglucosinolate is finally sulfated 
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1.3.4.2 Chemical Synthesis of Glucosinolates 
Over a hundred glucosinolates have been isolated from Nature and many are of 
interest on account of their biological activity. 68,69  To date, extraction procedures 
have been proven to be problematic and tedious in many cases; therefore synthetic 
approaches to natural 82-89  and unnatural 90-97  glucosinolates have been pursued. 
Pioneering work in the field was conducted by Ettlinger and Lundeen 82  in the late 
1950s. They first prepared glucotropaeolin (32) (benzyl glucosinolate) by coupling 
phenylacetothiohydroxamic acid (33) with acetylated bromoglucose (34) and 
sulfating the resultant adduct (35) (Scheme 15). The sulfated adduct was 
deacetylated in methanolic ammonia to yield glucotropaeolate 32. This initial work 
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Scheme 15: (a) NH 20H.HCI, H 20 (b) KOH, MeOH (c) S03-Pyridine, (d) NH 3/MeOH 
16 
A nitnle oxide based strategy for glucotropaeolin synthesis was first accomplished 
by Benn 83 ' 84 in the early 1960s (Scheme 16). The key step in the strategy is a 1,3-
addition of 2,3 ,4,6-tetra-O-acetyl-3-D-glucopyranosylthiol (36) to phenylacetonitrile 
oxide (37) to afford thiohydroximate product 35. O-Sulfation of the adduct with 
sulfur trioxide/pyridine and subsequent deacetylation afforded the desired 
glucosinolate 32. 
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Scheme 16:(a) NEt3 , Et20 (b) S03-Pyridine, KHCO3 (c) NH 3/MeOH 
The nitrile oxide based strategy has proved versatile and has been the most widely 
exploited, indeed Benn, 83 ' 84 Rollin,8589 Botting72 '73 and others53 have employed and 
extended the nitrile oxide route in the synthesis of a large number of natural and 
unnatural glucosinolates. The reasons for this are 3-fold; the 1,3-addition of thiols to 
nitrile oxides is stereospecific for the naturally occurring Z-isomer, 687° the nitrile 
oxide precursors can be made by a number of methods, and the products may 
obtained up to a gram scale if required .53 
Berm 98  has also proposed a route to glucosinolates that does not require the 
generation of a nitrile oxide intermediate. A modified version of the Copenhaver 
reaction is employed (Scheme 17) to couple 2,3,4,6-tetra-0-acetyl-3-D-
glucopyranosylthiol (31) with trialkylsilyl nitronate 38 to yield the thiohydroximate 
product as a 2:1 mixture of Z (39) and E isomers (40). The E-isomer readily 
rearranges to the Z-isomer under thermal and photochemical conditions (eg exposure 
to visible light at room temperature). O-sulfation and deacetylation is achieved by 
using standard conditions. The reported advantage of this route is the ability to 
access unnatural E-glucosinolates. 
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Scheme 17: (a) S03-Pyridine, KHCO 3 (b) NH3IMeOH 
1.4 Amidoximes 
Amidoximes constitute a large class of oxime derivatives 55  that adopt the general 
structure 41 (Scheme 18). Lossen and Schifferdecker first reported the synthesis of 
an amidoxime in 187399 by addition of hydroxylamine to hydrogen cyanide. There 
are three common modem synthetic routes to amidoximes (Scheme 18); 55  they 
involve nucleophilic attack by hydroxylamines on nitriles (43) and thioamides (42), 
and 1,3-addition of amines to nitrile oxides (1). The nitrile oxide based route is 
particularly amenable to the synthesis of N-mono and NN-disubstituted amidoximes. 
Interest in amidoximes stems from a number of areas; work has primarily focused on 
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Scheme 18: (a) NH20H (b) NHR' 2 (c) NR' 20H 
The most recent development in amidoxime synthesis is ready access to a-hydroxy 
variants (Scheme 19).b00  Addition of hydroxylamines and 1,1'-carbonyl-diimidazole 
(CDT) to cyanohydrins (44) results in the formation of 3-hydrox-4-imino-oxazolidin-
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Scheme 19: (a) H2NOR' (b) CDI (c) NaOMe 
1.4.1 Amidoximes: Bioactivity 
Compounds containing the amidine functional group possess a range of biological 
activity including inhibition of serine protease and nitric oxide synthase.' ° '' °3 
Amidine based drugs such as Lamifiban (47)104  serve as anti-thrombotic agents in the 
treatment of coronary heart disease. 
R = H = 47, R=OH 
The amidine group is strongly basic and is therefore protonated under physiological 
conditions. 105  The protonated species is not readily absorbed from the gastrointestinal 
tract and as a result the bioactivity of amidine therapeutics may be greatly reduced. 
Fortunately amidoximes are reduced to amidines in vivo, 105and amidoxime analogues 
of amidine containing agents have therefore been examined as pro-drugs.' 04  The 
mechanism of in vivo amidoxime reduction is the subject of continuing research, the 
currently proposed mechanism of reduction by b5, b5 reductase and a P450 
isoenzyme is presented in Scheme 20.105 
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Amidoximes are known to undergo nitric oxide synthase and P-450 dependent 
oxidative cleavage of the C=N(OH) bond ' °6111 (Scheme 21). The resultant product is 
nitric oxide, therefore interest in amidoximes as potential nitric oxide donors has 
recently arisen. This research is driven by the major role that NO plays in the 
cardiovascular, immune and central and peripheral nervous systems. 
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Scheme 21 
1.4.2 Amidoximes: Metal ligation 
Amidoximes exhibit similar behaviour to oximes in terms of their ability to bind to a 
number of metal species. Metal binding , normally takes place via the oxime nitrogen 
as is typical of most oximes, although in certain cases binding may take place 
through the oxime oxygenJ' 2"3  In general the amido nitrogen is not involved in 
metal binding, especially if there are other co-ordinating sites available on the ligand 
(48). A recent publication by Barybin et a1," 2 however, has demonstrated a chelating 
oximato ligand (49) that binds to Cr(IH) and Al(III) through the oxime oxygen and 
the amido nitrogen. 
21 
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Amidoximes are known to form complexes with Fe(III), Cr(III), Hg(ll), Pd(H), 
Os(II), Cu(II)" 3 and polyoxometalate ions' 4 ' 115  ( such as {M040,o(OMe)21 2 ), and 
they are primarily employed in the chelation of heavy metal ions for analytical 
purposes.55"3  Amidoximes have found wide application in the extraction of uranium 
(and other heavy metal ions) from seawater, indeed complexes with dioxouranium 
(UO2) are well known. 113  The ability of amidoximes to chelate metal ions has 
recently been exploited in the design of class II fructose- i ,6-bisphospate aldolase 
inhibitors (Scheme 22),' 16  such inhibitors are of interest in the design of antibiotics. 
Amidoxime 50 was prepared in an attempt to mimic of enolate transition state 51. 








1.4.3 Amidoximes: Synthesis of Heterocycles 
Amidoximes have found applications in heterocycle synthesis for a number of 
years. " 7 ' 24  Much of this work has been devoted to the preparation of 1,2,4-
oxadiazoles' (55); these are particularly useful compounds since they function 
as bioisosteres for esters and amides. Oxadiazoles are more stable than esters and 
amides and are therefore ideal for use in pharmaceuticals.' 17-119 
There are two routes to oxadiazoles from amidoximes (Scheme 23). The first 
involves the condensation of an activated carboxylic acid. derivatives (52) with an 
amidoxime (53), followed by cyclisation.' 17-119  The second route involves 1,3-dipolar 
cycloaddition of a nitrile oxide (1) onto the C=N bond of an amidoxime to afford a 
1,2,4-oxadiazole-4-oxide (54) . 120 Deoxygenation of the product with trimethyl 
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phosphite yields the desired 1 ,2,4-oxadiazole (55). The second route is not regularly 
employed since the product(s) are obtained in only moderate yields as a result of 
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Scheme 23: X = CI, Br, OR, OAc, OH 
Treatment of unsubstituted and morto-substituted amidoximes with thionyl chloride 
allows construction of 1,2,3,5-oxathiadiazoles (56),121 similarly reaction with 
phosgene derivatives affords 1,2,4-oxadiazol-5-ones (57) (Scheme 24).122  1,2,3,5-
Oxathiadiazoles have been examined as antihyperglycemic agents for the treatment 
of type 2 diabetes. 123  1,2,3,5-Oxathiadiazoles and 1,2,4-oxadiazol-5-ones have been 
shown to behave as tetrazole isosteres and are therefore of potential interest in 
















The products covered so far retain the RN-C=N-OR unit from the parent 
amidoxime. Recent work has been directed toward amidoximes as sources of 
amidine (R'NH-C=NR) containing heterocycles. Zard et a1125 have recently reported 
a conversion amidoximes to imidazolines and/or imidazoles (Scheme 25). The 
23 
method involves radical cyclisation of N-allyl-O-benzoylamidoximes (58). The key 
intermediate is believed to be an amidinyl species (59) and the cyclic product is an 
imidazoline (60) that can be converted to the corresponding imidazole (61) following 
an oxidation step. 
PhCO2 	
(a) 	
N 	r  I (b) Ph 	N 	 Ph Ph 	 Ph COPh COPh COPh 	 COPh 
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Scheme 25: (a) Bu 3SnH, AIBN, A (b) Pd/C, i\ 
A similar conversion has been achieved by Abell and co-workers' 26 via a palladium 
mediated amino Heck reaction (Scheme 26). N-Allyl-O-
perfluorobenzoylamidoximes (62) undergo oxidative addition to Pd(0) to form an 
alkylideneaminopalladium intermediate (63). n-Hydride elimination initially leads to 
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Scheme 26 
1.5 1,3-Nucleophilic Addition Reactions to Nitrile Oxides in Heterocyclic 
Synthesis 
As was seen in Section 1.2.3, nitrile oxides are frequently and effectively employed 
in the synthesis of heterocycles via 1,3-dipolar cycloaddition reactions. Nucleophilc 
addition reactions with nitrile oxides may also result in heterocyclic products via a 
24 
variety of addition-cyclisation processes.  127  A brief overview of the general 










+ N 	X 	
B 
V 	X 




1.5.1 Addition-Cyclisation A: Nucleophilic attack by the oxime hydroxyl 
In pathway A (Scheme 27) group X represents an electrophilic carbon centre. 
Addition of a nucleophile bearing an alkyl halide, followed by cyclisation step 
affords an 1,2,4-oxadiazine (66) [as does addition of an aziridine, Scheme 28 (i)].' 28 
Similarly, addition of amine and thiol nucleophiles possessing a pendant ester group 
afford an adduct which may undergo cyclisation to form 1 ,2,4-oxadiazine-6-ones 
(67)129 and 1 ,4,2-oxathiazin-6-one products (68)' °"' respectively [Scheme 28 (ii) 
and (iii)]. Hussein and co-workers  132  have reported that addition of isocyanate and 
thiocyanate' 33 ions led to formation of 1,2,4-oxadiazol-5-ones (69) and 5-imino-
1,4,2-oxathiazolines (70) [Scheme 28 (iv) and (v)}. There is dispute as to whether 
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Scheme 28 
1.5.2 Addition-Cyclisation B: Nucleophilic attack by the oxime nitrogen 
atom 
In pathway B (Scheme 27) group X still represents an electrophilic centre, but the 
cyclisation occurs via the oxime nitrogen atom; two representative examples are 
illustrated here. Addition of aryl N-methylhydrazones to nitrile oxides' 34  initially 
forms the expected Z-oxime 71, however subsequent reactions are possible, 
including reversible cyclisation to 72, isomerisation to E-adduct 73 or nitroso 

































Mono-substituted amidoximes have been found to add to nitrile oxides to afford 
adduct 76, which on heating may lead to the formation of 1 ,2,4-oxadiazole-4-oxides 
(77) (Scheme 30). 135 
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Scheme 30 
1.5.3 Addition-Cyclisation C: post 1,3-addition nucleophilic attack on 
the oxime group 
Pathway C (Scheme 27) differs from those above since X in this case is nucleophilic, 
and addition of ambident nucleophiles leads to the formation of oxime adducts (78) 
which undero attack by the remaining nucleophilic centre with the extrusion of 
hydroxylamine.' 27 o-Substituted anilines are known to afford the corresponding 
27 
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Scheme 31: Y = NH, S, 0 
A related example has been reported in the ring expansion of isoxazol-5-ones (80) to 
1,3-oxazin-6-ones (81),137  however the extruded species in this case is not 
hydroxylamine (Scheme 32). Nucleophilic attack on benzonitrile oxide leads to 
adduct 82, which may itself react with a further equivalent of nitrile oxide to form 
intermediate 83. The isoxazolo oxygen atom is belived to add to the C=N bond of 83 
to form shortlived 84, collapse of which leads to formation of the product (81), 
benzonitrile and nitrous acid. 
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Scheme 32 
1.5.4 Addition-Cyclisation D: 1,3 additions with functionalised nitrile 
oxides 
Examples have been reported of nucleophilic addition of ambident nucleophiles to 
nitrile oxide precursors containing good leaving groups. 127  Cyclisation may occur on 
generation of nitrile oxide and subsequent intra-molecular addition. The example 
illustrated in Scheme 33 involves addition of thioureas to chioro-substituted 
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Scheme 33 
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2. Results and Discussion 
The main objective of the present work has been to explore the synthetic potential of 
the 1 ,3-nucleophilic addition reactions of pyranosyl nitrile oxides. Additions of thiols 
have been employed in the synthesis and evaluation of new myrosinase inhibitors. 
Addition of amines has been applied in the synthesis of novel carbohydrate derived 
amidoximes, benzazoles and perimidines. 
2.1 Synthetic Strategy 
The 1,3-dipolar cycloaddition reactions of pyranosyl nitrile oxides have previously 
been employed in the synthesis of heterocyclic C-glycosides, ' 38" 39 including 
pyranosyl isoxazolines (Scheme 34, path A). It was anticipated that pyranosyl nitrile 
oxides would also be able to undergo 1 ,3-nucleophilic addition reactions, and hence 
provide routes to novel glycosyl oximes (path B) and glycosyl benzazoles (path Q. 
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Several synthetically useful routes are available for the generation of nitrile oxides 
(Section 1.2.2). Reliable and efficient routes to pyranosyl nitrile oxides have been 
developed within the group in recent years (Scheme 35)52140 
Pyranosylnitromethanes (87) are convenient sources of the corresponding aldoximes 
30 
(88),52 these in turn may be efficiently transformed into hydroximoyl chlorides 
(89)' ° and the hydroximoyl chloride may be dehydrohalogenated in the presence of 
base to generate the required nitrile oxide (90). The final stage is addition of the 
chosen nucleophile to the freshly generated nitrile oxide. 66 
OH 
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Scheme 35 
It was hoped to demonstrate the utility of the methodology by extending it to other 
carbohydrate scaffolds, many other sugar derived nitrile oxides are known.' 38 It was 
decided that D-glyceraldehyde derived nitrile oxide 91 and D-ribose derived nitrile 
oxide 92 would be suitable for such studies, since preparations for both had already 
been described. 141,142  It was also necessary to employ an easily synthesised nitrile 
oxide for pilot reactions. Benzonitrile oxide 93 was chosen on account of its ease of 
access from commercially available starting materials. 143 
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2.2 Synthesis of Pyranosylnitrile Oxide Precursors 
2.2.1 Synthesis of Pyranosylnitromethanes 
2.2.1.1 3,4,5-Tri-O-acetyl--D-xyIopyranosyInitromethane (95) 
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Scheme 36: (a) H3CN02, NaOMe/MeOH (b) Ac 20, TfOH 
3,4,5-Tri-O-acetyl--D-xylopyranosy1nitromethane (95) was prepared via a modified 
version of the general procedure reported by Koll for the synthesis of 
pyranosylnitromethanes (Scheme 37). The first stage is a nitroaldol (Henry) reaction 
between nitromethane and the open chain form of D-xylose (94). Dissolving metallic 
sodium in anhydrous methanol generated sodium methoxide, which was used to 
deprotonate nitromethane to form its nitronate anion. The aldehyde group of the 
xylose underwent nucleophilic attack by the nitronate anion to generate a nitroalditol 
(96) intermediate. Sodium ions were removed from the product liquor in an ion-
exchange column and residual methanol was removed in vacuo. Reflux of the 
resultant aqueous solution resulted in dehydration of the nitroalditol to form the a,-
unsaturated nitro compound (97). Nitroalkene 97 acts as an acceptor in the final step, 
which is an intramolecular Michael addition.' 45 
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Scheme 37 
The unprotected product (98) was acetylated in order to prevent free hydroxyl groups 
interfering with any of the later reaction steps and to make handling easier. 
Protection was achieved by dissolving a concentrate of the unprotected sugar in 
distilled acetic anhydride, adding a catalytic amount of triflic acid before heating the 
mixture under reflux. Triflic acid is employed as a catalyst in this procedure rather 
than the traditional basic conditions in order to avoid deprotonation a to the nitro 
group, and thus any potential side reactions. 
Excess acetic anhydride and acetic acid by-product were removed in vacuo and the 
product obtained on crystallisation of the concentrate from ethanol. The product was 
isolated as white needle-like crystalline solid in moderate yield (40%). 'H NMR 
spectroscopy indicated that the product (95) was obtained as the -anomer and in the 
5C2 conformation. The vicinal coupling constants involving ring protons H 2-H5 all 
fall in the range 9-11 Hz and are consistent with the p 5C2 conformation (Table 2). 
The -anomer is favoured over the a-anomer since the nitro methyl group is bulky 
and therefore adopts the more favourable equatorial position on cyclisation.1 44  'H 
and ' 3C NMR spectroscopy did not indicate that any of the a-anomer, starting 













Table 2: Vicinal coupling constants for nitromethyl sugar 95 
2.2.1.2 3,4,5,7-Tetra-0-acetyI-3-D-gI ucopyranosylnitromethane (99) 
3,4,5 ,7-Tetra-O-acetyl-f-D-glucopyranosylnitromethane (99) was prepared from D-
glucose in 20% overall yield by the approach described above (Section 2.2.1). 
Previous work 146  has demonstrated that the intermediate nitro sugar cannot be 
efficiently acetylated in situ; the free sugar was therefore isolated by liquid/liquid 
extraction before the protection stage. 
During the course of this work, an alternative route to unprotected D-glucose and L-
fucose derived pyranosylnitromethanes was reported by Gross et al. 147 This method 
differs from that above by employing DBU as base and pyridine as solvent. The 
reported reaction time is slightly shorter than Koll's procedure and the yields 
obtained are higher (50-60%). It is unclear, however, whether the reaction may be 
applied to as wide a range of aldoses as Kol1s method. 
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2.2.2 Synthesis of pyranosylaldoximes 
Several routes to pyranosylaldoximes have been reported in the last 40 years, many 
of which require a number of steps and were considered unattractive. The procedure 
chosen was developed by the group 52  and is based on a study by Bartra et al. 148 
Bartra's work demonstrated that primary and secondary nitro compounds may be 






The reducing species in this instance is believed to be the stannate complex 
[Sn(SPh) 3][Et3NH] that is readily generated in situ by mixing a solution of tin(II) 
chloride, thiophenol and triethylamine. The reducing species is believed to be in a 
rapid equilibrium with the starting reagents since attempts to isolate the complex 
have been unsuccessful. 141 
SnCl2 + 3PhSH + NEt3 	. 	 [Sn(SPh) 3][NHEt3] + 2HCI 
Scheme 39 
The proposed mechanism 148  for nitro group reduction is illustrated in Scheme 40. 
Primary and secondary nitroso intermediates are found to rapidly adopt the oxime 
tautomer, while tertiary nitroso species undergo further reduction to the 
corresponding hydroxylamine product. 
Sn(SPh)3 
c.,. (PhS)3Sn1(° 






The above procedure was employed in the synthesis of the pyranosyl oximes (100), 
(101) and (102) from D-xylose, D-glucose and D-mannose. 
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The respective pyranosylnitromethanes were treated with tin(II) chloride, thiophenol 
and triethylamine to afford the aldoxime products as white solids after separation 
from tin-based by-products by dry-flash chromatography. The reaction was found to 
proceed in good yields (69-86%) and the products were obtained as a mixture of E 
and Z isomers (Table 3). 
.....OH 




Aldoxime % Yield E: Z isomer ratio 
100 86 4:1 




Table 3: Pyranosylaldoxime E:Z ratios 
The 'H NMR spectra of the aldoxime products showed characteristic signals for the 
E and Z isomers and therefore allowed the E:Z ratio to be determined; 3,4,5 -tri-0-
acetyI--D-xy1opyranosyIformaldoxime (100) serves as convenient example. The 'H 
NMR spectrum contains doublets at 6.63 ppm and 7.22 ppm that correspond to the 1-
H protons of the Z-isomer and E-isomer respectively. Broad singlets are observed at 
8.62 ppm and 8.88 ppm for the OH proton of the E-isomer and Z-isomer 
respectively. The assignment of geometry was based on literature values 52  and NMR 
studies by Phillips 149  and Lustig. 150  Phillips has proposed that the cis arrangement of 
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the 1-H proton to the oxime oxygen atom induces a paramagnetic (downfield) shift 
of the 1-H (E-isomer) signal relative to the 1-H (Z-isomer) signal. 
During the course of this work there have been two significant developments in the 
field. Somsak and Toth reported a route to pyranosylaldoximes from the 
corresponding nitriles;' 5 ' this process is outlined in detail in section 2.7.2.3. In a 
more general case, Carreira et al 152  have very recently reported a route to alkyl 
aldoximes from primary nitro compounds. This method is based on the Komblum 
type oxidation of benzyl bromides to aldehydes by reaction with nitronate anions. In 
the future, application of this latter reaction might be advantageous in the synthesis 
of pyranosyl aldoximes since it does not lead to the formation of potentially toxic tin 
by-products. 
2.2.3 Synthesis of pyranosyl hydroximoyl chlorides 
There are two main routes to hydroximoyl chlorides from aldoximes, direct 
chlorination 32  or a treatment with a "Cl" source such as N-chlorosuccinimide 
(NCS).33 Direct chlorination is a fairly harsh method, but usually allows 
straightforward purification. Chlorination of aldoximes is achieved by bubbling 
chlorine gas through a cooled (-78 0 C) solution of the substrate in ether or 
chloroform. 
The mechanism of the reaction is understood to be a SE2' process 7 and involves 
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The nitroso intermediate 103 is believed to be responsible for the characteristic green 
and blue solutions that are observed over the course of the reaction. 53  The blue colour 
is due to a strong absorbance at 320 nm that arises from an N=O, t-ir electron 
transition. 53  On warming to room temperature the colour disappears indicating that 
the chloro-oxime (105) tautomer has been formed. The products were isolated as 
white solids on removal of the solvent in vacuo and did not require further 
purification. The D-xylose (106), D-glucose (107) and D-mannose (108) derived 
products were obtained in 96, 98, and 99% yields respectively. 
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Although it is theoretically possible to obtain E and Z isomers from this reaction only 
a single OH signal in the 'H NMR spectra was observed for each product. Work by 
Hegarty56  predicts that the Z-isomer is stereoelectronically favoured due to the 
antipenplanar relationship between the chlorine atom and the lone pair of electrons 
(compare with section 1.2.5). It is important to note that the Z-isomer is reported to 
NM 
undergo base induced dehydrohalogenation Ca. 107 times faster than the E-isomer . 56 
This phenomenon is also attributed to the trans relationship between the leaving 
group and the lone pair of electrons on the oximic nitrogen. The presence of single 
CNOH derived signals in the 'H and ' 3C NMR spectra in addition to the reactivity 
of the obtained hydroximoyl chlorides implies that the Z-isomer was obtained 
exclusively in all cases. 140 
.OH 
R 1 CI 
Z-Isome 
2.2.4 Generation of pyranosyl nitrile oxides 
In principle the pyranosyl nitromethanes, aldoximes and hydroximoyl chlorides 
could all be-used to generate the required nitrile oxides, however the hydroximoyl 
chlorides were ultimately chosen for two reasons. The nitromethyl compound to 
nitrile oxide transformation is achieved by employing Mukaiyama's method; 16  this is 
unsuitable in the presence of nucleophiles since the isocyanate dehydrating agent 
reacts with thiols, amines and alcohols/phenols. 52  Generation directly from the 
aldoxime was ruled out due past experience of this method suffering lack of control 
over the rate of 1,3-dipole formation. 140  Large concentrations of nitrile oxide result in 
the formation of furoxan dimer. The only remaining option was the well-known 
Huigsen27  method (Scheme 42), which involves the base mediated 
dehydrohalogenation of hydroximoyl chlorides. Huigsens method allows control of 
nitrile oxide concentration by slow addition of base to the hydroximoyl chloride 
precursor thus minimising the formation of unwanted furoxan. Recent work by 
Taddei et al has described further minimisation of furoxan formation by conducting 
1,3-dipolar cycloaddition reactions in ionic liquids. 153,154 - 
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Scheme 42 
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2.2.5 Synthesis of dipyranosyI-(2,3,4-tri-O-acetyl--D-xyIopyranosyI) 
1 ,2,5-oxadiazole-2-oxide (109) 
0"+"0 
N 	N 
 ---.---o.' II 
NEt3 , TDI, i
Co 
OAc AcO 
95 109 	ckOAC 
Scheme •43 
Dixylopyranosyl furoxan (109) was identified as a likely side-product in the 
proposed programme of 1,3-addition reactions, especially if poorer nucleophiles 
were employed. 146  An authentic sample of the furoxan was therefore prepared. The 
target compound was synthesised from the nitromethyl sugar by using a modified 
version of the Mukaiyama dehydration procedure. The approach employs an 
isocyanate to achieve dehydration of the primary nitro precursor to form the 
corresponding nitrile oxide (Scheme 44). The modified procedure of Baker et a! 140 
was employed in this work. This is a modification of the Mukaiyama procedure 
utilising tolylene diisocyanate (TDI), since a polymeric urea is formed as a co-
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Scheme 44 
The product was obtained as a white solid in 61 % yield. The 'H NMR spectrum was 
complex due to the overlap of the signals from the two xylose rings. The anomeric 
signals, however, were discernable as an overlapped pair of doublets centred at 4.53 
ppm. The anomeric protons showed axial-axial couplings (J,,2 = 9.5 Hz) to the 2-H 
protons that are indicative of each ring retaining the 3-configuration. The ' 3C NMR 
spectrum contained distinctive diagnostic peaks at 153 and 112 ppm that correspond 
im 
to the C-4 and C-3 respectively on the 1 ,2,5-oxadiazole-2-oxide ring. The FAB mass 
spectrum was also distinctive since a characteristic fragment peak at M-60 was 

















2.3 1,3-Addition reactions: Thiol nucleophiles 
2.3.1 Myrosinase inhibition 
One of the current challenges in carbohydrate chemistry is a full understanding of the 
mechanism of glucosinolate hydrolysis catalysed by myrosinase (see section 1.3.3). 
To date, a considerable amount is known about the mode of action of myrosinase, 
however some significant gaps still remain. An important goal is to obtain X-ray 
crystallographic data to establish the nature of the myrosinase-substrate interaction 
and, in order to achieve this aim a suitable myrosinase inhibitor is required. Several 
myrosinase inhibitors have been synthesised with varying success.  90-97  There are two 
main classes. The first function by stabilising the glycosyl-enzyme intermediate. 2-
Deoxy-2-fluoroglucotropaeolin (110)93  and 2-deoxyglucotropaeolin (111)96  have 
both proved to be successful competitive inhibitors of the hydrolysis of 
glucotropaeolin (32) (Km=lniM). The second class are non-hydrolysable analogues 
of glucotropaeolin. The C-glucoside analogue of glucotropaeolin 91 '92 [C-GTL(1 12)] 
was not recognised by myrosinase and thus ineffective, however the carba-
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One of the best candidates to date is 2-fluoro-2-deoxy-glucotropaeolin (110). X-ray 
studies with this inhibitor have proved valuable (section 1.3.3); however rapid 
Lossen rearrangement of theaglycon component prevents a full understanding of the 
nature of the binding between the aglycon part and myrosinase. 79 A non-
hydrolysable substrate should enable a fuller analysis of the myrosinase- 
glucosinolate interactions. The potential to introduce the thiohydroximate 
functionality at the anomeric position is of particular interest since the product (114) 
would be a non-hydrolysable C-linked glucosinolate analogue. A collaborative 
project was initiated with Professor Rollin's group at the University of Orleans to 
investigate the synthesis and biological activity of such "isoglucosinolates". The key 
steps of the proposed synthesis are outlined in Scheme 45. 1,3-addition of thiols to 
115 would deliver desulfoisoglucosinolates (116) which, following sulfation steps 

























Scheme 45: (a) NEt3 (b) RSH (c) S0 3-Pyridine, (d) MeOK/MeOH 
The D-glucose based precursor 107 was to be prepared in Edinburgh and sent to 
Orleans for the latter stages. Work in Edinburgh was also to include synthesis of D-
xylose analogues of the "isoglucosinolates". It was anticipated that the lack of a C-6 
hydroxyl group would alter the ability to bind to myrosinase. In previous studies by 
Rollin et al deoxy-glucosinolates were shown to have varying binding affinities with 
myrosinase. 78 The results indicated that the presence of the C-2 glycosyl hydroxyl is 
crucial to allow hydrolysis and that the remaining glycosyl hydroxyls play a 
secondary binding role. The importance of the C-2 hydroxyl stems from the 
polarisation it confers to the S-glucose bond and in orientation of the glycosyl moiety 
in the enzyme pocket. 78  The previous observations are based on the fact that 2- 
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deoxy-glucosinolates function as competitive inhibitors of the hydrolysis of natural 
glucosinolates. 
Preliminary work on 1,3-additions of thiols to pyranosyl nitrile oxides had been 
conducted within the group by Baker. 146  Pilot reactions with D-glucopyranosyl nitrile 
oxide 115 and thiophenol were encouraging and thus the reaction was investigated in 
more detail. 









The nitrile oxide was generated by slowly adding an ethereal solution of 
triethylamine over 24 hours via a syringe to a vigorously stirred solution of 106 in 
dry ether. The slow addition of base controlled the nitrile oxide concentration thus 
minimising dimerisation to furoxan 109. Furthermore, furoxan formation was limited 
by adding the nucleophile in 3-fold excess. The product (119) was isolated as a white 
solid (75 %) after an aqueous work up and dry-flash chromatography. The product 
was characterised by 'H and ' 3C NMR spectroscopy. The 'H NMR spectrum 
displayed characteristic signals for the pyranose ring protons and aromatic ring 
derived signals were observed between 7.35 and 7.55 ppm. A doublet was observed 
at 3.56 ppm due to H-2; this signal is shifted to lower frequency relative to that for 
the nitrile oxide precursor. The coupling between H-2 and H-3 was found to be 9.94 
Hz, thus confirming that the product was obtained as the -anomer. A broad singlet 
at 8.81 ppm indicated the presence of the C=NOH group; no significant shift was 
noted relative to the CNOH signal of the hydroximoyl chloride. The ' 3C NMR 
spectrum displayed the expected aromatic and pyranose ring carbon signals and an 






higher frequency relative to that of the hydroximoyl chloride (136.5 ppm). The 
appearance of a single oxime signal was consistent with the exclusive formation of a 
Z-configured product (refer to Section 1.2.5). 
2.3.3 Synthesis of S-(2-Propyl) 2,3,4-tri-O-acetyI--D- 
xylopyranosylformothiohydroximate (120) 
N— OH 	'PrSH 	 N_OH 
Ac2-_J_J 
OAc 	 NEt3 	 OAc 
106 	 120 
Scheme 47 
Following the success of the previous reaction the addition of an alkyl thiol as a 
nucleophile was attempted. The Rollin group had employed primary thiols with 
success, therefore a secondary thiol was considered. 2-Propanethiol was easily 
available and the resultant adduct would constitute a xylose analogue of 
glucoputranjivin (isopropyl glucosinolate). 68 Using the conditions outlined in Section 
2.3.2, 2-propanethiol was reacted with 3 ,4,5-tri-O-acetyl-3-D-xylopyranosyl nitrile 
oxide to afford the desired adduct (120) in 55% yield. Furoxan 109 was also isolated 
from the reaction mixture in 45% yield. The reaction yield in this case is comparable 
to earlier work with aromatic nitrile oxides. 8 The bulky isopropyl group is 
presumably responsible for the observed lower reactivity and thus the formation of 
by-product. 'H and ' 3C NMR spectroscopy displayed the characteristic C=NOH 
derived signals at 8.88 ppm and 147.7 ppm. Signals characteristic of the isopropyl 
group were also observed in the 'H NMR spectrum. A closely spaced pair of 
"roofed" doublets at 1.23 and 1.25 ppm is consistent with inequivalence between the 
two methyl groups. A septet for the isopropyl CH was also present at 3.83 ppm. 
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2.3.4 Reaction of 3,4,5-tri-O-acetyl--D-xyIopyranosyInitriIe oxide with 
1 ,2-ethanedithiol 
As the previous studies had focused on monofunctional thiols, it was decided to 
examine addition of a difunctional thiol. Initially a similar procedure to that outlined 
in section 2.3.2 was adopted. The nitrile oxide was present in excess in an attempt to 
encourage formation of the bridged 2:1 adduct 122. Both adducts 121 and 122 
(Scheme 48) were formed along with a significant amount of furoxan 90 (-65%). 
The reaction was considered only to be a moderate success, therefore a new addition 
strategy was attempted. 
It was envisaged that adding hydroximoyl chloride 106 dropwise to a solution of 
nucleophile and triethylamine would allow the concentration of nitrile oxide to be 
minimised. Adding the nitrile oxide precursor to the nucleophile/base solution 
afforded 121 and 122 in 40% and 20% yield respectively, with minimal furoxan 
formation. Following dry-flash chromatography, 121 was isolated as a white solid 
and the 122 as a semi-solid. 'H and ' 3C NMR spectroscopy showed that both 
compounds possessed characteristic C=NOH signals and that the side chain CH2s 
were inequivalent. The CH 2 signals appear as a pair of complex multiplets, however 
the signals are shifted to higher frequency and the separation decreases slightly in the 
2:1 adduct 122 (Table 4). The key difference between both adducts is the appearance 
of an SH resonance at 1.65 ppm in the 'H NMR spectrum. The SH signal appears as 
a triplet due coupling to the 2 adjacent protons. The identity of the signal was 







cH2a (8H/PPM) 3.10 3.15 
CH2b (8H/PPM) 2.63 2.82 
cH2a (00ppm) 34.7 31.7 
CH2b (0/ppm) 24.9 31.7 
OH 	(8H/PPM) 8.91 9.23 
C-i 	(Oc/ppm) 147.6 147.9 
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2.3.5 Biological Testing/Postscript 
On receipt of several batches of hydroximoyl chloride 107, the Rollin group was 
successful in completing the synthesis of a number of "isoglucosinolates". They 
selected isoglucotropaeolin (115) and isoglucolepidiin (123) for testing versus the 
natural substrate, glucotropaeolin. Unfortunately both analogues were not recognised 
by myrosinase and therefore did not function as planned. 
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This result is not unprecedented, similar results were obtained in studies with the C-
analogue of glucotropaeolin (112).9091  The failure of C-glucosinolates and 
isoglucosinolates to inhibit myrosinase indicates that the sulfated thiohydroximate 
linkage must be intact and linked to the glucose unit through an anomeric sulfur 
atom, in order to be recognised. These conclusions appear to be partially reinforced 
by subsequent work conducted independently by Professor Rollin's group.  81  In an 
effort to further establish the requirement for the thiohydroximate bridge, compounds 
such as 124 and 125 were prepared; these retain the anomeric sulfur atom and 












Compounds of the type 124 and 125 are found to generally display poor inhibitory 
properties. Carba-glucotropaeolin (113) retains a substrate-like sulfated 
thiohydroximate bridge and had been found to inhibit myrosinase before the 
collaboration began.90 The recent study finally achieved the objective of obtaining an 
X-crystal structure of a non-hydrolysable glucosinolate analogue bound to 
myrosinase. 8 ' The story is certainly not over, however, as recent work  8 ' has shown 
that analogues which do not resemble carbohydrates at all (!) such as 126 are actually 
superior inhibitors than Carba-glucotropaeolin. Clearly, there is more to learn about 






It has been shown that thiol nucleophiles successfully undergo 1,3-nucleophilic 
addition reactions with pyranosyl nitrile oxides to afford the corresponding 
thiohydroximates. Additions of alkyl and aryl thiols to 3,4,5-tri-O-acetyl-f3-D-
xylopyranosylnitrile oxide were found to give products in satisfactory yields (55 to 
75%). Collaborative work with the Rollin group was found to be successful with 
respect to synthetic aspects, however the targets that were ultimately prepared were 
found to be biologically inactive. The test results have, however, contributed toward 
the design of future myrosinase inhibitors. 
MG 
24 Carbohydrate Derived Amidoximes - Introduction 
Amidoxime derivatives of monosaccharides have attracted interest as inhibitors of 
glycosyl hydrolases' 55 and transferases.' 56" 57 Such compounds are known to have 
similar conformational and electrostatic features to oxocarbonium like species 127 
associated with the mechanism of glycosidase action. 155  Amidoximes like 128 have 
the advantage over their amidrazone and amidine analogues by virtue of increased 
stability. 155  Glucosyl (128), mannosyl and galactosyl amidoximes, in which the 
oximic unit is part of the carbohydrate ring have been shown to be effective 
inhibitors of metabolically important glycosidases. 1 55 N-acetylxylosamidoxime 129 
has been synthesised as part of a study toward potential inhibitors of N-
acetylglucosamine specific glycosyltransferases.'56' 157 
OH 	 OH 
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To the authors knowledge, there have been few attempts to install an amidoxime exo 
to a carbohydrate ring. Zhang et a1158 have prepared amidoxime 131 via addition of 
hydroxylamine to nitrile 130 (Scheme 49). This compound was the key intermediate 
in the synthesis of 3-3-D-xylopyranosyl- 1,2,4-oxadiazoles (general structure 132) 
that are of interest as potential antibacterial and antitumor agents. 158 
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Scheme 49: (a) NH20H, MeOH (b) RC(0)CI 
1,3 -Nucleophilic  addition of ammonia to 3,4,6-tri-O-benzoyl--D-ribofuranosyl 
nitrile oxide (133) has been reported to afford amidoxime 134, which was 
transformed (in a similar manner to above) to 1,2,4-oxadiazole 1 59  
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Scheme 50: (a) NH3/MeOH (b) Acetic anhydride, A 
It was envisaged that pyranosyl nitrile oxides would undergo 1,3-additions with 
amines in a similar manner to the furanosyl analogues (Scheme 50). The resultant 
amidoximes would be novel C-glycosides that could potentially function as NO 
donors or as ligands for metals (Section 1.4.1). 





2.4.1 Addition of Primary and Secondary Alkyl Amines 
The amidoximes were prepared by a modified version of the procedure employed in 
the synthesis of the pyranosyl thiohydroximates 121 and 122 (Section 2.3.4). In a 
typical experiment a solution of the glucopyranosyl-hydroximoyl chloride 107 in dry 
chloroform was added dropwise over 3 hours to a cooled (0 °C) vigorously stirred 
solution of benzylamine (3-4 equivalents) and excess triethylamine in chloroform. 
Removal of the solvent and chromatography of the residue afforded the N-benzyl 
amidoxime 137 (R' = Bn, R2 = H; 80% yield), 66 the furoxan dimer 109 was not 
detected. Xylopyranosyl-hydroximoyl chloride 106 reacted similarly to yield 
amidoxime 138 (R' = Bn, R2 = H; 67% yield). The structures of the products were 
assigned on the basis of their spectroscopic properties. Eg for D-xylose-derived 
amidoxime 138 in the NMR spectra there were, in addition to the expected signals 
for the carbons and protons of the pyranosyl and benzene rings, distinctive peaks for 
the oxime unit [c  148.9 ppm (C=N)] and the attached NHCH 2 group 4.38 ppm, 
dd, (CHa), 4.39 ppm, dd, (CHb), 5.22 ppm, t, (NH); JNH-CHa  5.5, JNH-CHb  6.8, JCHa-CI-Ib 
14.6 Hz; 8C 46.4 ppm (CH2)]. Shaking the N-benzylamine adducts with D20 resulted 
in loss of the NH signal and simplification of the benzyl signals to doublets. Both 
doublets displayed large geminal coupling constants (14.6 Hz). 66 
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Amidoxime R' R2 %Yield 
137 Bn CH20Ac 80 
138 Bn H 67 
139 Bu H 63 
140 CH2CH=CH2 H 41 
141 Ph H 90 
142 Ph CH20Ac 80 
Table 5: Mono-substituted pyranosyl amidoximes 66 
Hydroximoyl chloride 106 also reacted readily with 1-aminobutane and allylamine to 
afford corresponding adducts (139 R' = Bu, R 2 = H; 63% yield), and (140 R' = 
CH2CH=CH2, R2 = H; 41% yield). 66 It is noteworthy that in the latter case the 
isolated product results from addition of the nitrile oxide to the amine moiety in 
allylamine rather than cycloaddition to the alkene. Earlier work has shown that 1,3-
addition of propargylamine to benzonitrile oxide has been reported to produce the 
amidoxime product;' ° in this study it was concluded that the nucleophilic reactivity 
of the amine was higher than the dipolarophilic activity of the alkyne. It has also 
been postulated that alkenes are superior to alkynes as dipolarophiles and thus should 
not lead to significant quantities of amidoxime product. 10 Work by Abell et al 126  and 
Zard et al 125  (Section 1.4.3) with alkyl and aryl nitrile oxides, in addition to our 
own, 66  has clearly shown that the above theory is not necessarily correct. 
Having successfully reacted primary alkyl amines with pyranosyl nitrile oxides it 
was decided to examine the additions of aromatic amines. Hydroximoyl chloride 106 
was reacted with aniline according to the procedure employed in the alkyl amine 
study. Amidoxime 141 was isolated as a white solid in 28 % yield following aqueous 
work up and dry-flash chromatography. Furoxan by-product 109 was also isolated in 
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16 % yield. The pilot reaction was disappointing, therefore an improved procedure 
was attempted based on that of Barbyrin et al.' 2 Heating a 2:1 mixture of aniline and 
hydroximoyl chloride 106 in ethanol at reflux for five hours afforded amidoxime 141 
(R' = Ph, R2 = H; 90% yield). And the corresponding reaction with D-
glucopyranosyl nitrile oxide gave amidoxime 142 (R' = Ph, R 2 = CH20Ac; 80%). 
Conducting the above reactions at room temperature afforded the same products after 
16 hours. In neither case was there any evidence for the formation of the furoxan 
dimers. The products were characterised by 'H and ' 3C NMR spectroscopy. The 'H 
and ' 3C NMR spectra displayed characteristic C=NOH derived signals 7.91 ppm and 
146.8 ppm respectively for the D-xylose derived amidoxime. The structure of (Z)-N-
phenyl-(2,3 ,4-tri-O-acetyl--D-xylopyranosyl)formamide oxime was established by 
X-ray crystallography (Figure l).66 
Figure 1 - Crystal structure of (Z)-N-phenyl-(2,3,4-tri-O-acetyl-f-D-xyIopyranosyl)formamide 
oxime (141) 
The structure confirms the Z-configuration of the oxime moiety and demonstrates an 
s-trans (Zap) conformation about the amidic nitrogen with the H of the NHR facing 
the oxime OH. These results are in accord with previous studies indicating that such 
additions occur in a concerted, but non-synchronous manner. 54  The near planarity of 
the NH-C=N-O unit [torsion angle 2.6(3)°] and the short non-bonded distance 
53 
between the amidic N and the oxime 0 [N to 0 = 2.508(3)A] are consistent with the 
existence of an intramolecular H-bond between these atoms. 66,67 
2.4.2 Addition of morpholine to (3,4,5-tri-O-acetyl--D-xyIopyranosyI) 
nitrite oxide 
Having successfully reacted primary amines with pyranosyl nitrile oxides, addition 
of a secondary amine was considered next for study. The procedure outlined for 
primary amines was employed. Addition of hydroximoyl chloride 106 to a solution 
of morpholine (4-fold excess) afforded a white solid in 67 % yield. The 'H and ' 3C 
NMR spectra displayed characteristic oxime signals [8H.8.38 ppm, bs, (OH) and 5c  
154.7 ppm (C=N)]. The OH resonance in CDC1 3 was very broad, however using 
CD3S(0)CD3 led to a much sharper singlet [oH 10.08 ppm]. The data indicated that 
only one oximic product was present. Signals corresponding to the heterocyclic ring 
were also apparent in the 'H and ' 3C NMR spectra. The morpholine protons were 
observed as three sets of multiplets [3.77-3.8 1, ppm, m, CH 2 ; 3.24-3.26 ppm, m, CH 2 
and 3.09-3.16 ppm, m, CH21. The signal at highest frequency corresponds to the 
protons adjacent to the ring oxygen atom, and those at lower frequency to the protons 
adjacent to the morpholine nitrogen. Previous studies 62 on additions of morpholine to 
p-nitrobenzonitrile oxide demonstrated that the Z-configured product was obtained 
initially, which could then undergo acid assisted isomerisation to the E-amidoxime. It 
was found that exposure to silica during chromatography was an acidic enough 
environment to allow isomerisation. The 'H NMR data quoted above were compared 
to literature values 62  Hegarty et at found the ring CH2 signals adjacent to nitrogen in 
the E-adduct to appear ca 2.91 ppm (i.e similar to morpholine itself) while those of 
the Z-adduct were observed ca 3.27 ppm. The signal for the morpholine CH 2s 
adjacent to the nitrogen in this example is more complex due to the nearby chiral 
(anomeric) centre, therefore direct comparison is not really possible. The product 
was purified by dry-flash chromatography and was therefore assumed to adopt an E-
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2.4.3 Additions of amino acid derived nucleophiles: Introduction 
The success of the reactions of alkyl thiols and amines with pyranosyl nitrile oxides 
prompted work on addition of amino acid thiol and amine nucleophiles. The resultant 




Y= NH, S 
In general C-linked analogues of naturally occuring N- and O-glycosyl amino acids 
and peptides are of interest since they are resistant to enzymatic cleavage and are 
therefore useful, eg as probes for various biological processes. ' 6° The field is large 
and has been extensively reviewed, 161  a few representative are illustrated overleaf. 
Isoxazole 144 has been prepared by Dondoni et a! by 1,3-dipolar cycloaddition of a 
pyranosyl nitrile oxide with an amino acid derived alkyne.' 6° Glycopeptide analogue 
145 was made during an investigation into the synthesis of C-linked glycosyl 
asparagines.' 62  Glycopeptide analogue 146 has been synthesised and examined as a 
potential glycoamidase inhibitor. 163  Glycoamidase cleaves the amide linkage 
between the oligosaccharide and peptide units and is therefore important in the 
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2.4.4 Additions of N-(tert-butoxycarbonyl)cysteine methyl ester (147) to 
pyranosylnitrile oxides 
L-Cysteine was chosen for study since it is a common constituent in many proteins. 
A cysteine derivative that possessed carboxyl and amine protection was required in 
order to prevent side reactions and N-Boc protected L-cysteine methyl ester 147 was 
selected for this purpose. The synthesis was accomplished by following the 
procedure of Gledhill et al. 114 L-Cysteine methyl ester hydrochloride, Boc anhydride 
and triethylamine were stirred at room temperature for 16 hours. The desired product 
was obtained as a colourless oil (95% yield). It was feared that on prolonged storage 
thiol 147 would oxidatively couple to form a disulfide, however it was found that 
storage in a freezer for more than one year avoided disulfide formation. 
The procedure used was based on that described earlier for addition of amines 
(section 2.4.1). A solution of D-xylose derived hydroximoyl chloride 106 was added 
slowly added dropwise to a chloroform solution of cysteine derivative 147 (3 
equivalents) and triethylamine (6 equivalents). The target thiohydroximate 148 was 
obtained as a white solid in 88% yield after purification by dry-flash chromatography 
(Scheme 52). The 'H and ' 3C NMR spectra clearly demonstrated that addition had 
taken place. Signals corresponding to the thiohydroximate linkage and the amino 
acid unit were observed [8H 9.44 ppm (bs, OH), 4.59 ppm (1H, m, cysteine CH), 
3.78 ppm (3H, s, methyl ester), 3.35-3.58 ppm (2H, m, cysteine CH2), 1.47 ppm (9H, 
s, Boc CH3) 8C 147 ppm (C=N), 53.7 ppm (CH), 52.7 ppm (methyl ester), 32.5 ppm 
56 
(CH 2), 28.1 ppm (Boc CH 3)} in addition to the pyranosyl ring signals. A second 
product was obtained as a white crystalline solid after chromatography, the NMR and 
mass spectrometry data indicated that it was disulfide 149.165  Presumably the basic 






Cysteine derivative 147 was reacted with glucose derived hydroximoyl chloride 107 
in a similar fashion to above and the expected adduct 150 was obtained in a 
comparable yield (85%). 
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Scheme 52 
2.4.5 Additions of amino acid esters 
A larger range of amino acid N-nucleophiles were available for the preparation of 
amidoxime linked glycopeptide analogues; glycine was chosen for initial work since 
its simple structure would aid analysis of any products. A chloroform solution of D-
xylose derived hydroximoyl chloride 106 was added slowly to a stirred and cooled (0 
°C) mixture of glycine ethyl ester hydrochloride (3 equivalents) and triethylamine 
57 
(18-fold excess) in chloroform. 66  On completion of the addition, the reaction mixture 
was washed with 0.1 M HCI to remove excess amine. Analysis of the 'H and 13C 
NMR spectra of the crude product indicated that the expected amidoxime 152 was 
the major product (Scheme 53). Signals corresponding to the amidoxime linkage and 
the amino acid unit were evident [H  5.48 ppm (t, NH, JNH-CH  5.8 Hz), 4.16 ppm (q, 
Et ester CH2), 4.07 ppm (d, glycine Cl 2), 1.23 ppm (t, Et ester CH 3) öc 170. 7 ppm 
(C=O, Et ester), 148.1 ppm (C=N), 61.7 ppm (Et ester CH 2), 44.7 ppm (glycine 
CH2), 14.5 ppm (Et ester CH3)]. Purification by dry-flash chromatography was 
attempted, however two major and one minor product were obtained (Scheme 53). 
The amidoxime 152 was isolated in addition to a second compound which was later 
identified as oxadiazinone 153.66  The NMR spectra indicated that cyclisation had 
taken place, the ester peaks had been lost and the glycine-derived signals had 
simplified; [oH 5.61 ppm (bs, NH), 3.95 ppm (s, glycine CH 2 ) 0c  164.6 ppm 
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Scheme 53: (a) H2NCHRCO2EI.HCI, NEt3 (b) SiO2 , CHCI3 , A or prolonged standing (c) 
H2NCHRCO2 Et.HCI, NEt3 (d) glycylglycine.HCI, NEt3. 
Formation of the cyclised product is not entirely surprising since the Z-amidoxime 
geometry puts the nucleophilic OH group in a favourable position to attack the ester 
carbonyl in a 6-exo-trig process. Similar reactions have been observed for 
amidoximes in previous studies. 1297166A67  A minor product was also obtained that 
possessed similar spectroscopic properties to those of amidoxime 152. Two NH 
signals were clearly visible in the 'H NMR spectrum in addition to the ethyl ester 
quartet and triplet [H  7.45 ppm (t, NH, JNH-CH  7.5 Hz), 5.61 ppm (t, NH, JNH-CH  6.1 
Hz), 4.14 ppm, (q, Et ester CH2), 1.21 (t, CH 3 Et ester)]. The ' 3C NMR spectrum 
showed the diagnostic amidoxime imine signal and side chain attributed to a side 
chain 6c  170.9 ppm (Et ester C=O), 147.8 ppm (C=N), 61.0 ppm (Et ester CH2), 46.2 
ppm (Cl2), 40.9 ppm (CH2), 13.9 ppm (Et ester CH3)]. The minor product was 
therefore assigned structure 154, which results from attack on the oxadiazinone ring 
by a second equivalent of amino acid . 66 All three products could also be seen in the 
electrospray mass spectrum of the crude reaction mixture [ES 404 (MH, 152), 358 
(MH, 153), 461 (MH, 154)]. Similar results were obtained when the reaction was 
repeated with L-leucine methyl ester hydrochloride (Scheme 53). It was noted in this 
case that cyclisation took place to a greater extent before chromatography than in the 
previous experiment. Studies with L-leucine also found that formation of ring-
opened product could be minimised by reducing the amount of amino acid from 3 
equivalents to 1.5. 
The structures of oxadiazinones 153 and 156 were eventually confirmed by X-ray 
crystallography. To the author's knowledge these are the first such crystal structures 
to contain the 1,2,4-oxadiazin-6-one moiety. The crystals of oxadiazinone 153 were 
found too weakly diffracting and consequently gave poorer quality data than hoped. 
In contrast, the data obtained for oxadiazinone 156 were suitable for further analysis. 
Selected bond lengths, bond angles and torsion angles for the oxadiazinone ring 















Figure 2- 3-(2,3,4-Tri-Q-acetyl--D-xyIopyranosyI)-1 ,2,4-oxadiazin-6-one (153) 
61J 
1 
Figure 3- 3-(2,3,4-Tri-Q-acetyI--D-xyIopyranosyI)-5-(isopropyI)-1 ,2,4-oxadiazin-6-one 
(156) 
ZE 
Bond Lengths! A Bond Angles! 0 Torsion Angles! 0 
0(1)-N(2) 1.463(2) 0(1)-N(2)-C(3) 113.96(18) 0(1)-N(2)-C(3)-N(4) -6.10 
N(2)-C(3) 1.290(3) N(2)-C(3)-N(4) 126.7 1(2) N(2)-C(3)-N(4)-C(5) -17.80 
C(3)-N(4) 1.33 1(3) C(3)-N(4)-C(5) 120.12(19) C(3)-N(4)-C(5)-C(6) 	35.65 
N(4)-C(5) 1.452(2) N(4)-C(5)-C(6) 108.28(17) N(4)-C(5)-C(6)-O(1) -32.68 
C(5)-C(6) 1.512(3) C(5)-C(6)-O(I) 117.82(19) C(5)-C(6)-O(])-N(2) 13.14 
C(6)-0(1)1.352(3) C(6)-O( I )-N(2) 122.82(17) C(6)-O(])-N(2)-C(3) 7.84 
Table 6: Selected bond lengths, bond angles and torsion angles for 156 
A survey of the literature revealed that 1,2,4-oxadiazin-6-ones are relatively rare 
heterocycles. The first report of such an oxadiazinone synthesis was made by Takacs 
and Ajzert,' 66 who reported that 157 was formed on reacting glycine carboxymethyl 
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Scheme 54 
Suave et al have reported the formation of oxadiazinone 159 as a by-product under 
basic conditions whilst attempting to prepare amidoxime analogues of oligopeptides 
(Scheme 55)• 167 they also reported that oxadiazinone formation was avoided by 
replacing the methyl ester with a tbutyl  ester. 








The most detailed study to date has been conducted by Hussein and co-workers, 129 
who found that the amidoximes from addition of L-valine, L-isoleucine and L-
phenyiglycine to aryl nitrile oxides spontaneously cyclised in the presence of NEt 3 to 
the corresponding oxadiazinones. Amino acids with less bulky side chains (such as 
glycine) afforded only amidoxime products. Hussein et al also obtained small 
amounts of ring-opened products analogous to amidoximes 154 and 160 (Scheme 
53). Further ring-opening reactions with sodium borohydride were found to yield 
amino alcohols via an aldehyde intermediate (Scheme 56). 
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Reactions were therefore attempted to verify some of the observations made in the 
initial experiments, and by Hussein et al. 129  Addition of glycylglycine ethyl ester to 
D-xylose derived hydroximoyl chloride 106 under the same conditions as in the 
synthesis of amidoxime 152 afforded the expected amidoxime adduct 154 (43% 
yield). The analytical and spectroscopic data were identical to those obtained 
previously. The next stage of the amino acid addition study was to conduct further 
investigations into the cyclisation reaction. 
2.4.6 Cyclisation Reactions 
The glycine and L-leucine amidoximes 152 and 155 were found to cyclise (60% and 
70% yields respectively) when refluxed in chloroform in the presence of silica for 6-
16 hours or over 2-3 days at room temperature (Scheme 53). Hussein had indicated 
that addition of amino acids with bulkier substituents spontaneously cyclised. The 
results obtained in this study with L-leucine, however, did not fully support this 
observation, since amidoxime 155 was the predominant product immediately after 
amine addition. L-Phenylalanine ethyl ester was selected to examine further the 
effect of larger substituents. Addition of L-phenylalanine ethyl ester hydrochloride to 
hydroximoyl chloride 106 afforded exclusively the corresponding amidoxime (161) 
62 
immediately after addition and dry-flash chromatography. Cyclisation of 161 to 
oxadiazinone 162 took place when a solution of 161 in chloroform was left to stand 
in an NMR tube for over a month (Scheme 53), the cyclisation process was slower 
for pyranosyl amidoximes compared with aryl amidoximes, even when bulky side-
chains were present. The NMR data for oxadiazinine 162 were similar to those 
observed for the previously obtained oxadiazinones. 
The fact that the amino group in L-proline is NN-disubstituted made it an interesting 
experimental candidate for two reasons. Hussein et al 129  had claimed that the 
cyclisation step was faster than potential Z to E isomerism under basic conditions. 
The increased tendency of disubstituted amidoximes such as morpholine derived 
amidoxime 143 to isomerise would challenge the above postulate. The product of L-
proline addition and cyclisation would also produce the interesting fused bicyclic 
product 163 (Scheme 57). 
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Scheme 57 
Addition of L-proline benzyl ester hydrochloride to hydroximoyl chloride 106 was 
conducted according to the procedure employed in the earlier amino acid 
additions.' 3C NMR analysis of the crude reaction mixture indicated that the major 
products were oxadiazinone 163 [diagnostic signals 8c 168.7 ppm (C=O, 151.8 ppm 
(C=N)}, benzyl alcohol and possibly small amounts of amidoxime adduct. The crude 
mixture was stirred in refluxing chloroform for 2 hours in the presence of silica to 
ensure cyclisation went to completion, and on work up, the oxadiazinone product 
was obtained as a white solid in 57%. The rigid ring system is believed to assist 
cyclisation in this case due to the Thorpe-Ingold effect. 168 
Addition of -alanine ethyl ester hydrochloride to hydroximoyl chloride 106 was 
attempted in order to ascertain whether cyclisation to form a 7-membered 1,2,4- 
63 
oxadiazepin-7-one would take place under the conditions previously established. The 
amidoxime 164 was obtained (after chromatographic purification) as a gummy solid 
in 50% yield (Scheme 58). 
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The 'H and ' 3C NMR spectra contained diagnostic signals for the amidoxime group 
and showed that the ethyl ester protecting group was still present [oH 5.36 ppm (t, 
NH), 4.13 ppm (q, Ft ester CH 2 ), 1.22 ppm (t, Ft ester CH 3 ) Oc  149.0 ppm (C=N), 
61.1 ppm (Et ester CH2), 14.5 ppm (Et ester CH 3)]. Amidoxime 164 was stirred 
with silica in refluxing chloroform for >48 hours without any cyclisation being 
observed on analysis by TLC, 'H NMR or electrospray mass spectrometry. 
Cyclisation to form a 7-membered ring was found to be unfavourable under the 
conditions that had allowed access to the 6-membered products. 
An attempt was also made to favour exclusive amidoxime formation. It was reasoned 
that replacing the ethyl or methyl ester protecting groups with a more sterically 
demanding group would suppress oxadiazinone formation. 167 tButyl protection is 
frequently employed in peptide synthesis, therefore deprotection and subsequent 
peptide coupling would potentially allow access to chain extended amidoxime linked 
glycopeptide analogues. 
.OH 
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Scheme 59 
Amidoxime 165 was obtained (88% yield) in a similar fashion to the original glycine 
addition procedure (Scheme 59)•66  The 'H and ' 3C NMR spectra were comparable to 
those obtained for addition of glycine ethyl ester. Amidoxime 165 was stirred with 
silica in refluxing chloroform for >48 hours and the reaction monitored by NMR and 
electrospray mass spectrometry. No evidence was found for cyclisation having taken 
place, since the amidoxime imine and 'butyl signals were observed in the ' 3C NMR 
spectrum [öc 83.2 ppm (Cq) 148.9 ppm (C=N), 30.7 ppm (CH 3)1. 
2.4.7 Pyranosyl-1 ,4,2-oxathiazin-6-ones 
Sulfur analogues of 1 ,4,2-oxadiazin-6-ones are very rare, indeed, there has only been 
one publication related to 1,4,2-oxathiazin-6-ones. 130 Johnson and co-workers have 
accomplished the synthesis of such heterocycles by a two stage process; initial 
addition of a mercapto carboxylic acids to aromatic nitrile oxides was followed by a 
DCC mediated 6-exo-trig cyclisation (Scheme 60). The same researchers have also 
reported the synthesis of 5,6-dihydro-7-1,4,2-oxathiazepin-7-ones by a similar 
procedure. 13 ' 






Scheme 60: (a) mercatoacetic acid (b) DCC, THE 
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2.4.8 Attempted synthesis of 3-(2,3,4-tri-O-acetyI--D-xyIopyranosyI)-
1 ,4,2-oxathiazin-6-one 
An attempt was made to synthesise pyranosyl- 1 ,4,2-oxathiazin-6-ones from 








Thiohydroximate 166 was prepared by reacting methyl thioglycolate with xylose 
derived hydroximoyl chloride 106 under the conditions described in section 2.4.5. 
Analysis of the 'H and ' 3C NMR spectra of the purified product showed diagnostic 
signals for the thiohydroximate unit and side-chain in addition to the carbohydrate 
peaks [H  9.39 ppm (bs, OH), 3.82 (1H, d, CH2b), 3.77 (1H, d, CH2a) 8c 148.1 ppm 
(C=N), 33.3 ppm (CH 2)]. The purified thiohydroximate was stirred with silica in 
refluxing chloroform for more than 2 days without any cyclisation taking place, so 
the reaction was repeated in refluxing toluene. A white solid was obtained after dry-
flash purification, however the electrospray mass spectrum indicated the mass of the 
product to be 285 a.m.0 rather than the expected 375 a.m.u. The ' 3C NMR showed a 
characteristic signal for a nitrile group [öc 114.2 ppm (CN)] and the compound was 
therefore assigned structure 167. Formation of nitriles is known to arise from 
oxathiazinone rings in the presence of hydroxide ion (Path A, Scheme 62).' ° In this 
case, it was thought that cyclisation had taken place and then the product had 














An attempt was also made to repeat the procedure reported by Johnson et al, 130 
Mercapto acetic acid was added to xylose derived nitrile oxide and the resultant 
thiohydroximate treated with 1 -(3 -dimethylaminopropyl)-3-ethylcarbodiimide 
(EDCI). The reaction did not afford any identifiable products, extensive 
decomposition appeared to have taken place. The reasons for the failure of the 
reaction remain unclear, although it has been suggested that the stability of oxime 
acids such as 166 is R dependent.  130  It could be suggested that if 166 was unstable, it 
may decompose before cyclisation takes place. 
2.4.9 Conclusions/Further Work 
Addition of L-cysteine derived thiol 147 to D-xylose and D-glucose nitrile oxides 
was found to afford novel thiohydroximate linked glycopeptides 148 and 150 in good 
yield (88% and 85% respectively). Reactions of glycine, L-leucine and L-
phenylalanine ester hydrochlorides with hydroximoyl chloride 106 under basic 
conditions, were found to afford crude amidoximes 152, 155 and 161. Attempts to 
purify 152 and 155 by column chromatography led to the formation of 1,2,4-
oxadiazin-6-ones 153 and 156 (60% and 70% yield respectively). Compound 161 
was not found to cyclise during purification although, oxadiazinone 162 was 
obtained after allowing a chloroform solution of 161 to stand for 1 month. In 
contrast, L-proline benzyl ester hydrochloride afforded predominantly oxadiazinone 
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163 before column chromatography. Reaction of 3-alanine and glycine 'butyl ester 
with hydroximoyl chloride 106 in basic conditions afforded amidoximes which did 
not cyclise. Small amounts of by-products such as 154 were observed, these were the 
result of ring-opening of the oxadiazinone by residual amino acid. Further work 
could investigate the ring-opening reaction as a means of making chain extended 
amidoximes. An alternative chain extension strategy could involve deprotection of 
adduct 165 and employing classical peptide coupling conditions. 
2.5 Additions of carbohydrate derived nucleophiles: Introduction 
It was envisaged that sugar amines could be employed in 1,3-addition nucleophilic 
nucleophiles to pyranosyl nitrile oxides to afford a novel class of amidoxime-linked 
C-pseudodisaccharides (Scheme 63). There are few reports of such compounds in the 
literature; the closest relative known (168) was published by Gallos et al'69 as part of 
a study on nucleotide analogues. Oligonucleotides with a backbone that does not 
contain phosphorous are desirable, since they are resistant to nuclease induced 
cleavage and are more readily taken up by cells. Vasella et al 170  have prepared 
pyranose examples (eg 169), which have the amidoxime unit within the carbohydrate 
ring, as potential glycosidase inhibitors. The Rollin group have reported the synthesis 
of a series of thiohydroximate-bridged disaccharides (eg 170), as part of their work 



















Although a number of sugar amines are known in the literature, it was decided to 
limit the initial study to amines that would result in the (1—*6) and (1-1) linked 
compounds 171 and 172. 
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The proposed structures resemble amide-linked disaccharides. For example, 173 has 
been studied as a glycosyl mimic.' 7 ' The rationale behind the use of peptide linkages 
is that they should be resistant to cleavage by glycosidase enzymes. Amidoximes 
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2.5.1 Synthesis of (1—.6) amidoxime-linked pseudodisaccharides 
2.5.1.1 Synthesis of 6-amino-6-deoxy-1 ,2:3,4-di-O-isopropylidene-a-D-
galactopyranose Hydrochloride (177) 
Galactose derived amine 177 was selected as a suitable nucleophile for addition to 
pyranosylnitrile oxides. Reitz et al 172  had reported a straightforward 3-step synthesis 
(Scheme 64) from 1,2:3 ,4-di-O-isopropylidene-a-D-galactopyranose (174), which 
itself is a well-known precursor in various carbohydrate syntheses. 173 
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Scheme 64: (a) TsCI, pyridine, MeCN (b) NaN 3 , DMSO (c) H2 , 	10% Pd/C, 50:1 
EtOH/CHCI3 (20 atm) 
Treatment of D-galactose with acetone in the presence of acid and anhydrous CuSO 4 
gave an oil, which on purification by Kugelrohr distillation afforded the product as a 
colourless glass in 61% yield. The 'H and ' 3C NMR spectra, mass spectra and 
analytical data were all in agreement with literature 174  
Protected galactose compound 174 was then stirred with p-toluenesulfonyl chloride 
in a 2:1 mixture of pyridine/acetonitrile at room temperature for 6 hours, and the 
tosylated product 175 isolated as a white solid (67% yield) following washing and 
trituration. The signals due to the tosyl group were clearly visible in the 'H NMR 
spectrum [. 2.37 (1H, s, ArCH3), 7.73 ppm (2H, d, AM), 7.26 ppm (2H, d, AM)]. 
In the next step, the tosylated galactose derivative 175 and sodium azide were then 
dissolved in DMSO and heated to 115°C for 24 hours. On cooling, the reaction 
mixture was washed with water, before isolating the azido sugar 176 as a colourless 
oil (96% yield). A characteristic absorption for an azide group was observed in the 
JR spectrum [Uma,c 2lOS cm1 ].' 75 
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The final stage of the synthesis required hydrogenation of azido compound 176 to 
form the required amine 177. The original procedure of Reitz and co-workers 
achieved this transformation by high-pressure (-50 psi) hydrogenation in the 
presence of 10% palladium on charcoal catalyst, followed by treatment with ethereal 
HC1 to afford the amine as a hydrochloride salt. 172  A paper by Secrist and co-
workers 176  had shown that addition of chloroform (-2%) to the reaction mixture 
allowed the amine hydrochloride salt to be formed in situ rather than having to add 
ether/HCI afterwards. This latter procedure 176  was successfully applied in this case to 
afford the title compound 177 as a white solid. A very broad signal was observed in 
the JR spectrum [Umax 3377 cm'] of the product that is characteristic for amine 
hydrochloride salts. 17' The 'H and ' 3C NMR spectra were found to be in agreement 
with those obtained in the original work. 172 
2.5.1.2 Additions of 6-amino-6-deoxy-1 ,2:3,4-di-O-isopropylidene-cx-D-
galactopyranose (177) to pyranosylnitrile oxides 
With galactose derived amine 177 in hand, it was possible to proceed with additions 
to pyranosylnitrile oxides. A solution of xylose derived hydroximoyl chloride 106 
was added to a vigorously stirred mixture of amine 177 and triethylamine in 
chloroform over one hour. The reaction mixture was washed with 0.1 M HCI (to 
remove residual amine) before being subjected to dry-flash chromatography. The 
expected amidoxime 178 was obtained as a white solid (81% yield). 
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Diagnostic peaks for the amidoxime bridge were observed in the 'H and ' 3C NMR 
spectra [oF, 7.76 ppm (bs, OH) 5.24 ppm (m, NH), 0c  149 ppm (C=N)]. The 'H NMR 
spectrum proved to be valuable for characterisation an account of conformation 
differences for the two carbohydrate rings giving well dispersed and characteristic 
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signals. The D-xylose ring adopts a 4C, chair conformation (179), whereas the D-
galactose ring adopts a skew (twist-boat) conformation 180, due to the presence of 
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The peaks attributed to the xylose ring were similar to those observed in the 
amidoxime examples described previously (section 2.4.1). The anomeric proton [ö1, 
4.00 ppm (d, 1-11, JHIH2  10.1 Hz)] showed a large axial-axial coupling, thus 
confirming the f-configuration of the xylose component. The remaining xylose ring 
protons showed the expected large vicinal axial-axial couplings to each other (ca 9-
10 Hz), with the exception of the axial-equatorial coupling of H-4 to H-5e 
(equatorial) [H  4.15 ppm (dd, H-5e, JH5CH4  5.4 Hz)]. The peaks attributed to the 
galactose ring were found to have significantly different coupling patterns, since in 
the skew conformation the protons do not adopt formal axial and equatorial 
positions. The chemical shifts and coupling constants were found to compare 
favourably with those of literature compounds. 114  COSY and HSQC NMR 
experiments were conducted to confirm the identities of each of the carbohydrate 
ring protons. The ' 3C NMR spectrum showed the expected 12 carbohydrate skeletal 
carbon peaks and signals due to the xylose and galactose protecting groups [c 
(OAc) 170.2, 169.7, 169.3 ppm (3xC=O), (acetal) 109.3, 108.6 ppm (Cq), 25.9, 25.8 
24.8, 24.3 (CH3)}. The structure of amidoxime 178 was confirmed by X-ray 
crystallography. 
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Figure 4 (Z)-N-(6-deoxy-1 ,2:3,4-di-Q-isopropyIidene-(x-D-gaIactopyranosy)-(2,3,4-tri-Q- 
acetyl-f-D-xylopyranosyI)formamide oxime (178) 
Each unit cell contained 2 molecules of 178, one of which is illustrated in Figure 4. 
The structure shows that the amidoxime unit in pseudo-disaccharide 178 moiety has 
similar features to those of amidoxime 141, which was discussed in section 2.4.1. 
The Z-configuration of the oxime and s-trails (Zap ) conformation about the amidic 
nitrogen are again apparent. The existence of an intramolecular H-bond is again 
observed and is attributed to the near planarity of the NH-C=N-O unit [torsion angle 
2.14'] and the short non-bonded distance between the amidic N and the oxime 0 [N 
to  = 2.53 1 A]. The Cremer and Pople' 77 puckering parameters for the two pyranoid 
rings are given in Table 7. The D-xylose ring has 95% of the puckering of an ideal 
cyclohexane chair conformation, with Q = 0.600 A and 0 = 5.75° compared with Q = 
0.630 A and 0 = 00 for an ideal 4C 1 chair. The corresponding values for the D-
galactose ring are Q = 0.657 A and 0 = 83.77°, and are consistent with a skew (twist-
boat) conformation. 
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Ring Atoms Q I A 0/0 4,/O  
D-Xylose 0(7)-C(2)-C(3)-C(4)-C(5)-C(6) 0.600 5.75 36.42 
D-Galactose 0(6')-C( I ')-C(2')-C(3' )-C(4')-C(5') 0.657 83.77 326.53 
Table 7. Cremer and Pop1e 177 puckering parameters for the pyranoid rings of 
amidoxime 178 
The above reaction was repeated with glucose derived nitrile oxide 115 and the 
expected amidoxime 181 was obtained as a white solid in 75% yield. The 'H and 13C 
NMR spectra were found to be very similar to those obtained for the xylose example 
178. 
2.5.2 Synthesis of (1-1) amidoxime-linked pseudodisaccharides 
2.5.2.1 Synthesis of D-xylose and D-glucose derived amines 
The strategy for the synthesis of (1—*1) amidoxime-linked pseudodisaccharides 
involved a dual role for pyranosylnitromethanes 182 and 183 (Scheme 65). The 
nitromethyl sugars 95 and 99 were employed as sources of the corresponding amines 
(for previous examples ' 78" 79) and nitrile oxides (section 2.2). Secrist et al 176 reported 
that nitro compounds, nitriles and oximes could afford amine hydrochlorides in a 
similar fashion to azides. 
74 
-R-­O~~~O CH,NO,  
OAc 
95 R = H 
99 R = CH 20Ac 
'H 
Ac 
cO 	 CH2NH2 HCI 
OAc 
182 R' = H 
183 R' = CH 20Ac 
A 	 _OH 
A 0 J 
OAc 
106 R = H 
107 R = CH20Ac 
'H 	 OH 
OAc 
Ac2 \.1 




186 R = CH20Ac, R' = H 
187 R = CH20Ac, R' = CH 20Ac 
Scheme 65: (a) SnCl 2 , NEt3 , PhSH (b) C1 2 (c) H 2 , Pt02 , CHCI3/EtOH (d) NEt 3 
Nitro sugar 95 was therefore stirred with a catalytic amount of Pt0 2 in 
ethanol/chloroform (50:1) and heated (70°C) under hydrogen (40 atmospheres) in a 
high-pressure hydrogenation apparatus. The amino sugar 182 was obtained as a 
white solid after removal of the solvent. The product was water-soluble and again a 
very broad amine peak was observed in the IR spectrum [Umax 3367 cm'].' 75 The ' 3C 
NMR spectrum showed a significant chemical shift change to lower frequency of the 
exocyclic methylene group relative to that observed in the parent nitro compound [öc 
40.5 ppm (RCH 2NH2), Sc 75.8 ppm (RCH 2NO2)]. The reaction was found to be 
capricious; yields and product quality varied from batch to batch. An alternative 
procedure that involved stirring 95 in a mixture containing ZnIHC1 was therefore 
attempted. 180 A white solid product was obtained, however the 'H and ' 3C NMR 
spectra were not the same as those for the product obtained by high-pressure 
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hydrogenation. The new compound was identified as hydroxylamine 188, the 
product of partial reduction. The electrospray mass spectrum clearly showed 
formation of 188 (Scheme 66) since the molecular ion peak was 16 mass units 
heavier than the expected amine. Hydroxylamines of this kind are rare, although 
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Scheme 66 
The troublesome reactions with nitro sugar 95 led to pyranosylnitnles being 
examined as amine precursors instead. It should be noted that pyranosylaldoximes 
were not considered (despite their availability) due to the possibility of residual thiol 
deactivating the catalyst. 
2.5.2.2 Alternative synthesis of pyranosylmethylamines 
Pyranosyl nitriles are well known and may be prepared by addition of sodium 
cyanide to glycosyl halides' 81,182  or trimethylsilyl cyanide to glycosyl acetates. 183-185 
Previous work within the group has used the procedure of Köll et al 186 to convert 
pyranosylnitromethanes to the corresponding nitrile; the latter procedure was chosen 
for this study (Scheme 67). 
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Scheme 67 
Pd 3 was added to a cooled (0°C) mixture of pyridine and 3,4,5-tri-O-acetyl-f3-D-
xylopyranosylnitromethane (95) and the mixture stirred for 3 days at. room 
temperature. On work-up, the target nitrile 167 was obtained as a white solid (75% 
yield) after dry-flash chromatography. A diagnostic signal was observed in the 13C 
NMR [öc 114.2 ppm (CN)] and analytical data were in agreement with literature .' 86 
The glucose derived nitrile 189 was obtained by the same procedure in 82% yield. 
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The procedure described above has been known for over 25 years. The mechanism 
was believed to proceed by the addition/elimination sequence illustrated in Scheme 
68. 186 
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Scheme 68 
This mechanism has been challenged very recently in a study by Yao and co-
workers.' 87 The new proposal is of particular interest since the key step involves 
deoxygenation of a nitrile oxide intermediate (Scheme 69). 
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Nitriles 167 and 189 were hydrogenated under similar conditions to those employed 
in Section 2.5.1.1 (although lower temperatures and pressures were required) and the 
desired amine salts 182 and 183 were obtained in 99% and 90% yields respectively. 
In-situ generation of the amine as a hydrochloride salt was particularly important 
when nitriles were employed for two reasons; O—+N-acetyl migration could possibly 
occur  183  and/or formation of aldimines such as 190,188  if free amine was formed. 
H 	 OAc 
OAc 
190 
2.5.2.3 Additions of xylose and glucose derived amines 182 and 183 
pyranosylnitrile oxides 
Amines 182 and 183 were reacted with the D-xylose and D-glucose nitrile oxides 
115 and 151 in the presence of triethylamine as outlined in section 2.5.1.2. All of the 
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four possible products were purified by dry-flash chromatography and the expected 
amidoximes were obtained as white solids (Table 8). 
•R 	 OH 
OAc 
OAc 	H 
Compound R Yield (%) 
184 H H 44 
185 CH20Ac H 40 
186 H CH20Ac 31 
187 CH20Ac CH20Ac 49 
Table 8: (1 --A) linked pseudodisaccharides 
The 'H and ' 3C NMR spectra of the products showed characteristic signals for the 
amidoxime linkage; (Z)-N-(3 ,4,5-tri-O-acetyl-3-D-xylopyranosylmethyl)-(2,3 ,4-tri-
O-acetyl--D-xylopyranosyl)formamide oxime (184) serves as a typical example. 
The 'H NMR spectra were expected to be more complicated than those obtained for 
the (1—*6)-linked amidoximes since both carbohydrate rings adopted 4 C, chair 
conformations and would probably lead to overlap of both sets of signals. A 600 
MHz 'H NMR experiment was required to obtain the required peak dispersion to 
achieve a full structural analysis, and D6-DMSO was needed to get the sample to 
fully dissolve. Diagnostic amidoxime OH and NH signals were clearly observed [oH 
9.97 ppm (bs, OH), 5.26-5.29 ppm (m, NH)] in the 'H NMR. The anomeric protons 
[OH 4.27 ppm (d, 1-H, JHIH2  10.1 Hz), 3.62 ppm (ddd, 2'-H, JH2'-H3'  9.6 Hz)] both 
exhibited large axial-axial coupling with the adjacent ring protons, thus confirming 
the n-configuration had been retained in each of the xylose components. The 
identities of the remaining carbohydrate ring protons were established by COSY and 
2D-TOCSY 'H NMR experiments. 
The ' 3C NMR spectrum displayed peaks associated with the acetyl protecting groups, 
in addition to the 12 peaks that corresponded to the carbohydrate framework. The 
101. 
most diagnostic signals were those from the amidoxime unit and exo-methylene 
group [c 147.3 ppm (C=N), 42.4 ppm (C-l')]. Of the remaining ten signals, two 
corresponded, as expected, to the xylose ring methylene carbons [c  65.2 ppm (C-
6"), 65.1 ppm (C-5)]. 
2.5.2.4 By-product formation 
A polar by-product was identified on analysis by TLC (R1 <0.1 EtOAc), the 
formation of which was belived to responsible for the lower yields (31-49%) of the 
(1—*1) linked pseudodisaccharides. Attempts to isolate and analyse the by-product 
were unsuccessful, however it was thought to be compound 191 resulting from O—*N 
acetyl migration. 183  An authentic sample of the migration product was therefore 
prepared by hydrogenation of nitro sugar 95 under a balloon of hydrogen in the 
presence of Raney nickel. 162  A colourless oil was obtained from the reaction mixture, 
following filtration and solvent removal. The 'H and ' 3C NMR spectra indicated the 
acetate group had migrated from the 2-hydroxyl to the amino group since signals 
corresponding to a hydroxyl group [H  4.60 ppm (bs, OH)] and amide group were 
observed [c  174.7 ppm (C=O)]. The JR spectrum was particularly convincing since 
OH and amide C=O stretching frequencies were clearly visible, in addition to a 
signal attributed to N-H bending. [Umax 3364 cm' (OH), 1742 cm' (C=O ester), 
1651 cm-1 (C=O amide), 1550 cm' (NH bend)]. 175  Unfortunately the migration 
product 191 was never isolated from any of the addition reactions, although TLC 
analysis of reaction mixture versus the authentic migrated product indicated that 
migration could have occurred. Amide 191 is believed to be formed by 
intramolecular nucleophilic acyl substitution reaction between the amine group and 
the adjacent acetyl ester at C-2. 
Ac2'-' 2 O 




2.5.2.5 	Synthesis 	of 	deprotected 	(1—*1) 	amidoxime-linked 
pseudodisaccharide 
An attempt was made to deprotect amidoxime 184 by stirring the disaccharide in a 
triethylamine/methanol mixture at room temperature. 189  Analysis of the reaction 
mixture after two days by electrospray mass spectrometry showed that the reaction 
was taking place rather slowly. Peaks were observed for successive acetate loss [ES 
591 (MH, 6Ac), 549 (MH, SAc), 507 (MH, 4Ac), 465 (MH, 3Ac), 423 (MH, 
2Ac), 382 (MH2 , Ac), 340 (MH2, OAc)} from the fully protected form, right 







The reaction was driven to completion within 6 hours by heating the reaction mixture 
to afford the product as a viscous oil (95% yield). A full analysis of 192 by 'H NMR 
spectroscopy proved difficult since at 360 MHz all 12 ring proton signals overlapped 
and appeared as a large multiplet. A 600 MHz 'H NMR experiment was attempted to 
disperse the ring proton signals, however the resultant spectrum was too broad to be 
of any use. The 'H NMR spectra did show, however, that the acetyl groups had been 
removed. The ' 3C NMR spectrum showed that the 12 expected carbons were present, 
the most diagnostic being those due to the amidoxime unit and the exo-methylene 
group [c  153.7 ppm (C=N), 44.2 ppm (C- I')]. 
2.5.2.6 Conclusions/Further Work 
Reaction of galactose amine 177 with nitrile oxides 115 and 151 under basic 
conditions afforded (1—*6) linked pseudo-disaccharides 178 and 181 in good yield 
(81% and 75% respectively). Reactions of xylose and glucose amines (182 and 183) 
under similar conditions afforded (1—*1) linked pseudo-disaccharides 184, 185, 186 
and 187 (31-49% yield). The lower yields of the (1—*l) linked products were 
attributed to the formation of 191. Future work would be directed toward preventing 
formation of 191. This could be achieved by employing benzoyl protected amines. 
Deprotection of the pseudo-disaccharides would allow biological testing to be 
conducted, their potential function as nitric oxide donors would be of particular 
interest (Section 1.4.1). 
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2.6 Ambident nucleophile additions 2-pyranosylbenzazole synthesis 
A logical extension of the work with amines was to examine the reactivity of a 
variety of ambident nucleophiles. A survey of the literature revealed work in this 
field by Sasaki et al, 136 and latterly by Parkanyi' 90 and Risitano. 19 ' They reported that 
addition of o-phenylenediamine, o-aminophenol and o-aminothiophenol to aryl 
nitrile oxides offered a mild and high yielding method of synthesising 2-
arylbenzimidazoles, benzoxazoles and benzothiazoles (Scheme 71). 
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Scheme 71: Y= S, 0, NH 
This procedure has not received great attention since there are more accessible 
precursors for the synthesis of 2-arylbenzazoles; typically aromatic carboxylic acids 
or aldehydes are employed in the synthesis of such compounds. 192-194 
It was envisaged that the Sasaki procedure might provide a convenient route to 2-
pyranosylbenzothiazoles, benzimidazoles and benzoxazoles. The traditional routes 
are not as amenable to the synthesis of such compounds since the corresponding 
carboxylic acids and aldehydes are not easily accessed and/or the reaction conditions 
can be harsh. A brief survey of the current routes to pyranosylbenzazoles is presented 
below. 
2.6.1 Synthesis of 2-pyranosytbenzothiazoles 
2-Pyranosylbenzothiazoles have been known for over 25 years, 195  and have received 
attention as 3-D-galactosidase' 96 and glycogen phosphorylase inhibitors. 197  There are 
currently two major routes to 2-pyranosylbenzothiazoles: the first procedure involves 
addition of o-aminothiophenol to 2,6-anhydro-aldononitriles and subsequent 
cyclisation. Farkas' 95  and Somsak' 98 have employed this route in the synthesis of 2- 
-D- xylo, galacto, gluco, arabino and ribopyranosylbenzothiazoles. The Farkas 
procedure is relatively straightforward; the relevant acetylated glycosyl nitrile and 2- 
aminothiophenol are heated at reflux in ethanol under a nitrogen atmosphere for 4 








The second route, which was reported recently by Dondoni et al, 199 begins with 
addition of 2-lithiobenzothiazole to tetra- O-benzyl-D-gluconolactone (193) to afford 
a hemiacetal product 194 as a single isomer in 78% yield. Subsequent acetylation 
and deoxygenation leads to a 6:4 mixture of benzothiazole products (197 and 198); 
the a compound is transformed into the more stable P anomer 198 on treatment with 
NaOMe (80% combined yield on crystallisation). 
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Scheme 73: (a) 2-Iithiobenzothiazole, THF, -65 °C (b) Ac20, NEt3 (c) Et3SIH, TMSOTf, (d) 
NaOMe, MeOH. 
To date this procedure has not been extended to other monosaccharides. The 
benzothiazole may function as a masked aldehyde, on further manipulation 
hydrolysis of the heterocycle may be effected to afford the formyl C-glucoside 199 
(Scheme 73). 
2.6.2 Synthesis of 2-pyranosylbenzimidazoles 
Establishing a route to 2-pyranosylbenzimidazoles has proven to be more 
challenging, however a recent synthesis of 2-3-D-glucopyranosylbenzimidazole has 
been accomplished by Somsak et at (Scheme 74)•197  Somsaks route requires 
additiOn of ethanethiol to nitrile 200 to afford a thioimidate intermediate 201, which 
was transformed into the target 202 in a modest yield (34%) on treatment with o-
phenylenediamine. 
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Scheme 74: (a) EtSH, Et 20/HCI, 0°C, (b) 1 ,2-diaminobenzene, pyridine. 
The only other route known was reported by Chapleur and Castro 25 years ago 
(Scheme 75)•200  Coupling of ulosonic acid derivative 203 with o-phenylenediamine 
was achieved by employing Castro's reagent. The resultant amide 204 was found to 
cyclise in refluxing diglyme (1600C)  in the presence of Na 2CO3 to give 
benzimidazole 205 in 75% yield. Acid-induced hydrolysis then afforded a mixture 
of furanose and pyranosebenzimidazole products 206-208, the relative proportions of 
which were found to be solvent dependent. 
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Scheme 75: (a) 1 ,2-aminobenzene, BtOP(NMe) 3.PF6 , NEt3 (b) Na2CO3, Diglyme, (c) 
TFA, H20. 
2-Pyranosyimidazoles are also rare. 2-a-D-Glucopyranosylimidazole and 2-0-D-
glucopyranosylimidazole have been synthesised by Vasella and Granier (Scheme 
76)201 but, to the author's knowledge, no group has attempted to employ this 
methodology to prepare the analogous benzimidazoles. Vasella's route is similar to 
that of Dondoni (scheme 73); addition of 2-lithio-1-(dimethylamino)methyl-1H-
imidazole to tetra-O-benzyl-D-gluconolactone affords hemiacetal 209 (68%). 
Reduction of 209 formed a 12:88 mixture of diols 210 which, after chromatographic 
separation and dehydration, cyclised to the desired heterocyclic products 212 and 
213 (80% yield). 
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Scheme 76: (a) BuLi, 1-(Me2NCH2)lm, THF (b) NaBH4 , dioxane, H 20, AcOH (c) 3,5-
dinitrobenzoyl chloride, pyridine (d) NaH, DMF. 
2.6.3 Synthesis of 2-pyranosylbenzoxazoles 
At the outset of this work, 2-pyranosylbenzoxazoles were believed to be unknown, 
however rare examples of furanosyl analogues had been prepared. 202 The synthesis 
of these compounds is outlined later, in section 2.7.1. 
2.6.4 Nitrile oxide route to pyranosylbenzazoles 
2.6.4.1 2-Pyranosylbenzothiazoles 
Pilot work was conducted with D-xylose derived nitrile oxide 151, following a 
procedure based on that of Sasaki et al. 136 Stirring the hydroximoyl chloride 106 with 
2.5 equivalents of o-aminothiophenol in refluxing ethanol afforded 2-(2,3,4-tri-0-
acetyl-3-D-xylopyranosyl)benzothiazole (214, 90% yield) on cooling, or after dry-
flash chromatography. Distinctive NMR signals corresponding to the pyranosyl ring 
protons were observed. The coupling between H-i' and H-2' was found to be 9.5 Hz, 
which demonstrated that the expected f3-anomer was obtained. Signals characteristic 
for the heterocyclic ring were also observed in the 'H and ' 3C NMR spectra [&H 7.36-
7.44 (2H, m, Ar), 7.81-7.96 (2H, m, Ar), öc 166.6 ppm (C-2), 152.5 ppm (C-3a), 
134.7 ppm (C-7a)]. D-Glucose derived benzothiazole 215 was synthesised in a 
similar fashion (81% yield). The products of both reactions were found to have 




The proposed reaction mechanism is outlined in Scheme 77 . 1 36 One equivalent of 
amine is believed to dehydrochlorinate the hydroximoyl chloride to form a nitrile 
oxide, attack by a second equivalent of amine leads to amidoxime formation, and 
finally this intermediate can expel hydroxylamine and cyclise to the benzazole. In the 
case of benzothiazole formation, the possibility of initial attack by the thiol was 
considered unlikely on account of previous observations by the Sasaki group, 136 
presumably the neutral conditions do not allow formation of the more nucleophilic 
thiolate anion. Risitano et al'9 ' have isolated the postulated amidoxime intermediates 











S-2-aminophenyl-2,3 ,4-tri-O-acetyl-3-D-xylopyranosylformothiohydroximate (216) 
was prepared by stirring o-aninothiophenol with hydroximoyl chloride 106 in the 





The 'H and ' 3C NMR spectra were reminiscent of the thiophenol adduct, except for 
the presence of a broad singlet at 4.35 ppm due to the primary amino group. The 
structure of 216 was confirmed by X-ray crystallography (see Figure 5). The crystal 
structure clearly displayed that the thiohydroximate moiety exclusively adopted the 
expected Z-configuration. Stirring the thiohydroximate in refluxing ethanol over 5 
hours did not lead to any benzothiazole formation; this observation therefore also 
appeared to favour a mechanism involving initial attack on the nitrile oxide by the 
amino group. 
Figure 5- Crystal structure of S-2-aminophenyl-2,3,4-tri-O-acetyl-3-D- 
xylopyranosylformothiohydroximate (216) 
The work by Sasaki 136  and Parkanyi' 9° indicated that the reaction proceeded under 
milder conditions. For example, stirring benzohydroximoyl chloride with 2 
equivalents of o-aminothiophenol at room temperature for 3 hours afforded the 
corresponding benzothiazole in 95% yield. Attempts to employ such conditions with 
D-xylose and D-glucose derived hydroximoyl chlorides 106 and 107 proved to be 
unsuccessful. 
2.6.4.2 Synthesis of 2-pyranosylbenzimidazoles 
Reaction of hydroximoyl chloride 106 with o-phenylenediarnine in refluxing ethanol 
in a similar manner to above (section 2.6.4.1) afforded the expected benzimidazole 
217 (83% yield). Unlike the previous cases, the reaction was also found to proceed 
'SZ•I 
cleanly and efficiently when the starting materials were stirred at room temperature 
for 12-16 hours. In pilot studies the product was separated from excess starting 
material by dry-flash chromatography. The original work-up was found to be tedious, 
but was greatly improved by diluting the reaction mixture with DCM and washing 
with 4% CuSO4 solution. The washing step led to the formation of an insoluble lilac 
precipitate, which was attributed to the copper (II) ions chelating out the residual o-
phenylenediamine. Purified material was obtained after filtration through a silica pad 
and crystallisation from ethylacetate/hexane. The 'H and ' 3C NMR data provided 
useful structural information for identification of the product, since both were 
simpler than those obtained for the benzothiazoles. This phenomenon was attributed 
to certain positions becoming magnetically equivalent due to rapid proton exchange 
between N-i and N-3, Such prototropic tautomerism is well known to occur in 
CDC13 solutions of imidazoles and benzimidazoles (Scheme 113  
1 "N—H N'I 
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Scheme 78 
The 'H NMR spectrum for D-xylose derived benzimidazole 217 showed a distinctive 
broad signal corresponding to H-4 and H-7 [&,, 7.50 ppm (2H, vbs)], while the ' 3C 
NMR spectrum showed only two major (heterocyclic) peaks (C-2 148.8 ppm, C-5,6 
123.4 ppm). The remaining quaternary carbons, C-4 and C-7 gave very broad signals 
c.f 2-methylbenzimidazole. The D-glucose analogue 218 was prepared similarly 
(89% yield). 
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The structure of 217 was confirmed by X-ray crystallography (Figure 6, ethyl acetate 


















Figure 6- Crystal structure of 2-(2,3,4-Tri-O-acetyl--D-xylopyranosyi)benzimidazole (217) 
Selected bond lengths are compared with benzimidazole itself in Table 9•203  All bond 
distances are not significantly different (within 3), with the exception of N I A-CM, 
which is somewhat shorter than expected. This may be a direct result of the poor 
quality of the diffraction data. The distances quoted above were freely refined, 
whereas the benzene ring was constrained to be a perfect hexagon. No comparison 
was made with 2-methylbenzimidazole since the proton in this crystal structure is 
disordered over the two N atoms and this results in bond distances being averaged. 
Bond Length! A (217) Bond Length! A 
Benzirnidazole 203 
N3A-C2A 1.313(9) 1.311(5) 
N3A-C4A 1.380(9) 1.395(3) 
NIA-C2A 1.331(10) 1.346(4) 
NIA-C9A 1.346(8) 1.372(4) 
Table 9: Comparison of bond lengths in 217 and Benzimidazole 
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A number of substituted 1 ,2-diaminobenzenes are commercially available, therefore 
it was decided to investigate the possibility of subjecting such nucleophiles to the 
reaction conditions established in section 2.6.4.1. 4-Nitro-1,2-diaminobenzene was 
selected as a candidate due to the reduced nucleophilicity of the amino groups. It was 
believed that if this reaction was successful, other less electron poor nucleophiles 
(such as halogenated 1,2-diaminobenzenes) could be employed. Stirring 
hydroximoyl chloride 106 with 4-nitro- 1 ,2-diaminobenzene in refluxing ethanol 
afforded crude benzimidazole 219 (Scheme 80). In this case washing the reaction 
mixture with 4% CuSO4 solution did not efficiently chelate out the residual amine. 
Attempted purification by dry-flash and wet-flash chromatography was not 
completely successful, a red material was obtained which was estimated to be .90% 
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Scheme 80 
The pyranosyl ring region of the 'H NMR spectrum resembled those of the 
unsubstituted benzimidazoles although all of the ring proton signals were shifted to 
higher frequency. The aromatic region contained distinctive signals for each of the 3 
protons on the benzo-fused component [E, 8.64 ppm (d, 4-H, JH4H6  1.8 Hz), 8.28, 
(dd, 6-H, JH6-H7  8.8 Hz), 7.89, (d, 7-H, JH4-H6  1.8 Hz), 6.60 ppm (dd, H-4, JH4-H5  7.3 
Hz, JH4-H6  0.6 Hz), 6.58 ppm (dd, H-9, JH9-H8  7.3 Hz, JH9H7  0.6 Hz)]. Although the 
product was not fully purified, the experiment demonstrated that an electron poor 
1 ,2-diaminobenzene would indeed react under the established conditions. 
2.6.4.3 Synthesis of 2-pyranosylbenzoxazoles 
The success of the previous reactions encouraged attempts to prepare the hitherto 
unknown 2-pyranosylbenzoxazoles. Reaction of D-xylose nitrile oxide 151 with o- 
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aminophenol in refluxing ethanol, in a similar manner to that outlined in section 
2.6.4.1, afforded the expected benzoxazole 220 in 68% yield. The reaction was also 
found to proceed with no reduction of yield at room temperature after stirring for 16 
hours. Dry-flash chromatography was avoided by diluting the reaction mixture with 
DCM, as the phenol was found to be insoluble in chlorinated solvents. The solid was 
filtered off before removing any residual o-aminophenol with a 0.1 M HCI wash. 
Purified material was obtained after filtration through a silica pad and crystallisation 
from ethyl acetate/hexane. Again, the D-glucose analogue 221 was prepared 
similarly (71% yield). Distinctive NMR signals corresponding to the pyranosyl ring 
protons were observed in each case. Signals characteristic for the heterocyclic ring 
were also observed in the 'H and ' 3C NMR spectra [H  7.64-7.68 (1H, m, Ar), 7.49-
7.52 (111, m, Ar) 7.27-7.32 (214, m, Ar), öc 159.9 ppm (C-2), 150.6 ppm (C-7a), 
140.2 ppm (C-3a)]. The NMR data for both products were found to correlate with 




2.6.5 Deprotection studies 
On completion of the peracetylated series of pyranosyl heterocycles, it was decided 
to investigate deprotection of 217, 218 and 220. Many conditions are available for 
deprotection: The classic Zemplen method (NaOMeIMeOH) was considered too 
harsh 204  and methanolic ammonia was regarded as being inconvenient. 204  Milder 
conditions were ultimately employed. Treatment of the acetylated substrates with 
triethylamine in methanol, 189 or (as recently reported by Field et a!205) 4A molecular 
sieves in methanol, allowed efficient deprotection in all cases (refer to Table 11, 
section 2.6.7). The latter conditions were found to achieve deprotection more rapidly. 
NMR spectra were obtained in D20 and D 3COD, however d6-DMSO was found to 
give superior resolution. The 'H and 13C spectra of deprotected benzoxazole 222 
were not significantly different from the acetylated precursors, although coupling 
was observed between the pyranosyl ring protons and the ring OHs (JH-oH 5.0-5.9 
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Hz) and hence more complex coupling patterns than expected were observed for the 
ring protons. The 'H and 13C spectra of the deprotected henzimidazoles 223 and 224, 
however, were markedly different from their acetylated derivatives, The D-glucose 
derived product 224 serves as a convenient example. The 'H NMR spectrum no 
longer showed H-4 and 1-1-7 as broad signals and the 13C NMR contained individual 
signals for the aromatic CHs and quaternary carbons. The NMR data indicated that 
proton exchange between N-I and N-3 had been limited in DMSO and hence any 
previously magnetically/chemically atoms were no longer so. The structure of 224 
was confirmed by X-ray crystallography (Figure 7). 
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Figure 7- Crystal structure of 2--D-glucopyranosyIbenzimidazole (224) 
Selected bond lengths for compound 224 are compared with henzimidazole in Table 
10. The bond lengths were found to be in good agreement with those of 
benzimidazole (within 3). 
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Bond Length! A (224) Bond Length! A 
Benzimidazole 
N3A-C2A 1.314(2) 1.311(5) 
N3A-C4A 1.395(2) 1.395(3) 
NIA-C2A 1.360(2) 1.346(4) 
N1A-C9A 1.384(2) 1.372(4) 
Table 10: Comparison of bond lengths in 224 and benzimidazole 
As in the benzoxazoles case, coupling was observed between the pyranosyl ring 
protons and the OHs (JHOH  5-5.9 Hz) and again the ring protons gave rise to more 
complex splitting patterns. A COSY 'H NMR experiment allowed a full assignment 
of the spectrum. 
2.6.6 Biological activity 
During the course of the project, 2-3-D-g1ucopyranosy1benzimidazole was reported 
to inhibit glycogen phosphorylase (K 1 8.6 tM).' 97 This enzyme is currently a target 
for hypoglycemic drugs to treat impaired insulin production (type 2 diabetes). The 
function of glycogen phosphorylase is outlined below. 
2.6.6 Glycogen phosphorylase function 
Glycogen phosphorylase (GP) catalyses the breakdown of glycogen to glucose-i-
phosphate (Glc-1-P) (glycogenolysis), the process is illustrated in scheme 80.206 
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Scheme 80  
The mechanism of phospholytic cleavage of glycogen has been established by 
Helmreich and co-workers (Scheme 81).207  Pyridoxal phosphate is believed to 
function as an acid/base catalyst for orthophosphate, orthophosphate donates a proton 
to the departing "OR" group and then attacks the glucosyl cation to form (X-glucose-
1-phosphate. 
OH 







O=P 0—H 0P-0—H 

















0 	 0 	H 
I I =0 	 OHI OPO 	HOP / 	 0_G1ogen 
0 	 01 
H2C 
Peptide—NC--NH 
HO 	CH  
OH 
OH 







As indicated in Schemes 80 and 81, the process is reversible, as the glycogen 4-OH 
can displace the Glc-1-P phosphate group to reform chain extended glycogen. 
Glycogen phosphorylase exists in two forms, Phosphorylase b is usually inactive and 
Phosphorylase a is active. Phosphorylase b is transformed into the a form by 
phosphorylation of the serine 14-residue on each subunit (Scheme 82).206208 
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Scheme 82 
Both Phosphorylase a and b are structurally different, a exists in an R-state (relaxed) 
while b exists in a T-state (tense). The glycogen binding site is 30 A from the 
catalytic site, they are connected by a tunnel, which is blocked in the T state. 206 
Molecules that would stabilise the inactive T-form of GPb, and thus inhibit 
glycogenolysis, have become drug targets for controlling blood glucose levels. 
The presence of glucose and caffeine (225) are known to favour the inactive form, 
with glucose binding to the active site and caffeine to a site nearby. 209 Analogues of 
glucose and caffeine have therefore been investigated as GP inhibitors.  209  Adenosine 
mono phosphate (AMP) is a known allosteric activator of GP, and as a• result 
inhibitors of AMP have also received attention.  209,210  In the last five years new 
allosteric sites have been identified through X-ray studies with novel inhibitors, and 
these sites offer potentially new drug targets . 209'21° 
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An X-ray crystal structure of a 2--D-g1ucopyranosylbenzimidazole/enzyme 
complex has demonstrated that this inhibitor primarily binds to the catalytic site.2 
Binding was also found to take place at the indole/caffeine site and a previously 
unknown binding site, but it is unclear whether this new site will be of interest as a 
future drug target. 
2.6.7 Conclusions/Further Work 
2-3-D-Pyranosyl benzoxazoles, benzimidazoles and benzothiazoles have been 
synthesised in good yields (Table 11). The key addition/cyclisation reaction proceeds 
under mild and neutral conditions, which do not necessitate resilient protecting 
groups and chromatographic purification is largely avoided. Pilot experiments have 
indicated that substituted benzazoles could also be accessible by this methodology. 
Addition of halogenated o-hydroxy, thio or amino anilines could afford benzazoles 
which could be manipulated further using Pd(II) chemistry. 
Hydroximoyl 
Chloride 
X R Y Yield % 
214 H Ac S 90 
215 CH20Ac Ac S 81 
217 H Ac NH 88 
218 CH20Ac Ac NH 85 
220 H Ac 0 68 
221 CH20Ac Ac 0 71 
222 H H 0 92 
223 H H NH 93 
224 CH20H H NH 95 
Table 11: Summary of Benzazole Results 
2.6.7.1 Potential glycosidase inhibition 
The Vasella group have synthesised 2--D-glucopyranosylimidazo1e (213) (see 
section 2.6.2) 201  and found that this compound inhibits sweet almond glucosidase 
(K1 640j.tM). Glycosidase inhibitors have many therapeutic applications, including: 
antiviral activity, 212 anticancer activity, 213 treatment of diabetes , 214 treatment of 
97 
obesity,215 amongst others. The mode of action of retaining-3-0-glycosidases was 
outlined in section 2.6.1. Imidazoles such as 213 are believed to inhibit glycosidases 
by shuttling a proton between the glutamate residues in the glycosidase catalytic site 
(Scheme 83), thus preventing entry and binding of the substrate. 170  In principle, there 
is no reason why 2--D-glucopyranosylbenzimidazole or derivatives could not be 
employed in a similar capacity. 
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Scheme 83 
2.7 Ambident nucleophile additions 2-furanosylbenzazole synthesis 
Whilst investigating 2-pyranosylbenzazole chemistry, it was realised that the same 
methodology could be applied to the synthesis of furanosyl analogues. Such C-
nucleoside analogues are of great interest, particularly in the design of antiviral 
compounds .2' 6,217  2-Furanosylbenzimidazoles, benzoxazoles, and benzothiazoles 
have been the subject of a recent patent, held by Celltech, 218 who report them to be 
potential therapeutic agents for cystic fibrosis. A brief overview of the available 
methods for making 2-3-furanosylbenzazoles is provided below. 
2.7.1 Synthesis of 2-furanosylbenzazoles 
Early research in this area examined additions of o-substituted anilines to aldonic 
acids,219 such procedures required harsh conditions (reflux in the presence of mineral 
acids), which could result in anomeric mixtures of products. Addition of lithiated 
heterocycles to sugar lactones featured in section 2.6.1 in syntheses of 2-
pyranosylbenzazoles, and the most successful approaches to furanosyl analogues also 
employ this method. Early work by Ogura and Takahashi 220 examined addition of 
lithiobenzothiazole and 1-benzylbenzimidazole to lactones such as the D-gulose 
derived compound 226 (Scheme 84). The heterocyclic unit in resultant hemiacetals 
227 was found to occupy the f3-position (40-70%). Disappointingly, however, 
attempts to remove the anomeric OH group with trimethylammonium formate 
proved to be unsuccessful. 
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Scheme 84 
Ogura's methodology has been revisited in recent years by Benhida et al (Scheme 
85).221 222 The initial stage in the updated method still features addition of a lithiated 
heterocycle to a furanosyl lactone, however the anomeric OH is removed by a 
successive reduction / Mitsunobu cyclisation strategy. Addition of benzyloxymethyl 
(BOM) protected 2-lithiobenzimidazole to ribose derived-lactone 228 afforded 
hemiacetal 229 in 75% yield as a mixture of anomers (45:55). Subsequent 
hydrogenation and borohydride reduction afforded a diastereomeric mixture (-.1/1 
ratio) of diols 230, which was converted to 2-3-D-ribofuranosyl derivative 231, in 
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Scheme 85: (a) NBOM benzimidazole, LDA, THF, -50°C (b) H 2 (60 psi), Pd/C, MeOH, 
THE (c) NaBH 4 , MeOH (d) DEAD, PPh 3 , MeOH. 
2-a-D-Ribofuranosylbenzimidazoles have also been made by this method. 
Performing a Felkin-Ahn controlled borohydride reduction before heterocycle 
deprotection afforded a diastereomeric mixture of diols, where the S diol (C*)  was 
the major product (95:5, S:R). Ring-closure was achieved in a similar fashion. There 
have been no reports to date that employ Benhida's procedure to prepare 
benzothiazole or benzoxazole derivatives. 
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Scheme 86: (a) NaOMe (b) o-aminophenol, MeOH (c) EISH, HCI (d) H 2S, pyridine (e) o-
aminophenol, EIOH. 
It was stated in section 2.6.3 that furanosylbenzazoles were rare. The only synthesis 
reported until recently, was achieved by Kawai and El Khadem (Scheme 86).202  -D-
Ribofuranosyl cyanide 232 was converted to acetimidate 233, which was found to be 
highly hygroscopic and therefore required handling in a glove box. Refluxing 233 
and o-aminophenol in methanol for 2 hours afforded benzoxazole 234 in 20% yield. 
A second approach was attempted based on dithioate intermediate 237. Refluxing 
dithioate 237 with o-aminophenol in ethanol for 36 hours afforded benzoxazole 234 
in 24% yield. The low yields, careful handling and toxic reagents associated with the 
above procedures probably account for the limited use of this process. 
2.7.2 Nitrile oxide based strategy 
The first route examined the preparation of 2-3-D-ribofuranosylbenzazoles (Scheme 
87). The key difference between the strategy to be employed for the ribose-derived 
benzazoles and that for pyranose derivatives, was the use of a nitrile precursor, rather 
than a nitromethyl sugar. This decision was made since previous work within the 
group,223 and by others '224  had found the preparation of nitromethylribose in large 
quantities to be arduous and low yielding. In contrast, the ribose derived nitrile 238 
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Scheme 87: (a) o-ami not hiophenol, EtOH (b) TMSCN, BF 3.Et20,MeCN (c) 
PhNHCH2CH2 NHPh, Raney Ni, NaH2PO2 , pyridine/AcOH/H20 (d) TsOH (e) NH 20H. HCI, 
pyridine (f) C 2 (f) Y=NH, o-phenylenediamine; EtOH, Y=O, o-aminophenol. 
The proposed strategy was also believed to be particularly advantageous over 
previous strategies because all three possible 3-D-ribofuranosylbenzazoles could be 
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made from the same starting material. The benzothiazole 240 could be accessed from 
nitrile 238 directly via the previously mentioned procedure of Farkas and co-
workers. 1 95  The focus of the current work was to prepare the benzoxazole 241 and 
benzimidazole 242 by the nitrite oxide methodology (section 87). 
2.7.2.1 Ribose Nitrile Oxide Precursors 
2.7.2.2 Synthesis of 3,4,5-tri-O-benzoyI--D-ribofuranosyI cyanide (238) 
A survey of the literature revealed many methods for the preparation of the title 
compound,' 84,185,225-230  The method of Morelli et a1225 is representative and was 
ultimately chosen. -D-Ribofuranosyl acetate 239 was reacted with trimethylsilyl 
cyanide (TMSCN) in the presence of catalytic boron trifluoride etherate to afford an 
amber solution after 5 minutes. The reaction mixture was quenched with aqueous 
NaHCO3 and the target nitrile isolated in 86% yield after wet-flash chromatography. 
The reaction was found to proceed without reduction of yield when attempted on a 
gram scale. The 'H NMR spectrum was in agreement with the literature 225  and the 
' 3C NMR spectrum showed characteristic signals [c  115.6 ppm (CN)]. The 
reaction is stereospecific for the required 3-configured product, an effect attributed to 
neighbouring group participation of the benzoyl ester at C-2 (scheme 88).185 
CN 
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Scheme 88 
2.7.2.3 Synthesis of 2,5-anhydro-3,4,6-tri- O-benzoyI--D-aIlose oxime 
(243) 
Some years ago Moffat and co-workers reported a three-step synthesis of the title 
compound 243 from nitrile 238.231  The first step involved conversion of the nitrile to 
imidazoline 244, which on treatment with p-toluenesutfonic acid afforded formyl-C -
furanoside 245. Crude 245 was reacted with hydroxylamine hydrochloride to obtain 
the required oxime. A modified version of Moffat's procedure was employed in the 
current synthesis. 3 ,4,5-Tri-O-benzoyl-f3-D-ribofuranosyl cyanide was stirred with 
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Raney nickel, NN-diphenylethylenediamine (Wanzlicks reagent) and sodium 
hypophosphite in aqueous acetic acid and pyridine. Imidazoline 244 was isolated in 
59% yield after wet-flash chromatography. The separation between the product and 
diamine proved to be very small by TLC (R = —0.025, 30% EtOAc in hexane), 
which made purification more difficult than expected. In addition to the expected 
signals for the carbohydrate ring and its benzoyl protecting groups and the 
imidazoline N-phenyls, peaks corresponding to the imidazoline moiety itself were 
observed [öc 48.0 ppm (NCH2), 48.4 ppm (NCH2), 84.2 ppm (C-2), 6H 3.62-3.77 
ppm (2H, m, NCH2), 3.81-3.96 ppm (2H, m, NCH2), 5.97 ppm (1H, s, 2-H)]. The 
signal for H-2 appears as a singlet, an observation consistent with the product being 
obtained as the -anomer. Treatment of imidazoline 244 with p-toluenesulfonic acid 
afforded crude aldehyde 245, which was immediately reacted with hydroxylamine 
hydrochloride and pyridine. The title compound (45% yield) was finally obtained as 
a 4:1 mixture of isomers (E:Z) after purification by dry-flash chromatography. 
Diagnostic peaks for the oxime unit were seen in the NMR spectra [c  148.3 ppm 
(C=N), oH),  8.88 ppm, bs (OH) (E)),], and the analytical data were consistent with 
literature values. 142 
Although the required oxime 243 was obtained, the procedure was not considered 
satisfactory if larger scale syntheses were to be accomplished. Particular concerns 
included: the final yields of oxime and imidazoline were lower than expected, 
extensive chromatographic purification was required, and it was thought desirable to 
avoid the aldehyde intermediate if possible. The previously mentioned Somsak/Toth 
procedure 151  (section 2.2.2) for pyranosylaldoxime synthesis offered a viable 
alternative to that described above. 
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Scheme 89: (a) semicarbazide.HCI, KOH, Raney Ni, NaH 2PO2 , pyridine/AcOH/H 20 (b) 
NH20H. HCI, pyridine 
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The alternative procedure is essentially a modified version of that reported by Moffat 
et al.23 ' Somsak demonstrated 151  that sugar nitriles could be converted under 
reducing conditions into semicarbazones by reaction with semicarbazide and that 
these semicarbazones were found to efficiently undergo transimination with 
hydroxylamine to afford the corresponding aldoximes. Crucially, the aldehyde 
formation step is avoided and it was hoped that crude semicarbazone 246 could be 
employed in the final step and hence eliminate tedious purification steps. A mixture 
of 3 ,4,5-tri-O-benzoy1-3-D-ribofuranosyl cyanide (238) Raney nickel, semicarbazide 
hydrochloride, KOH, sodium hypophosphite in aqueous acetic acid and pyridine was 
heated to 40 'C for 4 hours. The reaction mixture was washed successively with 1 M 
HC1, saturated NaHCO 3 and water before isolating the crude semicarbazone as a 
light brown solid. Diagnostic peaks for the semicarbazone unit were seen in the 
NMR spectra [öc 157.4 ppm (C=O), 138.6 ppm (C=N) au).  9.85 ppm, bs, (OH), 7.13 
ppm, d, (CH=N), JHI-H2  5.2 Hz]. The crude material was taken on to the next step 
immediately. Hydroxylamine hydrochloride was added to a solution of crude 
semicarbazone in acetonitrile / pyridine and the reaction stirred at room temperature 
under argon for 16 hours. Purification by wet-flash chromatography afforded the title 
compound as a colourless oil (81% yield). The NMR data and physical properties 
were identical to those obtained previously by the original route. The second 
procedure was judged to be the more suitable of the two and allowed attempts to 
prepare ribose-derived hydroximoyl chloride 247. 
2.7.2.4 Attempted synthesis of ribose derived hydroximoyl chloride 
(247) 
It was envisaged that the procedures outlined in section 2.2.3 for the synthesis of 
pyranosylhydroximoyl chlorides would also be suitable for the required ribofuranose 
analogue. It was known that Moffat et a! 142  had used a similar procedure in the 
preparation of 247 toward the synthesis of -D-ribofuranosylisoxazoles. Repeated 
chiorinations were conducted in the manner described previously, but were 
disappointingly only partly successful. The 'H and ' 3C NMR spectra of the product 
were more complex than expected, indicating that more than one species was present 
after chlorination. Peaks corresponding to hydroximoyl chloride 247 could be 
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identified [c  137.2 ppm (C=N), oH 9.81 ppm, bs, (OH)], however they appeared to 
make up the minor component of the mixture. The identity of the other substance 
remains unclear. 
A milder chlorination procedure employing N-chlorosuccinimide 33  was attempted in 
order to avoid by-product formation. A pilot reaction with the aim of making the 
furoxan dimer 248 was employed to establish the usefulness of the new conditions. 
A mixture of oxime 243, N-chlorosuccinimide and pyridine in chloroform was 
heated to 40°C for ca 45 minutes. On cooling, triethylamine was added and the 
mixture stirred for 1 hour. Dry-flash chromatography afforded furoxan 248 as a 
colourless gum (107 mg, 72%). The formation of furoxan in high yield was a good 
indication that the NCS method was the better way of obtaining the desired nitrile 
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Scheme 90: (a) NCS, pyridine (b) o-aminophenot, EtOH 
A mixture of oxime 243, N-chlorosuccinimide and pyridine in chloroform was 
heated to 40°C for ca 45 minutes and, after cooling, the solvent was removed in 
vacuo. A solution of the resulting hydroximoyl chloride and o-aminophenol in 
ethanol was heated at reflux for 5 hours. The reaction mixture was washed with 1 M 
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HCI before dry-flash chromatography afforded 241 as a colourless gum (92% yield). 
Diagnostic peaks corresponding to the benzoxazole moiety were observed in the ' 3C 
NMR spectra [öc 162.5 ppm (C-2), 152.0 ppm (C-7a), 141.7 ppm (C-3a)]. 
2.7.2.6 Synthesis of 2-(2,3,5-Tri-O-benzoyI-3-D-
ribopyranosyl)benzimidazole (242)
OH 
N" 	 N' OH 
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Scheme 91: (a) NCS, pyridine (b) o-phenylenediamine, EtOH 
A mixture of oxime 243, N-chlorosuccinimide and pyridine in chloroform was 
heated to 40°C for ca 45 minutes. On cooling, the solvent was removed in vacuo. 
The residue and o-phenylenediamine were refluxed in ethanol for 5 hours. The 
reaction mixture was washed with 4% CuSO 4 solution before dry-flash 
chromatography afforded 242 as a colourless gum (90% yield). The 1 H and ' 3C NMR 
spectra showed a distinctive benzimidazole signals that were reminiscent of the 
pyranosyl analogues [oH 7.90-7.94 ppm (211, m), 7.23-7.27 ppm (2H, m)], while the 
' 3C NMR showed only two major peaks [Oc  151.3 ppm (C-2), 123.2 ppm C-S. C-6)}. 
Tautomerism of the benzimidazole ring led the C-4 and C-7 signals being broadened 
out in an analogous fashion to the pyranosylbenzimidazoles in section 2.6.4.2. 
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Studies were conducted to establish efficient deprotection conditions. Benzoate 
esters are known to be more resilient than their acetyl counterparts, 204  therefore 
Zemplen deprotection of 2-(2,3 ,5-tri-O-benzoyl-3-D-ribopyranosyI)benzoxazole 
(241) with methanolic sodium methoxide was attempted . 204 The benzoxazole was 
stirred in freshly prepared sodium methoxide/methanol solution for 16 hours. The 
reaction was quenched with Amberlite 120(H') resin before purification by wet-flash 
chromatography. The product was obtained as a mixture of anomers. A COSY 'H 
NMR experiment allowed the carbohydrate ring protons for both isomers to be 
identified. The most distinctive signals for each were the anomeric [, 4.47 ppm, d, 
(1-H3), 5.08 ppm, d, (1-Ha) I protons, which were assigned a (249a) and f3 (249b) 
by comparison with analogous compounds in the literature. 221  The anomeric integrals 
were measured and hence the isomer ratio calculated (3:(x, 62:38). The aromatic 
protons were observed as a large set of multiplets between 6.92 and 7.67 ppm. The 
conditions used were evidently too harsh, therefore milder conditions were sought. 
Time precluded any further work with the benzoxazoles, consequently the remaining 
stock of benzimidazole 242 was used for further deprotection reactions. 
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Stocks of benzimidazole 242 were limited and it was therefore impossible to 
investigate the effect on anomeric ratio by diluting the NaOMe solution or shortening 
the reaction time. It was therefore decided to employ the milder method of Bazin et 
al. ' 89 Benzimidazole 242 was dissolved in triethylamine and methanol; and heated to 
50°C for 4 days. After removal of the solvent and wet-flash chromatography, 2-13-D-
ribofuranosylbenzimidazole (250) was obtained as a white foam (91% yield). The 'H 
NMR spectrum showed diagnostic peaks for the benimidazole ring [H  7.07-7.10 
ppm (2H, m), 7.35-7.4 1 ppm (2H, m)] in addition to the expected carbohydrate ring 
signals. A comparison with literature 'H NMR values23 ' was made in order to 
confirm that the -anomer had indeed been prepared (Table 12). None of the c-
isomer was detected in the crude reaction mixture. 
H (PPM) Jr-2(Hz) 
Literature 0 23 ' 5.21 8.0 
Literature 3231 5.06 5.0 
250 4.92 5.3 
Table 12 Comparison of literature 8H / J values with benzimidazole 250 
The benzimidazole ring signals in the ' 3C NMR spectrum [c  152.9 ppm (C-2), 
123.2 ppm C-5, C-6)} were reminiscent of the protected compound 242; a very broad 
signal ca 115 ppm was attributed to C-4 and C-7. 
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2.7.3 Conclusions/Further Work 
A revised route to D-ribose derived hydroximoyl chloride 247 has been established. 
Reaction of nitrile 238 with semicarbazide afforded crude semicarbazone 246 in 
—85% yield and was transformed to oxime 243 by treatment with hydroxylamine 
hydrochloride. Hydroximoyl chloride 247 was initially prepared by chlorination, 
however the reaction was unsatisfactory due to formation of an unidentified by-
product. Treatment of 243 with NCS was found to afford crude hydroximoyl chloride 
in almost quantitative yield. Reaction of D-ribose derived nitrile oxide 92 with o-
phenylenediamine and o-aminophenol afforded benzimidazole 242 and benzoxazole 
241 in 90% and 92% yield respectively. An attempt to deprotect 241 under Zemplen 
conditions led to a 62:38 mixture of 2--D-ribofuranosylbenzoxazole (249b) and 2-
a-D-ribofuranosylbenzoxazole (249a). 24-D-Ribofuranosylbenzimidazole (250) 
was prepared in 91% yield by reacting 242 under mild conditions. The products 
obtained in this section are C-nucleoside analogues and may therefore be of interest 
as anti-viral agents, The established route offers a mild and stereocontrolled 
approach to future candidates for the treatment of cystic fibrosis. 
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2.8 Perimidine chemistry 
28.1 Introduction 
Perimidines (251) are peri-naptho-fused derivatives of pyrimidine. The chemistry of 
perimidines has been already been reviewed 232-234  and therefore only a brief 








Perimidines and their derivatives have found a variety of applications; they have 
been used in dyestuffs 232234 for many years and more recently in the manufacture of 
polyester fibres 232234 and antistatics. 235 The biological activity of perimidines and 
their derivatives have also been examined; they are believed to intercalate DNA, and 
have therefore been tested as antitumor agents .231,23'  They have also been found to 
possess antiulcer, antimicrobial and antifungal activity. 232-234 
A range of substituents have been installed at the 2-position of perimidines; these 
include alkyl, aryl and heterocyclic groups. In contrast, no report of a pyranosyl 
substituted perimidine has been made to date. The majority of the methods of 2-
perimidine (251) synthesis use 1,8-diaminonaphthalene (DAN) as the starting 
material, the most common routes are outlined in (Scheme 94)232234  Addition of 
DAN to carboxylic acid derivatives leads to amide intermediates (252), which 
cyclise in refluxing acid (4 M HCI or formic acid for example). The corresponding 
reaction with aldehydes affords 2,3-dihydroperimidine products (253), oxidation of 
which yield the desired 2-perimidine. Milder conditions 232  have been developed 
which involve cyclisation of amidine intermediates (254). 
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Scheme 94: (a) [X = halide, OR, COR, OH] 1 ,8-diaminonapthalene (b) H ref lux (c) 1,8-
DAN (d) Pd/C or DDQ (e) [Y = CN, HN=COR, HN=CNH 2] DAN (f) H. 
The rigid nature of 1 ,8-diaminonapthalene confers a reactivity similar to that of o-
phenylenediamine, 232 and it was therefore proposed that addition of DAN to nitrile 
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Scheme 95 
2.8.2 Pilot studies 
As 2-phenylperimidine had previously been synthesised and fully characterised '231  it 
was chosen as a target for pilot work. Benzohydroximoyl chloride (255), the 
precursor for benzonitrile oxide (93), was prepared by passing chlorine gas through a 
chloroform solution of syn-benzaldoxime.' 43 The product was obtained as a white 
solid in 74% yield. The procedure that had been successfully applied to benzazoles 
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was employed in the attempted perimidine synthesis. A mixture of 
benzohydroximoyl chloride (255) and DAN was stirred in refluxing ethanol for 5 
hours, before washing the reaction mixture with 4% CuSO4 solution. The washing 
procedure was found to work well, although the resultant mixture required more 
extensive purification by comparison with the benzimidazole syntheses. 2-






255 	 256 
Scheme 96 
The 'H NMR spectrum and analytical data agreed with those in the literature. 238  The 
coloured nature of the product is also consistent with the perimidine ring being 
present, and the electronic structure of the heterocycle. Perimidines have 14it-
electrons delocalised over 13 atoms, 232234 the electron density is not uniform and this 
results in an electron deficient heterocyclic ring and an electron rich napthalene 
component (257).232234  The observed colour is attributed to a it-it charge transfer 
absorption, which is derived from electron transition from the naphthalene ring to the 
heterocyclic ring. 233 
90C 6+ 
257 
2.8.3 Synthesis of 2-pyranosylperi midines 
The results of the pilot reaction were encouraging enough to attempt to transfer the 
procedure to carbohydrate scaffolds. D-Xylose derived hydroximoyl chloride 106 
was stirred with DAN in refluxing ethanol for 5 hours. Two compounds were 
isolated from the reaction mixture by chromatography. The least polar fraction (Rf 
[Et20] = 0.35) was found to contain glycal perimidine 258, the remaining fraction (Rf 
[Et20] = 0.27) afforded the expected pyranosyl perimidine 259. 
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The glycal derivative 258 was found to be the major product of the reaction (258 
43%,' 259 16%, 258:259 = 2.68:1, Table 16). The 'H NMR spectra of both 
compounds in CDCI3 had broad signals in the aromatic region due to annular 




Repeating the NMR experiments in D 6-DMSO appeared to suppress or sufficiently 
slow the interconversion to obtain well-resolved signals in the aromatic region; the 
same effect was observed on cooling below -40 °C by Yavari et al.239 In both cases in 
D6-DMSO, the heteroatomic ring CH protons were observed at lower frequency than 
those of the naphthyl unit. Values from glycal perimidine 258 are representative EH 
7.47-7.51 ppm (4H, m, H-5, 11-6, H-7, H-9), 6.60 ppm (dd, H-4, JH4-H5 7.3 Hz, JH4-H6 
0.6 Hz), 6.58 ppm (dd, 11-9, JH9-H8  7.3 Hz, JH9-H7  0.6 Hz) 1. The NH was clearly 
defined [oH 10.49 ppm (bs, OH)]. In both 258 and 259 the perimidine derived signals 
in the ' 3C NMR could be assigned by comparison with data from a detailed study by 
Claramunt et al; 240  representative data sets from glycal perimidine 258 and pyranosyl 
perimidine 259 are presented in Table 13. 
C-X 2 3a 4 5 6 6a 7 8 9 9a 9b 
259 154.0 145.8 115.0 130.3 121.1 136.6 119.2 129.5 104.1 139.4 123.6 
ic/ppm 
258 150.1 145.9 115.2 130.4 121.0 136.6 119.5 129.5 104.7 139.2 123.8 
6c/ppm 
Table 13: Comparison of 13C chemical shifts of glycal perimidine 258 and 
pyranosyl perimidine 259 
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Several key features in the 'H and ' 3C NMR spectra indicated that glycal 258 had 
been formed. Only two peaks corresponding to the acetyl protecting groups were 
observed [oH 2.12, 2.10 ppm (2x CH 3); 5c  171.0, 170.9 ppm (2x C=O); 22.3, 22.2 
ppm (2x CH3)] and no signal appeared in anomeric proton region. In contrast, in the 
case of pyranosyl perimidine 259, three acetyl signals were observed [OH 2.05, 2.03, 
1.93 ppm (3x CH3); 0c  171.2, 171.1 170.7 ppm (3x C=O); 0c  22.0, 21.9, 21.8 ppm 
(3x CH3)] and the anomeric peak appeared as a doublet [OH 4.24 ppm (d, H-l', .JHI 
H2' 9.7 Hz)]. Glycals are known to adopt a half-chair conformation, 146  therefore the 
carbohydrate ring signals differ from those observed for a chair conformer. The 
coupling constant between the 2'-H and 3'-H protons [J2,3 5.1 Hz] was smaller than 
that observed in pyranosyl perimidine 259 [J2,3 9.6 Hz].  The remaining signals are 
observed as complex multiplets rather than discrete doublets of doublets with large 
coupling constants. The alkene signals in the ' 3C NMR spectrum were particularly 
apparent, the chemical shift of the anomeric carbon atom being significantly higher 
than that in perimidine 259 [258 0c  C- 1' 149.2 ppm, 259 0c  C- 1' 78.8 ppm]. 
The expected pyranosyl perimidine was a green/yellow colour, which is consistent 
with literature data for similar compounds. 232-234 The glycal was orange in colour, 
this shift to lower frequency is probably due to conjugation of the heterocycle with 
the double bond in the carbohydrate ring. On repeating the above reaction at room 
temperature for 16 hours, the major product was found to be 259 (60%) together with 
traces of 258 (TLC). 
When D-glucose hydroximoyl chloride 107 was reacted in ethanol at room 
temperature, similar results were obtained to the xylose case (pyranosyl perimidine 
260 65% yield, traces of glycal perimidine 261). Perimidine 260 was found to be the 
major product (260 34%, 261 16%, 260:261 = 2.13:1, Table 16) when the reaction 









Both products 260 and 261 had similar 'H and ' 3C NMR spectra to the xylose 
analogues. The structure of pyranosyl perimidine 260 was confirmed by X-ray 
crystallography. Selected bond lengths and bond angles are compared with 2-(anthr-




Figure 8- Crystal structure of 2-(2,3,4,6-Tetra-0-acetyl-13-D-glucopyranosyl)perimidine 
(260) 
The mechanism of glycal formation was proposed to occur via an E1cB elimination 
process due to charge delocalisation onto the heterocycle. Deprotonation would have 
to occur by the basic DAN nucleophile or a molecule of the newly formed 
perimidine. The PKa of DAN is known to be ca 5, whereas the pK a of 2-perimidines 
232 is ca 6: Clearly, the perimidine would be more basic than DAN and might be 
expected to be more able to deprotonate the anomeric position, however the pK a 







N(1)-C(2) 1.351(3) 1.352(2) 
N(1)-C(9a) 1.396(3) 1.398(2) 
N(3)-C(2) 1.300(2) 1.301(2) 
N(3)-C(3a) 1.410(3) 1.408(2) 
C(3a)-C(4) 1.377(3) 1.378(3) 
C(4)-C(5) 1.409(4) 1.404(3) 
C(5)-C(6) 1.359(4) 1.358(4) 
C(6)-C(6a) 1.420(4) 1.416(3) 
C(6a)-C(7) 1.413(4) 1.412(3) 
C(7)-C(8) 1.367(4) 1.355(3) 
C(8)-C(9) 1.412(3) 1.408(3) 
C(9)-C(9a) 1.378(3) 1.374(3) 
C(9a)-C(9b) 1.414(3) 1.412(2) 
C(9b)-C(6a) 1.426(3) 1.420(2) 
C(3a)-C(9b) 1.425(3) 1.416(2) 





N(1)-C(2)-N(3) 125.57(18) 124.4(2) 
C(2)-N(3)-C(3a) 116.94(18) 117.5(1) 
N(3)-C(3a)-C(9b) 120.96(18) 120.8(1) 
C(3a)-C(9b)-C(9a) 119.57(18) 119.4(2) 
C(9b)-C(9a)-N(l) 116.08(18) 116.0(2) 
C(9a)-C(Nl)-C(2) 121.21(17) 121.9(1) 
Table 15: Comparison of bond angles in 260 and 2-(anthryl)perimidine 
117 
In order to provide further evidence for the reaction pathway, an attempt was made to 
prepare mannopyranosyl perimidine 262. In the mannose case, the OAc group would 
be anti-periplanar to the anomeric anion and thus ideally placed to undergo E2 
elimination in addition to E1cB and thus likely to favour formation of glycal 261. 
The glucopyranosyl perimidine 260 also afforded glycal 261, but the elimination was 
sluggish since only Elcb elimination is possible (Scheme 98). 
OAc OAc OAc  
o Ac 2C 	0\__Ji__ - _______ ACOJJ( 
LOAcH 	H 	 H 	 H 
	
260 	 261 	 262 
Scheme 98 
Conducting the reaction of DAN with D-mannose hydroximoyl chloride 108 in 
ethanol at room temperature afforded pyranosyl perimidine 262 (55%) with traces of 
glycal 261. When the reaction was conducted in refluxing ethanol, glycal 261 was 
indeed the predominant product (26134%, 262 4%, 261:262 = 8.5:1, Table 16). The 
1 H and ' 3C NMR spectra of 261 and 262 were comparable with those of the D-xylose 
and D-glucose analogues. The observation that the proportion of glycal perimidine 
261 is significantly higher from perimidine 262 is consistent with the tandem 















D-Xylose 25 60 <1 - 
D-Xylose 80 16 43 2.68:1 
D-Glucose 25 65 <1 - 
D-Glucose 80 34 16 1:2.13 
D-Mannose 25 55 <1 - 
D-Mannose 80 4 34 8.5:1 
Table 16: Glycal perimidine to pyranosyl perimidine ratios 
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The range of carbohydrate substituents was extended further with the room 
temperature synthesis of 2-(2,3 ,4,6-tetra-O-acetyl-3-D-gal actopyranosyl)perimidine 
(263) in 69% yield. The preparation of perimidine 263 and its precursors was 





2.8.4 Preparation of D-glyceraldehyde derived perimidine 
The success of the perimidine methodology encouraged an attempt to synthesise a 
perimidine with an acyclic carbohydrate substituent. D-Glyceraldehyde derived 
perimidine 264 was selected as a target since the precursor nitrile oxide (91) was 
known. 14 ' The nitrile oxide is generated by dehydrochiorination of hydroximoyl 
chloride 265, which is accessible from D-mannitol derivative 266 via aldehyde 267 
and oxime 268 (Scheme 99). 242,243 
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Scheme 99: (a) Na104 (b) NH20H.HCI, NaCO3 (c) C1 2 (d) DAN, 
1,2:5 ,6-Di-O-isopropylidene-D-mannitol (266) was oxidatively cleaved with sodium 
periodate to form two equivalents of aldehyde 267. Treatment of the crude aldehyde 
with hydroxylamine hydrochloride and sodium carbonate afforded oxime 268 as a 
mixture of isomers (E:Z 3:1) in 63% yield. The 'H NMR spectrum showed 
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diagnostic peaks for the E and Z isomers [oH 9.18 ppm (Z- isomer, bs, OH), 8.89 
ppm (E- isomer, bs, OH)]. Oxime 268 was dissolved in ether and treated with 
chlorine gas to afford hydroximoyl chloride 265 as a grey solid (98% yield).' 4 ' The 
product was immediately taken on to the next stage to avoid the risk of 
decomposition on standing at room temperature. Hydroximoyl chloride 265 was 
stirred with DAN in refluxing ethanol for 5 hours to afford the target perimidine 264 
as a yellow/green solid (61% yield). The aromatic region of the 'H and ' 3C NMR 
spectra (in D6-DMSO), were found to mirror those observed in the pyranosyl series. 
The signals in the 'H and ' 3C NMR spectra corresponding to the acyclic component 
were clearly visible [OH 4.67 ppm (t, CH), 4.02 ppm (d, CH 2); 0c  73.9 ppm (CH), 
66.6 ppm (CH2)1. 
2.8.5 Conclusions I Further work 
A new and mild method for the preparation of perimidines has been established. For 
example, reaction of 1 ,8-diaminonapthalene (DAN) with D-xylose derived 
hydroximoyl chloride 106 at room temperature afforded pyranosyl perimidine 259 in 
60% yield. Reaction of D-Glucose, D-mannose and D-galactose derived 
hydroximoyl chlorides with DAN proceeded in a similar fashion (55-65% yield). 
Reaction of D-glucose hydroximoyl chloride 107 with DAN in refluxing ethanol 
afforded a 2.1:1 mixture of pyranosyl perimidine 260 and glycal perimidine 261. 
Under the same conditions, D-mannose hydroximoyl chloride 108 afforded a 1:8.5 
mixture of perimidine 262 and glycal perimidine 261. Application of the method to 
the D-glyceraldehyde hydroximoyl chloride 265 was also successful in delivering the 
corresponding perimidine 264 (61% yield). Future work in this area could include 
extension of the methodology to a ribose scaffold and an examination of the products 
as potential antiviral agents. The methodology could also be extended to the 





All 'H and ' 3C NMR spectra were recorded on a Varian WP200SY, Bruker ARX250 
and Bruker avance 360 instruments by Mr J. R. A. Millar, Stewart Wharton and the 
author. High field 'H NMR was conducted on a Varian inova 600 instrument by Dr I. 
H. Sadler. 2D NMR spectra were obtained from the Bruker avance 360 and Varian 
inova 600 instruments. Chemical shifts (6) in all spectra are measured in parts per 
million (p.p.m), using tetramethylsilane (6 = 0.0) as a reference signal. 
FAB mass spectra and exact mass measurements were recorded on a Kratos 
MS50TC instrument using either glycerol or thioglycerol as a matrix by Mr A. 
Taylor. 
Melting points were measured on a Gallenkamp capillary tube apparatus and are 
uncorrected. Optical rotations were measured on an Optical Activity Polaar 20 
polarimeter using 2 cm  of filtered solution. IR spectra were obtained as liquid films 
or nujol mulls on a Perkin Elmer Paragon 1000 FT-JR spectrometer and are quoted in 
wavenumbers (cm'). Infrared spectra were recorded on a Jasco 1717/IR-460 using 
sodium chloride plates. 
Diffraction data were collected with graphite-monochromated Mo-Ka radiation (X = 
0.71073 A) on a Bruker Apex CCD diffractometer equipped with an Oxford 
Cryosystems low-temperature device operating at 150K. X-ray structural analysis of 
141, 153, 156, 178, 216, 217, 224, 260 by Dr S. Parsons, Dr I. Oswald, Mr S. 
Moggach, Miss F. Fabbiani and Mr F. White. 
High pressure hydrogenation was conducted using a Parr 4842 apparatus. 
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3.1.2 Chromatography 
Analytical TLC was carried out on Merck aluminium-backed plates with Kieselgel 
GF254 silica (0.2 mm). 
Dry flash chromatography was performed using a variety of sinters with different 
diameters filled with Kieselgel GF2 54 silica and eluted under a vacuum supplied by a 
water pump. 
3.1.3 Solvents and reagents 
All reagents and solvents were standard laboratory grade and were used as supplied 
unless specifically stated. 
Dichioromethane, chloroform and acetonitrile were purified by distillation from and 
stored over calcium hydride. 
Pyridine was purified by distillation from and stored over potassium hydroxide. 
Acetic anhydride was purified by fractional distillation and dried over 4A molecular 
sieves. 
THF was purified by distillation over calcium hydride. 
Toluene and ether were dried over sodium wire. 
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3.2 Synthesis of pyranosylnitrile oxide precursors 
3.2.1 Synthesis of pyranosylnitromethanes 
3.2.2.1 3,4,5-Tri-O-acetyl--D-xyIopyranosyInitromethane (95) 
Sample code: JASOO1 
Molecular formula: C 12H 17N09 
Molecular weight: 319 	 OAc 
Solid sodium (2.5 g, 108 mmol) was dissolved in methanol (90 ml) under an 
atmosphere of N 2. Sodium methoxide (90 ml in methanol) was added to a stirred 
solution of D-(+)-xylose (13.5 g, 83 mmol), nitromethane (45 ml, 0.83 mol) and dry 
methanol (30 ml). The solution was stirred for 24 h. The resultant brown solid was 
filtered, washed with ice-cold methanol, and dissolved in ice-cold deionised water 
(200 ml). The solution was rapidly forced through an amberlite 120 (H) ion-
exchange column. Excess nitromethane was removed in vacuo, and the residual 
liquid was heated at reflux for 48 h. Charcoal (5 g) was added to the solution and the 
mixture was heated at reflux for 2 h. The charcoal was filtered through celite and the 
filtrate concentrated in vacuo to yield an orange oil. The oil was dissolved in dry 
acetic anhydride (140 ml) (under an atmosphere of N 2), cooled to 0 °C, triflic acid 
(0.1 ml) was added, and the mixture stirred for 14 h. The resultant solution was 
added to ice-water (100 ml), extracted with chloroform (3 x 40 ml), washed with 
NaHCO3 (3 x 40 ml) and the combined extracts dried (MgSO4. The dried extract 
was concentrated in vacuo (residual water was co-evaporated with toluene) to afford 
an orange oil. The oil was dissolved in chloroform (100 ml) and activated charcoal (2 
g) was added. The solution was heated under reflux for 30 minutes, charcoal was 
filtered over celite and the filtrate concentrated in vacuo to yield an orange oil which 
was crystallised from ethanol. The purified product (95) was isolated as a white 
crystalline solid (10.48 g, 40%); M.p 163-165 °C (lit. 114  164-165 °C); 8H  (250 MHz, 
CDC13) 2.40 (9H, 3s, 3xCOCH3), 3.72 (1H, dd, 6b-H), 4.41 (1H, dd, 6a-H), 4.55 
(1H, m, 2-H), 4.74 (1H, dd, lb-H), 4.81 (1H, dd, la-H), 5.20 (1H, dd, 3-H), 5.36 
(1H, m, 5-H), 5.61 (1H, dd, 4-H); Ax-y)/Hz la-lb 13.3, la-2 8.8, lb-2 2.9, 2-3 10.6, 
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3-4 9.3, 4-5 9.4, 5-6a 10.6, 5-6b 5.8, 6a-6b 11.3; 8c (63 MHz, CDCI3) 21.1, 21.2, 
21.4 (3xCOCH 3), 66.1, 68.5, 69.3, 72.9, 74.8, (C-6, C-2, C-3, C-4, C-5), 75.8 (C- 1), 
170.1, 170.2, 170.6 (3xCOCH3) 
3.2.2 3,4,5,7-Tetra-0-acetyI-3-D-gI ucopyranosylnitromethane (99) 
Sample code: IAS004 	 OAc  
Ac 	 0 Molecular formula: C 1 5H2 1 N0 1 1 	 CO 	 CH2NO2 
O 
Molecular weight: 391 	 OAc 
Solid sodium (2.5 g, 108 mmol) was dissolved in methanol (90 ml) under an 
atmosphere of N 2. Sodium methoxide (90 ml in methanol) was added to a stirred 
solution of D-(+)-glucose (15.1 g, 84 mmol), nitromethane (45 ml, 0.83 mol) and dry 
methanol (30 ml). The solution was stirred for 24 h. The resultant brown solid was 
filtered, washed with ice-cold methanol, and dissolved in ice-cold deionised water 
(200 ml). The solution was rapidly forced through an amberlite 120 (H) ion-
exchange column. Excess nitromethane was removed in vacuo, and the residual 
liquid was heated at reflux for 48 h. Charcoal (5 g) was added to the sugar solution 
and the mixture was heated at reflux for 2 h. The charcoal was filtered through celite 
and the filtrate concentrated in vacuo to yield an orange oil. The product was isolated 
as a white solid by continuous liquid/liquid extraction using ethyl acetate/water (48 
hours), followed by concentration of the organic layer in vacuo. The resultant solid 
was dissolved in dry acetic anhydride (50 ml) (under an atmosphere of N2), cooled to 
0 °C , triflic acid (0.2 ml) was added, and the mixture stirred for 14 h. The resultant 
solution was added to ice-water (100 ml), extracted with chloroform (3 x 40 ml), 
washed with NaHCO3 (3 x 40 ml) and the combined extracts dried (MgSO 4). The 
dried extract was concentrated in vacuo (residual water was co-evaporated with 
toluene) to afford an orange oil. The oil was dissolved in chloroform (100 ml) and 
activated charcoal (2 g) was added. The solution was heated under reflux for 30 
minutes, charcoal was filtered over celite and the filtrate concentrated in vacuo to 
yield an orange oil which was crystallised from hexane/ethanol. The purified product 
(99) was isolated as a white crystalline solid. (6.72 g, 20%); M.p 143-145 °C (lit. 144 
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144-145 °C); oH (250 MHz, CDC13) 1.96,1.98, 2.00 (12H, 4s, 4xCOCH3), 3.67 (1H, 
ddd, 6-H), 3.98 (1H, dd, 7a-H), 4.21 (1H, dd, 7b-H), 4.22-4.27 (1H, m, 2-H), 4.34 
(1H, dd, lb-H), 4.47 (1H, dd, la-H), 4.87 (1H, dd, 3-H), 5.01 (1H, dd, 5-H) 5.21 
(1H, dd, 4-H); J(x-y)/Hz la-lb 13.7, la-2 2.8, lb-2 8.9, 2-3 9.3, 3-4 9.3, 4-5 9.6,5-6 
9.98, 6-7a 2.21, 6-7b 4.97, 7a-7b 12.5; 0c  (63 MHz, CDC13) 20.4, 20.4 (4xCOCH3), 
61.4 (C-7) 67.7, 69.3, 72.7, 73.4, 74.2 (C-2, C-3, C-4, C-S, C-6), 75.5 (C-l) 169.2, 
169.5, 169.9, 170.4 (4xCOCH 3). 
3.2.3 Synthesis of pyranosyloximes 
The acetylated D-gluco, D-xylo and D-mannose (provided by Mr A. Fromm) derived 
nitromethanes were reduced to their respective oximes using a modified version of 
the procedure of Bartra et a152 . 
3.2.3.1 Pyranosyloximes- General Procedure 
Triethylamine (5 equivalents) and thiophenol (4.5 equivalents) were added to a 
cooled (0 °C) solution of tin (II) chloride (1.5 equivalents) and acetylated 
pyranosylnitromethane (1 equivalent) in dry THF (5 ml) under nitrogen. The 
resulting yellow mixture was stirred for 16 hours. After removal of THF in vacuo, 
the residue was washed with hexane to remove excess thiophenol. The product was 
separated by dry-flash chromatography (silica / 0-100 % ether in hexane; gradient 
elution). 
3.2.3.2 3,4,5-Tri-O-acetyl--D-xyIopyranosyIformaIdoxime (100) 
Sample code: IAS005 
Molecular formula: C 12H 17N08 	 Nt 1 OH 
Molecular weight: 303 
OAc 
3,4,5-Tri-O-acetyl--D-xy1opyranosylnitromethane (95) (1.5 g, 3.13 mmol) was 
added to a cooled (0 °C) solution of tin (II) chloride (1.34 g, 4.7 mmol), 
triethylamine (3.3 ml, 15.7 mmol), and thiophenol (1.5 ml, 14.1 mmol) as outlined in 
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the general procedure above. The product (100) was isolated by dry-flash 
chromatography as a white solid (1.2 g, 86 %). Oxime 100 was recrystallised from a 
60:40 ether/hexane mix. The oxime was obtained as a mixture of E/Z isomers in a 
4:1 ratio; M.p 128-130°C (lit. 52  135-137 °C); 5H  (250 MHz, CDCI3); 1.95, 1.97, 
1.98 (9H, 3s, 3xCOCH3), 3.29 (1H, dd, 6a-H), 3.92 (1H, dd, 2-H), 4.08 (1H, dd, 6b-
H), 4.85-4.93 (1H, m, 5-H), 4.99 (1H, dd, 3-H), 5.19 (1H, dd, 4-H),.6.63 (1H, d, 1-H 
(Z)), 7.72 (1H, d, 1-H (E)), 8.62 (1H, bs, OH (E)), 8.88 (IH, bs, OH (Z)); J(x-y)/Hz 
1-2 6.6, 2-3 9.8, 3-4 9.4, 4-5 9.5, 5-6a 10.2, 5-6b 5.6, 6a-6b 11.2; 8C (63 MHz, 
CDC13) 20.4, 20.5 (3xCOCH 3), 66.5 (C-6), 68.8, 69.6, 72.9, 75.9 (C-2, C-3, C-4, C-
5), 146.7 (C-1),169.7, 169.8, 170.3 (3xCOCH3) 
3.2.3.3 3,4,5,7-Tetra-0-acetyI--D-gIucopyranosyIformaIdoxime (101) 
Sample code: IAS002/007 	 OAc N" OH '4 Molecular formula: C15H21N010 	 AC \JjCO 
Molecular weight: 375 	 OAC 
3,4,5,7-Tetra-0-acety1-3-D-glucopyranosylnitromethane (99) (1.1 g, 3.84 mmol) was 
added to a cooled (0 °C) solution of tin (II) chloride (1.1 g, 5.76 mmol), 
triethylamine (3.3 ml, 19.2 mmol), and thiophenol (2.1 ml, 17.3 mmol) as outlined in 
the general procedure above. The product (101) was isolated by dry- flash 
chromatography as a white solid (660 mg, 69 %). Oxime 101 was recrystallised from 
a 60:40 ether/hexane mix. The oxime was obtained as a mixture of E/Z isomers in a 
4:1 ratio; M.p 158-160°C (lit. 52  155-157 °C); oH (250 MHz, CDCI3) 1.94, 1.95, 
1.97, 2.02 (12H, 4s, 4xCOCH3), 3.66 (1H, ddd, 6-H), 4.03 (1H, dd, 2-H), 4.08 (1H, 
dd, 7b-H), 4.21 (1H, dd, 7a-H), 5.06 (1H, dd, 3-H), 5.08 (1H, dd, 5-H), 5.20 (1H, dd, 
4-H), 6.8 (1H, d, 1-H (Z)), 7.41 (1H, d, 1-H(E)), 8.35 (1H, bs, OH (E)), 8.53 (1H, bs, 
OH (Z)); J(x-y)JHz 1-2 6.9, 2-3 9.9, 3-4 9.1, 4-5 9.8, 5-6 9.6, 6-7a 2.06, 6-7b 4.7, 7a-
7b 12.5; Oc  (63 MHz, CDC13) 20.5 (4xCOCH 3), 61.9 (C-7), 68.0, 69.4, 73.4, 75.7, 
75.7 (C-2, C-3, C-4, C-5, C-6), 146.7 (C- 1)169.4, 169.6, 170.2, 170.6 (4xCOCH3). 
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3.2.3.4 3,4,5,7-Tetra-0-acetyl--D-mannopyranosylformaldoxime (102) 
Sample code: 1AS088 	 OAc 	OH 
4OAc N 
Molecular formula: C 15H21 N0 1 0 Ac 
Co 
Molecular weight: 375 
3,4,5 ,7 -Tetra- 0-acetyl- P-D-mannopyranosylnitromethane (supplied by A. Fromm) 
(1.57 g, 4.2 mmol) was added to a cooled (0 °C) solution of tin (II) chloride (1.15 g, 
6.28 mmol), triethylamine (2.8 ml, 20.9 mrnol), and thiophenol (1.85 ml, 18.8 mmol) 
as outlined in the general procedure above. The product (102) was isolated by dry-
flash chromatography as a white solid (1.16 g, 77 %). Oxime 102 was recrystallised 
from a 60:40 ether/hexane mix. The oxime was obtained as a mixture of E/Z isomers 
in a 2:1 ratio; M.p 151-152°C (lit. 52  152-154 °C); 6H  (360 MHz, CDC13) 2.00, 2.01 
2.08, 2.13, 2.14, 2.17, 2.19 (24H, 4s, 4xCOCH 3), 3.71-3.75 (2H, m, 6-H(E), 6-H(Z)), 
4.19 (211, dd, 7a-H(E), 7b-H(Z)), 4.25 (2H, dd, 7b-H(E), 7b-H(Z)), 4.40 (111, d, 2-
H(E)), 4.86 (1H, d, 2-H(Z)), 5.11-5.19 (2H, m, 4-H(E), 4-H(Z)), 5.24-5.33 (2H, m, 5-
H(E), 5-H(Z)), 5.54 (1H, dd, 3-H (H)), 5.85 (1H, dd, 3-H(Z)), 6.75 (1H, d, 1-11(Z)), 
7.35 (1H, d, 1-H(E)), 8.67 (1H, bs, OH (E)), 8.94 (1H, bs, OH (Z)); E-isomer J(x-
y)/Hz 1-2 5.5, 2-3 3.2, 3-4 nd, 4-5 nd, 5-6 nd, 6-7a 2.1, 6-7b 5.7, 7a-7b 12.3, Z-
isomer J(x-y)/Hz 1-2 4.0, 2-3 1.3, 3-4 nd, 4-5 nd, 5-6 nd, 6-7a 2.1, 6-7b 5.7, 7a-7b 
12.3. 
3.2.4 Synthesis of pyranosyihydroximoyl chlorides 
3.2.4.1 Hydroximoyl chlorides-General procedure 
Dry chlorine gas was bubbled through a cooled (-78 ° C) solution of 
pyranosylformaldoxime, in dry chloroform (under nitrogen) until the solution turned 
emerald green. Nitrogen gas was bubbled through the solution and it was allowed to 
warm to room temperature. On warming, the solution became green, blue, then 
colourless and the solvent was removed in vacuo to afford an oily solid. The product 
was obtained as a white solid on trituration with ice-cold ether. 32 
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3.2.4.2 3,4,5, -Tri-O-acetyl-2,6-anhydro-1 -deoxy-1 -chloro-1 - 
hydroxyimino-D-xylo-D-gu!o-hexitol (106) 
Sample code: IAS008 	 N_OH 
Molecular formula: C 12H 1 6N08C1 
Molecular weight: 337.5 	
OAc 
Following the procedure above, 3 ,4,5-tri-O-acetyl-3-D-xylopyranosylformaldoxime 
(100) (550 mg, 1.6 mmol) was converted to the corresponding hydroximoyl chloride. 
The product (106) was obtained as a white solid (600 mg, 98%); M.p 147-149°C; oH 
(250 MHz, CDC13); 1.92, 1.95, 1.98 (9H, 3s, 3xCOCH 3), 3.34 (111, dd, 6a-H), 4.12 
(1H, dd, 6b-H), 4.17 (1H, d, 2-H), 5.01 (1H, td, 5-H), 5.15 (1H, dd, 3-H), 5.22 (1H, 
dd, 4-H), 8.80 (1H, bs, OH; J(x-y)/Hz 2-3 9.3, 3-4 9.2, 4-5 8.0, 5-6a 10.8, 5-6b 6. 1, 
6a-6b 11.3; Oc  (63 MHz, CDCI 3) 20.4, 20.6 (3xCOCH3), 66.5 (C-6), 68.5, 68.9, 73. 1, 
78.8 (C-3, C-4, C-S, C-2), 136.5 (C-i) 169.3, 169.9, 170.5 (3xCOCFI 3); in/z (FAB) 
338 (M+1); HRMS (FAB) Found: M+l 338.06427. C 15H21NO1035C1 requires M+1 
338.06442. 
3.2.4.3 3,4,5,7 -Tetra-O-acetyl-2,6-anhydro-1 -deoxy-1 -chloro-1 - 
hydroxyimino-D-g!ycero-D-gulo-heptitol (107) 
Sample code: IAS003 	 ç_OAc N_OH 
Molecular formula: C15H20N010C1 	 Ac °\jCO 
Molecular weight: 409.5 	 OAc 
Following 	the 	procedure 	above, 	3,4,5 ,7-tetra- O-acetyl-3-D- 
glucopyranosylformaldoxime (101) (600 mg, 1.5 mmol) was converted to the 
corresponding hydroximoyl chloride. The product (107) was obtained as a white 
solid (620 mg, 99%); M.p 158-160°C (lit."' 157-159°C); umaxlcm' (Nujol) 3311 
(OH), 1747 (C=O); [a]018  -5.0 (c = 1.0, CHC13); 0H  (250 MHz, CDCI 3); 2.14, 2.25, 
2.30, 2.35 (12H, 4s, 4xCOCH 3), 3.73 (1H, ddd, 6-H), 4.08 (1H, dd, 7a-H), 4.17 (1H, 
dd, 7b-H),4.24 (1H, dd, 2-H), 5.07 (1H, dd, 3-H), 5.19 (1H, dd, 5-H), 5.30 (1H,dd, 
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4-H), 8.78 (1H, bs, OH); J(x-y)IHz 2-3 9.8, 3-4 9.3, 4-5 9.4, 5-6 9.5, 6-7a 2.4, 6-7b 
4.6, 7a-7b 12.5; 6C (63 MHz, CDCI 3) 20.4, 20.5, 20.6 (4xCOC171 3), 61.8 (C-7), 67.8, 
68.7, 73.7, 75.7, 78.3 (C-3, C-4, C-S, C-6, C-2), 136.5 (C-i) 169.4, 169.6, 170.2, 
170.6 (4xCOCH 3); m/z (FAB) 410 (M +1) HRMS (FAB) Found M+1 410.08565, 
C 1 5H21 NO 1 035C1 requires M ++1 410.08540. 
3.2.4.4 3,4,5,7 -Tetra-O-acetyl-2,6-anhydro-1 -deoxy-1 -chloro-1 - 
hydroxyimino-D-g!ycero-D-galacto-heptitol (108) 
Sample code: 1AS089 	 OAc 	OH 
Molecular formula: C15H20NO10C1 	
AcR.IiI CO 
Molecular weight: 409.5 
Following 	the 	procedure 	above, 	3,4,5 ,7-tetra-O-acetyl-3-D- 
mannopyranosylformaldoxime (102) (200 mg, 0.48 mmol) was converted to the 
corresponding hydroximoyl chloride. The product (108) was obtained as a white 
solid (210 mg, 96%). 
M.p 101°C (lit,  141 102-103°C); 8. (250 MHz, CDCI 3); 1.97, 2.04, 2.08, 2.10 (12H, 
4s, 4xCOCH3), 3.78 (1H, m, 6-H), 4.17 (1H, dd, 7a-H), 4.26 (1H, dd, 7b-H), 5.09-
5.34 (3H, m, 2-H, 4-H, 5-H), 5.71 (1H, dd, 3-H), 9.76 (1H, bs, OH); Ax-y)/Hz 2-3 
nd, 3-4 3.3, 4-5 nd, 5-6 nd, 6-7a 2.3, 6-7b 5.7, 7a-7b 12.2; öc (63 MHz, CDCI 3) 20.9, 
21.1, 21.1 (4xCOCH 3), 62.9 (C-7), 63.2, 66.1, 68.4, 72.2, 76.9 (C-3, C-4, C-S, C-6, 
C-2), 134.8 (C-l) 170.1, 170.6, 170.8, 171.3 (4xCOCH 3); m/z (FAB) 410 (M +1) 
HRMS (FAB) Found M+i 410.0855 1, C 15H2 1 N0 1 035C1 requires M+1 410.08540. 
3.2.4.5 DipyranosyI-(2,3,4-tri-O-acetyl-J-D-xyIopyranosyI)-1 ,2,5-
oxadiazole-2-oxide (109) 
Sample code: 1A5006 
CO 
N 	N 
Molecular formula: C24H32N2016 	 Ac °\jL 
Molecular weight: 602 	
OA 
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3,4,5-Tri-O-acetyl-13-D-xylopyranosylnitromethane (95) (1 g, 3.13 mmol) was 
dissolved in dry toluene (30 cm 3)  with stirring. Tnethylamine (0.5 ml) and TDI (1.56 
ml, 10.9mmol) were added and the resulting mixture was heated under reflux (85 °C) 
for 7 days. The mixture was stirred at room temperature for 1 h before cooling to 0 
T. The reaction was quenched with ethylenediamine (0.3 ml) and allowed to stir for 
18 h. Polymeric urea by-product was filtered off over celite, washed with toluene and 
chloroform and the filtrate was concentrated in vacuo. Dry flash chromatography (0-
100 % ether in hexane; gradient elution) of the residue yielded the product (109) as a 
white solid (568 mg, 61%); M.p 186-189°C (lit.' 40 190 °C); oH (250 MHz, CDCI 3); 
1.90, 1.93, 1.94, 1.95, 1.97 (18H, 6s, 6xCOCH3), 3.35-3.43 (2H, m,), 4.19-4.27 (2H, 
m), 4.54 (2H, 2 x d, 1'-H, 1"-H), 4.93-4.97 (2H, m), 5.20-5.31 (4H, m); Ax-Y)/Hz  1'-
2' 9.5, l"-2" 9.1; Oc  (63 MHz, CDCI3) 20.3, 20.5, 20.1 (6x COCH 3), 66.8, 66.9 (C-
6', C6") 68.3, 69.8, 70.3, 71.7, 72.4, 72.5, 73.9 (C-1'-C-5', C-1"-C-5"), 112.7 (C-3), 
153.7 (C-4), 169.3, 169.5, 169.7, 169.9, 169.9 (6x COCH3). 
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3.3 Synthesis of the pyranosylthiohydroximates 
3.3.1 Thiohydroximates- General procedures 
General procedure A 
To a cooled solution (0 °C) of the pyranosyl hydroximoyl chloride (0.6 mmol, 1 
equivalent) and thiol (1.2 mmol, 2 equivalents) in dry ether (5 ml), a solution of 
triethylamine (1.8 mmol, 3 equivalents) in dry ether (30 ml) was added dropwise via 
a syringe and the solution left to stir overnight. The mixture was then poured into 
water, the organic layer separated and the aqueous layer extracted with chloroform (3 
x 50 ml). The combined organic layers were dried (MgSO4) and the solvent removed 
in vacuo to yield the crude product, which was purified by dry-flash chromatography 
(silica, hexane/Et20 gradient elution). 
General procedure B 
A solution of the hydroximoyl chloride (1 equivalent) in dry ether or chloroform (35 
ml) was added dropwise over 1 hour to a cooled (0°C) and stirred solution of the 
nucleophile (2 equivalents) and triethylamine (3 equivalents) in dry ether or 
chloroform (5 ml) under N2. After stirring for 1 hour the mixture was poured into 
water (50 ml), extracted with DCM (3 x 50 ml), the combined organic layers dried 
(MgSO4), and the solvent removed in vacuo. The product was isolated by dry-flash 
chromatography (silica, hexanefEt20 gradient elution). 
3.3.1.1 5-Phenyl 2,3,4-tri-O-acetyl-13-D-
xylopyranosylformothiohydroximate (119) 
Sample code: IAS009 	 NOH 
Molecular formula: C 18H21 N208 s 
Molecular weight: 411 	
OAc 
To D-xylose derived hydroximoyl chloride (106) (200 mg, 0.6 mmol) in dry ether (5 
ml) was added thiophenol (0.12 ml, 1.2 mmol) followed by triethylamine (0.25 ml, 
1.8 mmol) in accordance to the general procedure A. Dry-flash chromatography 
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yielded (in order of elution) residual thiophenol, the title compound (119) as a white 
solid (180 mg, 75%) and a trace amount of furoxan by-product (<5 mg). 
M.p 177-178 °C (from Et20/hexane); [aID2°  7.3 (c = 0.8, CHC1 3); 8H  (250 MHz, 
CDCI 3); 1.89, 1.97 (9H, 3s, 3xCOCH3), 2.40 (1H, dd, 5a-H), 3.56 (1H, d, 1-H) 3.81 
(1H, dd, Se-H), 4.80 (1H, td, 4-H), 4.84 (1H, dd, 2-H), 5.34 (1H, dd, 3-H), 7.20-7.58 
(5H, m, ArH) 8.75 (1H, bs, OH); J(x-y)/Hz 1-2 9.9, 2-3 9.2, 3-4 9.8, 4-5a 10.2, 4-5e 
5.3, 5a-5e 11.3; 8c (63 MHz, CDCI3) 20.6 (3xCOCH 3), 66.1 (C-5), 68.6, 69.2, 73.8, 
75.2 (C-2, C-3, C-4, C-i), 127.3, 128.9, 129.8 (ArCH), 136.4 (ArC), 148.9 (C=N), 
169.5, 169.6, 170.6 (3xCOCH 3); in/z (FAB) 412 (M+i); HRMS (FAB) Found: 
M+i 412.10629. C 1 8H21 N08S requires M+H 412.10661. 
3.3.1.2 S-(2-Propyl) 2,3,4-tri-O-acetyI--D-
xylopyranosylformothiohydroximate (120) 
Sample code: JASO1O 
Molecular formula: C 15H23N08S 
Molecular weight: 377 	
OAc 
To D-xylose derived hydroximoyl chloride (106) (200 mg, 0.6 mmol) in dry ether (5 
ml) was added 2-propane thiol (0.11 ml, 1.2 mmol) followed by triethylamine (0.25 
ml, 1.8 mmol) in accordance to general procedure A. Dry-flash chromatography 
yielded (in order of elution) residual 2-propane thiol, the title compound (120) as a 
white solid (120 mg, 55%) and furoxan by-product (80 mg, 45%) 
M.p 97-98 °C; oH (250 MHz, CDCI 3); 1.23 (3H, d, CH3), 1.25 (3H, d, CH3), 1.95, 
1.97 (9H, 3s, 3xCOCH3), 3.27 (1H, dd, 5a-H), 3.83 (1H, septet, CH) 4.11 (1H, d, 1-
H) 4.13 (1H, dd, Se-H), 5.00 (1H, td, 4-H), 5.17 (1H, dd, 2-H), 5.32 (1H, dd, 3-H), 
8.88 (1H, bs, OH); J(x-y)/Hz 1-2 9.4, 2-3 9.3, 3-4 9.5, 4-5a 10.3, 4-5e 5.5, 5a-5e 
11.2 ; Oc (63 MHz, CDCI 3) 20.0 (3xCOCH 3), 22.9, 23.8 (CH 3), 36.1 (CH), 66.1 (C-
5), 68.1, 69.2, 73.2, 78.7 (C-2, C-3, C-4, C-i), 147.8 (C=N), 168.9, 169.3, 169.9 
(3xCOCH 3); 'n/z (FAB) 378 (M+i); HRMS (FAB) Found: M+1 378.12198. 




Sample code: IASOI1.1 
Molecular formula: C 1 4H21 N08S2 	
Ac2-\.j v- S   
Molecular weight: 395 	
OAc 
To a stirred mixture of 1,2-ethanedithiol (0.24 ml, 3 mmol) and triethylamine (0.31 
ml, 2.2 mmol) in dry ether (10 ml), D-xylose derived hydroximoyl chloride (106) 
(250 mg, 0.7 mmol) was added in accordance to general procedure B. Dry-flash 
chromatography yielded (in order of elution) residual 1 ,2-ethanedithiol, the title 
compound (121) as a white solid (112 mg, 40%) and 2:1 adduct 122 as a viscous oil• 
(57 mg, 22%). 
M.p 144-146 °C; [a]D20 -48 (c = 0.5,CHC13); 8H  (250 MHz, CDCI3); 1.65 (1H, t, SH), 
1.95, 1.97 (9H, 3s, 3xCOCH3), 2.63 (2H, m, CH2b),  3.10 (2H, m, cH2a),  3.26 (1H, 
dd, 5a-H), 4.02 (1H, d, 1-H), 4.06 (111, dd, 5e-H), 4.99 (1H, dt, 4-H), 5.18 (lH, dd, 
2-H), 5.32 (1H, dd, 3-H), 8.91 (1H, bs, OH); Ax-y)/Hz 1-2 9.6, 2-3 9.3, 3-4 9.52, 4-
5a 10.3, 4-5e 5.5, 5a-5e 11.0, SH-CH2 8.5; 8c (63 MHz, CDC13) 20.6 (3xCOCH3), 
24.9 (CH2b),  34.7 (CH) 66.5 (C-S), 68.6, 69.4, 73.5, 78.8 (C-2, C-3, C-4, C-i), 
147.6 (C=N) 169.5, 169.8, 170.4 (3xCOCH3); m/z (FAB) 396 (M+i); HRMS (FAB) 
Found: M+1 396.07842. C 1 8H2 1 N08S requires M+H 396.07869. 
3.3.1.4 2:1 adduct (122) 
Oft Sample code: IASO11.2 	
N_OH 	
j4—OAc 
Molecular formula: C 26H36N20 1 6S2 
Oft 	 b 
Molecular weight: 696 	 HO_N 
H (250 MHz, CDC13); 1.93, 1.98 (18H, 6s, 6xCOCH3), 2.82 (2H, m, CH2b),  3.15 
(2H, m, CH2a)  3.31 (1H, dd, 5a-H), 4.10 (1H, dd, Se-H) 4.15 (1H, d, i-H), 5.01 (1H, 
dt, 4-H), 5.18 (1H, dd, 2-H), 5.29 (1H, dd, 3-H), 9.23 (1H, bs, OH); Ax-Y)/Hz  1-2 
9.52, 2-3 9.3, 3-4 9.6, 4-5a 10.2, 4-5e 5.2, 5a-5e 10.8; 8C (63 MHz, CDC13) 21.1 
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(6xCOCH3), 31.7 (CH2b),  38.9  (cH2a),  66.9 (C-5), 69.1, 70.0, 74.0, 79.3 (C-2, C-3, 
C-4, C-i), 147.9 (C=N) 170.4, 170.9 (6xCOCH3); mlz (FAB) 697 (M+l); HRMS 
(FAB) Found: M+1 697.15834. C 1 8H2 1 N08S requires M+H 697.15833. 
3.3.1.5 N-(tert-Butoxycarbonyl)cysteine methyl ester (147) 
Sample code: 1AS038 SH 4')(  
Molecular formula: C9H17N04S 	X 
N CO2 Me 
Molecular weight: 235 	 H 
Triethylamine (1.01 g, 10 mmol) was added to a well stirred slurry of L-cysteine 
methyl ester hydrochloride (1.72 g, 10 mmol) in DCM (20 ml), followed after 10 
minutes by di-tert-butyl dicarbonate (2.18 g, 10 mmol). The mixture was stirred for 
16 hours at room temperature, washed with water and dried (MgSO4). Evaporation of 
the solvent afforded the target (147) as a colourless oil (2.26 g, 95 %). 
H (250 MHz, CDC13); 1.45 (9H, s, 3xCH 3), 2.95-2.99 (2H, m, CH2), 3.76 (3H, s, 
OCH3), 4.60 (1H, dt, CH), 5.48 (iH, d, NH), J(x-y)IHz CH-CH2 4.1, CH-NH 7.0; 6c  
(63 MHz, CDC13) 27.1 (CH2), 28.1 (3xCH 3), 52.5 (OCH3), 54.7 (CH), 80.0 (C Boc), 
154.9 (C=O Boc) 170.6 (CO 2CH3); m/z (FAB) 236 (M+1); HRMS (FAB) Found: 
M+1 236.09575 C9H 18N04S requires M+H 236.09566. 
3.3.1.6 S-2-Methoxycarbonyl-2- tbutoxycarbonylamino-2,3,4-tri-O-acetyI-
-D-xylopyranosyIformothiohydroximate (148) 
Sample code: IAS040 	 NOH 
Molecular formula: C 21 H32N201 2 s 	Ac2 °\.J_s.CO2Me 
OAc 
Molecular weight: 536 	 NHB0c 
To a stirred mixture of N-(tert-butoxycarbonyl)-L-cysteine methyl ester (350 mg, 1.5 
mmol) and triethylamine (0.31 ml, 2.2 mmol) in dry chloroform (10 ml), D-xylose 
derived hydroximoyl chloride (106) (150 mg, 0.4 mmol) was added in accordance to 
general procedure B. Dry-flash chromatography yielded (in order of elution) NN- 
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bis(tert-Butoxy)carbonyl-L-cystine dimethyl ester (149, 107 mg, 31% recovery) and 
the title compound (148) as a white solid (209 mg, 88%). 
M.p 94-96 °C; [aID 2° -39 (c = 1.0 ,CHCI 3); 8H  (250 MHz, CDC1 3); 1.47 (9H, s, 
3xCH3), 1.97, 2.03, 2.05 (9H, 3s, 3xCOCH 3), 3.35-3.58 (3H, m, 5a-H, CH 2 a,b), 
3.78 (3H, s, OCH3), 4.16 (1H, d, 1-H), 4.18 (1H, dd, 5e-H), 4.59 (1H, m, CH), 5.03 
(1H, dt, 4-H), 5.23 (111, dd, 2-H), 5.39 (1H, dd, 3-H), 9.44 (1H, bs, OH; J(x-y)/Hz 1-
2 9.6, 2-3 9.4, 3-4 9.4, 4-5a 10.2, 4-5e 5.4, 5a-5e 11.3; 6 C (63 MHz, CDC1 3) 20.5 
(3xCOCH3), 28.1 (3xCH3), 32.5 (CH2), 52.7 (OCH 3), 53.7 (CH), 66.4 (C-5), 68.6, 
69.3, 73.5, 78.4 (C-i, C-2, C-3, C-4), 80.3 (C Boc), 147.0 (C=N) 155.2 (C=O Boc), 
169.5, 169.7, 170.3 (3xCOCH3), 170.7 (CO2CH3); m/z (FAB) 537 (M+1); HRMS 
(FAB) Found: M+i 537.17542 C 21 H33N201 2S requires M+H 537.17542. 
3.3.1.7 N, N-bis(tert-Butoxy)carbonyl-L-cystine dimethyl ester (149) 
Sample code: TAS039 	 NHBoc 
Molecular formula: C1 8H32N20852 	
B0cHN 	
CO,Me 
Molecular weight: 468 	 CO2 Me 
M.p 89-90 °C (lit 96-97°C); 8H  (250 MHz, CDCI 3); 1.45 (18H, 2xs, 6xCH 3), 3.16 
(4H, 2xd, 2xCH2), 3.77 (6H, 2xs, 2xOCH 3), 4.60 (2H, 2xdt, 2xCH), 5.41 (2H, 2xd, 
2xNH), Ax-y)/Hz CH-CH2 5.2, CH-NH 7.0; 8c (63 MHz, CDC1 3) 28.2 (6xCH3), 
41.1 (2xCH2) 52.5 (2xOCH3) 52.6 (2xCH), 80.2 (2xC Boc), 154.9 (2xC=O Boc), 
171.0 (2xCO2CH3); m/z (FAB) 469 (M+1); HRMS (FAB) Found: M+1 469.16810 
C 1 8H33N208S2 requires M+H 469.16784. 
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3.3.1.8 S-2-Methoxycarbonyl-2- tbutoxycarbonylamino-2,3,4,6-tetra-0-
acetyI-3-D-g I ucopyranosylformothiohydroximate (150) 
Sample code: 1AS042 	 fAc NOH 
Molecular formula: C24H36N20 1 4S 	 S2Me 
Molecular weight. 608 	 OAc 	 NHB0c 
To a stirred mixture of N-(tert-Butoxycarbonyl)cysteine methyl ester (260 mg, 1.1 
mmol) and triethylamine (0.31 ml, 2.2 mmol) in dry chloroform (10 ml), D-glucose 
derived hydroximoyl chloride (107) (150 mg, 0.36 mmol) was added in accordance 
to general procedure B. Dry-flash chromatography yielded (in order of elution) N, N-
bis(tert-Butoxy)carbonyl-L-cystine dimethyl ester (101 mg, 39% recovery) and the 
title compound (150) as a white solid (145 mg, 85%). 
M.p 145-147 °C; [a]u2°  -15 (c = 1.0 ,CHC1 3); 8H  (250 MHz, CDCI3); 1.40 (9H, S, 
3xCH3), 1.90, 1.93, 1.97, 2.03 (12H, 4xs, 4xCOCH3), 3.35 (1H, dd, CH2a), 3.54 
(1H, dd, CH2b), 3.73 (3H, s, OCH 3), 3.93-3.78 (1H, m, 5-H), 4.11-4.17 (2H, m, 6a-
H, 6b-H), 4.22 (1H, d, 1-H), 4.53 (1H, m, CH), 5.06 (1H, dd, 2-H), 5.17 (1H, dd, 4-
H), 5.39 (1H, dd, 3-H), 5.62 (1H, dd, NH), 9.63 (1H, bs, OH; J(x-y)/Hz 1-29.8,2-3 
9.6, 3-4 9.3, 4-5 9.2, 5-6a nd, 5-6b nd, 6a-6b nd ; 8 c (63 MHz, CDC13) 20.5 
(4xCOCH3), 29.5 (3xCH 3), 32.1 (CH 2), 52.6 (OCH3), 53.7 (CH), 62.0 (C-6), 65.7, 
67.8, 69.1, 74.1, 75.6 (C-i, C-2, C-3, C-4, C-5), 80.3 (C Boc), 146.4 (C=N) 155.1 
(C=O Boc), 169.4, 170.3, 170.5 (4xCOCH 3), 170.6 (CO2CH3); m/z (FAB) 609 





Sample code: 1AS067 	 NOH 
Molecular formula: C 15H2 1 N O10S 
Molecular weight: 407 	
OAc 
To a stirred mixture of methyl thioglycolate (0.08 ml, 0.9 mmol) and triethylamine 
(0.25 ml, 1.8 mmol) in dry chloroform (30 ml), D-xylose derived hydroximoyl 
chloride (106) (100 mg, 0.3 mmol) was added in accordance to general procedure B. 
Dry-flash chromatography yielded (in order of elution) residual methyl thioglycolate, 
and the title compound (166) as a white solid (85 mg, 70%) 
M.p 144-145°C; oH (360 MHz, CDC13); 1.98, 2.04, 2.05 (9H, 3s, 3xCOCH3), 3.38 
(1H, dd, 5a-H), 3.75 (1H, d, CH 2a), 3.77 (3H, s, CO2CH3), 3.82 (1H, d, CH2b), 4.14 
(1H, dd, 5e-H), 4.29 (1H, d, i-H), 5.01-5.08 (1H, m, 4-H), 5.25 (1H, dd, 2-H), 5.41 
(1H, dd, 3-H), 9.39 (1H, bs, OH; Ax-y)/Hz 1-2 9.6, 2-3 9.3, 3-4 9.5, 4-5a 10.6, 4-5e 
5.6, 5a-5e 11.2, 2a'-2b' 15.8; Oc (93 MHz, CDC1 3) 21.7, 21.8 (3xCOCH3), 33.3 
(SCH2CO2CH3) 53.9 (C0CH3) 67.5 (C-5), 69.7, 70.4, 74.6, 79.2 (C- 1, C-2, C-3, C-
4), 148.1 (C=N) 170.8, 170.9, 171.1 (3xCOCH3), 171.7 (CO2CH3); m,/z (ES) 408 
(MH). 
3.3.1.10 S-2-Am inophenyl 2,3,4-tri-O-acetyI-E-D-
xylopyranosylformothiohydroximate (216) 
Sample code: IAS021 
Molecular formula: C 1 8H22N208S 





S 	NH 2 
OAc 
To a stirred mixture of 2-amino-thiophenol (225 mg, 1.8 mmol) and triethylamine 
(0.25 ml, 1.8 mmol) in dry ether (10 ml), D-xylose derived hydroximoyl chloride 106 
(200mg, 0.6 mmol) was added in accordance to general procedure B. Dry-flash 
chromatography yielded (in order of elution) residual 2-amino-thiophenol , and the 
title compound (216) as a white solid (196 mg, 78%). 
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M.p 97-98°C ; [U]ii °  30 (c = 0.5 ,CHCI 3); 8H (250 MHz, CDC13); 1.91, 1.92, 1.98 
(9H, 3s, 3xCOCH3), 2.41 (IH, dd, 5a-H), 3.59 (1H, d, 1-H) 3.80 (1H, dd, 5b-H), 4.35 
(2H, bs, NH2), 4.84 (1H, td, 4-H), 4.90 (1H, dd, 2-H), 5.34 (1H, dd, 3-H), 6.64-6.73 
(2H, m, ArH), 7.14-7.18 (111, m, ArH), 7.36 (1H, dd, Ar); Ax-y)fHz 1-2 9.9,2-3 8.9, 
3-4 10.0, 4-5a 10.3, 4-5b 5.6, 5a-5b 11.1; 8C (63 MHz, CDC1 3) 21.0, 21.1 
(3xCOCH3), 66.6 (C-5), 69.2, 69.6, 74.5, 75.6 (C-2, C-3, C-4, C- 1), 110.2 (ArC-SR) 
115.7, 118.7, 132.3, 138.9 (ArCH) 148.6 (C=N) 150.3 (ArC-NH2)) 170.1, 170.2, 
171.1 (3xCOCH 3); mlz (FAB) 427 (M +1) HRMS (FAB) Found M+1 427.1167, 
C 1 8H22N208S requires M+H 427.1175. 
138 
3.4 Synthesis of the pyranosylamidoximes 
3.4.1 Alkyl/Aryl Am idoximes- General procedure 
A solution of the hydroximoyl chloride (1 equivalent) in chloroform (35-50 ml) was 
added dropwise over 2 hours to a cooled (0°C) and stirred solution of the amine (2 
equivalents) and triethylamine (3-18 equivalents) in chloroform (3-5 ml) under N2. 
After stirring for 1 hour the mixture was poured into water (50 ml), extracted with 
DCM (3 x 50 ml), the combined organic layers dried (MgSO 4), and the solvent 
removed in vacuo. The product was isolated by dry-flash chromatography (silica, 
hexanefEt 20 gradient elution). 
3.4.1.1 (Z)-N-BenzyI-(2,3,4,6-tetra-O-acetyl--D-
glucopyranosyl)formamide oxime (137) 
Sample code: IAS061 	 OAC NOH 
Molecular formula: C22H23N2010 	 CO 
Molecular weight: 480 	 OAc 	H 
To a stirred mixture of benzylamine (0.18 ml, 1.6 mmol) and triethylamine (1 ml, 7.2 
mmol) in dry chloroform (3 ml), D-glucose derived hydroximoyl chloride 107 (200 
mg, 0.5 mmol) was added in accordance to the general procedure above. Dry-flash 
chromatography yielded the title compound (137) as a white solid (205 mg, 88%). 
M.p. 128-129 °C ; [am 20  -12 (c = 1 CHCI3); 8H  (360 MHz, CDCI3) 1.85, 1.95, 1.98 
(12H, 4s, 4xCOCH 3), 3.59 (1 H, ddd, 5'-H), 4.00 (1H, d, 2'-H), 4.02 (1H, dd, 6a'-H), 
4.06 (1H, dd, 6b'-H), 4.36 (111, dd, Bna-H), 4.49 (1H, dd, Bnb-H), 5.02 (1H, dd, 3'-
H), 5.13 (1H, dd, 5'-H), 5.30 (lH, t, NH), 5.35 (1H, dd, 4'-H) 7.18-7.29 (5H, m, 
PhH), 8.55 (1H, bs, OH); Ax-y)/Hz l'-2' 10.3, 2'-3' 9.8, 3'-4' 9.7, 4'-5' 9.9, 5'-6a' 
2.4, 5'-6b' 4.7, 6a-6b 12.5 Bna-Bnb 14.5, Bna-NH 7.0, Bnb-NH 6.8; ac (93 MHz, 
CDCI3) 21.5, 21.6, 21.7, (4xCOCH 3), 47.5 (PhCFI), 63.0 (C-6'), 69.0, 69.5, 74.3, 
75.0, 76.6 (C- 1',C-2',C-3', C-4', C-5'), 128.4, 129.9, (5xPhCH), 140.0 (PhC), 149.7 
(C=N), 170.5, 170.7, 171.4, 171.7 (4xCOCH 3); mlz (FAB) 481 (M+1) HRMS 





Sample code: 1AS023 
	 Ac °\j N 
Molecular formula: C 1 9H24N208 
	 OAc 	H 
Molecular weight: 408 
To a stiffed mixture of benzylamine (0.14 ml, 1.3 mmol) and triethylamine (1 ml, 7.2 
mmol) in dry chloroform (3 ml), D-xylose derived hydroximoyl chloride 106 (150 
mg, 0.4 mmol) was added in accordance to the general procedure above. Dry-flash 
chromatography yielded the title compound (138) as a white solid (121 mg, 67%). 
M.p. 64-66'C ; [ all020  -3.7 (c = 0.54 CHCI3); & (250 MHz, CDCI3) 1.95, 1.96, 1.97 
(9H, 3s, 3xCOCH 3), 3.19 (1H, dd, 5a'-H), 3.89 (1H, d, l'-H), 4.07 (1H, dd, 5e'-H), 
4.38 (1H, dd, Bna-H), 4.39 (1H, dd, Bnb-H), 4.92 (1H, ddd, 4'-H), 5.11 (1H, dd, 3'-
H), 5.22 (IH, t, NH), 5.29 (1H, dd, 2'-H), 7.14-7.31 (5H, m, PhH); Ax-Y)/Hz  1'-2' 
10.0, 2'-3' 9.2, 3'-4' 9.5, 4'-5a' 10.4, 4'-5e' 5.6, 5a'-5e' 11.2, Bna-Bnb 14.6, Bna-
NH 5.5, Bnb-NH 6.8; öc (63 MHz, CDC13) 20.5 (3xCOCH3), 46.4 (PhCH2), 67.7 (C-
5'), 68.6, 68.7, 73.5, 76.1 (C-1',C-2',C-3', C-4'), 127.3, 127.4, 128.6 (5xPhCH), 
138.8 (PhC), 148.9 (C=N), 169.5, 169.7, 170.2 (3xCOCH 3); m/z (FAB) 409 (M +1) 
HRMS (FAB) Found M+1 409.16095, C 19H24N208 requires M-i-1 409.16 109. 
3.4.1.3 	(Z)-N-Butyl-(2,3,4-tri-O-acetyl--D-xyIopyranosyI)formamide 
oxime (139) 
Sample code: IAS016 
Molecular formula: C 1 6H26N208 
Molecular weight: 374 
N - OH 
Ac2T°\I 
N OAc 
To a stirred mixture of n-butylamine (0.21 ml, 2.2 mmol) and triethylamine (1 ml, 
7.2 mmol) in dry chloroform (5 ml), D-xylose derived hydroximoyl chloride 106 
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(250 mg, 0.75 mmol) was added in accordance to the general procedure above. Dry-
flash chromatography yielded the title compound (139) as a white solid (169 mg, 
63%). 
M.p 111-113 oc; [aID2°  —41 (c = 0.8 ,CHC13); oH (250 MHz, CDC13); 1.91, 1.96, 
1.97 (9H, 3s, 3xCOCH3), (3H, t, Cl 3 0, (6H, m, CH2), 3.21 (1H, dd, 5a'-H), 3.86 
(1H, d, 1'-H), 4.10 (1H, dd, 5e'-H), 4.93 (1H, td, 4'-H), 5.12 (1H, dd, 2'-H), 5.24 
(1H, dd, 3'-H), 8.57 (1H, bs, OH); J(x-y)IHz 1'-2' 9.8, 2'-3' 9.3, 3'-4' 9.3, 4'-5a' 
10.7, 4'-5e' 6.0, 5a'-5e' 11.1; 0c  (63 MHz, CDC13) 14.1 (CH 3), 20.1 (CH2), 20.9 
(3xCOCH3), 33.3 (CH), 42.4 (CH2), 67.1 (C-5'), 69.2, 70.7, 73.9, 77.6 (C- V, C-2', 
C-3', C-4'), 149.5 (C=N) 169.9, 170.2, 170.6 (3xCOCH 3); m/z (FAB) 375 (M +1) 
HRMS (FAB) Found M+1 375.17622, C 1 6H26N208 requires M+1 375.17674. 
3.4.1.4 (Z)-N-PropenyI-(2,3,4-Tri-O-acetyI--D-xyIopyranosyI) formamide 
oxime (140) 
This experiment was done in collaboration with Miss K. S. Homer 
Sample code: KH09 	 NOH 
Molecular formula: 	
AcY °\j N 
C 15H22N208Molecular weight: 358 	
OAc 	H 
To a stirred mixture of allylamine (0.13 ml, 1.8 mmol) and triethylamine (1 ml, 7.2 
mmol) in dry chloroform (3 ml), D-xylose derived hydroximoyl chloride 106 (150 
mg, 0.4 mmol) was added in accordance to the general procedure above. Dry-flash 
chromatography yielded the title compound (140) as a white solid (66 mg, 41%). 
Mp 52-54'C; [a]D20 = -3.5 (c = 0.34, CHC13); 8H  (250 MHz, CDC13); 1.99, 2.01 (9H, 
3s, 3xCOCH3), 3.24 (1H, dd, 5a-H), 3.85 (2H, d, CH 2), 3.88 (1H, d, 1-H), 4.09 (1H, 
dd, 5b-H), 4.95 (1H, m, 4-H), 5.11 (2H, dd, CH2), 5.13 (1H, dd, 2-H), 5.26 (1H, dd, 
3-H), 5.83 (1H, m, CH), 8.71 (1H, bs, OH); Ax-y)/Hz 1-2 9.8, 2-3 9.5, 3-4 5.4, 4-5a 
10.8, 4-5b 11.2; oc (63 MHz, CDC1 3); 20.0 (COCH3), 44.3 (CH2), 66.2 (C-S), 68.0, 
68.1, 72.9, 75.3 (C-2, C-3, C-4, C-i), 115.5 (Cl2), 134.7 (CH), 148.4 (C=N), 168.9, 
169.2, 169.6 (COCH3); m/z (FAB) 359 (M +1) HRMS (FAB) Found M+1 
359. 145 14, C15H22N 208 requires M+1 359.14544. 
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3.4.1.5 (Z)-N-Phenyl-(2,3,4-tri- O-acetyl-f-D-xyIopyranosyI)formamide 
oxime (141) 
Procedure A 
Sample code: IAS014 
Molecular formula: C 1 8H22N208 
Molecular weight: 394 
NOH 
CAOc 0 ~ ~~' 0 N 
OAc 	H 
To a stirred mixture of aniline (0.24 ml, 1.8 mmol) and triethylamine (0.25 ml, 1.8 
mmol) in dry chloroform (5 ml), D-xylose derived hydroximoyl chloride 106 (200 
mg, 0.6 mmol) was added in accordance to the general procedure above. Dry-flash 
chromatography yielded the title compound (141) as a crystalline solid (65 mg, 
28%). 
Procedure B 
Xylose derived hydroximoyl chloride 106 (200 mg, 0.6 mmol) and aniline (0.12 ml, 
1.5 mmol) were dissolved in ethanol (10 ml) and the mixture stirred under an 
atmosphere of nitrogen at room temperature for 16 h or heated under reflux for 5 
hours. The reaction mixture was concentrated in vacuo to afford the crude product, 
which was purified by dry-flash chromatography (silica, hexanelEt 20 gradient 
elution). The title compound (141) was obtained as a crystalline solid (211 mg, 90%) 
M.p 179-180°C; [a]D20-82  (c = 1, CHC13); 8H (250 MHz, CDC1 3); 1.93, 1.95 (9H, 
3s, 3xCOCH3), 3.07 (1H, dd, 5a'-H), 4.05 (1H, dd, 5e'-H) 4.09 (1H, d, l'-H), 4.95 
(1H, td, 4'-H), 5.02 (1H, dd, 2'-H), 5.35 (1H, dd, 3'-H), 6.94 (1H, b.s, NH), 7.04-
7.31 (5H, m, Ar), 7.91 (1H, bs, OH); J(x-y)/Hz 1'-2' 10.0, 2'-3' 9.1, 3'-4' 9.9, 4'-
5a' 10. 1, 4'-5b' 5.45, 5a'-5b' 11.00; öc (63 MHz, CDCI 3) 20.60 (3xCOCH3), 66.53 
(C-5), 68.59, 69.17, 73.31, 73.83 (C-i, C-2, C-3, C-4), 123.59, 124.84, 129.14 
(ArCH), 138.11 (ArC), 146.77 (C=N) 169.25, 169.61, 170.38 (3xCOCH 3); mlz 




glucopyranosyl)formamide oxime (142) 
Sample code: JAS060 	 _OAc NOH 
Ac 0 Molecular formula: C 21 H26N20 1 0 	 CO 
Molecular weight: 466 	 OAc 	H 
D-Glucose derived hydroximoyl chloride 107 (200 mg, 0.5 mmol) and aniline (0.11 
ml, 1.2 mmol) were dissolved in ethanol (10 ml) and the mixture stirred under an 
atmosphere of nitrogen at room temperature for 16 h or heated under reflux for 5 
hours. The reaction mixture was concentrated in vacuo to afford the crude product, 
which was purified by dry-flash chromatography (silica, hexanelEt 20 gradient 
elution). The title compound (142) was obtained as a crystalline solid (190 mg, 83%) 
M.p 55-56°C; [aID20  —79 (c = 1, CHCI 3); 8H  (360 MHz, CDCI3); 1.91, 1.93, 1.94, 
1.98 (12H, 4s, 4xCOCH3), 3.48 (1H, dd, 5'-H), 4.01 (1H, dd, 6a'-H), 4.08 (1H, dd, 
6b'-H), 4.15 (1H, d, 1'-H), 4.97 (in, dd, 3'-H), 5.03 (1H, dd, 5'-H), 5.40 (1H, dd, 
4'-H), 7.04 (1H, b.s, NH), 7.10-7.30 (5H, m, ArH), 8.30 (1H, bs, OH); J(x-y)IHz 1'-
2' 10.2, 2'-3' 9.5, 3'-4' 9.3, 4'-5' 10.1, 5'-6a' 2.3, 5'-6b 6.1, 6a'-6b' 12.4; öc (93 
MHz, CDCI3) 20.3, 20.4, 20.6, 20.9 (4xCOCH3), 62.4 (C-6'), 68.0, 68.6, 72.7, 74.3, 
75.8 (C-2', C-3', C-4', C-5', C-I'), 123.6, 124.9, 129.1 (ArCH), 138.1 (ArC), 146.4 
(C=N) 170.4, 171.3, 171.5, 171.7 (4xCOCH3); m/z (FAB) 467 (M +1) HRMS 
(FAB) Found M-,-1 467.16695, C 21 H26N20 1 0 requires M+i 467.16657. 
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3.4.1.7 (E)-N-MorphoIino-(2,3,4-tri-O-acetyl--D-
xylopyranosyl)formamide oxime (143) 
Sample code: TAS018 
Molecular formula: C 16H24N209 





To a stirred mixture of morpholine (0.26 ml, 3 mmol) and triethylamine (1 ml, 7.2 
mmol) in dry chloroform (5 ml), D-xylose derived hydroximoyl chloride 106 (250 
mg, 0.75 mmol) was added in accordance to the general procedure above. Dry-flash 
chromatography yielded the title compound (143) as a white solid (192 mg, 67%). 
M.p 108-111 °C [aID2°  16 (c = 0.5 ,CHC13); 8H (250 MHz, CDCI3); 2.06, 2.10, 2.11 
(9H, 3s, 3xCOCH3), 3.09-3.16 (2H, m, morpholine CH2), 3.24-3.36 (2H, m, 
morpholine CH2), 3.39 (1H, dd, 5a'-H), 4.24 (1H, dd, 5e'-H) 3.77-3.81 (4H, m, 
morpholine CH 2), 5.12-5.16 (2H, m, 4'-H, l'-H), 5.3 1-5.36 (2H, m, 2'-H, 3'-H), 8.33 
(1H, bs, OH); Ax-y)/Hz l'-2' 9.9, 2'-3', nd, 3'-4' nd, 4'-5a' 10.9, 4'-5e' 5.6, 5a'-5e' 
11.3; öc (63 MHz, CDCI 3) 20.5 (3xCOCH 3), 47.4 (CH), 65.7 (CH2), 66.8 (C-5'), 
68.6, 69.3, 73.3, 77.1 (C-l', C-2', C-3', C-4'), 154.7 (C=N) 169.3, 169.6, 170.4 
(3xCOCH3); mlz (FAB) 389 (M +1) HRMS (FAB) Found M+1 389.15644, 
C26H24N209 requires M-i-1 389.15601. 
3.4.2 General procedure —Amidoxime linked glycopeptide analogues 
A solution of the hydroximoyl chloride (1 equivalent) in chloroform (35-50 ml) was 
added dropwise over 2 hours to a cooled (00  C) and stirred solution of the amino acid 
ester (1.5-2 equivalents) and triethylamine (18 equivalents) in chloroform (3-5 ml) 
under N2. On completion of addition, the mixture was diluted with DCM (50 ml), 
washed with 0.1 M HC1 (2 x 50 ml) and the organic layers dried (MgSO 4). The 




xylopyranosyl)formamide oxime (152) 
Sample code: IAS019 	 NOH 
Molecular formula: C16H24N2010 	 Ac-T°\j, 
Molecular weight: 404 
To a stirred mixture of glycine ethyl ester hydrochloride (186 mg, 1.125 mmol) and 
triethylamine (1 ml, 7.2 mmol) in dry chloroform (5 ml), D-xylose derived 
hydroximoyl chloride 106 (250 mg, 0.75 mmol) was added in accordance to the 
general procedure above. Dry-flash chromatography (silica, hexane/EtOAc gradient 
elution) yielded the title compound (152) as a gum (156 mg, 52%). 
oH (250 MHz, CDCI3) 1.23 (3H, t, CO 2CH2CH3), 1.96, 1.97, 1.98 (9H, 3s, 
3xCOCH3), 3.28 (lB. dd, 5a'-H), 3.85 (1H, d, i'-H), 4.07 (2H, d, CH2), 4.06 (1H, 
dd, 5e'-H), 4.16 (211, q, CO 2CH2CH3), 4.8-5.0 (1H, m, 4'-H), 5.1-5.2 (2H, m, 2'-H & 
3'H), 5.48 (1H, t, NH); Ax-y)/Hz 1'-2' 9.8, 2'-3' 9.2, 3'-4' nd, 4'-5a' 10.2, 4'-5e' 
5.5, 5a'-5e' 11.5, CH2-NH 5.8; Oc  (63 MHz, CDC13) 14.5 (CO2CH2CH3), 21.0 
(3xCOCH3), 44.7 (CH), 61.7 (CO 2 CH2CH3), 67.1 (C-5'), 68.9, 69.1, 73.6, 76.9 (C-
4',C-2',C-3', C-I'), 148.1 (C=N), 170.1, 170.2, 170.5 (3xCOCH 3), 170.7 
(CO2CH2CH3); m/z (FAB) 405 (M +1) HRMS (FAB) Found M+1 405.15194, 
C 1 6H24N2010 requires M 1 -i-i 405.151092. 
3.4.2.2 2:1 Adduct (154) 
Sample code: IAS051 	 NOH 
H 
Molecular formula: 8H27N3011 	 N ..CO2 Et 





To a stirred mixture of glycyl glycine ethyl ester hydrochloride (120 mg, 0.6 mmol) 
and triethylamine (1 ml, 7.2 mmol) in dry chloroform (5 ml), D-xylose derived 
hydroximoyl chloride 106 (150 mg, 0.4 mmol) was added in accordance to the 
general procedure above. Dry-flash chromatography (silica, hexane/EtOAc gradient 
elution) yielded the title compound (154) as a gum (88 mg, 43%). 
Procedure B 
To a cooled (0°C) and stirred mixture of glycine ethyl ester hydrochloride (188 mg, 
1.4 mmol) and triethylamine (1 ml, 7.2 mmol) in dry chloroform (5 ml), D-xylose 
derived hydroximoyl chloride (106) (300 mg, 0.9 mmol) in chloroform (45 ml) was 
added dropwise over 2 hours. On completion of addition the mixture was allowed to 
stir for 16 hours. The mixture was diluted with DCM (50 ml), washed with 0.1 M 
HCI (2 x 50 ml) and the organic layers dried (MgSO4). The organic layers were 
concentrated in vacuo and the residue subjected to dry-flash chromatography (silica, 
hexane/EtOAc gradient elution) to yield the product (154) as a white solid (82 mg, 
20%). 
[aID20  —35 (c = 1.0 ,CHC13); oH (250 MHz, CDC1 3) 1.21 (3H, t, CO2CH2CH3), 1.92, 
1.95, 1.97 (9H, 3s, 3xCOCH3), 3.29 (1H, dd, 5a-H), 3.90 (1H, d, 1-H), 3.98-4.08 
(5H, m, Se-H, CH2a, CH2b), 4.14 (2H, q, CO 2CH2CH3), 4.86-5.39 (3H, m, 4-H, 3-H, 
2-H), 5.61 (1H, t, NH), 7.45 (1H, t, NH); Ax-y)/Hz 1-2 9.6, 2-3 nd, 3-4 nd, 4-5a 
10.8, 4-5e nd, 5a-5e 11.0, CH 2-NH 5.8; Oc  (63 MHz, CDC13) 13.9 (CO2CH2CH3), 
20.4 (3xCOCH 3), 40.9 (CH2), 46.2 (CH2), 61.0 (CO 20H2CH3), 66.5 (C-5), 68.5, 
69.7, 73.0, 76.1 (C-i, C-2, C-3, C-4), 147.8 (C=N), 169.7, 169.9, 170.0 (3xCOCH3), 
170.9 (CO2CH2CH3); m/z (FAB) 462 (M +1) HRMS (FAB) Found M-i-1 
462.17268, C7H28N2010 requires M++1 462.17238. 
146 
3.4.2.3 (Z)-N-CarbmethoxymethyI-2-'butyI-(2,3,4-tri-O-acetyI-3-D-
xylopyranosyl)formamide oxime (155) 
Sample code: IAS046A 
Molecular formula: C 1 9H30N2010 




N 	CO2 Me 
OAc 	H 
To a stirred mixture of L-leucine methyl ester hydrochloride (110 mg, 0.6 mmol) and 
triethylamine (1 ml, 7.2 mmol) in dry chloroform (5 ml), D-xylose derived 
hydroximoyl chloride 106 (150 mg, 0.4 mmol) was added in accordance to the 
general procedure above. Dry-flash chromatography (silica, hexane/EtOAc gradient 
elution) yielded the title compound (155) as a colourless gum (105 mg, 53%). 
H (250 MHz, CDCI3) 0.88, 0.91 (6H, 2s, CH3(iPr)), 1.48-1.57 (2H, m, CH2(iPr)), 
1.60-1.78 (1H, m, CH(iPr)) 1.89, 1.97, 1.99 (9H, 3s, 3xCOCH 3), 3.29 (1H, dd, 5a-H), 
3.66 (3H, s, CO2CH3), 3.85 (1H, d, 1-H), 4.04 (1H, dd, Se-H), 4.16-4.27 (1H, m, 
CH), 4.86-5.03 (1H, m, 4-H), 5.09-5.31 (3H, m, 2-H, 3-H, NH) ; J(x-y)fHz 1-2 9.8, 
2-3 nd, 3-4 nd, 4-5a 10.8, 4-5e 5.7, 5a-5e 11.2, CH 2-NH 5.6; 8c (63 MHz, CDC13) 
20.5, 21.2, 21.3 (3xCOCFI 3), 24.0, 24.7 (CH3('Pr)), 40.8 (CH 2('Pr)), 48.8 (CO2CH 3), 
66.5 (C-S), 68.4, 68.9, 72.2, 74.7 (C-i, C-2, C-3, C-4), 149.8 (C=N), 169.6, 169.7, 
169.8 (3xCOCH 3), 173.0 (CO2CH3); m/z (FAB) 447 (M +1) HRMS (FAB) Found 
M-i-1 447. 19823, C 19H30N20 10 requires M-i-1 447.19787. 
3.4.2.4 (Z)-N-CarbethoxymethyI-2-benzyI-(2,3,4-tri-O-acetyI-f-D-
xylopyranosyl)formamide oxirne (161) 
Sample code: 1A5045 
Molecular formula: C23H 30N20 1 0 	
NOH 





To a stirred mixture of L-phenylalanine ethyl ester hydrochloride (306 mg, 0.6 
mmol) and triethylamine (1 ml, 7.2 mmol) in dry chloroform (5 ml), D-xylose 
derived hydroximoyl chloride 106 (150 mg, 0.4 mmol) was added in accordance to 
the general procedure above. Dry-flash chromatography (silica, hexane/EtOAc 
gradient elution) yielded the title compound (161) as a gum (115 mg, 52%). 
M.p 209-210 °C; [a]020-161  (c = 1.0 ,CHCI3); 8H  (250 MHz, CDCI3) 1.12 (3H, t, 
CO2CH2C), 1.89, 1.97, 1.98 (9H, 3s, 3xCOCH3), 3.01 (1H, dd, C1-1 2a), 3.09 (1 H, 
dd, CH2b), 3.21 (1H, dd, 5a-H), 3.82 (1H, d, 1-H), 4.00-4.09 (3H, m, CO2CH2CH3, 
5b-H), 4.46-4.55 (1H, m, CH), 4.86-4.97 (1H, m, 4-H), 5.09-5.20 (2H, m, 2-H, 3-H), 
5.26 (1H, d, NH), 7.08-7.39 (5H, m, PhH); Ax-y)/Hz 1-2 9.5, 2-3 nd, 3-4 nd, 4-5a 
10.7, 4-5e nd, 5a-5e 10.8., CH-NH 10.0; 8c (63 MHz, CDC1 3) 13.9 (CO2CH2 CH3), 
20.5 (3xCOCH3), 39.8 (PhCH 2), 56.2 (CH), 61.1 (CO2 CFI2CH3), 66.5 (C-5), 68.6, 
69.1, 73.3, 76.2 (C-i, C-2, C-3, C-4), 126.9, 128.4, 129.3 (ArCH), 135.6 (ArC), 
147.1 (C=N), 169.4, 169.7, 170.2 (3xCOCH 3), 172.1 (CO2CH2H3); m/z (FAB) 495 
(M +1) HRMS (FAB) Found M+l 495.19803, C23H3 1 N20 1 0 requires M+1 
495.19787. 
3.4.2.5 (Z)-N-CarbethoxyethyI-(2,3,4-tri-O-acetyI--D-
xylopyranosyl)formamide oxime beta alanine (164) 
Sample code: 1AS049 	 NOH 
Molecular formula: C1 7H27N2010 	
AcYg°\j 
Molecular weight: 418 
To a stirred mixture of -alanine ethyl ester hydrochloride (92 mg, 0.6 mmol) and 
triethylamine (1 ml, 7.2 mmol) in dry chloroform (S ml), D-xylose derived 
hydroximoyl chloride 106 (150 mg, 0.4 mmol) was added in accordance to the 
general procedure above. Dry-flash chromatography (silica, hexane/EtOAc gradient 
elution) yielded the title compound (164) as a gum (90 mg, 50%) 
M.p 110-112 °C; [c]o203S  (c = 1.0 ,CHC13); &- (360 MHz, CDCI 3); 1.22 (3H, t, 
CO2CH2CH3), 1.94, 1.98, 2.01 (9H, 3s, 3xCOCft), 2.53 (2H, t, CH2CH2CO 2Et), 
3.29 (1H, dd, 5a'-H), 3.53 (2H, m, CCH2CO2Et), 3.91 (1H, d, 1-H), 4.12 (1H, dd, 
5e'-H), 4.13 (3H, q, CO2CCH3), 4.96 (1H, ddd, 4-H), 5.18 (1H, dd, 2-H), 5.24 
(1H, dd, 3'-H), 5.36 (1H, t, NH); J(x-y)IHz 1-2 9.3,2-3 9.4, 3-4 9.0, 4-5a 10.8, 4-5e 
5.4, 5a-5e 11.2; 5c (93 MHz, CDC13) 14.5 (CO 2CH2CH3), 20.9, 21.0 (3xCOCH3), 
36.1 (CH20H2CO2Et), 38.9 (CH2CH2CO2Et), 61.1 (CO2CH2CH3), 67.14 (C-5), 69.0, 
69.2, 73.9, 76.9 (C- 1, C-2, C-3, C-4), 149.0 (C=N) 170.0, 170.2, 170.60 (3xCOCH3) 
170.3 (CO2CH2CH3); m/z (FAB) 419 (M +1) HRMS (FAB) Found M+l 
419.16741, C 17H28N20 1 0 requires M+i 419.16657. 
3.4.26 (Z)-N-Carb tbutoxymethyI-(2,3,4-tri-O-acetyI--D-
xylopyranosyl)formamide oxime (165) 
Sample code: IAS050 
Molecular formula: C 1 8H28N20 1 0 




N 	CO2'Bu OAc 	H 
To a stirred mixture of glycine tertiarybutyl ester.AcOH (115 mg, 0.6 mmol) and 
triethylamine (1 ml, 7.2 mmol) in dry chloroform (5 ml), D-xylose derived 
hydroximoyl chloride 106 (150 mg, 0.4 mmol) was added in accordance to the 
general procedure above. Dry-flash chromatography (silica, hexane/EtOAc gradient 
elution) yielded the title compound (165) as a colourless gum (170 mg, 88%). 
[a] 20 -49 (c = 1.35 ,CHC13) oH (360 MHz, CDC13) 1.45, (9H, s, CH3), 1.97, 2.02, 
2.03 (9H, 3s, 3xCOCH3), 3.32 (1H, dd, 5a-H), 3.87 (1H, d, 1-H), 3.92 (1H, dd, 
CH2a), 4.04 (1H, dd, CH2b), 4.16 (1H, dd, Se-H), 4.97-5.04 (1H, m, 4-H), 5.18-5.22 
(2H, m, 2-H & 3H), 5.49 (1H, t, NH) ; J(x-y)/Hz 1-2 9.8, 2-3 nd, 3-4 nd, 4-5a 10.8, 
4-5e 5.6, 5a-5e 11.2, CH2-NH 5.8; Oc  (93 MHz, CDCI 3) 21.7, 21.8 (3xCOCH3), 30.7 
(CH3), 45.8 (CH 2), 67.8 (C-S'), 69.6, 69.9, 74.3, 77.9 (C-4',C-2',C-3', C-l'), 83.2 
(Cq), 148.9 (C=N), 170.4, 170.8, 171.0 (3xCOCH3), 171.3 (CO2 tBu); m/z (FAB) 433 
(M +1) HRMS (FAB) Found M+1 433.18226, C 1 6H24N20 10 requires M+1 
433.18222. 
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3.4.3 Cyclisation Reactions 
3.4.3.1 	3-(2,3,4-Tri-O-acetyl--D-xyIopyranosyI)-1 ,2,4-oxadiazin-6-one 
(153) 
Sample code: IAS020 
Molecular formula: C 14H 1 8N209 
Molecular weight: 358 
co_~:~
j N :ro 
OAc 	H 
(Z)-N-Carbethoxymethyl-(2' ,3' ,4 ' -tri-O-acetyl--D-xylopyranosyl)formamide oxime 
(152) (156 mg, 0.4 mmol) was dissolved in chloroform (15 ml), stirred with silica 
(500 mg) and heated under reflux for 32 hours. On cooling, the product was obtained 
as a crystalline solid (83 mg, 60%) after dry-flash chromatography (silica, 
hexanelEt 20 gradient elution). 
M.p. 165 °C (decomp.) (from hexane-EtOAc), [a]0 2° —151 (c = 2.25, CHC13); 
(250 MHz, CDC1 3) 1.98, 1.99, 2.00 (9H, 3s, 3xCOCH 3), 3.37 (1H, dd, 5a'-H), 3.94 
(1H, d, 1'-H), 3.95 (2H, s, CH 2), 4.14 (111, dd, 5e'-H), 4.93 (1H, ddd, 4'-H), 4.98 
(1H, dd, 3'-H), 5.26 (1H, t, 2'H), 5.61 (1H, br s, NH); Ax-y)/Hz i'-2' 9.7, 2'-3' 9.4, 
3'-4' 9.9, 4'-5a' 10.3, 4'-5e' 6.2, 5a'-5e' 11.6; öc (63 MHz, CDC13) 20.4 
(3xCOCH3), 40.2 (CH2), 66.5 (C-5'), 68.4, 69.1, 71.7 (C-2',C-3',C-4'), 74.9 (C-l'), 
150.4 (C=N), 164.6 (C=O), 169.7, 169.8, 170.1 (3xCOCH 3); m/z (FAB) 359 (M + 
1) HRMS (FAB) Found M+ 1 359.10950, C 14H 1 8N209 requires M + 1, 359.10906. 
3.4.3.2 	3-(2,3,4-Tri-O-acetyl--D-xyIopyranosyI)-5-(isopropyl)-1 ,2,4- 
oxadiazin-6-one (156) 
Sample code: IAS046B 	
N 
Molecular formula: C18H26N209 
	 Ac2°\J N 
Molecular weight: 414 
	
OAc 	H 
Amidoxime 155 (199 mg, 0.44 mmol) was dissolved in chloroform (15 ml), stirred 
with silica (500 mg) and heated under reflux for 32 hours. On cooling, the product 
150 
(156) was obtained as a crystalline solid (130 mg, 70%) after dry-flash 
chromatography (silica, hexanefEt 20 gradient elution). 
M.p 182-184 °C; [aID2°  —107 (c = 1.0 ,CHCI3); oH (360 MHz, CDCI3 ) 0.95, 0.99 
(6H, 2d, CH3(iPr)), 1.72-1.81 (2H, m, CH 2(iPr)), 2.04, 2.05 (9H, 3s, 3xCOCH3), 3.41 
(1H, dd, 5a'-H), 3.99-4.03 (2H, m, CH, F-H), 4.21 (1H, dd, 5e'-H), 5.00 (1H, m, 4'-
H), 5.02 (1H, dd, 2'-H), 5.28 (1H, dd, 3'-H); J(x-y)/Hz l'-2' 9.8, 2'-3' 9.5, 3'-4' 9.6, 
4'-5a' 10.8, 4'-5e' 5.6, 5a'-5e' 11.4; E,c (93 MHz, CDC1 3) 21.7, 22.4 (3xCOCH3), 
23.7, 25.2 (CH3('Pr)), 41.9 (CH20r)), 50.0 (C-5), 67.7 (C-5'), 69.6, 70.0, 73.3, 75.8 
(C-l', C-2', C-3', C-4'), 151.0 (C=N), 168.6 (C=O) 170.8, 170.9, 171.0 
(3xCOCH3); in/.z (FAB) 415 (M +1) HRMS (FAB) Found M+1 415.17168, 
C 1 8H27N209 requires M+1 415.17 166. 
3.4.3.3 3-(2,3,4-Tri- O-acetyI--D-xyIopyranosyI)-5-(benzyI)-1 ,2,4-
oxadiazin-6-one (162) 
Sample code: 1AS068 
Molecular formula: C21H24N209 	 Ac °\j N 
Molecular weight: 448 	 OAc 	H 
Amidoxime 161 (115 mg, 0.23 mmol) was allowed to stand in an N.M.R tube for - 6 
months at room temperature, after which time, the solvent was removed in vacuo to 
afford the title compound (162) as a white solid (104 mg, 98%). 
M.p 82-84 °C; [a]020  —24 (c = 5.1 ,CHCI 3); oH  (360 MHz, CDCI3) 2.08, 2.11, 2.14 
(9H, 3s, 3xCOCH3), 3.04 (1H, dd, CH 2a), 3.38 (1H, dd, 5a'-H), 3.45 (1H, dd, CH 2b), 
3.97 (1H, d, 1'-H), 4.12 (1H, dd, 5e'-H), 4.23 (1H, ddd, 5-H), 4.93 (1H, ddd, 4'-H), 
5.03 (1H, dd, 2'-H), 5.08 (1H, d, NH), 5.32 (1H, dd, 3'-H) ; J(x-y)IHz 1'-2' 9.8, 2'-
3' 9.6, 3'-4' 9.6, 4'-5a' 10.8, 4'-5e' 5.7, 5a'-5e' 11.4., CH-NH 1.8; Oc  (93 MHz, 
CDC13) 21.7, 21.8, 22.0 (3xCOCH3), 39.7 (CH2Ph), 52.9 (C-5), 67.2 (C-5'), 67.7, 
69.6, 73.1, 75.8 (C-l', C-2', C-3', C-4'), 128.8, 129.7, 130.3 (PhCH), 136.3 (PhC), 
150.4 (C=N), 167.6 (C=O) 170.9, 171.0, 171.2 (3xCOCH3); m/z (FAB) 449 (M +1) 




Sample code: 1AS053 	
N 
Molecular formula: C17H22N209 	 AC \I 	 H 
NJ 
Molecular weight: 398 	 OAc 
To a cooled (0°C) and stirred mixture of L-proline benzyl ester hydrochloride (326 
mg, 1.4 mmol) and triethylamine (1 ml, 7.2 mmol) in dry chloroform (5 ml), D-
xylose derived hydroximoyl chloride 106 (300 mg, 0.9 mmol) in chloroform (45 ml) 
was added dropwise over 2 hours. On completion of addition, the mixture was 
diluted with DCM (50 ml), washed with 0.1 M HCI (2 x 50 ml) and the organic 
layers dried (MgSO4). The organic layers were concentrated in vacuo and the residue 
subjected to dry-flash chromatography (silica, hexane/Et 20 gradient elution) to 
remove residual amino acid. The amidoxime/oxadiazinone mixture was dissolved in 
chloroform (15 ml), stirred with silica (500 mg) and heated under reflux for 2 hours. 
On cooling, the product (163) was obtained as a white solid (200 mg, 57%) after dry-
flash chromatography (silica, hexanelEt 20 gradient elution). 
M.p 71-73 °C; [(x]02° —99 (c = 1.0 ,CHCI 3); E, (360 MHz, CDC1 3) 2.03, 2.07 (9H, 
3s, 3xCOCH3), 2.01-2.37 (4H, m, 2xproline CH2), 3.39 (1H, dd, 5a'-H), 3.72-3.80 
(2H, m, proline CH 2), 3.85-3.91 (1H, m, proline CH ), 4.03 (1H, d, 1'-H), 4.18 (1H, 
dd, 5e'-H), 5.02 (1H, ddd, 4'-H), 5.10 (1H, dd, 3'-H), 5.32 (1H, dd, 2'-H); Ax-Y)/Hz 
1'-2' 10.3, 2'-3' 9.6, 3'-4' 9.6, 4'-5a' 10.8, 4'-5e' 5.7, 5a'-5e' 11.3; 8c (93 MHz, 
CDC13) 20.3, 20.4 (3xCOCH 3), 24.1 (CH2), 26.8 (CH2), 47.1 (CH 2), 54.8 (CH), 66.6 
(C-5'), 68.0, 68.6, 72.2, 75.7 (C-l', C-2', C-3', C-4'), 151.8 (C=N), 168.7 (C=O) 
169.5, 169.7, 170.1 (3xCOCH3); m/z (FAB) 399 (M +1) HRMS (FAB) Found M-i-1 
399.14027, C17H23N209 requires M++1 399.14036. 
152 
3.5 Synthesis of Pyranosylamines 
3.5.11 ,2:3,4-Di-0-isopropylidene-a-D-galactopyranose (174) 
Sample code: 1AS034 
Molecular formula: C 1 2H20 0 
Molecular weight: 260 
X  0 OH 
D-Galactose (20 g, 0.11 mol), anhydrous Cu504 (43.7 g, 0.27 mol) and dry acetone 
(440 ml) were stirred at room temperature under nitrogen. Concentrated H2SO4 ( 
(2.2 ml) was added with vigourous stiring, the resulting mixture was left to stir for 24 
hours. The mixture was filtered, the resultant yellow filtrate was stirred with CaOH 2 
(15 g) for 24 hours. The mixture was filtered and the filtrate was concentrated in 
vacuo to afford an amber coloured oil that contained crude product. The crude 
material was purified by kugelrohr distillation, the product (174) was obtained as a 
colourless glass (17.5 g, 61%) 
[a] 20-56  (c = 3 ,CHC1 3) (lit. 
173  [aID2° -59 (c = 3, CHCI 3)); 8H  (360 MHz, CDCI 3); 
1.32, 1.44, 1.52, (12H, 4s, 4xCH 3), 2.38 (1H, bs, OH), 3.71 (1H, dd, 6a-H) 3.80-3.88 
(2H, m, 6b-H, 5-H), 4.25 (1H, dd, 4-H), 4.31 (1H, dd, 2-H), 4.59 (1H, dd, 3-H), 5.55 
(1H, d, 1-H); Ax-y)/Hz 1-2 5.0, 2-3 2.4, 3-4 7.9, 4-5 1.6, 5-6a 3.4, 5-6b 6a-6b 10.4; 
C (63 MHz, CDC13) 24.2, 24.8, 25.8, 25.9 (4xCH3), 62.2 (C-6), 68.4, 70.7, 70.8, 
71.6 (C-2, C-3, C-4, C-5), 96.2 (C-l), 108.5, 109.3, (2xC); m/z (FAB) 261 (M+l); 
HRMS (FAB) Found: M+1 261.13366. C12H2006 requires M+1 261.13381. 
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3.5.2 6-O-(p-Tolylsulfonyl)-1 ,2 :3,4-di-O-isopropylidene-a-D-
galactopyranose (175) 
Sample code: 1A5030 
Molecular formula: C 1 9H26 08 S 




1 ,2:3,4-Di-O-isopropylidene-a-D-galactopyranose (174) (5 g, 19 mmol) and p-
toluenesulfonyl chloride (4.2 g, 22 mmol) were dissolved in a 2:1 mixture of 
pyridine:acetonitrile (60 ml) and stirred for 6 hours. The reaction mixture was mixed 
with ether (80 ml), washed 3 times water (70 ml) and once with 0.2 M HC1 (80 ml) 
before drying over MgSO4. The mixture was filtered and concentrated in vacuo to 
yield an oil. The oil was chilled in ice until it became a gum, and was vigourously 
triturated with 9:1 hexane:ethyl acetate (5 ml) to afford the title compound (175) as a 
white solid (5.3 g, 67 %). 
H (250 MHz, CDC1 3); 1.21, 1.24, 1.27, 1.43 (12H, 4s, 4xCH3), 2.37 (1H, s, ArCH3), 
3.94-4.05 (2H, m, 6a-H, 6b-H) 4.10-4.16 (2H, m, 5-H, 4-H), 4.22 (1H, dd, 2-H), 4.52 
(1H, dd, 3-H), 5.38 (1H, d, 1-H), 7.26 (2H, d, ArH) 7.73 (2H, d, ArH) ; Ax-Y)/Hz 1- 
2 4.9, 2-3 2.5, 3-4 7.9, 4-5 nd, 5-6a nd, 5-6b nd, 6a-6b nd; öC (63 MHz, CDC13) 21.5 
(ArMe), 24.2, 24.7, 25.6 (4xCH3), 68.0 (C-6), 65.7, 70.1, 70.2, 70.3 (C-2, C-3, C-4, 
C-5), 96.0 (C-i), 108.8, 109.4, (2xC), 127.9, 129.0, 132.6 (ArCH) 144.6 (ArC); mlz 
(FAB) 412 (M+1); HRMS (FAB) Found: M t-i-i 414.14292. C 1 9H2608S requires 
M+1 414.14267. 
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3.5.3 6-Azido-6-deoxy-1 ,2:3,4-di-O-isopropylidene-a-D-galactopyranose 
(176) 
Sample code: IAS031 	 0 	N3 
Molecular formula: C 1 2H 1 9N3 05 
Molecular weight. 285 	 0 
6-O-(p-tolylsulfonyl)- 1,2:3 ,4-di-O-isopropylidene-a-D-galactopyranose (175) (1 g, 
2.4 mmol) was dissolved in DMSO (10 ml) before adding sodium azide (315 mg, 5 
mmol). The mixture was heated to 115°C under reflux for 24 hours. On cooling, 
water (50 ml) and ether (50 ml) were added and the mixture was allowed to partition. 
The aqueous layer was extracted with ether (2x 50 ml) and the combined organic 
layers dried over MgSO 4 . The solution was filtered and concentrated in vacuo to 
afford the title compound (176) as a colourless oil (663 mg, 96%). 
'O max1cm (Nujol) 2105 (N3); 8H  (250 MHz, CDCI3); 1.27, 1.39, 1.48 (12H, 4s, 
4xCH3), 3.29 (lH, dd, 6a-H), 3.44 (1H, dd, 6b-H) 3.79-3.88 (2H, m, 5-H), 4.13 (1H, 
dd, 4-H), 4.26 (1H, dd, 2-H), 4.56 (1H, dd, 3-H), (1H, d, I-H); Ax-Y)/Hz 1-2 5.0, 2-
3 2.5, 3-4 7.9, 4-5 2.0, 5-6a 5.4, 5-6b 7.8, 6a-6b 12.7; 8C (63 MHz, CDC1 3) 24.2, 
24.7, 25.8, 25.9 (4xCH3), 50.5 (C-6),,66.9, 70.2, 70.6, 71.0 (C-2, C-3, C-4, C-5), 
96.2 (C-i), 108.6, 109.5, (2xC); m/z (FAB) 286 (M+l); HRMS (FAB) Found: M+1 
286. 14094. C 1 2H 1 9N305 requires M+1 286. 14030. 
3.5.4 6-Am ino-6-deoxy-1 ,2:3,4-di-O-isopropylidene-a-D-galactopyranose 
Hydrochloride (177) 
Sample code: 1AS033 
Molecular formula: C12H2 1 N 05 Cl 
Molecular weight: 295.5 
X 0 NH2.HCI 
A 
6-azido-6-deoxy- 1,2:3 ,4-di-O-isopropylidene-cx-D-galactopyranose (176) (660 mg, 2 
mmol) was dissolved in a mixture of ethanol (50 ml) and chloroform (1 ml) and 
stirred vigourously with 10% Pd/C (110 mg) for 16 hours under an atmosphere of 
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hydrogen gas (20 bar) in a Parr high pressure hydrogenator. The Pd catalyst was 
filtered off through a celite pad and the filtrate removed in vacuo to afford the title 
compound (177) as a white solid (611 mg, 89%). 
umax/cm ' (Nujol) 3377 v.broad (NH 2); oH (250 MHz, D20); 1.39, 1.48, 1.56 (12H, 
4s, 4xCH3), 3.14-3.30 (2H, m, 6a-H, 6b-H), 4.08-4.16 (1H, m, 5-H) 4.46 (1H, dd, 4-
H), 4.57 (1H, dd, 2-H), 4.71-4.88 (1H, m, 3-11), 5.70 (1H, d, 1-H); Ax-y)/Hz 1-2 5.0, 
2-3 2.4, 3-4 7.9, 4-5 1.6, 5-6a nd, 5-6b nd, 6a-6b nd; OC (63 MHz, D20) 23.7, 24.3, 
25.3 (4xCH 3), 40.2 (C-6), 64.8, 70.2, 70.6, 71.5 (C-2, C-3, C-4, C-5), 96.3 (C-i), 
110.4, 110.9, (2xC); m/z (FAB) 260 (M+1); HRMS (FAB) Found: MH 260.14998. 
C 1 2H22N05 requires MH 260.14980. 
3.5.5 2,6-Anhydro-3,4,5-tri-O-acetyl--D-xyIopyranosyInitriIe (167) 
Sample code: 1AS043 
Molecular formula: C,2H, 5N 07 
Molecular weight: 285 	 OAc 
3,4,5-Tri-O-acetyl-3-D-xylopyranosylnitromethane (95) (1.5 g, 4.7 mmol) was 
dissolved in pyridine (30 ml) and cooled in an ice bath. PC13 0  ml) was added and 
the mixture stirred for 3 days at room temperature. Ice-cold 1 M HCI (30 ml) was 
added to the solution and the mixture stirred for 1 hour. The solution was extracted 
with chloroform (3 x 50 ml) and the combined organic layers were washed with 
NaHCO3 (2 x 50 ml) and water before drying over MgSO 4. The solvent was co-
evaporated with water (to remove residual pyridine) to afford crude product as a 
gummy solid. The title compound (167) was obtained as a white solid (1.34 g, 75%) 
after dry-flash chromatography. 
M.p 128-130°C (, it. 116 131-132°C); u max/cm' (Nujol) 2257 (CN) 1759 (C=0); 0H 
(250 MHz, CDC1 3); 2.02, 2.04, 2.06 (9H, 3s, 3xCOCH3), 3.54 (1H, dd, 6a-H), 4.17 
(1H, dd, 6b-H), 4.46 (1H, d, 2-H), 4.82-4.89 (1H, m, 5-H), 5.00-5.08 (2H, m, 3-H, 4-
H); J(x-y)/Hz 2-3 6.7, 3-4 nd, 4-5 nd, 5-6a 6.8, 5-6b 4.0, 6a-6b 12.4; Oc  (63 MHz, 
CDC1 3) 20.41, 20.58 (3xCOCH3), 65.1 (C-6), 65.3, 66.7, 67.7, 68.7 (C-3, C-4, C-5, 
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C-2), 114.2 (CN) 168.7, 169.2, 169.3 (3xCOCH 3); mlz (FAB) 286 (M+l); HRMS 
(FAB) Found: M+1 286.09240. C12H1 5N07 requires M+1 286.09268. 
3.5.6 2,3,4,6-Tetra-0-acetyl-1 -deoxy-1 --D-gIucopyranosyInitriIe (189) 
Sample code: 1AS057 	 OAc 
Ac 	 0 Molecular formula: C 15H, 9N 09 
07 
Molecular weight: 357 	 OAc 
2,3 ,4,6-Tetra-O-acetyl--D-g1ucopyranosy1nitromethane (99) (1.5 g, 4.2 mmol) was 
dissolved in pyridine (30 ml) and cooled in an ice bath. PC1 3 (1 ml) was added and 
the mixture stirred for 3 days at room temperature. Ice-cold 1 M HCI (30 ml) was 
added to the solution and the mixture stirred for 1 hour. The solution was extracted 
with chloroform (3 x 50 ml) and the combined organic layers were washed with 
NaHCO3 (2 x 50 ml) and water before drying over MgSO 4. The solvent was co-
evaporated with water (to remove residual pyridine) to afford crude product as a 
gummy solid. The title compound (189) was obtained as a white solid (1.2 g, 82%) 
after dry-flash chromatography. 
M.p 114°C (lit. 186 114-115°C); u,,,,,,/cm- I max/cm ' (Nujol) 2257 (CN), 1753 (C=0); ö,, (250 
MHz, CDC13); 1.96, 1.97, 2.05 (12H, 4s, 4xCOCH 3), 3.67 (1H, ddd, 6-H), 4.07 (1H, 
dd, 7a-H), 4.17 (1H, dd, 7b-H), 4.29 (lH, dd, 2-H), 5.04 (1H, dd, 3-H), 5.12 (1H, dd, 
5-H), 5.25 (1H, dd, 4-H), 8.78 (1H, bs, OH); J(x-y)fHz 2-3 9.9, 3-4 9.2, 4-5 9.7, 5-6 
9.0, 6-7a 2.2, 6-7b 4.7, 7a-7b 12.7; 8 C (63 MHz, CDC13) 20.7, 20.8, 21.0 
(4xCOCFI3), 61.7 (C-7), 66.68, 67.5, 69.2, 73.1, 76.9 (C-2, C-3, C-4, C-5, C-6,), 
114.5 (C-l) 169. 1, 169.5, 170.3, 170.8 (4xCOCH 3); ,nlz (ES) 358 (MH) 
157 




Molecular formula: C 12H20N7 07 Cl 	 OAc 
Molecular weight: 325.5 
2,6-Anhydro-3,4,5-tri-O-acetyl-3-D-xylopyranosylnitrile (167) (500 mg, 1.8 mmol) 
was dissolved in a mixture of ethanol (50 ml) and chloroform (1 ml) and stirred 
vigourously with Pl02 (Adams catalyst) (60 mg) for 16 hours under an atmosphere 
of hydrogen gas (20 bar) in a Parr high pressure hydrogenator. The catalyst was 
filtered off through a celite pad and the filtrate removed in vacuo to afford the title 
compound as a white solid (182) (565 mg, 99%). 
Umax/cflTi' (Nujol) 3364 (NH2), 1745 (C=0); Rx1 20 129 (c = 1.5 , D20); M.p 183-
184°C, [ct]0 18 -38 (c = 1.6, D 20); 8H (250 MHz, D20); 2.01, 2.04 (9H, 3s, 
3xCOCH3), 3.02 (1H, dd, la-H), 3.18-3.25 (1H, m, lb-H), 3.45 (1H, dd, 6a-H), 3.79-
3.86 (1H, m, 2-H), 4.13 (1H, dd, 6e-H), 4.90 (1H, dd, 3-H), 4.95-5.06 (1H, m, 5-H), 
5.25 (1H, dd, 4-H); Ax-y)/Hz la-2 8.8, lb-2 nd, la-lb 13.5, 2-3 9.6, 3-4 9.3, 4-5 9. 1, 
5-6a 10.7, 5-6e 5.9, 6a-6e 11.4; 8c (63 MHz, D 20) 20.6 (3xCOCH 3), 40.5 (C- 1), 66.2 
(C-6), 69.3, 70.6, 74.2 (C-2, C-3, C-4, C-5), 173.3, 173.7 (3xCOCH3); m/z (FAB) 
290 (M+1); HRMS (FAB) Found: M+l 290.12351. C 1 2H 1 9N07 requires M+l 
290.12398. 
3.5.8 (3,4,5,7-Tetra- O-acetyl--D-glucopyranosyl) methylamine 
hydrochloride (183) 
Sample code: 1AS058 	 OAc 
Molecular formula: 5H3N 09 	 Ac 	 CH2NH2HCI
CO_ 
Molecular weight: 397.5 	 OAc 
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2,3 ,4,6-Tetra-O-acetyl- I -deoxy- 1 --D-glucopyranosylnitnle (189) (500 mg, 4.2 
mmol) was dissolved in a mixture of ethanol (50 ml) and chloroform (1 ml) and 
stirred vigourously with Pt0 2 (Adam's catalyst) (60 mg) for 16 hours under an 
atmosphere of hydrogen gas (20 bar) in a Parr high pressure hydrogenator. The 
catalyst was filtered off through a celite pad and the filtrate removed in vacuo to 
afford the title compound (183) as a waxy solid (476 mg, 90%). 
D rnax/cm (Nujol) 3367 (NH2), 1742 (C=O); [ct]D' 8 -5.0 (c = 0.2, D20); oH (250 MHz, 
D20); 2.03, 2.07, 2.08 (12H, 4s, 4xCOCH 3), 3.08 (111, dd, la-H), 3.24-3.32 (1H, m, 
lb-H), 3.81-4.03 (IH, dd, 2-H, 6-H), 4.18-4.24 (1H, m, 7a-H), 4.41 (1H, dd, 7b-H), 
4.97 (1H, dd, 3-H), 5.11 (1H, dd, 5-H), 5.36 (1H, dd, 4-H); J(x-y)/Hz la-2 9.1, lb-2 
nd, la-lb 13.5, 2-3 9.1, 3-4 10.1, 4-5 10.2, 5-6 9.2, 6-7a nd, 6-7b 3.6, 7a-7b 12.7; & 
(63 MHz, D20) 20.5 (4xCOCH3), 40.5 (C- 1), 62.4 (C-7), 68.5, 70.4, 73.7, 74.5, 75.3 
(C-2, C-3, C-4, C-5, C-6,), 173. 2, 173.7, 174.1 (4xCOCH 3); m/z (FAB) 362 (M ++ 1) 
HRMS (FAB) Found M+l 362. 14517, C 15H 1 9N09 requires M'1 +l 362.14511. 
3.5.9 (3,4,5-Tn- O-acetyl-f-D-xylopyranosyl) methylhydroxylam me 
hydrochloride (188) 
Sample code: 1AS054 
Molecular formula: C 1 2H 1 9N08 
Molecular weight: 341.5 
Ac 	 0 
NHOH. HCI 
OAc 
Nitromethyl compound 95 (312 mg, 1 mmol) was dissolved in a mixture of THF (75 
ml), conc HCI (3 ml), glacial acetic acid (16 ml) and water (30 ml). The mixture was 
cooled (0° C) and stirred before adding Zn dust (1.57 g, 24 mmol). On completion of 
the reaction (2 hours) the Zn was filtered off through a, celite pad and the filtrate 
diluted with DCM (50 ml). The solution was washed with NaHCO 3 (2x 50 ml) and 
water before drying over MgSO 4 The solvent was removed in vacuo and the title 
compound (188) was afforded as a white solid (565 mg, 98%) on treatment with 1 M 
ethereal HC1. 
M.p 156-157°C, [aID'8  -39 (c = 1, D20); 0H  (250 MHz, D20); 1.90, 1.95 (9H, 3s, 
3xCOCH3), 3.21-3.40 (3H, m, la-H, lb-H, 6a-H), 3.89-3.96 (1H, m, 2-H), 4.02 (1H, 
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dd, 6e-H), 4.85 (1H, dd, 3-H), 4.86-4.91 (1H, m, 5-H), 5.15 (111, dd, 4-H); Ax-y)/Hz 
la-2 nd, lb-2 nd, la-lb nd, 2-3 9.1, 3-4 10.2, 4-5 10.1, 5-6a nd, 5-6e 5.6, 6a-6e 11.5; 
öc (63 MHz, D20) 20.6 (3xCOCH3), 51.7 (C- 1), 66.2 (C-6), 69.3, 70.5, 71.5, 74.2 (C-
2, C-3, C-4, C-5), 173. 2, 173.3, 174.7 (3xCOCH3); mlz (FAB) 306 (M+l) HRMS 
(FAB) Found M-i-1 306.11864, C 12H 19N08 requires M+l 306.11889. 
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3.6 Synthesis of amidoxime-linked pseudodisaccharides 
3.6.1 Amidoxime linked pseudo-disaccharides- General procedure 
A solution of the hydroximoyl chloride (1 equivalent) in dry chloroform (40 ml) was 
added dropwise over 2 hours to a cooled (0°C) and stirred solution of the pyranosyl 
amine (1.5 equivalents) and triethylamine (1 ml, 18 equivalents) in dry chloroform (3 
ml) under N2. The mixture was diluted with DCM (50 ml), washed with 0.1 M HCI 
(2 x 50 ml) and the combined organic layers were dried over MgSO 4 . The product 
was isolated by dry-flash chromatography (silica, hexaneLEt 20 gradient elution). 
3.6.1.1 (Z)-N-(6-Deoxy-1 ,2 :3,4-di-O-isopropylidene-a-D-
galactopyranosyl)-(2,3,4-tri-O-acetyl-f-D-xylopyranosyl)formamide 
oxime (178) 
Sample code: IAS041 
Molecular formula: C24H36N20 1 3 
Molecular weight: 560 
N 
A 	 J 
OAc 
To a stirred mixture of D-galactose amine 177 (395 mg, 1.3 mmol) and triethylamine 
(1 ml, 7.2 mmol) in dry chloroform (3 ml), D-xylose derived hydroximoyl chloride 
106 (150 mg, 0.4 mmol) was added in accordance to the general procedure above. 
Dry-flash chromatography yielded the title compound (178) as a white solid (201 
mg, 8 1%). 
M.p 167-168°C; [a]D20 -74 (c = 1.0 ,CHC1 3); 8H  (360 MHz, CDC13); 1.33, 1.38, 1.49, 
1.53 (12H, 4s, 4xCH 3), 1.97, 2.04, 2.05 (9H, 3s, 3xCOCH3), 3.33 (1H, dd, 5a-H), 
3.34-3.59 (2H, m, 6a'-H, 6b'-H), 3.84-3.89 (111, m, 5'-H), 4.00 (1H, d, 1-H), 4.15 
(1H, dd, Se-H), 4.29-4.34 (2H, m, 4'-H, 2'-H) 4.63 (1H, dd, 3'-H), 5.04 (1H, ddd, 4-
H), 5.20 (1H, dd, 3-H), 5.24 (1H, m, NH), 5.40 (1H, dd, 2-H), 5.53 (1H, d, 1'-H), 
7.76 (1H, bs, OH); J(x-y)/Hz 1-2 10.1, 2-3 9.4, 3-4 9.4, 4-5a 9.0, 4-5e 5.4, 5a-5e 
11.2, 1'-2' 5.0, 2'-3' 2.5, 3'-4' 7.9, 4'-5' nd, 5'-6a' nd, 5'-6b' nd, 6a'-6b' nd; 8C (93 
MHz, CDC13) 20.6 (3xCOCH3), 24.3, 24.8, 25.8, 25.9 (acetal 4xCH3), 42.6 (C-6'), 
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66.7 (C-5), 67.4, 68.6, 68.7, 70.4, 70.6, 70.9, 73.7, 76.2 (C-i, C-2, C-3, C-4, C-2', 
C-3', C-4', C-5'), 96.1 (C- 1'), 108.6, 109.3 (2xC), 149.0 (C=N), 169.3, 169.7, 170.2 
(3xCOCH3); m/z (FAB) 561 (M+1) HRMS (FAB) Found M +1 561.22821, 
C24H36N20 13 requires M +1 561.22919. 
3.6.1.2 (Z)-N-(6-Deoxy-1 ,2 :3,4-di-O-isopropyl idene-a-D-
gaIactopyranosyt)-(2,3,4,6-tetra-O-acetyI-J-D-gI ucopyranosyl)formamide 
oxime (181) 
Sample code: 1AS044 
Molecular formula: C27H40N201 





To a stirred mixture of D-galactose amine 177 (395 mg, 1.3 mmol) and triethylamine 
(1 ml, 7.2 mmol) in dry chloroform (3 ml), D-xylose derived hydroximoyl chloride 
107 (150 mg, 0.36 mmol) was added in accordance to the general procedure above. 
Dry-flash chromatography yielded the title compound (181) as a white solid (173 
mg, 75%). 
M.p 110-ill °C; [(x]"20 -48 (c = 1.0 ,CHCI 3); 6H  (360 MHz, CDC1 3); 1.35, 1.40, 1.47, 
1.49 (12H, 4s, 4xCH3), 1.94, 1.98, 2.01, 2.06 (12H, 4s, 4xCOCH 3), 3.38 (1H, ddd, 
6a'-H), 3.58 (1H, ddd, 6b'-H), 3.68 (1H, dt, 5-H), 3.78-3.82 (IH, m, 5'-H), 4.08 (1H, 
d, 1-H), 4.13-4.18 (2H, m, 6a-H, 6b-H), 4.27 (IH, dd, 2'-H), 4.32 (1H, dd, 4'-H), 
4.61 (1H, dd, 3'-H), 5.11 (1H, dd, 4-H), 5.18 (1H, dd, 3-H), 5.17-5.20 (1H, m, NH), 
5.45 (1H, dd, 2-H), 5.50 (1H, d, i'-H), 7.78 (1H, bs, OH); J(x-y)/Hz 1-2 10.1, 2-3 
9.2, 3-4 9.5, 4-5 9.7, 5-6a nd, 5-6b nd, 6a-6b nd, i'-2' 5.0, 2'-3' 2.7, 3'-4' 8.0, 4'-5' 
1.8, 5'-6a' 6.5, 5'-6b' 6.8, 6a'-6b' 13.2; öc (93 MHz, CDC13) 20.5 (3xCOCH3), 24.2, 
24.7, 25.9 (ãcetal 4xCH3), 42.5 (C-6'), 61.8 (C-6), 67.3, 67.8, 68.3, 70.4, 70.6, 70.8, 
74.2, 75.6, 75.7 (C-I, C-2, C-3, C-4, C-5, C-2', C-3', C-4', C-5'), 96.2 (C- V), 108.5, 
109.3 (2xC), 148.7 (C=N), 169.3, 170.1, 170.6 (3xCOCH3); mlz (FAB) 633 (M+1) 
HRMS (FAB) Found M +1 633.25026, C27H 40N20 15 requires M +1 633.25069 
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3.6.1.3 (Z)-N-(3,4,5-Tri- O-acetyI--D-xyIopyranosyI methyl)-(2,3,4-tri-0-
acetyI--D-xyIopyranosyI)formam ide oxime (184) 
Sample code: 1AS037 	 OH 	 OAc 
Molecular formula: C24H34N70 15 	 OAc 
Molecular weight: 590 
To a stirred mixture of D-xylose derived amine (182) (215 mg, 0.7 mmol) and 
triethylamine (1 ml, 7.2 mmol) in dry chloroform (3 ml), D-xylose derived 
hydroximoyl chloride 106 (150 mg, 0.4 mmol) was added in accordance to the 
general procedure above. Dry-flash chromatography yielded the title compound 
(184) as a white solid (115 mg, 44%). 
M.p 140-141 °C; 8H  (600 MHz, CD3S(0)CD 3); 1.89, 1.96, 1.97, 1.98, 1.99, 2.04 
(18H, 6s, 6xCOCH 3), 3.03 (1H, ddd, la'-H), 3.44-3.51 (2H, m, lb'-H, 6a'-H), 3.62 
(lB. ddd, 2'-H), 3.94 (IH, dd, Se-H), 3.98 (1H, dd, 6e'-H), 4.27 (1H, d, 1-H) 4.73 
(ill, dd, 3'-H), 4.79-4.85 (2H, m, 4-H, 5'-H), 5.15 (1H, dd, 2-H), 5.22 (1H, dd, 3-H), 
5.23 (1H, dd, 4'-H), 5.26-5.29 (1H, m, NH), 9.97 (1H, bs, OH); Ax-Y)/Hz  2-3 9.9,3- 
4 9.5, 4-5 9.5, 5-6a nd, 5-6e 5.5, 6a-6e 10.9, la'-2' 3.6, lb'-2 2.6, la'-lb' 11.3, 2'-3' 
9.6, 3'-4' 9.6, 4'-5' 9.5, 5'-6a' nd, 5'-6e' 5.6, 6a'-6e' 11,0; 8c (63 MHz, 
CD3S(0)CD 3) 20.5 (6xCOCH3), 42.4 (C- F), 65.1, 65.2 (C-5, C-6'), 68.2, 68.6, 69.6, 
72.6, 72.9, 74.3, 76.7 (C-i, C-2, C-3, C-4, C-2', C-3', C-4', C-5'), 147.3 (C=N), 168. 
4, 169.4, 169.5 (6xCOCH 3); m/z (FAB) 591 (M+1) HRMS (FAB) Found M +1 
591.20377, C24H34N20 15 requires M +1 59 1.20374. 
163 
3.6.1.4 (Z)-N-(3,4,5-Tri-O-acetyl--D-xyIopyranosyI methyl)-(2,3,4,6-tetra-
0-acetyI--D-gIucopyranosyI)formamide oxime (185) 
Sample code: 1AS055 	 çOAc N 	 OAc 
Ac 
Molecular formula: C27H38N7017 	 A77OAc 
Molecular weight: 662 
To a stirred mixture of D-xylose derived amine 182 (200 mg, 0.7 mmol) and 
triethylamine (1 ml, 7.2 mmol) in dry chloroform (3 ml), D-glucose derived 
hydroximoyl chloride 107 (150 mg, 0.36 mmol) was added in accordance to the 
general procedure above. Dry-flash chromatography yielded the title compound 
(185) as a white solid (100 mg, 40%). 
M.p 141-143°C; [a]D20 -36 (c = 1.0 ,CHCI 3); 6H  (600 MHz, CDC13); 1.93, 1.95, 1.98, 
1.99, 2.00, 2.03, 2.04 (21H, 7s, 7xCOCH3), 3.17 (1H, ddd, la'-H), 3.26 (1H, dd, 6a'-
H), 3.43 (1H, ddd, 2'-H), 3.54 (1H, ddd, lb'-H), 3.64 (1H, ddd, 5-H), 4.03 (1H, d, 1-
H) 4.04-4.07 (IH, m, 6a-H), 4.09 (1H, m, 6e'-H), 4.14 (1H, dd, 6b-H), 4.85 (1H, dd, 
3'-H), 4.89-4.93 (1H, m, 5'-H), 4.95 (1H, dd, 4-H), 5. 14-5.19 (2H, m, 4'-H, 3-H), 
5.25 (1H, dd, 2-H), 5.34 (1H, dd, NH); J(x-y)/Hz 1-2 10.2, 2-3 9.6, 3-4 9.7, 4-5 9.9, 
5-6a 2.2, 5-6b 5.8, 6a-6e 12.4, la'-2' 6.6, lb'-2 2.6, la'-lb' 11. 1, 2'-3' 9.6, 3'-4' 9.6, 
4'-5' 9.9, 5'-6a' 10.9, 5'-6e' 5.8, 6a'-6e' 11,2; 8c (93 MHz, CDCI 3) 20.4, 20.5, 20.6 
(7xCOCH3), 43.2 (C- 1'), 62.2 (C-6), 65.2 (C-6'), 68.0, 68.2, 68.9, 70.0, 73.1, 73.8, 
75.1, 75.9,77.5 (C-i, C-2, C-3, C-4, C-S, C-2', C-3', C-4', C-5'), 147.8 (C=N), 169. 
3, 169.7, 170.1, 170.4 (7xCOCH 3); in/z (FAB) 663 (M+1) HRMS (FAB) Found M 
+1 663.22504, C 27H38N2017 requires M +1663.22487. 
.4 
3.6.1.5 (Z)-N-(3,4,5,7-Tetra- O-acetyI--D-gIucopyranosyI methyl)-(2,3,4-
tri-O-acetyI--D-xyIopyranosyI)formam ide oxime (186) 
Sample code: 1AS059 	 OAc 




OAc 	H 	 OAc 
Molecular weight: 662 
To a stirred mixture of D-glucose derived amine 183 (240 mg, 0.6 mmol) and 
triethylamine (1 ml, 7.2 mmol) in dry chloroform (3 ml), D-xylose derived 
hydroximoyl chloride 106 (150 mg, 0.4 mmol) was added in accordance to the 
general procedure above. Dry-flash chromatography yielded the title compound 186 
as a white solid (76 mg, 3 1%). 
M.p 193-194°C; 8H  (360 MHz, CD3S(0)CD3); 1.91, 1.97, 1.98, 2.00, 2.01, 2.03, 
2.06 (21H, 7s, 7xCOCH 3), 3.02-3.09 (1H, m, la'-H), 3.45-3.52 (2H, m, lb'-H, 5a-
H), 3.76 (1H, ddd, 2'-H), 3.95-4.08 (3H, m, 6'-H, Se-H, 7a'-H), 4.14 (1H, dd, 7b'-
H), 4.35 (1H, d, i-H) 4.77 (1H, dd, 3'-H), 4.87 (1H, dd, 5'-H), 4.82-4.88 (1H, m, 4-
H), 5.17 (lH, dd, 2-H), 5.23 (1H, dd, 3-H), 5.32 (1H, dd, 4'-H), 5.36 (1H, dd, NH), 
9.79 (1H, bs, OH); J(x-y)IHz 1-2 9.5, 2-3 10.0, 3-4 9.6, 4-5a 10.7, 4-5e nd, 5a-5e 
11.0, la'-2'7.4, lb'-2 2.5, la'-ib' nd, 2'-3' 9.7, 3'-4' 9.5, 4'-5' 9.8, 5'-6' 9.7, 6'-7a' 
nd, 6'-7b' 6.1, 7a'-7b' 12.3; 8c (93 MHz, CD 3S(0)CD3) 21.8 (7xCOCH3), 44.2 (C-
1'), 63.8 (C-6), 67.2 (C-6'), 70.1, 70.2, 70.3, 71.3, 74.9, 75.0, 76.0, 76.4, 77.9 (C- 1, 
C-2, C-3, C-4, C-5, C-2', C-3', C-4', C-5'), 149.2 (C=N), 170. 0, 170.7, 170.9, 
171.0, 171.4 (7xCOCH3); m/z (FAB) 663 (M+1) HRMS (FAB) Found M +1 
663.22507, C27H38N2017 requires M +1 663.22487. 
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3.6.1.6 (Z)-N-(3,4,5,7-Tetra-O-acetyI--D-g lucopyranosyl methyl)-(2,3,4,6-
tetra- O-acetyI-3-D-gIucopyranosyt)formam ide oxime (187) 
Sample code: 1AS062 	 OAc N 	 OAc 
0 
Molecular formula: C30H42N2019 	
Ac2 \j N 
OAc 	H 	 OAc 
Molecular weight: 734 
To a stirred mixture of D-glucose derived amine 183 (240 mg, 0.6 mmol) and 
triethylamine (1 ml, 7.2 mrnol) in dry chloroform (3 ml), D-glucose derived 
hydroximoyl chloride 107 (150 mg, 0.36 mmol) was added in accordance to the 
general procedure above. Dry-flash chromatography yielded the title compound 187 
as a white solid (131 mg, 49%). 
M.p 180-181 °C; [a]D20 -12 (c= 1.0 ,CHCI 3 ); oH (360 MHz, CDCI 3); 1.90, 1.91, 1.93, 
1.94, 1.95, 2.01, 2.02, 2.04 (24H, 8s, 8xCOCH 3), 3.13-3.20 (1H, m, la'-H), 3.47-
3,51 (1H, m, 2'-H), 3.53-3.68 (3H, m, 5-H, 6'-H, lb'-H), 4.01-4.18 (511, m, 1-H, 6a-
H, 6b-H, 7a'-H, 7b'-H), 4.87-4.97 (3H, m, 4-H, 3'-H, 5'-H), 5.09-5.27 (3H, m, 2-H, 
3-H, 4'-H) 5.36 (1H, dd, NH), 8.09 (lH, bs, OH); J(x-y)/Hz 1-2 nd, 2-3 nd, 3-4 nd, 
4-5 nd, 5-6a nd, 5-6b nd, 6a-6e nd, la'-2' nd, lb'-2 nd, la'-lb' nd, 2'-3' nd, 3'-4' nd, 
4'-5' nd, 5'-6' nd, 6'-7a' nd, 6'-7b' nd, 7a'-7b'nd; Oc  (93 MHz, CDC1 3) 21.6, 21.7, 
21.8 (8xCOCH3), 44.1 (C- F), 63.2, 63.4 (C-6, C-7'), 69.3, 69.4, 70.0, 70.7, 74.4, 
74.8, 75.0, 76.2, 76.6, 77.1, 78.3 (C-I, C-2, C-3, C-4, C-5, C-2', C-3', C-4', C-5', C-
6'), 149.3 (C=N), 170.7, 170.8, 170.9, 171.3, 171.5, 171.6, 171.9 (8xCOCH 3); mlz 
(FAB) 735 (M+1) HRMS (FAB) Found M +1 735.24605, C 30H42N20 19 requires 
M +1 735.24600. 
3.6.2 N-Acetyl(4,5-di- O-acetyI--D-xyIopyranosyI) methylam me (191) 
Sample code: IAS081 	
CH2NHAc 
Molecular formula: C 1 2H 1 9N07 	 OH 
Molecular weight: 289 
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Nitromethyl compound 95 (300 mg, I mmol) was vigourously stirred in methanol (8 
ml) (THF added to improve solubility) with Raney nickel (500 mg) (stored under 
methanol-not water!) under a balloon of hydrogen gas for 16 hours. The mixture was 
filtered through a pad of celite and washed with methanol and DCM, before 
removing the solvent in vacuo to afford the title compound (191) as a colourless oil 
(260 mg, 96%). 
Umax/cm (Nujol) 3364 (OH), 1742 (C=O ester), 1651 (C=O amide), 1550 (NH 
bend); [a]D '8 129 (c = 1.5, CHC13); 8H  (360 MHz, CHCI3); 1.99, 2.03, 2.05 (9H, 3s, 
2xCOCH3 , 1xCONHCH 3), 3.16-3.31 (3H, m, la-H, 2-H, 3-H), 3.22 (1H, dd, 6a-H), 
3.86 (1H, ddd, lb-H), 4.01 (IH, dd, 6e-H), 4.60 (1H, bs, OH), 4.83 (1H, dt, 5-H), 
5.09 (1H, dd, 4-H); J(x-y)fHz la-2 2.9, lb-2 8.2, la-lb 11.0, 2-3 nd, 3-4 9.4, 4-5 
10.7, 5-6a 10.9, 5-6e 5.7, 6a-6e 11.0; öc (63 MHz, CHCI3) 20.6, 20.7 (2xCOCH 3), 
22.6 (1xCONHCH 3) 39.8 (C- 1), 66.2 (C-6), 68.4, 69.3, 74.4, 79.5 (C-3, C-5, C-4, C-
2), 170.1, 170.5 (2xCOCH 3) 172.5 (IxCONHCH 3); m/z (FAB) 290 (M+l) HRMS 
(FAB) Found M+l 290.1235 1, C 12H 19N07 requires M-i-1 290.12398. 
3.6.3 	(Z)-N-(-D-xyIopyranosyImethyI)-(-D-xyIopyranosyI)formamide 
oxime (192) 
Sample code: 1AS086 
Molecular formula: C 1 2H22N209 
	 OH 	
OH 
Molecular weight: 338 
OH 	H 
pseudodisaccharide 184 (110 mg, mmol) and triethylamine (0.05 ml, mmol) were 
stirred in methanol (5 ml) and the mixture heated (65° C), for 16 hours. On cooling, 
the reaction mixture was concentrated in vacuo to yield the title compound (192) as a 
viscous oil (60 mg, 95%). 
c (93 MHz, D20); 44.2 (C- 1'), 70.0 (C-5), 70.1 (C-6'), 70.3, 70.5, 71.7, 72.2, 77.3, 
78.1, 78.4, 80.9 (C-1, C-2, C-3, C-4, C-2', C-3', C-4', C-5'), 153.7 (C=N); m/z (ES) 
340 (MH2). 
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3.7 Synthesis of pyranosylbenzazoles 
3.7.1 Benzothiazoles - General procedure 
Pyranosyl hydroximoyl chloride (1 equivalent) and o-aminothiophenol (2.5 
equivalents) were dissolved in ethanol (10 ml) and the mixture refluxed (80 °C) 
under an atmosphere of nitrogen for 5 h. The products were usually found to 
crystallize on cooling, although, an alternative work-up could be employed, this 
proceeded as follows: The reaction mixture was diluted with DCM (50 ml) and 
washed with 0.1 M HC1 (50 ml), the aqueous layer was further extracted with DCM 
(2x 50 ml), and the combined organic layers dried (MgSO 4). Removal of the solvent 
in vacuo afforded the crude product which was purified by dry-flash chromatography 
(silica, hexanelEt 20 gradient elution). 
3.7.1.1 2-(2,3,4-Tri-O-acetyl--D-xylopyranosyl)benzothiazole (214) 
Sample code: 1AS024 
Molecular formula: C18H 1 9N07S 
	
Ac2 jj 
Molecular weight: 393 	 OAc 
Xylose derived hydroximoyl chloride 106 (200 mg, 0.6 mmol) and o-amino 
thiophenol (185 mg, 1.5 mmol) were added according to the general procedure 
above. The title compound (214) was obtained as a white solid (220 mg, 90%) after 
dry-flash chromatography. 
M.p 160-161 °C (lit. 115 161-162 °C); MD 20 = -36 (c = 0.6, CHCI 3); 6H (250 MHz, 
CDC13); 1.91, 1.97, 2.00 (9H, 3s, 3xCOCH 3), 3.48 (1H, dd, 5a'-H), 4.28 (1H, dd, 
5e'-H), 4.76 (1H, d, 1'-H), 5.06 (1H, m, 4'-H), 5.19 (1H, dd, 2'-H), 5.34 (1H, dd, 3'-
H), 7.36-7.44 (2H, m, Ar), 7.81-7.96 (2H, m, Ar); J(x-y)/Hz 1-2 9.5, 2-3 9.4, 3-4 9.3, 
4-5a 10.5, 4-5e 5.5, 5a-5e 11.2; 6C (63 MHz, CDCI 3); 20.5 (3xCOCH 3), 66.9 (C-5'), 
68.8, 71.4, 72.8, 77.9 (C- I - , C-2', C-3', C-4'), 121.8, 123.2, 125.4, 126.1 (C-7, C-6, 
C-5, C-4),134.7 (C-7a), 152.5 (C-3a), 166.6 (C-2), 169.3, 169.7, 170.1 (3xCOCH3); 
m/z (FAB) 393 (M +1) HRMS (FAB) Found M+l 393.09568, C 1 8H20N07S 
requires M+l 393.09605. 
3.7.1.2 2-(2,3,4,6-Tetra-O-acetyI-3-D-g Iucopyranosyl)benzothiazole (215) 
Sample code: 1AS027 
Molecular formula: C 21 H23N09S 




Glucose derived hydroximoyl chloride 107 (200 mg, 0.5 mmol) and o-
aminothiophenol (188 mg, 1.5 mmol) were added according to the general procedure 
above. The title compound (215) was obtained as a white solid (185 mg, 81%) after 
dry-flash chromatography. 
M.p 128-129 °C (lit.' 98 129-130 °C); MD 20 -24 (c = 1, CHCI 3); s,-, (250 MHz, 
CDC13); 1.99, 2.05, 2.10, 2.14 (12H, 4s, 4xCOCH3), 3.99 (1H, m, 5'-H), 4.28 (1H, 
dd, 6b-H), 4.37 (1H, dd, 6a'-H), 4.97 (1H, d, 1'-H), 5.30 (1H, dd, 2'-H), 5.37 (1H, 
dd, 4'-H), 5.47 (1H, dd, 3'-H) 7.39-7.54 (2H, m, Ar), 7.89-8.56 (2H, m, Ar); Ax-
y)/Hz 1-2 9.5, 2-3 9.2, 3-4 9.3, 4-5 9.5, 5-6a 4.7, 5-6b 2.5, 6a-6b 12.4; öc (63 MHz, 
CDC13); 20.2, 20.3, 20.4 (4xCOCH3), 61.7 (C-6'), 67.9, 71.1, 73.3, 76.1, 76.4 (C-l', 
C-2', C-3', C-4'), 121.6, 123.1, 125.3, 125.9 (C-7, C-6, C-5, C-4), 134.6 (C-7a), 
152.4 (C-3a), 166.2 (C-2), 168.9, 169.1, 169.9, 170.3 (4xCOCH3); m/z (FAB) 466 
(M +1) HRMS (FAB) Found M+1 466.11680, C2 1 H24N09S requires M±1 
466.11718. 
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3.7.2 Benzimidazoles-General procedures 
General Procedure A 
Pyranosyl hydroximoyl chloride (1 equivalent) and o-phenylenediamine (2.5 
equivalents) were dissolved in ethanol (10 ml) and the mixture stirred under an 
atmosphere of nitrogen at room temperature for 16 h. The reaction mixture was 
diluted with DCM (50 ml) and washed with 4% CuSO 4 solution (50 ml), the aqueous 
layer was further extracted with DCM (2x 50 ml), and the combined organic layers 
dried (MgSO4). Removal of the solvent in vacuo afforded the crude product which 
was purified by filtration through a silica pad. 
General Procedure B 
Pyranosyl hydroximoyl chloride (1 equivalent) and o-phenylenediamine (2.5 
equivalents) were dissolved in ethanol (10 ml) and the mixture refluxed (80 °C) 
under an atmosphere of nitrogen for 5 h. The reaction mixture was diluted with DCM 
(50 ml) and washed with 4% CuSO4 solution (50 ml), the aqueous layer was further 
extracted with DCM (2x 50 ml), and the combined organic layers dried (MgSO 4). 
Removal of the solvent in vacuo afforded the crude product which was purified by 
filtration through a silica pad. 
3.7.2.1 2-(2,3,4-Tri-O-acetyl-f-D-xyIopyranosyl)benzim idazole (217) 
Sample code: 1AS025 
Molecular formula: C 1 8H20N207 
Molecular weight: 376 
AC2 
o / P 
Xylose derived hydroximoyl chloride 106 (200 mg, 0.6 mmol) and o-
phenylenediamine (162 mg, 1.5 mmol) were added according to general procedures 
A or B. The title compound (217) was obtained as a white solid (185 mg, 83%) after 
dry-flash chromatography. 
M.p 152-153 °C; [a] D20 = -78 (c = 1, CHC13); 8H  (250 MHz, CDC1 3); 1.89, 1.98, 2.01 
(9H, 3s, 3xCOCH3), 3.46 (1H, dd, 5a"-H), 4.18 (111, dd, 5e'-H), 4.70 (1H, d, I'-H), 
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5.03 (1H, m, 4'-H), 5.21 (1H, dd, 2'-H), 5.35 (1H, dd, 3'-H), 7.13-7.72 (2H, m, Ar), 
7.50 (2H, bs, Ar); J(x-y)IHz 1-2 9.7, 2-3 9.4, 3-4 9.6, 4-5a 10.4, 4-5e 5.6, 5a-5e 11.3; 
c (63 MHz, CDC13); 20.5, 20.5, 20.6 (3xCOCH3), 67.0 (C-5'), 68.9, 70.6, 72.7, 75.1 
(C-l - , C-2', C-3', C-4'), 122.9 (C-5, C-6), 148.6 (C-2), 169.8, 169.9, 170.0 
(3xCOCH3); mlz (FAB) 377 (M +1) HRMS (FAB) Found M+i 377.13424, 
C 1 8H21N207 requires M+1 377.13488. 
3.7.2.2 2-(2,3,4,6-Tetra-O-acetyI-f-D-gIucopyranosyI)benzimidazoIe (218) 
Sample code: 1AS032 
Molecular formula: C21H24N209 
Molecular weight: 448 
4OAc 
Ac2TTJ N>' CO 
OAc 	H 
Glucose derived hydroximoyl chloride 107 (350 mg, 0.8 mmol) and o-
phenylenediamine (231 mg, 1.9 mmol) were added according to general procedures 
A or B. The title compound (218) was obtained as a white solid (292 mg, 89%) after 
dry-flash chromatography. 
M.p 171-172 °C; [aJ020 = -20 (c = 1, CHC13); oH (250 MHz, CDCI3); 2.14, 2.21, 2.25 
(12H, 4s, 4xCOCH3), 4.12 (1H, m, 5'-H), 4.33 (1H, dd, 6b'-H), 4.51 (111, dd, 6a'-H), 
5.04 (1H, d, 1'-H), 5.36 (1H, dd, 2'-H), 5.50 (1H, dd, 4'-H), 5.61 (iH, dd, 3'-H) 
7.41-7.48 (2H, m, Ar), 7.76 (2H, bs, Ar); J(x-y)fHz 1-2 9.7, 2-3 9.5, 3-4 9.1, 4-5 
10.1, 5-6a 5.2, 5-6b 2.0, 6a-6b 12.5; Oc  (63 MHz, CDC13); 20.9, 21.0, 21.0, 21.1 
(4xCOCH3), 62.5 (C-6'), 66.2, 68.7, 70.9, 73.8, 75.1 (C- 1', C-2', C-3', C-4'), 123.4 
(C-5, C-6), 148.8 (C-2), 170.0, 170.5, 169.9, 171.1 (4xCOCH 3); m/z (FAB) 449 (M 




Sample code: TA5076 	 NO2 
Molecular formula: C18H19N309 	
N 
Molecular weight: 421  
Xylose derived hydroximoyl chloride 106 (200 mg, 0.6 mmol) and 4-nitro-1,2-
diamino benzene (230 mg, 1.5 mmol) were added according to general procedure B. 
The title compound (219) was obtained in a crude form (reddish solid) which resisted 
attempts at purification by dry and wet-flash chromatography. 
H (250 MHz, DMSO); 2.03, 2.19, 2.22 (9H, 3s, 3xCOCH 3), 3.98 (1H, dd, 5a'-H), 
4.36 (1H, dd, 5e'-H), 5.25 (1H, d, 1'-H), 5.19-5.34 (1H, m, 4'-H), 5.47 (1H, dd, 2'-
H), 5.70 (1H, dd, 3'-H), 7.89 (1H, d, 7-H), 8.28 (1H, dd, 6-H), 8.64 (1H, d, 4-H); 
Ax-y)/Hz 1'-2' 9.7, 2'-3' 9.4, 3"-4' 9.5, 4'-5a' 10.6, 4'-5e' 5.6, 5a'-5e' 11.0, 4-6 1.8, 
6-7 8.8; ,n/z (FAB) 422 (M +1) HRMS (FAB) Found M-i-1 422.11996, C 1 8H 1 9N309 
requires M+1 422.11995. 
3.7.3 Benzoxazoles - General procedures 
General procedure A 
Pyranosyl hydroximoyl chloride (1 equivalent) and o-aminophenol (2.5 equivalents) 
were dissolved in ethanol (10 ml) and the mixture stiffed under an atmosphere of 
nitrogen at room temperature for 16 h. The reaction mixture was diluted with DCM 
(50 ml) and washed with 0.1 M HCl (50 ml), the aqueous layer was further extracted 
with DCM (2x 50 ml), and the combined organic layers dried (MgSO4). Removal of 
the solvent in vacuo afforded the crude product which was purified by filtration 
through a silica pad. 
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General procedure B 
Pyranosyl hydroximoyl chloride (1 equivalent) and o-aminophenol (2.5 equivalents) 
were dissolved in ethanol (10 ml) and the mixture refluxed (80 °C) under an 
atmosphere of nitrogen at for 5 h. The reaction mixture was diluted with DCM (50 
ml) and washed with 0.1 M HCI (50 ml), the aqueous layer was further extracted 
with DCM (2x 50 ml), and the combined organic layers dried (MgSO 4). Removal of 
the solvent in vacuo afforded the crude product which was purified by filtration 
through a silica pad. 
3.7.3.1 2-(2,3,4-Tri-O-acetyl--D-xyIopyranosyI)benzoxazoIe (220) 
Sample code: 1AS026 
Molecular formula: C I 8H I 9N08 	
CO 
Molecular weight: 377 	 OAc 
Xylose derived hydroximoyl chloride 106 (185 mg, 0.6 mmol) and o-aminophenol 
(164 mg, 1.5 mmol) were added according to general procedures A or B. The title 
compound (220) was obtained as a white solid (140 mg, 68%) after dry-flash 
chromatography. 
M.p 155-156 °C; MD 20 = -74 (c = 1, CHC13); 8H  (250 MHz, CDCI3); ); 1.84, 1.97, 
2.00 (9H, 3s, 3xCOCH 3), 3.47 (1H, dd, 5a'-H), 4.26 (1H, dd, 5e'-H), 4.68 (1H, d, I'- 
H), 5.08 (1H, m, 4-H), 5.31 (1H, dd, 2'-H), 5.43 (1H, dd, 3'-H), 7.27-7.32 (2H, m, 
Ar), 7.47-7.51 (1H, m, Ar), 7.64-7.68 (1H, m, Ar); Ax-Y)/Hz  1-2 10.2, 2-3 9.1, 3-4 
9.2, 4-5a 10.3, 4-5e 5.5, 5a-5e 11.3; 8c (63 MHz, CDCI 3); 20.5, 20.6 (3xCOCH3), 
66.9 (C-5'), 68.5, 69.9, 72.6, 73.9 (C-1, C-2', C-3', C-4'), 110.8, 120.4, 124.6, 125.8 
(C-7, C-4, C-6, C-5), 140.2 (C-3a), 150.6 (C-7a), 159.9 (C-2), 169.1, 169.6, 170.1 
(3xCOCH3); inIz (FAB) 378 (M +1) HRMS (FAB) Found M+1 378.11935, 
C18H20N08 requires M+1 378.11889. 
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3.7.3.2 2-(2,3,4,6-Tetra-0-acetyI--D-gIucopyranosyI)benzoxazoIe (221) 
Sample code: 1AS029 
Molecular formula: C2 1 H24N0 10 
Molecular weight: 465 
OAc 
Ac 	 °\ JI 
OAc 
Glucose derived hydroximoyl chloride 107 (200 mg, 0.5 mmol) and o-aminophenol 
(110 mg, 1.0 mmol) were added according to general procedures A or B. The title 
compound (221) was obtained as a white solid (156 mg, 71%) after dry-flash 
chromatography. 
M.p 174-175 °C; [U]D20 = -36 (c = 1, CHC1 3); 6H  (250 MHz, CDC13); 1.81, 1.97, 1.99, 
2.01 (12H, 4s, 4xCOCH 3), 3.86 (1H, m, 5'-H), 4.09 (1H, dd, 6b'-H), 4.25 (1H, dd, 
6a'-H), 4.76 (1H, d, 1'-H), 5.19 (1H, dd, 2'-H), 5.33 (1H, dd, 4'-H), 5.51 (1H, dd, 3'-
H) 7.28-7.33 (2H, m, Ar), 7.49-7.52 (1H, m, Ar), 7.65-7.69 (1H, m, Ar); Ax-Y)/Hz  1-
2 10, 2-3 9.5, 3-4 9.3, 4-5 9.9, 5-6a 4.8, 5-6b 2.2, 6a-6b 12.6; 6C (63 MHz, CDC13); 
20.7, 20.9, 21.0, 21.1 (4xCOCH3), 62.3 (C-6'), 68.3, 69.5, 70.2, 73.9, 76.9 (C- I', C-
2', C-3', C-4'), 111.5, 120.9, 125.1, 126.4 (C-7, C-4, C-6, C-5), 140.7 (C-3a), 151.2 
(C-7a), 159.9 (C-2), 169.3, 169.7, 170.6, 171.0 (4xCOCH 3); m/z (FAB) 450 (M +1) 
HRMS (FAB) Found M+1 450.14098, C21H2 4N0 10 requires M+1 450. 14002. 
3.7.4 Deprotections 
Procedure A 
The acetylated substrate (1 equivalent) and tnethylamine (1.33 mmol) were stirred in 
methanol (5 ml) at room temperature, under nitrogen for 36h. The reaction mixture 
was concentrated in vacuo to yield the crude product, which were crystallised from 
ice-cold methanol. 
Procedure B 
The acetylated substrate (1 equivalent) and powdered 4A molecular sieves (equal 
mass to that of substrate) were stirred in warm (40 °C) HPLC grade methanol (5 ml) 
for 12-24h. On completion of the reaction, the mixture was filtered through celite and 
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concentrated in vacuo to afford the crude product. The deprotected products were 
crystallised from ice-cold methanol. 
3.7.4.1 2--D-XyIopyranosytbenzoxazoIe (222) 
Sample code: 1AS047 
Molecular formula: C12H13N0 5 
0 	
nQ 
Molecular weight: 251 	 OH 
2-(2,3 ,4-Tri- O-acetyl-43-D-xylopyranosyl)benzoxazole (220) (100 mg, 0.3 mmol) 
was deacetylated according to deprotection A to afford the title compound (222) as a 
white solid (61 mg, 92%). 
M.p 192-194 °C; [a]D20 = -26 (c = 1, MeOH); 8H  (360 MHz, DMSO); 3.22 (1H, dd, 
5a-H), 3.24 (1H, td, 3'-H), 3.39 (1H, d, 4-H), 3.60 (1H, td, 2-H), 3.78 (1H, dd, 5&-
H), 4.32 (1H, d, 1'-H), 5.09 (1H, d, OH), 5.12 (1H, d,OH), 5.29 (1H, d, OH), 7.29-
7.40 (2H, m, Ar), 7.62-7.71 (2H, m, Ar); Ax-y)/Hz 1-2 9.8, 2-3 8.6, 3-4 nd, 4-5a 
10.4, 4-5e 5.2, 5a-5e 10.9; 8c (93 MHz, DMSO); 69.3 (C-3'), 70.0 (C-5'), 71.9 (C-
2), 75.8 (C-1), 77.5 (C-4'), 110.8, 119.8, 124.4, 125.4 (C-7, C-4, C-6, C-5), 140.1 
(C-7a), 149.9 (C-3a), 162.8 (C-2); m/z (FAB) 252 (M +1) HRMS (FAB) Found 
M+1 252.08679, C 1 2H 14N05 requires M+1 252.08720. 
3.7.4.2 2--D-XyIopyranosyIbenzimidazoIe (223) 
Sample code: 1AS048 
Molecular formula: C12H 14N204 
Molecular weight: 250 	 OH 	H 
2-(2,3 ,4-Tri-O-acetyl-J3-D-xylopyranosyl)benzimjdazole (217) (100 mg, 0.3 mmol) 
was deacetylated according to deprotections A or B to afford the title compound 
(223) as a white solid (62 mg, 93%). 
M.p 232-233 °C; [a] 020 = -17 (c = 1, MeOH); 5H (360 MHz, DMSO) 3.20 (1H, dd, 
5a'-H), 3.25 (1H, dd, 3"-H), 3.42 (1H, ddd, 4'-H), 3.59 (1H, dd, 2-H), 3.81 (1H, dd, 
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5e'-H), 4.25 (lB. d, 1'-H), 5.12 (3H, bs, OH), 7.09-7.13 (2H, m, Ar), 7.45-7.49 (2H, 
m, Ar); J(x-y)/Hz 1-2 9.7, 2-3 8.7, 3-4 9.1, 4-5a 10.7, 4-5e 5.2, 5a-5e 10.9; & (93 
MHz, DMSO); 69.4 (C-3), 70.0 (C-5'), 72.6 (C-2'), 76.8 (C-1), 77.8 (C-4'), 111.2, 
118.6, 121.0, 122.0 (C-4, C-5, C-6, C-7), 134.6 (C-7a), 142.2 (C-3a), 152.2 (C-2); 
m/z (FAB) 251 (M +1) HRMS (FAB) Found M+1 25 1.10372, C12H15N 204 requires 
M+1 251.10318. 
3.7.4.3 2--D-GIucopyranosyIbenzjmjcjazole (224) 
Sample code: 1A5063 	 OH 
Molecular formula: C13H16N 205 
Molecular weight: 280 	 OH 	H 
2-(2,3 ,4,6-Tetra-O-acety1--D-g1ucopyranosy1)benzjmjdazole (218) (150 mg, 0.3 
rnmol) was deacetylated according to deprotection B to afford the title compound 
(224) as a white solid (89 mg, 95%). 
M.p 253-254 °C; [a]20= 21 (c = 1, MeOH); 8H (360 MHz, DMSO) 3.24 (111, dt, 4'-
H), 3.33 (1H, dt, 3'-H), 3.37 (1H, m, 5'-H), 3.49 (1H, dt, 6b'-H), 3.67 (1H, dt, 2'-H), 
3.75 (1H, ddd, 6a'-H), 4.37 (1H, d, 1'-H), 4.58 (1H, t, OH), 5.12 (1H, d, OH), 5.16 
(1H, d, OH), 5.19 (1H, d, OH), 7.12-7.26 (2H, m, Ar), 7.46-7.65 (2H, m, Ar); Ax-
y)/Hz 1-2 9.8, 2-3 9.2, 3-4 9.3, 4-5 9.0, 5-6a 1.4, 5-6b 5.8, 6a-6b 11.9; 8c (93 MHz, 
DMSO); 62.9 (C-6'), 71.6, 74.3, 77.5, 79.3 (C-2', C-3', C-4', C-5'), 83 (C- I'), 112.8, 
120.2, 122.6, 123.7 (C-4, C-5, C-6, C-7), 135.5 (C-7a), 144.0 (C-3a), 154.0 (C-2); 
mlz (FAB) 281 (M +1) HRMS (FAB) Found M-i-1 281.11362, C13H17N20 5 requires 
M-i-1 281.11375. 
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3.8 Synthesis of furanosylbenzazoles 
3.8.1 3,4,5-Tri-O-benzoyI--D-ribofuranosyI cyanide (238) 
Sample code: 1AS077 	 BzO'\.(O7fr 
Molecular formula: C27H2 1 N07 
Molecular weight: 471 	 Bzd 	OBz 
To a stirred solution of tri-O-benzoyI--D-ribofuranosyl acetate 239 (450 mg, 1 
mmol), trimethylsilyl cyanide (0.5 ml, 4 mmol) and dry acetonitnie (15 ml) a few 
drops (0.2 ml) of BF3.Et20 were added. The reaction mixture was stirred under argon 
at room temperature for 10 minutes. The reaction mixture was quenched with 
NaHCO3 (10 ml), the mixture extracted with ether (3 x 30 ml) and the organic layers 
were dried over MgSO4. The solvent was removed in vacuo, the resultant oil was 
purified by wet-flash chromatography (silica, 25% ethyl acetate in hexane) to afford 
the title compound (238) as a white solid (360 mg, 86%). 
M.p 78-80 °C (lit. 225 77-80 °C); [a}020 21 (c = 0.5 ,CHCI3) (lit [cx] 02° 23.9 (c = 0.5 
CHCI 3)); 81, (250 MHz, CDC1 3); 4.51 (1H, dd, 5a-H), 4.61-4.69 (2H, m, 4-H, 5b-H) 
4.91 (1H, d, 1-H), 5.78 (1H, dd, 3-H), 5.93 (1H,dd, 2-H), 7.27-7.53 (9H, m, ArH), 
7.82-8.06 (6H, m, ArH); J(x-y)IHz 1-2 4.3, 2-3 5.0, 3-4 5.4, 4-5a 4.7, 4-5b nd 5a-5b 
13.2; 8C (63 MHz, CDC13) 63.0 (C-S), 69.3, 71.7, 74.3, (C-2, C-3, C-4) 80.7 (C- 1)
115.6 (CN), 128.4, 129.7 (ArCH), 133.3, 133.7, 133.9 (ArC), 164.7, 164.9, 166.0 
(3xCOPh); m/z (ES) 472 (MH). 
3.8.2 1 ,3-DiphenyI-2-(2,3,5-tri-O-benzoyI--D-ribofuranosyI) imidazoline 
(244) 
Sample code: 1AS078 
Molecular formula: C26H30N20 7 
Molecular weight: 482 
Ph 




Raney nickel (2 g) was added to a vigourously stirred solution of pyridine (8 ml), 
glacial acetic acid (6 ml) and water (6 ml). NaH2PO2.H20 0 g) was added, along 
with NN-diphenylethylenediamine (550 mg) and D-ribose derived nitrile 238 (550 
mg, 2.5 mmol). The reaction was stirred for 16 hours. The resultant mixture was 
filtered through a pad of celite and the filter cake was washed thoroughly with DCM. 
The filtrate was washed with water (-200 ml), extracted with DCM (2 x 50 ml) and 
the combined organic layers were dried over MgSO 4 . The solvent was co-evaporated 
with water (to remove residual pyridine) to yield a gum. The gum was dissolved in 
DCM (5 ml), acetic anhydride (4.72 ml) and triethylamine (8.3 ml) and the reaction 
mixture was stirred for 16 hours. The mixture was diluted with DCM (20 ml) and 
stirred with water (20 ml) for 20 minutes before extracting with DCM (2 x 10 ml). 
The combined organic layers were washed with NaHCO 3 (20 ml) and dried over 
MgSO4. Dry-flash chromatography (silica, hexane/Et 20 gradient elution) afforded 
the product (244) as a colourless oil, which solidified on addition of methanol (295 
mg, 59%). 
[aID2° 10 (c = 0.1 ,CHCI 3) (lit. 23 ' [ct]D20 11.2 (c = 0.1 ,CHC1 3)); oH (360 MHz, 
CDCI3); 3.62-3.77 (2H, m, NCH 2), 3.81-3.96 (2H, m, NCH 2), 4.48 (1H, dd, 5a'-H), 
4.57-4.61 (1H, m, 4'-H) 4.66 (1H, dd, 5b'-H), 4.92 (1H, d, 1'-H), 5.61 (1H, dd, 3'-
H), 5.81 (1H, dd, 2'-H), 5.97 (1H, s, 2-H), 6.79-6.97 (4H, m, ArH), 7.26-7.68 (15H, 
m, ArH), 7.82-8.06 (6H, m, ArH); Ax-y)/Hz 1'-2' 5.4, 2'-3' 5.7, 3'-4' 5.8, 4'-5a' 
4.7, 4'-5b' 3.2 5a-5b 11.6; OC (93 MHz, CDC13) 48.0 (NCH2), 48.4 (NCH2), 65.3 (C-
5'), 73.4, 73.8, 74.4, (C-2', C-3', C-4') 80.6 (C- l - ) 84.2 (C-2), 114.2, 114.6, 119. 1, 
128.5, 130.85 (ArCH), 134.1, 134.4, 134.5 (ArC), 166.5, 166.6, 167.2 (3xCOPh); 
m/z (ES) 483 (MH). 
3.8.3 2,5-Anhydro-3,4,6-tri-O-benzoyI--D-aIlose semicarbazone (246) 
Sample code: 1AS084 
Molecular formula: C 28H25N308 






BzO 	 H 
Bzd 	bBz 
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Raney nickel (3.75 g) was added to a vigourously stirred solution of pyridine (10 
ml), glacial acetic acid (9 in]) and water (5 ml). NaH2PO2.H 20 (1.85 g) was added, 
followed by semicarbazide hydrochloride (550 mg) and KOH (285 mg) in water (5 
ml) and D-ribose derived nitrile 238 (1.05 g) in pyridine (5 ml). The reaction was 
heated to 40°C for 4 hours. The resultant mixture was filtered through a pad of celite 
and the filter cake was washed thoroughly with DCM. The filtrate was washed with 
water (-.200 ml), extracted with DCM (2 x 50 ml) and the combined organic layers 
were dried over MgSO4. The solvent was co-evaporated with water (to remove 
residual pyridine) to yield a gum. The mixture was diluted with DCM (50 ml) and 
washed with 1 M HC1 (2 x 30 ml), NaHCO 3 (2 x 30 ml) and dried over MgSO 4 . 
removal of the solvent in vacuo to afford crude semicarbazone (246) as a brown 
foam (-1 g, -.85%). 
oH (250 MHz, CDC13); 4.43 (1H, dd, 5a-H), 4.51-4.64 (2H, m, 4-H, 5b-H) 4.76 (lH, 
d, 1-H), 5.67 (1H, dd, 3-H), 5.87 (1H, dd, 2-H), 7.13 (HC=N(NHCONH 2)), 7.22-7.49 
(9H, m, ArH), 7.82-8.03 (6H, m, ArH), 9.85 (1H, bs, OH); J(x-y)/Hz 1-2 5.7, 2-3 
5.2, 3-4 4.7, 4-5a 3.6, 4-5b nd 5a-5b 11.4; OC (63 MHz, CDCI 3) 63.8 (C-5), 67.7, 
72.6, 72.8, (C-2, C-3, C-4) 79.9 (C-i), 128.2, 128.3, 128.8, 129.2, 129.5 (ArCH), 
133.1, 133.3; 133.6 (ArC), 138.6 (HC=N(NHCONH 2), 157.4 (HC=N(NHCONH 2), 
165.1, 165.2, 166.0 (3xCOPh); m/z (ES) 532 (MH 1 ). 
3.8.4 2,5-Anhydro-3,4,6-tri-O-benzoyI--D-aIlose oxime (243) 
Sample code: IAS080 
Molecular formula: C27H23N08 





BzO 	 H 
Bzd 	bBz 
TsOH (212 mg, mmol) was added to a solution of D-ribose derived imidazoline 244 
in DCM (4.5 ml), and the mixture stiffed at room temperature under nitrogen for 45 
minutes. The resultant mixture was filtered and the filter cake washed with DCM, 
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before concentrating the filtrate in vacuo (the water bath temperature did not exceed 
30°C!). The residue was dissolved in ethanol (2.5 in]) and pyridine (2.25 ml), 
hydroxylamine hydrochloride (160 mg) was added, and the mixture heated to 95°C 
under reflux for 2.5 hours.On cooling, the reaction mixture was diluted with DCM 
(50 ml) and washed with saturated NHCO 3 solution (50 ml), water (50 ml) and 1 M 
HCl (50 ml) and the organic layer dried over MgSO 4 . Dry-flash chromatography 
(silica, hexanefEt 20 gradient elution) afforded the title compound (243) as a 
colourless oil (100 mg, 45%). 
Procedure B 
Hydroxylamine hydrochloride (278 mg) was added to crude semicarbazone 246 
(..500 mg) dissolved in acetonitrile (12.5 ml) and pyridine (4.2 ml), the resulting 
mixture was stirred at room temperature under argon for 16 hours. The mixture was 
diluted with ethyl acetate (30 ml) and washed with 1 M HCl (3 x 30 ml), NaHCO3 
(3x 30 in]) and brine (30 ml), before drying the organic layer over MgSO 4. Wet-flash 
chromatography (silica, 25% ethyl acetate in hexane) afforded the title compound 
(243) as a colourless oil (236 mg, 81 %).  
[cx}02° 14 (c = 0.2 ,MeOH) (lit.  142 [(Xm 20 12.9 (c = 0.2, MeOH)); 8H  (360 MHz, 
CDCI 3); 4.61 (1H, dd, 5a-H), 4.66-4.71 (1H, m, 4-H), 4.77 (1H, dd, 5b-H), 4.95 (1H, 
dd, 1-H(E)), 5.53 (1H, dd, 1-H(Z)), 5.75 (1H, dd, 3-H(Z)), 5.80-5.84 (2H, m, 3-H, 2-
H(E)) 5.92 (1H, dd, 2-H(Z)), 6.99 (1H, d, HC=NOH(Z)), 7.31-7.61 (19H, m, 
HC=NOH(E)), ArH), 7.92-8.22 (12H, m, ArH), 8.88 (1H, bs, OH (E)); Ax-y)/Hz 1-
2 5.5, 2-3 nd, 3-4 nd, 4-5a 4.3, 4-5b 3.2 5a-5b 11.7; (Z) J(x-y)/Hz 1-2 4.7, 2-3 5.5, 3-
4 5.2, 4-5a nd, 4-5b nd 5a-5b nd; öC (93 MHz, CDCI 3) 64.9 (C-5(Z)), 65.2 (C-S(E)), 
73.4, 73.6, 74.6, 75.1, 78.5, 79.6, (C-2, C-3, C-4 (E and Z) 80.2 (C-1(Z)), 80.4 (C-
1(E)), 129.5, 129.6, 129.9, 130.1, 130.4, 130.5, 130.8, 130.9, 131.2 (ArCH), 134.4, 
134.6, 134.7 (ArC), 148.8 (C=N), 166.3, 166.4, 166.5, 167.4 (6xCOPh); m/z (ES) 
490 (MW') 
3.8.5 Difuranosyl-(2,3,5-tri- O-benzoyI-f-D-ribofuranosyI)-1 ,2,5-
oxadiazole-2-oxide (248) 
Sample code: 1AS083 
Molecular formula: C54H 42N20 16 




BzO 	'OBz BzOQBz 
A stirred mixture of ribose derived oxime 243 (150 mg, 0.3 mmol), N-
chlorosuccinimide (41 mg, 0.3 mmol), pyridine (0.01 ml) and chloroform (2.5 ml) 
was heated to 40°C under nitrogen for 45 minutes. On cooling, triethylamine (0.3 ml) 
was added and the mixture stirred for 1 hour. The solution was diluted with DCM 
(40 ml), 1 M HC1 (40 ml) and dried over MgSO 4 . Dry-flash chromatography (silica, 
hexane/Et 20 gradient elution) afforded the title compound (248) as a colourless gum 
(107 mg, 72%). 
[a]D2°  -7.4 (c = 5.65 ,CHCI3); 8H  (250 MHz, CDCI 3 ); 4.45-4.63 (6H, m, 5a-H, 5b-H, 
5a'-H, 5b-H, 4-H, 4'-H), 5.37 (2H, d, 1-H), 5.46 (2H, d, 1'-H) 5.73-5.77 (211, m, 3-
H, 3"H), 6.03 (1H, dd, 2-H), 6.15 (111, dd, 2'-H), 7.21-7.45 (18H, m, ArH), 7.81-8.18 
(12H, m, ArH); Ax-y)/Hz 1-2 5.4, 2-3 6.1, 3-4 nd, 4-5a nd, 4-5b nd 5a-5b nd, 1'-2' 
4.7, 2-3 5.3, 3'-4' nd, 4-5a nd, 4'-5b' nd 5a'-5b' nd; 8C (63 MHz, CDC1 3) 63.6 
(C-5), 63.8 (C-5'), 71.9, 72.4, 72.6, 73.9, 74.4, 76.0 (C-2, C-2',C-3, C-3', C-4, C-4') 
80.6 (C-i), 80.3 (C-I') 112.6 (C=N), 128.9, 129.1, 129.2, 129.7, 129.8, 130.0, 130.2 
(ArCH), 133.7, 134.1 (ArC), 155.0 (C=N), 165.6, 165.8, 166.4, 166.6 (6xCOPh); 
HRMS (FAB) Found: M+1 975.26020. C 54H42N20 16 requires M-t-H 975.26126. 
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3.8.6 2-(2,3,5-Tri-O-benzoyI-3-D-ribopyranosyI)benzoxazoIe (241) 
Sample code: 1AS085 
Molecular formula: C33H25N08 
Molecular weight: 563 BzO P 
Bzc3 	OBz 
A stirred mixture of ribose derived oxime 243 (150 mg, 0.3 mmol), N-
chiorosuccinimide (41 mg, 0.3 mmol), pyridine (0.01 ml) and chloroform (2.5 ml) 
was heated to 40°C under nitrogen for 45 minutes. The solvent was removed in 
vacuo before adding ethanol (10 ml) and o-aminophenol (85 mg, 0.75 mmol) and the 
mixture was heated to reflux for 5 hours. On cooling, the solvent was removed in 
vacuo and DCM added to precipitate out excess o-aminophenol. The solution was 
washed with 1 M HC1 (20 ml) and dried over Mg50 4 . Dry-flash chromatography 
(silica, hexanelEt 20 gradient elution) afforded the title compound (241) as a 
colourless gum (155 mg, 92%). 
[a]D20 -125 (c = 2.9 ,CHC13); 8H  (360 MHz, CDCI3); 4.66 (1H, dd, 5a-H), 4.83-4.92 
(2H, m, 4'-H, 5b-H) 5.62 (1H, d, F-H), 6.11 (1H, dd, 3-H), 6.28 (1H, dd, 2-H), 
7.30-7.41 (10H, m, ArH), 7.53-7.58 (3H, m, ArH), 7.72-7.74 (1H, m, ArH), 7.98-
8.12 (5H, m, ArH); J(x-y)/Hz 1-24.6,2-34.9,3-45.4, 4-5a 3.0, 4-5b nd 5a-5b 11.5; 
C (93 MHz, CDCI3) 61.4 (C-5'), 64.6, 73.6, 75.7, (C-2', C-3', C-4',) 81.6 (C-F) 
112.0 (C-7), 121.7 (C-4), 125.7 (C-6), 126.9 (C-5) 129.4, 129.5, 129.8, 129.9, 130.6, 
130.9 (ArCH), 131.0, 134.2, 134.6 (ArC), 141.7 (C-3a), 152.0 (C-7a), 162.5 (C-2), 
166.2, 166.3, 167.2 (3xCOPh); m/z (FAB) 564 (M+1); HRMS (FAB) Found: M+1 
564.16656 C33H 25N08 requires M+H 564.16584. 
3.8.7 2-(2,3,5-Tri-O-benzoyI--D-ribopyranosyI) benzimidazole (242) 
Sample code: 1AS087 
Molecular formula: C33H26N20 7 





A stirred mixture of ribose derived oxime 243 (150 mg, 0.3 mmol), N-
chiorosuccinimide (41 mg, 0.3 mmol), pyridine (0.01 ml) and chloroform (2.5 ml) 
was heated to 40°C under nitrogen for 45 minutes. The solvent was removed in 
vacuo before adding ethanol (10 ml) and o-phenylenediamine (85 mg, 0.75 mmol) 
and the mixture was heated to reflux for 5 hours. On cooling, the reaction mixture 
was diluted with DCM (50 ml) and washed with 4% CuSO 4 solution (50 ml), the 
aqueous layer was further extracted with DCM (2x 50 ml), and the combined organic 
layers dried (MgSO4). Dry-flash chromatography (silica, hexaneIEt 20 gradient 
elution) afforded the title compound (242) as a colourless gum (152 mg, 90%). 
[am20 -106 (c = 3.65 ,CHC13); oH (360 MHz, CDCI 3); 4.78-4.88 (3H, dd, 5a'-H, 4'-
H, 5b'-H) 5.72 (1H, d, i'-H), 5.80 (1H, dd, 3'-H), 6.09 (1H, dd, 2'-H), 7.23-7.27 
(2H, m, ArH), 7.33-7.59 (11H, m, ArH), 7.90-7.94 (2H, m, ArH), 8.03-8.08 (4H, m, 
ArH); J(x-y)/Hz 1-2 4.4, 2-3 4.8, 3-4 5.3, 4-5a nd, 4-5b nd 5a-5b nd; OC (93 MHz, 
CDC13) 64.6 (C-5'), 72.6, 76.5, 78.9 (C-2', C-3', C-4',) 80.9 (C-i') 114.2.-118.7 (bs, 
C-4, C-7),123.2 (C-S. C-6) 128.9, 129.0, 129.2, 129.3, 129.6, 130.2 (ArCH), 130.3, 
133.9 (ArC), 151.3 (C-2), 165.7, 167.2 (3xCOPh); m/z (FAB) 563 (M+i); HRMS 
(FAB) Found: M+1 563.18113. C33H26N207requires M+H 563.18183. 
3.8.8 2--D-RibofuranosyIbenzoxazoIe/2-a-D-RibofuranosyIbenzoxazoIe 
(249b1249a) 
Sample code: 1AS094 
Molecular formula: C12H 1 3NO5 
Molecular weight: 251 
CQ 
Ho 	 0 
HO 	OH 
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Ribose derived benzoxazole 241 (169 mg, 0.3 mmol) was stirred in methanol (8 ml) 
at room temperature. Freshly prepared 1 M NaOMe (7 ml) solution was added, and 
the reaction stirred for 16 hours. Amberlite 120(H') resin was added in portions until 
the solution was neutral to pH paper. All solids were filtered off and the filtrate 
concentrated in vacuo to afford a residue. Following wet-flash chromatography 
(silica, 10% methanol in ethyl acetate), the title compounds were obtained as an 
inseperable mixture of anomers (249b f3: 249a a, 62:38) (colourless foam, 65 mg, 
87%). 
oH (360 MHz, D20); 3-anomer éarbohydrate signals, 3.74 (1H, dd, 5a-H), 3.89 (1 H, 
dd, 5b'-H) 4.05-4.09 (1H, m, 4'-H), 4.11-4.16 (1H, m, 3'-H), 4.34 (1H, dd, 2'-H), 
4.47 (1H, d, 1'-H), a-anomer carbohydrate signals, 3.71 (lH, dd, 5a'-H), 3.82 (lH, 
dd, 5b-H) 4.11-4.16 (1H, m, 4'-H), 4.26 (1H, dd, 3-H), 4.53 (1H, dd, 2'-H), 5.08 
(1H, d, 1k-H), aromatic signals, 6.92-6.96 (2H, m, ArH), 7.12-7.14 (lH, m, ArH), 
7.38-7.44 (3H, m, ArH), 7.59-7.67 (2H, m, ArH); -anomer J(x-y)fHz 1'-2' 3.3, 2-
3 4.6, 3'-4' nd, 4-5a 4.1, 4'-5b 2.9 5a'-5b' 12.7; ct-anomer J(x-y)fHz 1'-2' 5.3, 
2-3' 5.2, 3"4' 5.2, 4-5a' 5.3, 4'-5b 3.44 5a'-5b' 12.6; OC (63 MHz, D 20) 60.6, 
61.8 (C-5'a, C-5'), 70.5, 71.5, 74.8, 74.9, 78.0, 83.3, 83.4, 85.1 (C-1'a, C-2a, C-
3'a, C-4'(x, C-1'3, C-2 - P, C-3', C-4'3), 111.5, 116.6, 119.8, 120.9, 123.4, 125. 5, 
126.5, 128.3 (ArCH), 139.6, 149.3, 150.8 (ArC) 164.1 (C=N); m/z (FAB) 252 
(M+1); HRMS (FAB) Found: M+1 252.08755. C 12H 14N05 requires M+H 
252.08720. 
3.8.9 2--D-RibofuranosyIbenzimidazoIe (250) 
Sample code: 1A5095 
Molecular formula: C 1 2H 14N204 
Molecular weight: 250 HO7P 
HO 	OH 
Ribose derived benzimidazole (242) (90 mg, 0.16 mmol) was stirred in a mixture of 
methanol (5 ml) and triethylamine (0.8 ml, 5.7 mmol) which was heated to 50°C for 
4 days. On cooling, the mixture was purified by wet-flash chromatography (silica, 
10% methanol in ethyl acetate) to afford the title compound (250) as a colourless 
foam (43 mg, 91%). 
H (250 MHz, D20); 3.61 (1H, dd, 5a'-H), 3.76 (1H, dd, 5b'-H) 3.98-4.05 (2H, m, 
3'-H, 4'-H), 4.21 (1H, dd, 2'-H), 4.92 (lH, d, 1'-H), 7.07-7.10 (2H, m, ArH), 7.35-
7.41 (2H, m, ArH); Ax-y)/Hz 1-2 5.3, 2-3 4.4, 3-4 4.7, 4-5a 3.8, 4-5b 2.0 5a-5b 
12.3; öC (63 MHz, D20) 61.7 (C-5'), 71.2, 75.7, 78.9, 84.7 (C-3', C-2', C-l), 115.3 
(broad) (C-4, C-7), 123.2 (C-5, C-6), 152.9 (C-2); mlz (FAB) 251 (M+1); HRMS 
(FAB) Found: M+1251.10318.  C 12H 15N2O4 requires M+H 251.10318. 
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3.9 Synthesis of Pyranosylperimidines 
3.9.1 Synthesis of perimidine precursors 
3.9.1.1 Benzohydroximoyl chloride (255) 
N 
Sample code: IAS017 
- 	CI 
Molecular formula: C 7H6NO3CI 
Molecular weight: 155.5 
Syn-benzaldoxime (5 g, 33 mmol) was dissolved in dry chloroform (60 ml) and 
cooled in a dry-ice/acetone bath. Chlorine gas was passed through the solution until 
the colour changed from blue, through green, to yellow. The solvent was removed in 
vacuo to afford an oil, which gave the title compound (255) as a white solid (4.1 g 
74%) on trituration with pentane.; 49-50 °C (lit. 143 50-51 °C). 
3.9.1.2 2,2-Dimethyl-4-formyl-1 ,3-dioxolane oxime (268) 
Sample code: 1AS072 	
/ 
Molecular formula: C6H, ,NO3 
O, 	 N 





1,2:5,6-Di-0-isopropylidene-D-mannitol (266) (5.00 g, 20 mmol) in THF (48 ml) 
was added to a stirred solution of water (7 ml), THF (10 ml) and Na10 4 (4.56 g, 21.3 
mmol). The resulting mixture was stirred vigorously for 2 h before adding Et20 (70 
ml) and filtering of the resultant white flocculate. The filtrate was concentrated and 
extracted into DCM (2x 50 ml), dried (MgSO 4) and the solvent removed in vacuo to 
afford crude 2,2-Dimethyl-4-formyl-1,3-dioxolane (267) (ca 4 g). Na2CO3 (3.00 g, 
27.5 mmol) was added in portions to a stirred solution of NH20H.HCI (3.74 g, 54 
mmol) in water (40 ml). aldehyde 267 was added and the mixture stirred for 16 h. 
The reaction mixture was partitioned between water (20 ml) and Et20 (50 ml) and 
aqueous layer was extracted with Et 20 (2 x 50 ml). The combined layers were dried 
(MgSO4) and the solvent removed in vacuo to afford the title compound as an oil 
(3.48 g, 63%) (3:1 mixture of E:Z isomers). 
E-isomer 8H  (250 MHz, CDC1 3); 1.43, 1.48 (6H, s, CH3), 3.91 (1H, dd, 5a-H), 4.20 
(1H, dd, 5b-H), 4.67 (IH, q, 4-H), 7.42 (1H, d, H-i-H), 8.89 (1H, bs, OH); J(x-
y)fHz 1'-4 6.9, 4-5a 6.3, 4-5b 6.5, 5a-5b 8.6; (63 MHz CDCI3); 24.8, 25.8 (CH3), 
66.7 (C-5), 72.5 (C-4), 109.7 (C-2), 149.0 (C-1); Z-isomer 6H  (250 MHz, CDCI 3); 
1.43, 1.48 (6H, s, CH 3), 3.84 (1H, dd, 5a-H), 4.40 (1H, dd, 5b-H), 5.15 (1H, m, 4-H), 
6.99 (1H, d, H-1-H), 9.18 (1H, bs, OH); J(x-y)IHz 1-4 4.1, 4-5a 6.7, 4-5b 7.1, 5a-
5b 8.5; (63 MHz CDCI 3); 24.6, 25.4 (CH3), 67.2 (C-5), 70.0 (C-4), 109.1 (C-2), 
152.1 (C-i); m/z (ES) 146. 
3.9.1.3 2,2-Dimethyl-4-formyl-1 ,3-dioxolane Chloro-oxime (265) 
Sample code: 1AS073 
Molecular formula: C6H 1 1 NO3 
Molecular weight: 179.5 	 ON OH 
C! 
(E,Z) 2,2-Dimethyl-4-formyl-1,3-dioxoiane oxime (268) (1.00 g) was dissolved in 
dry Et20 (60 ml) and cooled to -78°C. Dry C12 gas was bubbled through the stirred 
solution for 20 minutes. The solution initially turned blue and then to emerald green. 
Nitrogen gas was bubbled through the solution and it was allowed to warm to room 
temperature. On warming, the solution became colourless and the solvent was 
removed in vacuo to afford an oily solid. The product was obtained as a grey solid 
(1.20 g, 98%) on trituration with cold pentane. The freshly prepared 2,2-Dimethyl-4-
formyl- 1 ,3-dioxolane Chloro-oxime (265) was taken on to the next step immediately. 
(250 MHz, CDC1 3); 1.68, 1.76 (6H, s, CH3), 4.35-4.50 (2H, m, 5a-H, 5b-H), 5.08 
(1H, dd, 4-H), 8.61 (1H, bs, OH); Ax-y)/Hz 4-5a 6.3, 4-5b 6.5, 5a-5b nd; (63 MHz 
CDCI3); 26.2, 26.7 (CH 3), 67.7 (C-5), 76.9 (C-4), 112.1 (C-2), 140.1 (C-i). 
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3.9.2 Synthesis of perimidines 
General Procedure A 
Hydroximoyl chloride (1 equivalent) and 1 ,8-diaminonapthalene (2.5 equivalents) 
were dissolved in ethanol (10 ml) and the mixture stirred under an atmosphere of 
nitrogen at room temperature for 16 h. The reaction mixture was diluted with DCM 
(50 ml) and firstly shaken with saturated K2CO3 (50 ml), and then with 4% CuSO 4 
solution (50 ml) until a dark precipitate was observed, the combined layers were 
filtered through a pad of celite. The organic layer was separated off, dried (MgSO 4) 
and the solvent removed in vacuo. The product was isolated by dry-flash 
chromatography (silica, hexaneLEt 20 gradient elution). 
General Procedure B 
Hydroximoyl chloride (1 equivalent) and 1 ,8-diaminonapthalene (2.5 equivalents) 
were stirred in refluxing ethanol (10 ml) under an atmosphere of nitrogen for 5 h. On 
cooling, the reaction mixture was diluted with DCM (50 ml) and firstly shaken with 
saturated K2CO3 (50 ml), and then with 4% CuSO4 solution (50 ml) until a dark 
precipitate was observed, the combined layers were filtered through a pad of celite. 
The organic layer was separated off, dried (MgSO 4) and the solvent removed in 
vacuo. The product was isolated by dry-flash chromatography (silica, hexane/Et 20 
gradient elution). 
3.9.2.1 2-(Phenyl)perimidine (256) 
Sample code: 1AS066 
Molecular formula: C17H 1 2N2 
Molecular weight: 244 
Benzohydroximoyl chloride (200 mg, 1.3 rnmol) and 1 ,8-diaminonapthalene (402 
mg, 2.5 mmol) were added according to general procedure B. The title compound 
was obtained as an orange crystalline solid (214 mg, 68%) after dry-flash 
chromatography. 
W. 
M.p 187-188 °C (lit. 238 187-188 °C); 8H  (360 MHz, CDCI3); 6.65 (2H, br s, 9-H, 4-
H), 7.14-7.26 (4H, m, ArH), 7.47-7.55 (3H, m, ArH), 7.85-7.90 (2H, m, ArH); m/z 
(El) 244 (Mt) HRMS (El) Found M 244. 10036, C 17H 12N2 requires M 244.10005. 
3.9.2.2 2-(2,3,4-Tri- O-acetyI--D-xyIopyranosyI)perimidine (259) 
Sample code: 1AS065 
Molecular formula: C22H22N 207 
Molecular weight: 426 
In 
Ac2 
D-Xylose derived hydroximoyl chloride 106 (120 mg, 0.35 mmol) and 1,8-
diaminonapthalene (170 mg, 1 mmol) were added according to general procedure A. 
In order of elution, glycal 258 (trace) was obtained as an orange solid and the title 
compound (259) was obtained as a yellow/green solid (92 mg, 60%) after dry-flash 
chromatography. 
M.p 169-170 °C; [a]D20 = -40 (c = 0.2, CHC13); ö (360 MHz, CD3S(0)CD 3); 1.93, 
2.03, 2.05 (9H, 3s, 3xCOCH 3), 3.67 (1H, dd, 5'a-H), 4.10 (1H, dd, 5'e-H), 4.24 (1 H, 
d, 1'-H), 5.02 (lH, m, 4'-H), 5.24 (1H, dd, 2-H), 5.41 (1H, dd, 3-H), 6.42 (1H, dd, 
9-H), 6.54 (1H, dd, 4-H), 6.99-7.17 (4H, m, H-S. H-6, H-7, H-8), 10.48 (1H, bs, 
NH); J(x-y)IHz 1'-2 9.7, 2'-3' 9.6, 3'-4' 9.5, 4'-5a 10.9, 4'-5'e 5.5, 5'a-5'e 11.0,4-
5 7.5, 4,6 1.1, 9-8 7.2, 9-7 0.9; 6c (93 MHz, CD 3S(0)CD3); 21.8, 21.9, 22.0 
(3xCOCFI3), 66.8 (C-5'), 69.8, 71.2, 73.6, 78.8 (C-2', C-3', C-4, C- 1'), 104.1 (C-9), 
115.0 (C-4), 119.2 (C-7), 121.1 (C-6), 123.6 (C-9b), 129.5 (C-8), 130.3 (C-5), 136.6 
(C-6a), 139.4 (C-9a), 145.8 (C-3a), 154.0 (C-2), 170.7, 171.1, 171.2 (3xCOCH 3); 
m/z (FAB) 427 (M +1) HRMS (FAB) Found M+1 427.15109, C 22H22N207 requires 
M 1 -i-1 427.15053. 
V M-61 
3.9.2.3 2-(3,4-Di- O-acetyl-2-deoxy-1 ,2-didehydro-D-threo-pento-
pyranosyl)perimidine (258) 
Sample code: 1AS064 
Molecular formula: C20H 1 8N205 
Molecular weight: 366 
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D-Xylose derived hydroximoyl chloride 106 (150 mg, 0.4 mmol) and 1,8-
diaminonapthalene (170 mg, 1 mmol) were added according to general procedure B. 
In order of elution, the title compound (258) was obtained as an orange solid (70 
mg, 43%) and perimidine 259 (31 mg, 16%) after dry-flash chromatography. 
M.p 148-149 °C; [a]D20 = -113 (c = 0. 15, CHC13); 6H  (360 MHz, CD 3S(0)CD3); 2. 10, 
2.12 (611, 2s, 2xCOCH 3) 4.14 (1H, dd, 5'a-H), 4.48 (1H, dd, 5'b-H), 5.04 (1H, m, 3'-
H), 5.12 (1H, m, 4'-H), 6.02 (1H, d, 2'-H), 6.58 (1H, dd, 9-H), 6.60 (1H, dd, 4-H), 
7.47-7.5 1 (4H, m, H-5, H-6, H-7, H-8), 10.49 (1H, bs, NH); Ax-Y)/Hz  2'-3' 5.13, 3'-
4' nd, 4'-5"a nd, 4'-5'e nd, 5'a-5'e 12.3, 4-5 7.3, 4-6 0.6, 9-8 7.3, 9-7 0.6; öc (93 
MHz, CD3S(0)CD3); 22.2, 22.3 (2xCOCH 3), 64.5, 66.2, 67.6 (C-3', C-5', C-4'), 99.9 
(C-2'), 104.7 (C-9), 115.2 (C-4), 119.5 (C-7), 121.0 (C-6), 123.8 (C-9b), 129.5 (C-8), 
130.4 (C-5), 136.6 (C-6a), 139.2 (C-9a), 145.9 (C-3a), 149.2 (C-l'), 150.1 (C-2), 
170.9, 171.0 (2xCOCH 3); mlz (FAB) 367 (M +1) HRMS (FAB) Found M+1 
367.12985, C20H 1 8N205 requires M ++1 367.12940. 
3.9.2.4 2-(2,3,4,6-Tetra-0-acetyI--D-gIucopyranosyI)perjmjdjne (260) 
Sample code: 1AS069 
Molecular formula: C23H26N209 	 OAc 





D-Glucose derived hydroximoyl chloride 107 (150 mg, 0.4 nmiol) and 1,8- 
diaminonapthalene (170 mg, 1 nimol) were added according to general procedure A. 
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In order of elution, glycal 261 (trace) was obtained as an orange solid and the title 
compound (260) was obtained as a yellow solid (120 mg, 65%) after dry-flash 
chromatography. 
M.p 105-106°C; [a]D20=  -233 (c = 0. 15, CHCI 3 ); 6H  (360 MHz, CD 3 S(0)CD3); 1.9 1, 
1.99, 2.05 (12H, 4s, 4xCOCH 3), 4.08-4.19 (3H, m, 6"a-H, 6'b-H, 5"-H), 4.33 (1H, d, 
1"-H), 5.05 (1H, dd, 2'-H), 5.35 (1H, dd, 4"-H), 5.45 (1H, dd, 3"-H), 6.38 (1H, d, 9-
H), 6.55 (1H, d, 4-H), 6.94-7.21 (4H, m, H-S. H-6, H-7, H-8), 10.44 (1H, bs, NH); 
Ax-y)/Hz 1"-2" 9.7, 2"-3" 8.9, 3"-4' 9.5, 4"-5" 8.6, 5"-6"a nd, 5"-6'b nd, 6"a-6'b nd, 4-
57.2, 9-8 7.3; 8c (93 MHz, CD3S(0)CD 3); 21.8, 21.9, 22.0 (4xCOCH 3), 63.9 (C-6'), 
69.5, 70.9, 74.1, 75.8, 78.2 (C-2", C-3", C-4', C-5", C-I"), 104.0 (C-9), 115.3 (C-4), 
119.3 (C-7), 121.3 (C-6), 123.5(C-9b), 129.5 (C-8), 130.3 (C-5), 136.6 (C-6a), 139.3 
(C-9a), 145.7 (C-3a), 153.8 (C-2), 170.6, 171.0, 171.1, 171.7 (4xCOCH 3); mlz (FAB) 
499 (M +1) HRMS (FAB) Found M+1 499.17171, C2 5H26N209 requires M+1 
499.17166. 
3.9.2.5 	2-(3,4,6-Tri- O-acetyl-2-deoxy-1 ,2-d idehydro-D-arabino-hexo- 
pyranosyl)perimidine (261) (via Glucose derived hydroximoyl chloride) 
Sample code: JAS070 
Molecular formula: C23H22N207 





D-Glucose derived hydroximoyl chloride 107 (150 mg, 0.4 mmol) and 1,8-
diaminonapthalene (170 mg, 1 mmol) were added according to general procedure B. 
In order of elution, The title compound (261) was obtained as an orange solid (40 
mg, 16 %) and perimidine 260 was obtained as a yellow solid (100 mg, 34%) after 
dry-flash chromatography. 
M.p 154-155 °C; [a] 020 = 175 (c = 0.2, CHC1 3); 5H (360 MHz, CD3S(0)CD3); 2.06, 
2.07 (9H, 3s, 3xCOCH 3), 4.24 (1H, dd, 6'a-H), 4.59 (1H, dd, 6"b-H), 4.69 (1H, m, 
5"-H), 5.22 (1H, m, 3'-H), 5.44 (1H, dd, 4'-H), 5.92 (1H, d, 2"-H), 6.56 (1H, d, 9-H), 
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6.58 (1H, d, 4-H), 7.00-7.18 (4H, m, H-5, H-6, H-7, H-8), 10.28 (11-1, bs, NH); Ax -
y)/Hz 2'-3 3.8, 3-4' nd, 4'-5' nd, 5'-6a 3.1, 5-6'b 5.5, 6'a-6'b 12.3, 4-5 7.2, 9-8 
7.3; 6c (93 MHz, CD 3S(0)CD 3); 21.8, 22.1, 22.2 (3xCOCH 3), 61.6 (C-6'), 69.7, 
69.7, 76.1 (C-3, C-4', C-5), 99.9 (C-2'), 104.6 (C-9), 115.3 (C-4), 119.5 (C-7), 
121.1 (C-6), 123.7 (C-9b), 129.5 (C-8), 130.4 (C-5), 136.6 (C-6a), 139.1 (C-9a), 
145.8 (C-3a), 148.1 (C-1), 148.6 (C-2), 170.7, 171.3, 171.6 (3xCOCH 3); m/z (FAB) 
439 (M +1) HRMS (FAB) Found M+l 439.15068, C231-1 22N207 requires M-i-1 
439.15053. 
3.9.2.6 	2-(3,4,6-Tri-O-acetyl-2-deoxy-1 ,2-didehydro-D-arabino-hexo- 
pyranosyl)perim idine (261) (via mannose derived hydroximoyl chloride) 
Sample code: IAS070 
Molecular formula: C23H 22N207 	 OAc 
Molecular weight: 438 
	
AcR 0 j 
H 
D-Mannose derived hydroximoyl chloride 108 (250 mg, 0.6 mmol) and 1,8-
diaminonapthalene (242 mg, 1.5 mmol) were added according to general procedure 
B. In order of elution, The title compound (261) was obtained as an orange solid (90 
mg, 34%) and perimidine 262 was obtained as a yellow solid (12 mg, 4%) after dry-
flash chromatography. 
3.9.2.7 2-(2,3,4,6-Tetra-0-acetyl--D-mannopyranosyI)perimjdjne (262) 
Sample code: IAS090 
Molecular formula: C23H 26N209 






Mannose derived hydroximoyl chloride 108 (250 mg, 0.6 mmol) and 1,8- 
diaminonapthalene (242 mg, 1.5 mmol) were added according to general procedure 
In order of elution, glycal 261 (trace) was obtained as an orange solid and the title 
compound (262) was obtained as a yellow solid (170 mg, 55%) after dry-flash 
chromatography. 
M.p 120-121 °C; [U]D20 = -193 (c = 0.75, CHC1 3); 6H (360 MHz, CD3S(0)CD 3); 2.00, 
2.04, 2.08 (12H, 4s, 4xCOCH3), 4.09 (1H, m, 5'-H), 4.14 (111, dd, 6'a-H), 4.34 (1H, 
dd, 6b-H), 4.83 (1H, d, F-H), 5.17 (IH, dd, 4'-H), 5.36 (1H, dd, 3'-H), 5.67 (1H, 
dd, 2'-H) 6.50 (1H, d, 9-H), 6.60 (IH, d, 4-H), 7.03-7.19 (4H, m, H-S. H-6, H-7, H-
8), 10.06 (1H, bs, NH); J(x-y)fHz 1'-2 1. 1, 2"-3' 3.4, 3'-4' 10. 1, 4'-5 10.0, 5'-6'a 
2.5, 5"-6'b, 5.7, 6'a-6b 12.2, 4-5 6.8, 9-8 6.4; 8c (93 MHz, CD3S(0)CD 3); 21.8, 
21.9, 22.0, 22.2 (4xCOCH3), 63.1 (C-6'), 68.4, 69.0, 72.3, 75.3, 78.0 (C-2', C-3', C-
4", C-5", C-F'), 104.5 (C-9), 114.8 (C-4), 119.5 (C-7), 120.8 (C-6), 123.4(C-9b), 
129.4 (C-8), 130.3 (C-5), 136.6 (C-6a), 139.0 (C-9a), 145.6 (C-3a), 153.8 (C-2), 
171.2, 171.7 (4xCOCH 3); m/z (FAB) 499 (M' +1) HRMS (FAB) Found Mi-1 
499.17 133, C25H25N209 requires M+1 499.17166. 
3.9.2.8 2-(2,3,4,6-Tetra-0-acetyI--D-gaIactopyranosyI)perjmjdjne (263) 
This experiment was done in collaboration with Mr A. Fromm 
Sample code: AF015 
Molecular formula: C23H26N209 	 OAc OAc 
Molecular weight: 498 	
AcO L 
OAc 	H 
D-Galactose derived hydroximoyl chloride (150 mg, 0.36 mmol) and 1,8- 
diaminonapthalene (145 mg, 0.9 mmol) were added according to general procedure 
The title compound (263) was obtained as a yellow/orange glass (126 mg, 69%) 
after dry-flash chromatography. 
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Yellow/orange glass (%); MD 20 = -120 (c =, CHC1 3); 6H  (360 MHz, CD3S(0)CD3); 
1.95, 1.98, 2.04, 2.21 (12H, 4s, 4xCOCH3), 4.13 (1H, dd, 6'a-H), 4.18 (1H, dd, 6'b-
H), 4.26 (1H, d, l-H), 4.39 (1H, dd, 4'-H), 5.22-5.42 (3H, m, 2'-H, 3-H, 5-H), 
6.55 (2H, d, (9-H, 4-H), 7.04-7.13 (4H, m, 5-H, 6-H, 7-H, 8-H), 10.42 (1H, bs, NH); 
Ax-y)/Hz l-2 8.6, 2'-3' nd, 3'-4 6.3, 4'-5' 6.4, 5'-6a 7.14, 5'-6b, 5.77, 6'a-6'b 
11.53, 4-5 7.3, 9-8 7.3; 6c (93 MHz, CD3S(0)CD 3); 21.8, 21.9, 22.0, 22.2 
(4xCOCH 3), 63.2 (C-6'), 68.4, 69.0, 72.3, 75.3, 78.0 (C-l', C-2, C-3', C-4', C-5), 
104.4 (C-9), 115.0 (C-4), 119.3 (C-7), 121.1 (C-6), 123.6(C-9b), 129.4 (C-8), 130.3 
(C-5), 136.6 (C-6a), 139.3 (C-9a), 145.7 (C-3a), 153.6 (C-2), 170.2, 171.1, 171.5, 
171.6 (4xCOCH3); m/z (FAB) 499 (M +1) HRMS (FAB) Found M+1 499.17217, 
C25H25N209 requires M+1 499.17166. 
3.9.29 2-(2,2-Dimethyl-1 ,3-dioxolan-4-yI)perimidine (264) 
Sample code: 1A5074 
Molecular formula: C 1 6H 1 6N202 	
ON 
Molecular weight: 268 
HN ) 
D-glyceraldehyde derived hydroximoyl chloride 265 (150 mg, 0.8 mmol) and 1,8-
diaminonapthalene (316 mg, 2 mmol) were added according to general perimidine 
procedure B. The title compound (264) was obtained as a yellow/green solid (137 
mg, 61%) after dry-flash chromatography. 
M.p 101-102 °C; MD 20 = 60 (c = 0.2, CHCI 3); 6H  (250 MHz, CD3S(0)CD3); 1.21, 
1.26 (6H, s, CH3), 4.02 (2H, d, 5a-H, 5'b-H), 4.67 (1H, t, 4'-H), 6.37 (2H, d, 9-H, 4-
H), 6.68-7.04 (4H, m, , H-5, H-6, H-7, H-8), 10.13 (1H, bs, NH); J(x-y)/Hz 4'-5'a 
6.4, 4"-5"b 6.4, 5'a-5b 6.4, 4-5 7.2, 9-8 7.2; (63 MHz, CD 3S(0)CD 3); 25.2, 25.6 
(CH3), 66.6 (C-2'), 73.9 (C- 1 - ), 102.7 (C-9), 109.8 (acetal Cq) 113.1 (C-4), 117.6 (C-
7), 119.0 (C-6), 121.8 (C-9b), 127.7 (C-8), 128.5 (C-5), 134.9 (C-6a), 137.5 (C-9a), 
144.3 (C-3a), 155.5 (C-2); m/z (FAB) 268 (M t) HRMS (FAB) Found M 268.12111, 
C 1 6H 1 6N202 requires M 268.12 118. 
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able 1. crystal data and structure refinement for CRYSTALS—Cif. 
Contact 	 Stephen Moggach, S.Moggach@ed.aC.uk  
A. CRYSTAL DATA 
Empirical formula 	 C18 H22 N2 08 
LJ.Ø HZZ NZ UO 
Formula weight 394.38 
wavelength 0.71073 A 
Temperature 150 K 
crystal system monoclinic 
Space group P 1 21 1 
Unit cell dimensions a = 9.440(3) A 	alpha = 
b = 8.007(2) A beta = 
90 deg. 
103.711(4) deg. 
C = 12.932(4) A 	gamma = 90 deg. 
volume 949.6(5) AA3 
Number of reflections for cell 3805 (4.839 < theta < 56.847 deg.) 
Z 2 
Density (calculated) 1.379 Mg/mA3 
Absorption coefficient 0.110 mmt'-1 
F(000) 416.000 
DATA COLLECTION 
crystal description 	 colourless 	block 
crystal size 	 0.35 x 0.35 x 0.94 mm 
Instrument 	 Bruker smart apex 
Theta range for data collection 	2.221 to 28.510 deg. 
index ranges 	 -11<=h<=12, -10<=k<=10, -17<=l<=14 
Reflections collected 	 5834 
Independent reflections 	 2377 [R(int) = 0.02] 
scan type 	 \f & \w scans 
Absorption correction 	 semi-empirical from equivalents 
(Tmin= 0.819585, Tmax=1.00) 
SOLUTION AND REFINEMENT. 
solution 	 direct methods 
Refinement type 	 Full-matrix least-squares on F 
Program used for refinement 	CRYSTALS 
Hydrogen atom placement 	 geom 





Goodness-of-fit on FA2 
R 
RW 
Final maximum delta/sigma 
weighting scheme 








0.48 and -0.27 e.AA-3 
Table 2. Atomic coordinates ( x 10A4) and equivalent isotropic 
displacement parameters (AA2 x 10A3) for iasO14. 	u(eq) is defined 
as one third of the trace of the orthogonalized uij tensor. 
x y z u(eq) 
CM -1256(2) -584(3) -8902(2) 22 
N(1) -2561(2) -801(3) -9443(1) 25 
C(2) -1075(2) -45(3) -7765(2) 22 
N(2) -52(2) -916(3) -9304(1) 28 
C(3) -2315(2) 1071(3) -7595(2) 21 
C(4) -2074(2) 1424(3) -6408(2) 21 
C(S) -1851(2) -187(3) -5765(2) 24 
C(6) -662(3) -1236(3) -6054(2) 32 
0(7) -1044(2) -1553(2) -7171(1) 30 
C(10) 1427(2) -1113(3) -8736(2) 23 
C(11) 2131(2) -2554(3) -8912(2) 28 
0(11) -2543(2) -1481(2) -10455(1) 28 
C(12) 3593(3) -2803(4) -8417(2) 36 
C(13) 4341(3) -1597(4) -7743(2) 37 
C(14) 3645(3) -138(4) -7573(2) 36 
C(15) 2185(2) 126(3) -8087(2) 30 
0(31) -2180(2) 2608(2) -8145(1) 23 
C(32) -3417(2) 3417(3) -8616(2) 26 
0(33) -4598(2) 2896(3) -8594(2) 39 
C(34) -3116(3) 5019(3) -9116(2) 36 
0(41) -3325(2) 2250(2) -6176(1) 25 
C(42) -3235(3) 3934(3) -6041(2) 30 
0(43) -2236(2) 4759(2) -6170(2) 43 
C(44) -4550(4) 4580(4) -5716(3) 51 
0(51) -1413(2) 349(2) -4669(1) 25 
C(52) -1454(2) -798(3) -3912(2) 27 
0(53) -1842(2) -2208(2) -4108(2) 42 
C(54) -945(3) -57(4) -2830(2) 34 


















































































































































































































Symmetry transformations used to generate equivalent atoms: 
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Table 4. 	AnisotrOpiC displacement parameters (AA2 x 10A3) for iasO14. 
The anisotropic displacement factor exponent takes the form: 
-2 piA2 [ hA2 a*A2 ull + ... + 2 h k a* b u12 I 



































































































































































































Table 5. Hydrogen coordinates ( x 10A4) and isotropic 
displacement parameters (M2 x 10A3) for iasO14. 
x y z u(eq) 
 -3507 -1650 -10745 50 
 -250 -1629 -9868 50 
H(21) -168 638 -7536 26 
H(31) -3296 546 -7858 25 
H(41) -1190 2149 -6213 25 
H(51) -2751 -893 -5902 28 
 285 -617 -5863 37 
 -564 -2317 -5657 37 
H(111) 1587 -3429 -9400 34 
H(121) 4098 -3851 -8548 43 
H(131) 5388 -1777 -7376 44 
H(141) 4192 732 -7081 43 
H(151) 1693 1201 -7987 37 
H(341) -4058 5577 -9454 44 
 -2560 4784 -9668 44 
 -2526 5767 -8556 44 
 -4471 5816 -5619 64 
 -5445 4305 -6279 64 
 -4616 4042 -5029 64 
H(541) -983 -922 -2280 41 
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-1591 	 902 	 -2751 









141) 	 I 	-' 
0(181) 	I I N(41) 
quNP, 	




able 1. crystal data and structure refinement for ias02O. 
Contact 	 Simon Parsons, s.parsons@ed.ac.uk 
 







Unit cell dimensions 
vol ume 




C14 H18 N2 09 





P 1 21 1 
a = 5.3400(6) A alpha = 90 deg. 
b = 17.884(2) A 	beta = 92.321(6) deg. 
c = 18.154(2) A gamma = 90 deg. 
1732.3(3) AA3 














Absorption correction  
colourless block 
0.37 x 0.18 x 0.16 mm 
Bruker SMART 
1.123 to 28.543 deg. 
-7<=h<=7, -23<=k<=23, -23<=l<=23 
15939 
2255 [R(int) = 0.0311 
\w 
Sadabs 
(Tmin= 0.622, Tmax=1.000) 
C. SOLUTION AND REFINEMENT. 
Solution 
Refinement type 
Program used for refinement 
Hydrogen atom placement 
direct (S1R92 (Altomare et al, 1994)) 





Hydrogen atom treatment 	 mixed 
Data I restraints / parameters 	3118/477/451 
Goodness-of-fit on FA2 
Conventional R [F>4sigma(F)] 
weighted R (FA2 and all data) 
Final maximum delta/sigma 
weighting scheme 
Largest diff. peak and hole 
0.9748 
Ri = 0.0835 [2673 data] 
wR2 = 0.1936 
0.009153 
shel drick weights. 
0.54 and -0.45 e.AA-3 
Table 2. Atomic coordinates ( x 10A4) and equivalent isotropic 
displacement parameters (AA2 x 10A3) for ias020. 	u(eq) is defined 































































































































































































































































































































































21) -c(31) -c(81) 
41)-C(31)-C(81) 
31)-N(41)-C(51) 
31) -N(41) -H(41) 
51) -N(41) -H(41) 






51) -c(61) -0(11) 
51) -c(61) -0(71) 
11) -c(61) -0(71) 
31) -c(81) -0(91) 
31)-C(81)-C(131) 
91) -c(81) -c(131) 
31)-c(81)-H(811) 
91) -c(81) -H (811) 
131) -c(81) -H(811) 
81) -0(91) -c(101) 
91) -c(101) -c(111) 
91)-C(101)-H(1011) 
111) -c(101) -H(1011) 
91)-C(101)-H(1012) 












































































141)-c (111)-H (1111) 
111) -c(121) -c(131) 
111)-c(121) -0(181) 
131)-C(121)-0(181) 




























































































































































































symmetry transformations used to generate equivalent atoms: 
Table 4. 	Anisotropic displacement parameters (AA2 x 10A3) for ias02O. 
The anisotropic displacement factor exponent takes the form: 
-2 piA2 [ hA2 a*A2 Ull + ... + 2 h k a* b* u12 ] 
ull 	u22 	u33 	u23 	u13 	u12 
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23(2) 66(4) 45(3) 6(3) 1(2) -7(3) 
24(2) 27(4) 44(3) -3(3) 1(2) 3(3) 
23(2) 11(3) 38(3) -9(2) -2(2) 3(3) 
20(2) 32(3) 32(3) 0(2) -1(2) -4(3) 
25(3) 38(4) 40(4) 6(3) -1(3) -602 
25(3) 38(4) 36(3) -1(3) 0(2) -13(3 
44(3) 54(4) 42(3) 7(3) 5(2) -15(3 
14(3) 30(3) 37(3) -4(2) -10(2) 4(2 
36(3) 26(3) 33(2) 3(2) -9(2) -8(22 
40(4) 18(3) 34(3) 5(2) -15(3) 0(32 
28(4) 26(3) 37(3) 3(2) -11(3) 2(22 
30(4) 19(3) 35(3) -2(2) -12(3) 5(22 
25(3) 26(3) 36(3) -1(2) -10(3) 1(2 
35(3) 42(3) 33(2) 1(2) -1(2) -3(22 
38(3) 27(4) 36(3) -7(3) 3(2) -1(3 
28(3) 39(3) 65(4) 3(3) -4(2) 1(32 
65(6) 51(6) 42(4) 4(4) 7(4) -13(5: 
36(3) 27(3) 44(3) -5(2) 4(2) 5(22 
63(5) 42(5) 30(4) -5(3) 7(3) -4(4 
93(5) 76(5) 48(4) -23(4) -33(4) 22(4 
94(8) 51(6) 40(5) -14(4) 28(5) -io(s 
28(3) 27(2) 41(3) -8(2) -7(2) -1(2: 
27(3) 23(3) 56(5) -7(3) 1(3) 5(3 
32(3) 34(3) 63(4) 10(3) -1(2) 4(32 
34(4) 26(4) 77(7) 0(4) 0(4) -3(3: 
22(2) 46(4) 42(3) 6(2) 0(2) -3(2: 
22(2) 36(4) 37(3) -3(3) 0(2) -2(3: 
23(2) 18(3) 28(3) -7(2) 6(2) 5(3 
18(2) 26(3) 29(3) -3(2) 3(2) 7(3: 
19(3) 33(4) 38(4) 5(3) 0(2) 10: 
21(3) 31(4) 36(3) 5(3) -2(2) 4(3 
37(3) 51(4) 34(2) 8(3) -5(2) 5(3: 
24(3) 24(3) 32(3) -1(2) 3(2) 1(2: 
26(2) 26(3) 27(2) -3(2) 0(2) 3(2 
31(4) 30(4) 28(3) 0(2) -2(3) 2(3 
25(3) 26(3) 29(3) 2(2) 5(3) 
28(3) 22(3) 27(3) 2(2) 6(2) -5(2 
24(3) 24(3) 25(2) 1(2) 10(2) 0(2 
33(3) 29(3) 29(2) -1(2) 1(2) 5(2 
28(3) 30(4) 26(3) -6(3) -1(2) 1(3 
33(3) 34(3) 36(3) 7(3) 7(2) 8(2 
59(6) 38(5) 31(3) 5(4) -3(3) 11(4 
34(3) 28(3) 33(2) -3(2) -1(2) 0(2 
56(5) 34(4) 29(3) -1(3) 1(3) 2(3 
92(6) 68(5) 50(4) -20(4) 38(4) -24(4 
66(6) 51(5) 45(5) -18(4) -10(5) 5(4 
22(2) 27(2) 40(3) -2(2) 6(2) 0(2 
25(3) 28(3) 41(4) -1(3) -3(3) 0(3 
47(3) 32(3) 49(4) 8(3) 9(2) 2(3 
42(5) 38(5) 70(7) 1(5) 10(4) 11(4 
Table 5. 	Hydrogen coordinates ( x 10A4) 
displacement parameters (AA2 x 10A3) for 
and isotropic 
ias02O. 
x y z u(eq) 
 -5498 550 -1893 35 
 -4084 -678 -2777 30 
 -5353 1250 -2959 41 
 -4412 1855 -2360 41 
H(811) -559 34 -737 34 
H(1011) -5782 -942 -261 39 
H(1012) -2860 -824 -65 39 
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H(1111) -6677 245 238 38 
H(1211) -1474 348 638 34 
H(1311) -4078 1210 -467 36 
H(1711) -8834 -1276 2064 66 
H(1712) -6992 -616 2334 66 
H(1713) -5864 -1382 2033 66 
H(2111) -2440 1992 2419 76 
H(2112) -5181 1770 2103 76 
H(2113) -3540 2363 1671 76 
H(2511) 1666 2964 -757 58 
H(2512) 1928 2613 54 58 
H(2513) 3218 2208 -619 58 
 -2556 -1935 -2256 38 
 -3502 -1322 -1688 38 
H(821) 383 -123 -3961 34 
H(1021) -2339 729 -4619 36 
H(1022) -5198 794 -4394 36 
H(1121) -6088 -387 -4903 34 
H(1221) -1020 -467 -5327 31 
H(1321) -3156 -1323 -4181 30 
H(1721) -9090 1027 -6731 53 
H(1722) -7456 324 -6970 53 
H(1723) -6121 1108 -6793 53 
H(2121) -2429 -2114 -7086 68 
H(2122) -5073 -1962 -6728 68 
H(2123) -3068 -2504 -6322 68 
H(2521) 2555 -3115 -4066 61 
H(2522) 2465 -2718 -4857 61 

















Table 1. crystal data and structure refinement for ias046. 
contact Simon Parsons, S.Parsons@ed.ac.uk  
A. CRYSTAL DATA 
Empirical formula c18 H26 N2 09 
C18 H26 N2 09 
Formula weight 414.41 
wavelength 0.71073 A 
Temperature 150 K 
Crystal system Monoclinic 
Space group C 2 
unit cell dimensions a = 28.1300(9) A alpha = 90 deg. 
b = 5.3729(2) A beta = 123.387(2) deg. 
c = 16.9066(5) A gamma = 90 deg. 
volume 2133.57(13) AA3 
Number of reflections for cell 6621 (2 < theta < 31 deg.) 
Z 4 
Density (calculated) 1.290 Mg/mA3 
Absorption coefficient 0.104 mmA-1 
F(000) 880 
DATA COLLECTION 
Crystal description 	 colourless slab 
crystal size 	 2.60 x 0.72 x 0.18 mm 
Instrument 	 Bruker SMART AX CCD 
Theta range for data collection 	1.734 to 30.541 deg. 
index ranges 	 -40<=h<=38, -7<=k<=7, -23<=l<=23 
Reflections collected 	 17968 
Independent reflections 	 3455 [R(int) = 0.0461 
Scan type 	 \w 
Absorption correction 	 Semi-empirical from equivalents 
(Tmin= 0.75, Tmax=0.98) 
SOLUTION AND REFINEMENT. 
Solution 	 direct (S1R92 (Altomare et al., 1994)) 
Refinement type 	 Full-matrix least-squares on FA2 
Program used for refinement 	CRYSTALS 
Hydrogen atom placement 	 geom 
Page 1 
Hydrogen atom treatment 
Data 
Parameters 
Goodness-of-fit on FA2 
conventional R [F>4sigma(F)] 
RW 
Final maximum delta/sigma 
weighting scheme 










0.39 and -0.26 e.AA-3 
Table 2. Atomic coordinates ( x 10A4) and equivalent isotropic 
displacement parameters (AA2 x 10A3) for ias046. 	u(eq) is defined 





z 	 u(eq) 
0(1) 10049(1) 5053(3) 3837(1) 41 
N(2) 9493(1) 4715(4) 3703(2) 36 
C(3) 9358(1) 2418(4) 3699(2) 26 
N(4) 9646(1) 422(4) 3723(2) 29 
C(5) 10067(1) 645(4) 3483(1) 26 
C(6) 10360(1) 3134(4) 3838(2) 28 
0(6) 10840(1) 3562 (4) 4081(1) 34 
C(7) 9801(1) 443(5) 2412(2) 34 
C(8) 10225(1) 270(5) 2118(2) 35 
C(9) 10526(1) -2223(6) 2377(2) 49 
C(10) 9924(2) 758(8) 1061(2) 67 
C(11) 8820(1) 2000(4) 3686(1) 26 
C(21) 8302(1) 1493(4) 2681(1) 27 
0(12) 8152(1) 3751(3) 2131(1) 30 
c(22) 8209(1) 3788(4) 1388(1) 29 
0(22) 8407(1) 2110(4) 1192(1) 37 
C(32) 7996(1) 6198(5) 858(2) 41 
C(31) 7796(1) 827(4) 2733(1) 28 
0(13) 7331(1) 37(4) 1807(1) 35 
C(23) 6817(1) 1115(7) 1468(2) 47 
0(23) 6747(1) 2913(5) 1811(2) 65 
C(43) 6360(1) -374(10) 640(2) 72 
C(41) 7942(1) -1316(4) 3415(1) 27 
0(14) 7456(1) -1566(3) 3484(1) 31 
C(24) 7419(1) -3705(5) 3864(2) 32 
0(24) 7781(1) -5288(3) 4174(1) 37 
C(34) 6879(1) -3810(6) 3834(2) 50 
C(51) 8474(1) -685(4) 4373(1) 27 
0(61) 8932(1) -142(3) 4254(1) 27 









































































c(5)-c(6)-0(1) 117. 51(17) 
C(5)-C(6)-0(6) 124.9(2) 































:3) -C(11) -c(21) 






























:432) -c(43) -H(433) 
:31)-c(41)-0(14) 
31)-c(41)-c(51) 










































































































symmetry transformations used to generate equivalent atoms: 
Table 4. 	AnisotrOpiC displacement parameters (AA2 x 10A3) for ias046. 
The anisotropic displacement factor exponent takes the form: 
-2 piA2 [ hA2 aA2 ull + ... + 2 h k a* b* u12 ] 
ull 	u22 	u33 	u23 	u13 	u12 
0(1, 
N(2 


























43(1) 21(1) 75(1) -5(1) 421 
38(1) 22(1) 63(1) -2(1) 371 
27(1) 22(1) 32(1) 1(1) 181 
31(1) 18(1) 51(1) 2(1) 301 
24(1) 22(1) 36(1) 1(1) 191 
30(1) 23(1) 35(1) 5(1) 211 
29(1) 31(1) 42(1) 4(1) 19 
26(1) 39(1) 33(1) -3(1) 131 
39(1) 37(1) 36(1) 0(1) 24 
63(2) 39(2) 70(2) 0(1) 51 
79(2) 80(3) 41(1) 2(2) 34 
27(1) 24(1) 33(1) 0(1) 20 
31(1) 22(1) 31(1) 3(1) 19 
37(1) 24(1) 34(1) 4(1) 22 
30(1) 24(1) 30(1) -1(1) 14 
50(1) 31(1) 41(1) 2(1) 31 
57(2) 29(1) 35(1) 5(1) 24 
24(1) 28(1) 31(1) -2(1) 15 
28(1) 40(1) 33(1) -3(1) 14 
29(1) 64(2) 41(1) 2(1) 15 
40(1) 77(2) 64(1) -2(1) 19 
36(1) 105(3) 56(2) -17(2) 13 
25(1) 27(1) 34(1) -1(1) 20 
26(1) 31(1) 43(1) -2(1) 23 
33(1) 35(1) 35(1) -8(1) 22 
41(1) 30(1) 48(1) 0(1) 29 
45(1) 58(2) 67(2) -7(2) 43 
26(1) 28(1) 33(1) 1(1) 20 
24(1) 28(1) 35(1) 5(1) 20 
Table 5. 	Hydrogen coordinates ( x 10A4) and isotropic 





























x 	 y 	 z 	 u(eq) 
H(4) 9550(13) -850(70) 3790(20) 43(9) 
H(51) 10358 -708 3815 33 
 9558 1951 2104 39 
 9556 -1079 2177 39 
H(81) 10519 1593 2463 45 
 10800 -2265 2175 68 
 10740 -2460 3080 68 
 10240 -3583 2053 68 
 10206 646 876 80 
 9755 2470 914 80 
 9617 -496 700 80 
H(111) 8747 3469 3968 33 
H(211) 8386 125 2373 33 
 8043 6175 311 48 
 8219 7608 1288 48 
 7584 6406 613 48 
H(311) 7677 2310 2943 33 
 5980 408 392 77 
 6437 -422 132 77 
 6359 -2116 855 77 
H(411) 8000 -2876 3154 35 
 6859 -5406 4116 68 
 6864 -2377 4197 68 
 6545 -3705 3158 68 
 8581 -2135 4812 35 
 8399 798 4647 35 
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(Z)-N-(6-deoxy- 1,2:3,4-di-0-isopropyl idene-a-D-galactopyra nosy l)-(2,3,4-tri-








Table 1. Crystal data and structure refinement for mp0502. 








unit cell dimensions 
deg. 
vol ume 














0.724652, Tmax=].. 00) 
C52 H80 N4 028 






a = 7.3600(4) A 	alpha = 91.927(3) deg. 
b = 11.6820(6) A beta = 91.103(3) deg. 
C = 18.9910(10) A gamma = 108.254(3) 
1549.03(14) AA3 






0.54 x 0.35 x 0.15 mm 
1.07 to 23.26 deg. 
-8<=h<=8, -12<=k<=12, -20.<=l.<=21 
15677 
8344 [R(int) = 0.0436] 
semi-empirical from equivalents (Tmi n= 
C. SOLUTION AND REFINEMENT. 
Solution 
Refinement type 
Program used for refinement 
Hydrogen atom placement 
direct (SHELxS-97 (sheidrick, 1990)) 





Hydrogen atom treatment 	 mixed 
Data / restraints / parameters 	8344/3/773 
Goodness-of-fit on FA2 
Conventional R [F>4sigma(F)] 
weighted R (FA2 and all data) 
Absolute structure parameter 
Final maximum delta/sigma 
1.124 
Ri = 0.0674 [7800 data] 




caic w=1/{\sA2A(F0A2A)+(0.0935p)A2A+0.6247p] where P=(F0A2A+2FcA2A)/3 
Largest diff. peak and hole 	0.439 and -0.312 e.AA-3 
Table 2. Atomic coordinates ( x 10A4) and equivalent isotropic 
displacement parameters (AA2 x 10A3) for mp05O2. 	u(eq) is defined 
as one third of the trace of the orthogonalized uij tensor. 
x y z u(eq) 
C1'l -2119(8) -533(5) 6078(3) 40(1) 
011 -899(6) -2311(3) 2690(2) 53(1) 
Nil -606(6) -1035(4) 2640(2) 41(1) 
dl 21(7) -488(4) 3239(3) 32(1) 
0111 -2469(5) 601(3) 6019(2) 49(1) 
N21 398(6) -1050(4) 3816(2) 39(1) 
c2'1 -4032(8) -1447(5) 5859(3) 43(1) 
C21 487(7) 859(4) 3210(3) 32(1) 
02'l -4979(5) -782(3) 5457(2) 43(1) 
03'i -3020(5) -3171(3) 5839(2) 45(1) 
C3'1 -3845(7) -2504(5) 5412(3) 39(1) 
C31 2662(7) 1512(4) 3200(3) 32(1) 
041 -1401(6) -2940(3) 4817(2) 51(1) 
C4'l -2456(7) -2104(5) 4813(3) 38(1) 
041 3436(5) 1088(3) 2599(2) 36(1) 
C4A1 4619(8) 443(6) 2699(4) 56(2) 
C41 2938(7) 2844(4) 3125(3) 34(1) 
C5'1 -1130(7) -818(4) 4931(3) 33(1) 
051 4967(4) 3505(3) 3206(2) 35(1) 
C5B1 5851(7) 4085(4) 2629(3) 37(1) 
C5A1 5227(9) 45(6) 2026(4) 57(2) 
05A1 5056(11) 214(8) 3279(3) 130(3) 
C51 1935(8) 3305(5) 3704(3) 38(1) 
C6'1 709(7) -593(5) 4534(3) 35(1) 
06'l -611(5) -570(3) 5650(2) 38(1) 
061 2069(5) 4532(3) 3534(2) 43(1) 
C6C1 2258(7) 5329(5) 4086(3) 38(1) 
C6B1 7865(8) 4801(5) 2833(3) 51(2) 
06B1 5089(5) 4033(4) 2071(2) 51(1) 
C61 -157(8) 2538(5) 3722(3) 42(1) 
C7C1 2489(9) 6567(5) 3829(3) 54(2) 
07C1 2289(7) 5063(4) 4672(3) 67(1) 
071 -263(5) 1309(3) 3800(2) 39(1) 
C121 -4376(8) 415(5) 5764(3) 45(1) 
C131 -4318(10) 1292(6) 5189(4) 63(2) 
C141 -5650(9) 514(6) 6351(4) 61(2) 
C341 -1810(8) -3641(5) 5431(3) 45(1) 
C351 -2832(9) -4936(5) 5184(4) 57(2) 
Page 2 
Appendix 4 
C361 -44(10) -3501(7) 5850(4) 65(2) 
c12 -1292(7) -2917(4) 10647(3) 32(1) 
C1'2 -3596(8) -2963(5) 7794(3) 45(1) 
01t2 -5081(6) -4059(4) 7883(2) 53(1) 
012 -369(6) -1108(3) 11204(2) 55(1) 
N12 -1339(6) -2383(4) 11245(2) 43(1) 
N22 -404(6) -2355(4) 10085(2) 41(1) 
C2'2 -4511(8) -2004(5) 7983(3) 46(1) 
o2'2 -6041(5) -2601(3) 8411(2) 43(1) 
C22 -2172(7) -4279(4) 10656(3) 35(1) 
C3'2 -3207(8) -920(5) 8402(3) 42(1) 
03'2 -1735(6) -318(4) 7943(2) 52(1) 
C32 -674(7) -4926(4) 10674(3) 32(1) 
042 565(5) -4524(3) 11282(2) 40(1) 
C4A2 2414(8) -3877(6) 11192(3) 54(2) 
C4'2 -2157(8) -1268(5) 9005(3) 41(1) 
04'2 -254(6) -462(3) 8980(2) 52(1) 
C42 -1710(7) -6276(4) 10749(3) 37(1) 
C5A2 3450(9) -3476(6) 11865(4) 59(2) 
05A2 3026(7) -3631(8) 10620(3) 136(3) 
C5'2 -2176(7) -2577(5) 8947(2) 35(1) 
C52 -3258(8) -6725(4) 10166(3) 39(1) 
052 -358(5) -6938(3) 10664(2) 39(1) 
C5B2 10(7) -7511(4) 11233(3) 38(1) 
C6'2 -557(7) -2806(5) 9350(3) 37(1) 
062 -2002(5) -2909(3) 8230(2) 42(1) 
C62 -4528(7) -5956(5) 10153(3) 41(1) 
062 -4319(5) -7944(3) 10334(2) 46(1) 
C6C2 -4859(8) -8769(5) 9802(3) 46(1) 
C682 1318(8) -8212(5) 11037(3) 49(1) 
06B2 -652(6) -7464(4) 11797(2) 53(1) 
072 -3421(5) -4721(3) 10066(2) 37(1) 
C7C2 -5859(9) -9990(5) 10043(4) 56(2) 
07c2 -4547(8) -8523(4) 9200(3) 81(2) 
C122 -6722(8) -3835(6) 8148(3) 52(2) 
C132 -7466(9) -4658(6) 8737(4) 59(2) 
C142 -8162(10) -3964(7) 7541(4) 70(2) 
C342 -62(10) 198(6) 8349(3) 55(2) 
C352 1623(10) 65(7) 7948(4) 69(2) 
C362 229(12) 1516(6) 8571(4) 75(2) 
033 -6110(10) -6610(5) -2904(3) 88(2) 
053 -3086(10) -5777(7) -3122(4) 113(2) 
C43 -4297(16) -6278(8) -2717(5) 90(3) 
C13 -8798(15) -6896(10) -3754(7) 133(4) 
C23 -6722(15) -6377(8) -3589(5) 95(3) 
C53 -3810(20) -6513(10) -2022(6) 127(4) 



























































































































































































C121-01' 1-cl' 1 110.3(4) 










071-c21-c31 108. 7(4) 











































C5B1-051-c41 117. 1(4) 
06B1-c5B1--051 124.1(5) 
06B1-c5Bl-c6Bl 126. 7(5) 
051-05B1-c6B1 1(5) 



















c6c1-o61-c51 116. 5(4) 
07c1-c6c1-o61 122.9(5) 





















02 '1-c121-ol' 1 104.7(4) 
02' 1-C121-C141 110.2(5) 
1-c121-c141 111.2(5) 
1-c121-c131 108.8(5) 
01' 1-c121-c131 108.4(5) 












































































C4A2-042-C32 118. 8(4) 
05A2-C4A2-042 6(6) 































































































































Symmetry transformations used to generate equivalent atoms: 
Table 4. 	Anisotropic displacement parameters (AA2 x 10A3) for mp05O2. 
The anisotropic displacement factor exponent takes the form: 
-2 piA2 [ hA2 a*A2 ull + ... + 2 h k a* b* U12 ] 
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ull u22 u33 u23 u13 u12 
CF1 49(3) 30(3) 34(3) 0(2) 2(2) 5(2) 
011 92(3) 9(2) 51(2) -1(2) -4(2) 7(2) 
Nil 59(3) 13(25 49(3) 7(2) 2(2) 8(2) 
Cli 38(3) 18(3) 36(3) -1(2) 2(2) 6(2) 
oi'l 51(2) 32(2) 61(2) -9(2) 0(2) 9(2) 
N21 64(3) 25(2) 34(2) 3(2) 3(2) 23(2) 
C2'1 58(3) 37(3) 35(3) 4(2) 1(2) 18(3) 
C21 36(3) 16(3) 38(3) 5(2) 5(2) 1(2) 
02'i 42(2) 28(2) 54(2) 0(2) 2(2) 5(2) 
03'1 58(2) 30(2) 47(2) 15(2) 12(2) 9(2) 
c3'1 45(3) 24(3) 45(3) 0(2) -5(2) 6(2) 
c31 43(3) 21(3) 32(3) 1(2) 4(2) 10(2) 
04'l 74(3) 33(2) 50(2) 10(2) 20(2) 21(2) 
C4'l 49(3) 32(3) 31(3) -4(2) -3(2) 13(2) 
041 47(2) 21(2) 42(2) 5(2) 8(2) 11(2) 
C4A1 49(3) 61(4) 64(4) -2(3) 9(3) 25(3) 
C41 40(3) 17(3) 40(3) 7(2) 3(2) 2(2) 
C5'l 42(3) 21(3) 36(3) 3(2) -6(2) 11(2) 
051 37(2) 23(2) 42(2) 8(2) 1(2) 3(1) 
C5B1 43(3) 18(3) 52(3) 1(2) 5(3) 11(2) 
C5A1 53(3) 40(4) 75(4) -5(3) 14(3) 11(3) 
05A1 175(7) 223(9) 63(4) -5(4) -11(4) 169(7) 
C51 57(3) 20(3) 39(3) 8(2) 3(2) 15(2) 
C6'1 44(3) 22(3) 40(3) 8(2) 4(2) 10(2) 
06'l 44(2) 28(2) 39(2) -3(2) -3(2) 8(2) 
061 62(2) 14(2) 49(2) -4(2) -7(2) 10(2) 
C6C1 40(3) 26(3) 42(3) -8(2) -5(2) 2(2) 
c6B1 45(3) 20(3) 82(4) 16(3) 5(3) 0(2) 
06B1 51(2) 49(3) 46(2) 13(2) 1(2) 6(2) 
C61 53(3) 22(3) 55(3) 0(2) 8(3) 17(2) 
C7C1 67(4) 20(3) 75(4) -13(3) -18(3) 19(3) 
07c1 107(4) 40(3) 57(3) -15(2) -5(2) 29(2) 
071 46(2) 15(2) 53(2) 5(2) 10(2) 7(2) 
C121 47(3) 27(3) 61(4) -3(3) 10(3) 12(2) 
C131 63(4) 35(4) 91(5) 2(3) 4(3) 17(3) 
C141 64(4) 44(4) 79(4) 2(3) 18(3) 22(3) 
C341 57(3) 33(3) 46(3) 7(2) 10(3) 13(3) 
C351 67(4) 32(3) 70(4) 10(3) -2(3) 13(3) 
C361 77(4) 62(5) 60(4) -9(3) -6(3) 29(4) 
C12 34(2) 17(3) 41(3) 7(2) -3(2) 5(2) 
c1'2 58(3) 48(4) 31(3) -7(2) -9(2) 22(3) 
oV2 53(2) 38(2) 67(3) -14(2) -6(2) 13(2) 
012 91(3) 7(2) 53(2) 0(2) 1(2) -3(2) 
N12 60(3) 12(2) 51(3) 5(2) 2(2) 1(2) 
N22 46(2) 23(2) 42(3) 3(2) 0(2) -7(2) 
C2'2 52(3) 47(4) 44(3) 0(3) -2(3) 22(3) 
02v2 50(2) 33(2) 48(2) 1(2) 6(2) 15(2) 
C22 49(3) 19(3) 34(3) 4(2) -1(2) 7(2) 
C3'2 52(3) 36(3) 43(3) 4(2) 8(2) 23(3) 
03'2 67(3) 44(3) 46(2) 10(2) 1(2) 16(2) 
C32 41(3) 19(3) 32(3) 2(2) 3(2) 5(2) 
042 49(2) 24(2) 42(2) 6(2) -3(2) 6(2) 
C4A2 35(3) 63(4) 59(4) 2(3) 16(3) 9(3) 
C4'2 55(3) 25(3) 42(3) -1(2) 15(2) 11(2) 
04'2 63(2) 31(2) 55(2) 6(2) -7(2) 6(2) 
C42 44(3) 16(3) 52(3) 2(2) 8(2) 10(2) 
C5A2 57(4) 45(4) 72(4) -9(3) -16(3) 14(3) 
05A2 45(3) 235(9) 71(4) -28(4) 19(3) -36(4) 
C5'2 44(3) 29(3) 30(3) 2(2) 7(2) 8(2) 
C52 54(3) 14(3) 44(3) 1(2) 2(2) 4(2) 
052 48(2) 21(2) 48(2) 5(2) 5(2) 11(2) 
C5B2 39(3) 17(3) 52(3) 4(2) -4(3) 2(2) 
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C6'2 47(3) 24(3) 38(3) 4(2) 4(2) 6(2) 
06'2 52(2) 36(2) 38(2) -3(2) 6(2) 15(2) 
C62 37(3) 27(3) 48(3) 3(2) -6(2) -4(2) 
062 57(2) 18(2) 52(2) -4(2) 13(2) -4(2) 
c6c2 54(3) 28(3) 51(4) -8(3) 5(3) 8(3) 
c6B2 49(3) 31(3) 68(4) 11(3) 11(3) 11(3) 
06B2 65(3) 54(3) 50(3) 14(2) 12(2) 31(2) 
072 40(2) 18(2) 47(2) 2(2) -9(2) 1(1) 
C7C2 57(3) 24(3) 75(4) -8(3) 22(3) -4(2) 
07C2 119(4) 37(3) 57(3) -13(2) 4(3) -18(3) 
C122 48(3) 45(4) 65(4) -11(3) -2(3) 17(3) 
C132 56(4) 43(4) 76(4) -2(3) 5(3) 14(3) 
C142 68(4) 68(5) 72(5) -17(4) -16(3) 20(4) 
C342 78(4) 37(4) 56(4) 13(3) 12(3) 26(3) 
C352 75(4) 53(4) 73(5) -5(3) 11(4) 12(3) 
C362 98(5) 26(4) 100(6) 14(3) 12(4) 13(3) 
033 101(4) 43(3) 109(5) -1(3) -2(3) 7(3) 
053 95(4) 121(6) 119(5) 24(4) 17(4) 25(4) 
C43 109(7) 55(5) 113(7) 14(5) 38(6) 35(5) 
C13 106(8) 75(7) 194(12) -38(7) -13(8) 1(6) 
C23 119(7) 53(5) 103(7) -14(4) 0(5) 15(5) 
C53 197(13) 98(8) 114(8) 30(6) 27(8) 82(9) 
Table 5. Hydrogen coordinates ( x 10A4) and isotropic 
displacement parameters (AA2 x 10A3) for mp05O2. 
x y z u(eq) 
H1'1 -1793 -643 6579 47 
Hil -1224 -2657 2291 79 
H21 458 -1785 3738 46 
H2'1 -4777 -1749 6286 51 
H21 -124 1045 2772 38 
H3'1 -5128 -3018 5222 47 
H31 3308 1379 3644 39 
H4'1 -3185 -2187 4355 45 
H41 2436 2982 2653 41 
H5t1 -1808 -248 4772 39 
H5A11 6185 -360 2117 86 
H5A21 5783 746 1741 86 
H5A31 4117 -518 1771 86 
H51 2590 3302 4170 45 
H611 1382 286 4541 42 
H6'21 1549 -978 4781 42 
H6B11 8742 4562 2522 77 
H6B21 8138 4650 3322 77 
H6B31 8037 5662 2788 77 
H6A1 -778 2816 4122 50 
H6B1 -835 2616 3280 50 
H7C11 2334 7090 4222 80 
H7C21 1517 6516 3459 80 
H7C31 3767 6903 3639 80 
H13A1 -3768 2120 5383 94 
H13B1 -5620 1173 5005 94 
H13C1 -3527 1150 4807 94 
H14A1 -5675 -98 6694 92 
H14B1 -6949 387 6161 92 
H14C1 -5161 1319 6583 92 
H35A1 -3956 -4968 4889 85 
H35B1 -3240 -5430 5594 85 
H35C1 -1961 -5247 4910 85 
H36A1 807 -3833 5577 97 
H36B1 -364 -3935 6286 97 
H36C1 602 -2644 5965 97 
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H1'2 -3220 -2904 7290 54 
H12 -173 -786 11612 82 
H22 373 -1617 10169 49 
H2'2 -5017 -1737 7546 55 
H22 -2938 -4474 11091 42 
H3'2 -3930 -373 8571 50 
H32 78 -4790 10234 38 
H4'2 -2731 -1123 9459 49 
H42 -2297 -6417 11222 45 
H5Al2 4824 -3148 11783 89 
H5A22 3217 -4162 12172 89 
H5A32 3005 -2850 12090 89 
H5'2 -3417 -3108 9122 42 
H52 -2653 -6724 9699 47 
H612 -751 -3684 9338 45 
H6'22 658 -2410 9116 45 
H6A2 -5485 -6236 9760 49 
H6B2 -5221 -6024 10599 49 
H6B12 2612 -7656 10982 74 
H6B22 861 -8669 10591 74 
H6B32 1340 -8770 11408 74 
H7C12 -6370 -10539 9634 84 
H7C22 -6914 -9958 10343 84 
H7C32 -4958 -10282 10314 84 
H13A2 -7630 -5492 8579 88 
H13B2 -8701 -4588 8879 88 
H13C2 -6553 -4431 9140 88 
H14A2 -7504 -3541 7136 105 
H14B2 -9149 -3613 7688 105 
H14C2 -8759 -4820 7409 105 
H35A2 1517 -791 7896 104 
H35B2 2815 503 8208 104 
H35C2 1627 398 7481 104 
H36A2 333 1994 8151 113 
H36B2 1404 1830 8864 113 
H36C2 -866 1568 8842 113 
H1A3 -9076 -6684 -4230 199 
H1B3 -9512 -6572 -3413 199 
H1C3 -9181 -7775 -3730 199 
H2A3 -6023 -6697 -3945 114 
H2B3 -6351 -5492 -3635 114 
H5A3 -4977 -6925 -1776 190 
H5B3 -3131 -5749 -1768 190 
H5C3 -2981 -7026 -2042 190 
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Table 1. crystal data and structure refinement for ias021. 
contact iain.oswald@ed.ac.Uk 
A. CRYSTAL DATA 
Empi rical formula C18 H22 N2 08 S 
C18 H22 N2 08 S 
Formula weight 426.44 
wavelength 0.71073 A 
Temperature 150(2) K 
crystal system orthorhombic 
space group p2(1)2(1)2(1) 
Unit cell dimensions a = 9.1358(5) A alpha = 90 deg. 
b = 13.3082(7) A beta = 90 deg. 
c = 17.5321(9) A gamma = 90 deg. 
volume 2131.6(2) AA3 
Number of reflections for cell 9029 (2 < theta < 29 deg.) 
z4 
Density (calculated) 1.329 Mg/mA3 
Absorption coefficient 0.197 mmA-1 
F(000) 896 
DATA COLLECTION 
crystal description COLOURLESS BLOCK 
crystal size 0.46 x 0.40 x 0.31 mm 
Theta range for data collection 1.92 to 28.72 deg. 
Index ranges -11<=h<=12, -17.<=k<=17, -23<=l<=23 
Reflections collected 19133 
independent reflections 5175 [R(int) = 0.02561 
scan type \f &\w scans 
Absorption correction semi-empirical from equivalents (Tmin= 0.921, Tmax=1.000) 
SOLUTION AND REFINEMENT. 
Solution direct (SHELXS-97 (Sheidrick, 1990)) 
Refinement type Full-matrix least-squares on FA2 
Program used for refinement SHELXL-97 
Hydrogen atom placement geom 
Hydrogen atom treatment mixed 
Data / restraints I parameters 5175/0/278 
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Goodness-of-fit on FA2 1.094 
conventional R [F>4sigma(F)] Ri = 0.0380 [4960 data] 
weighted R (FA2 and all data) wR2 = 0.0964 
Absolute structure parameter 0.04(7) 
Final maximum delta/sigma 0.007 
weighting scheme 
calc w=1/[\5A2A(FOA2A)+(0.0490P)A2A+0.4805P] where P=(F0A2A+2FCA2A)/3 
Largest diff. peak and hole 0.364 and -0.216 e.AA-3 
Table 2. Atomic coordinates ( x 10A4) and equivalent isotropic 
displacement parameters (AA2 x 10A3) for IAS021. u(eq) is defined 
as one third of the trace of the orthogonalized uij tensor. 
x y z u(eq) 
c(1) 7573(2) 5714(1) 8513(1) 23(1) 
N(1) 7086(2) 6436(1) 8915(1) 30(1) 
0(1) 6418(2) 7169(1) 8462(1) 38(1) 
c(2) 8191(2) 4821(1) 8936(1) 21(1) 
c(3) 8945(2) 5117(1) 9685(1) 22(1) 
0(31) 10308(1) 5593(1) 9450(1) 27(1) 
10870(2) 6307(1) 9907(1) 33(1) 
0(321) 10241(2) 6613(1) 10465(1) 44(1) 
12346(3) 6642(2) 9644(1) 47(1) 
c(4) 9307(2) 4187(1) 10154(1) 22(1) 
0(41) 9688(1) 4483(1) 10924(1) 27(1) 
c(42) 11118(2) 4517(1) 11108(1) 29(1) 
0(421) 12091(1) 4322(1) 10675(1) 36(1) 
C(43) 11298(2) 4858(2) 11918(1) 49(1) 
C(S) 7985(2) 3504(1) 10227(1) 25(1) 
0(51) 8516(1) 2601(1) 10590(1) 31(1) 
7518(2) 2062(2) 10983(1) 34(1) 
0(521) 6246(2) 2288(1) 11020(1) 37(1) 
8201(3) 1173(2) 11352(2) 71(1) 
C(6) 7391(2) 3265(1) 9438(1) 27(1) 
0(7) 6963(1) 4191(1) 9089(1) 25(1) 
s(1) 7307(1) 5710(1) 7514(1) 28(1) 
C(1') 8224(2) 4605(1) 7213(1) 26(1) 
c(2) 9501(2) 4709(2) 6779(1) 32(1) 
N(2') 10061(2) 5627(2) 6584(1) 47(1) 
C(3') 10234(2) 3818(2) 6565(1) 44(1) 
9719(3) 2892(2) 6781(1) 51(1) 
8431(3) 2800(2) 7187(1) 47(1) 
C(6') 7668(2) 3655(2) 7387(1) 36(1) 






















































0(51)-C(5)-C(4) 105. 56(13) 
















c(3')-C(4')-C(5 ') 121.0(2) 
c(6')-c(5')-C(4') 119.2(2) 
c(SD-C(6')-C(lt) 120.5(2) 
symmetry transformations used to generate equivalent atoms: 
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Table 4. Anisotropic displacement parameters (AA2 x 10A3) for IAS021. 
The anisotropic displacement factor exponent takes the form: 
-2 pi A2 [ hA2 a*A2 ull + ... + 2 h k a* b* U12 J 
U11 u22 u33 u23 u13 u12 
c(l) 22(1) 24(1) 22(1) 0(1) 2(1) -2(1) 
N(].) 37(1) 25(1) 29(1) -2(1) 3(1) 6(1) 
0(1) 52(1) 29(1) 33(1) 0(1) 7(1) 19(1) 
C(2) 22(1) 20(1) 22(1) -3(1) 0(1) -1(1) 
c(3) 21(1) 23(1) 23(1) -4(1) -1(1) -4(1) 
0(31) 26(1) 28(1) 28(1) 0(1) -2(1) -9(1) 
35(1) 26(1) 37(1) 4(1) -10(1) -11(1) 
0(321) 51(1) 38(1) 44(1) -14(1) -5(1) -14(1) 
42(1) 50(1) 48(1) 10(1) -10(1) -24(1) 
C(4) 21(1) 25(1) 21(1) -2(1) -3(1) -2(1) 
0(41) 24(1) 36(1) 21(1) -3(1) -2(1) -3(1) 
27(1) 32(1) 27(1) -1(1) -6(1) -2(1) 
0(421) 25(1) 49(1) 35(1) -5(1) -4(1) 0(1) 
33(1) 84(2) 30(1) -13(1) -8(1) -6(1) 
C(S) 23(1) 25(1) 27(1) 3(1) -1(1) -2(1) 
0(51) 28(1) 31(1) 36(1) 11(1) -4(1) -3(1) 
36(1) 36(1) 31(1) 7(1) -6(1) -10(1) 
0(521) 35(1) 40(1) 36(1) 3(1) 3(1) -10(1) 
51(1) 68(2) 94(2) 57(2) -14(2) -10(1) 
C(6) 29(1) 21(1) 30(1) 1(1) -5(1) -5(1) 
0(7) 23(1) 25(1) 28(1) 2(1) -5(1) -4(1) 
S(1) 30(1) 31(1) 22(1) 0(1) 0(1) 10(1) 
c(l') 29(1) 28(1) 22(1) -5(1) -3(1) 5(1) 
28(1) 36(1) 31(1) -5(1) -2(1) 5(1) 
N(2') 36(1) 40(1) 66(1) -1(1) 20(1) 3(1) 
35(1) 47(1) 49(1) -16(1) 7(1) 11(1) 
60(2) 38(1) 54(1) -20(1) -4(1) 17(1) 
C(S') 75(2) 29(1) 38(1) -9(1) -1(1) -2(1) 
C(6') 45(1) 34(1) 29(1) -6(1) 2(1) -5(1) 
Table 5. Hydrogen coordinates ( x 10A4) and isotropic 
displacement parameters (AA2 x loA3) for IAS021. 
x y z u(eq) 
8901 4456 8601 26 
8324 5594 9983 27 
H(33A) 13090 6172 9831 70 
H(33B) 12548 7315 9843 70 
H(33C) 12368 6657 9085 70 
10139 3813 9915 27 
H(43A) 12335 4826 12060 73 
H(43B) 10730 4419 12255 73 
H(430 10948 5550 11968 73 
7213 3829 10547 30 
H(53A) 8685 1382 11825 106 
H(53B) 8925 878 11006 106 
H(53C) 7445 675 11469 106 
H(6A) 8152 2930 9127 32 
H(6B) 6538 2809 9478 32 
H(3') 11100 3861 6266 52 
H(4 t ) 10255 2306 6648 61 
H(5') 8075 2155 7328 57 
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H(6') 6757 3597 7644 43 
H(1'1) 10770(40) 5600(20) 6259(18) 65(9) 
H(1'2) 9550(30) 6151(18) 6685(13) 34(6) 
H(1) 6060(30) 7500(20) 8753(16) 45(7) 
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C(6') N (1 ' ) 9 1 ) 
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Appendix 6 
Table 11. Crystal data and structure refinement for 1as025. 








unit cell dimensions 
Volume 














C22 H28 N2 09 






a = 12.1781(2) A alpha = 90 deg. 
b = 12.1781(2) A beta = 90 deg. 
c = 28.1631(6) A gamma = 120 deg. 
3617.18(11) AA3 






0.97 x 0.66 x 0.24 mm 
1.93 to 24.99 deg. 
-14<=h<=14, -14<=k<=14, -33<=l<=33 
21712 
2060 [R(int) = 0.06731 
omega scans 
Multiscan (Tmin= 0.924, Tmax=0.976) 
C. SOLUTION AND REFINEMENT. 
Solution 	 direct (sHELxS-97 (Sheldrick, 1990)) 
Refinement type 	 Full-matrix least-squares on FA2 
Program used for refinement 	SHELXL-97 
Hydrogen atom placement 	 geom 
Hydrogen atom treatment 	 noref 
Data / restraints / parameters 	2060/15/295 
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Goodness-of-fit on FA2 
conventional R [F>4sigma(F)] 
weighted R (FA2 and all data) 
Absolute structure parameter 
Final maximum delta/sigma 
1.214 
Ri = 0.1049 [1810 data] 




calc w=1/[\sA2A(F0A2A)+(0.1307P)A2A+2.0931P] where P=(F0A2A+2FcA2A)/3 
Largest diff. peak and hole 	0.344 and -0.239 e.AA-3 
Table 12. Atomic coordinates ( x 10A4) and equivalent isotropic 
displacement parameters (AA2 x 10A3) for ias025. 	u(eq) is defined 
as one third of the trace of the orthogonalized uij tensor. 
x 	 y 	 z 	 u(eq) 
0(1) 10850(6) 11602(6) 68(2) 64(2) 
0(2) 8142(5) 8798(5) -447(2) 55(1) 
0(3) 7021(6) 10186(7) -98(2) 69(2) 
0(4) 8814(7) 12955(6) -106(2) 75(2) 
C(11) 7028(16) 6646(10) -616(4) 101(4) 
0(6) 6447(11) 10701(13) -763(4) 131(4) 
0(7) 7574(11) 12655(12) 516(3) 117(3) 
N(3A) 10657(10) 9066(9) 228(2) 81(3) 
N(1A) 11022(6) 9184(7) -540(2) 53(2) 
c(1) 10182(9) 10503(8) -244(2) 57(2) 
 8793(8) 9900(8) -142(2) 54(2) 
C(2A) 10653(7) 9611(8) -174(2) 52(2) 
 8314(8) 10797(8) -233(2) 56(2) 
 9099(9) 12012(9) 48(3) 64(2) 
 10488(10) 12522(9) -33(3) 68(2) 
C(4A) 11044(7) 8213(6) 109(2) 74(3) 
C(5A) 11209(9) 7357(8) 383(2) 104(4) 
C(6A) 11581(9) 6565(8) 169(2) 95(4) 
C(7A) 11787(8) 6629(7) -318(2) 94(3) 
C(8A) 11621(7) 7485(7) -592(2) 76(3) 
C(9A) 11250(6) 8277(6) -378(2) 58(2) 
C(].0) 7547(12) 7662(11) -237(2) 87(3) 
 7205(15) 7470(14) 176(4) 69(5) 
 7940(30) 7570(20) 142(5) 97(6) 
c(12) 6177(12) 10170(13) -388(4) 87(3) 
 4866(13) 9370(20) -212(7) 129(6) 
 8041(13) 13193(15) 162(5) 93(4) 
 7926(18) 14246(16) -66(6) 121(5) 
0(34) 1264(12) 4060(15) -1173(5) 162(5) 
 -634(18) 4120(20) -1312(9) 195(12) 
 563(15) 4228(15) -1501(6) 147(7) 
 2359(18) 4070(30) -1374(7) 178(9) 
 3070(20) 3950(30) -951(8) 217(16) 
0(33) 1010(30) 4430(30) -1889(6) 510(40) 
Table 13. Bond lengths [A] and angles [deg] for ias025. 
0(1)-C(S) 	 1.423(12) 
o(i)-c(1) 1.461(10) 







C 11) -c(l0) 
6)-C(12) 
7)-C(14) 
N 3A) -c(2A) 



























C 2A) -N(3A) -C(4A) 
C 2A) -N(1A) -c(9A) 
0 1) -c(1) -c(2A) 
0 l)-c(1)-c(2) 




N 3A) -c(2A) -N (iA) 
N 3A) -c(2A) -C(1) 








N 3A) -c(4A) -c(5A) 
N 3A) -c(4A) -c(9A) 
C SA) -c(4A) -c(9A) 
C 6A) -c(5A) -C(4A) 
C 5A) -c(6A) -c(7A) 
C 8A) -c(7A) -c(6A) 
C 7A) -C(8A) -c(9A) 
N LA) -c(9A) -c (8A) 

























































































Symmetry transformations used to generate equivalent atoms: 
Table 14. 	Anisotropic displacement parameters (AA2 x 10A3) for 1as025. 
The anisotropic displacement factor exponent takes the form: 
-2 piA2 [ hA2 a*A2 Ull + ... + 2 h k a* b* u12 ] 
ull u22 u33 u23 u13 u12 
0(1) 62(3) 86(4) 41(3) -6(2) -8(2) 36(3) 
0(2) 72(3) 67(3) 27(2) -2(2) -9(2) 36(3) 
0(3) 75(4) 95(4) 41(3) -12(3) -13(3) 44(3) 
0(4) 106(5) 65(4) 61(3) -4(3) -16(3) 48(4) 
c(11) 158(12) 63(6) 70(6) 4(5) -6(7) 45(7) 
0(6) 111(7) 212(12) 114(7) 16(8) -36(6) 113(8) 
0(7) 136(8) 171(10) 84(6) -9(6) 13(5) 107(8) 
N(3A) 136(7) 122(7) 27(3) 31(4) 30(4) 96(6) 
N(1A) 44(3) 102(5) 23(3) 21(3) 7(2) 44(3) 
c(1) 77(5) 81(5) 16(3) 7(3) -1(3) 41(5) 
 72(5) 62(4) 27(3) 4(3) -3(3) 34(4) 
C(2A) 51(4) 75(5) 24(3) 5(3) 9(3) 27(4) 
 62(5) 75(5) 28(3) -2(3) -10(3) 33(4) 
 87(6) 71(5) 34(4) -3(3) -2(4) 38(5) 
 84(6) 68(5) 50(4) 2(4) -10(4) 36(5) 
C(4A) 99(7) 90(6) 40(4) 32(4) 27(4) 52(6) 
c(5A) 154(11) 139(10) 46(5) 46(6) 45(6) 95(10) 
c(6A) 112(9) 118(9) 88(7) 41(7) 30(6) 83(8) 
c(7A) 99(8) 126(10) 77(7) -4(6) 12(6) 72(8) 
C(8A) 83(6) 113(8) 60(5) 10(5) 7(4) 70(6) 
C(9A) 39(4) 105(6) 34(3) 7(4) 16(3) 40(4) 
MO) 136(10) 82(7) 37(4) 13(4) -17(5) 50(7) 
 59(8) 49(7) 48(7) 22(5) -2(6) -12(7) 
 117(16) 77(11) 67(10) 15(7) -22(10) 27(13) 
c(12) 109(9) 121(9) 66(6) -23(6) -27(6) 85(8) 
c(13) 77(8) 186(17) 140(12) -41(11) -13(8) 78(10) 
c(14) 100(8) 125(10) 80(7) -38(7) -11(6) 78(8) 
c(15) 153(13) 124(11) 132(11) -9(9) -1(10) 103(11) 
o(34) 136(11) 153(11) 165(12) -28(9) 0(9) 49(9) 
 210(30) 116(15) 220(30) 38(16) 80(20) 55(15) 
 140(16) 145(16) 110(12) 3(11) -10(12) 36(12) 
 129(16) 200(20) 180(20) 23(18) 59(16) 68(16) 
 140(20) 300(40) 140(19) -20(20) 25(15) 60(20) 
0(33) 790(120) 320(50) 320(50) 190(40) 160(60) 210(60) 
Table 15. 	Hydrogen coordinates ( x 10A4) and isotropic 
displacement parameters (AA2 x 10A3) for ias025. 
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x y z u(eq) 
H(11A) 6589 5808 -466 152 
H(11B) 7728 6719 -811 152 
H(11C) 6432 6753 -817 152 
H(1A) 11102 9448 -836 64 
 10337 10800 -581 69 
 8634 9624 197 65 
 8387 11003 -580 67 
 8903 11841 394 77 
H(5A) 10694 12796 -368 82 
H(5B) 10980 13274 171 82 
H(5A1) 11069 7313 716 124 
H(6A) 11694 5980 356 114 
H(7A) 12040 6088 -464 113 
H(8A) 11762 7529 -925 91 
H(13A) 4884 9041 103 194 
H(13B) 4391 8668 -431 194 
H(130 4454 9888 -190 194 
H(15A) 8422 14508 -360 182 
H(15B) 8247 14968 153 182 
H(15C) 7033 13949 -138 182 
H(31A) -694 3944 -970 293 
H(31B) -1363 3428 -1474 293 
H(31C) -628 4918 -1366 293 
H(35A) 2896 4877 -1546 214 
H(35B) 2101 3357 -1596 214 
H(36A) 3833 3956 -1063 325 
H(36B) 2521 3156 -784 325 







Table 1. crystal data and structure refinement for mpOSOl. 
Contact 	
Fraser J. white, f.j.white@sms.ed.ac.Uk 
A. CRYSTAL DATA 
Empirical formula 	 C13 H16 N2 05 







a = 6.2177(2) A alpha = 90 deg. - 
b = 9.6686(3) A beta = 92.6760(10) 
c = 10.6720(3) A gamma = 90 deg. 
640.86(3) AA3 










unit cell dimensions 
deg. 
vol ume 














Absorption correction  
block Colourless 
0.40 x 0.27 x 0.16 mm 
Bruker Smart AX CCD 
1.91 to 28.27 deg. 
-7<=h<=8, -12<=k<=12, -14<=l<=14 
18479 
1680 [R(int) = 0.03283 
Omega and Phi scans 
semi-empirical from equivalents 
(Tmin= 0.815, Tmax=0.98) 
C. SOLUTION AND REFINEMENT. 
solution 
Refinement type 
Program used for refinement 
Hydrogen atom placement 
direct (SHELXS-97 (sheidrick, 1990)) 












































































































Goodness-of-fit on FA2 
conventional R [F>4sigma(F)] 
Rw 
Absolute structure parameter 
Final maximum delta/sigma 
weighting scheme 












0.328 and -0.225 e.AA-3 
Table 2. Atomic coordinates ( x 10A4) and equivalent isotropic 
displacement parameters (AA2 x 10A3) for mpOSOl. 	u(eq) is defined 




	 z 	 u(eq) 















































C(4)-N(3)-H(3) 131. 3(17) 
N(3)-C(4)-C(5) 131.98(17) 
N(3)-C(4)-C(9) 105. 31(15) 














N(1)-C(9)-.C(8) 129. 93(17) 
C(4)-C(9)-C(8) 120.46(16) 
C(1')-0(1')-c(5') 112.74(12) 
o(1')-c(l' )-c(2) 107.40(13) 
0(1')-c(1')-c(2) 110.62(12) 
C(2)-c(1')-c(2') 110.97(13) 













C(4 1  
o(3' 
C(4' 1  
 
















C(5 1  
0(6' 






-c(3' )-H(3' 1) 






-c(4' )-H(4' 1) 
-c(4' )-H(4' 1) 







)-C(6' )-H(6' 1) 
)-C(6' )-H(6' 1) 
)-C(6' )-H(6' 2) 






























symmetry transformations used to generate equivalent atoms: 
Table 4. 	AnisotropiC displacement parameters (AA2 x 10A3) for mpOSOl. 
The anisotropic displacement factor exponent takes the form: 
-2 piA2 [ hA2 a*A2 ull + ... + 2 h k a* b* U12 ] 
ull 	u22 	u33 	u23 	u13 	
u12 
N(1) 19(1) 18(1) 20(1) 01 
C(2) 16(1) 17(1) 17(1) -11 
N(3) 19(1) 19(1) 18(1) 11 
C(4) 18(1) 19(1) 17(1) -31 
C(S) 26(1) 21(1) 21(1) ii 
c(6) 32(1) 26(1) 17(1) Si 
 28(1) 36(1) 19(1) ii 
 24(1) 27(1) 21(1) -2 
C(9) 19(1) 18(1) 18(1) -1 
0(1') 21(1) 16(1) 15(1) 1' 
c(1') 17(1) 17(1) 17(1) 1 
0(2') 21(1) 28(1) 25(1) -11 
C(2') 16(1) 18(1) 18(1) -1 
0(3') 22(1) 29(1) 21(1) -5 
C(3') 18(1) 16(1) 18(1) 1 
0(4') 24(1) 27(1) 18(1) 5 
c(4') 17(1) 18(1) 15(1) 2 
C( 15' ) 18(1) 18(1) 15(1) 2 
0(6 1 ) 22(1) 17(1) 27(1) -2 
C(6') 20(1) 20(1) 18(1) -1 
Table 5. 	Hydrogen coordinates ( x 10A4) and isotropic 




























































































































Table 1. crystal data and structure refinement for 1as069. 
contact 	 Stephen Moggach, s.moggach@ed.ac.uk  
A. CRYSTAL DATA 






Unit cell dimensions 





P 21 21 21 
a = 9.9570(9) A alpha = 90 deg. 
b = 13.8850(12) A beta = 90 deg. 
c = 18.0620(18) - A gamma = 90 deg. 
2497.1(4) AA3 











B. DATA COLLECTION 
Crystal description 
crystal size 






0.86, Tmax=1.00)  
yellow block 
0.50 x 0.36 x 0.20 mm 
1.85 to 30.31 deg. 
-13<=h<=14, -19<=k<=17, -15<=l<=24 
16966 
7043 [R(int) = 0.0323] 
\w 
semi-empirical from equivalents (Tmi n= 
C. SOLUTION AND REFINEMENT. 
Solution 
Refinement type 
Program used for refinement 
Hydrogen atom placement 
Hydrogen atom treatment 
direct (sHELxS-97 (sheldrick, 1990)) 






Data / restraints / parameters 	7043/4/350 
Goodness-of-fit on FA2 
Conventional R [F>4sigma(F)] 
weighted R (FA2 and all data) 
Absolute structure parameter 
Final maximum del ta/sigma 
1.112 
RI = 0.0546 [6329 data] 




caic w=1/[\5A2A(F0A2A)+(0.0509p)A2A+0. 7065P] where P=(F0A2A+2FcA2A)/3 
Largest diff. peak and hole 	0.310 and -0.244 e.AA-3 
Table 2. Atomic coordinates ( x 10A4) and equivalent isotropic 
displacement parameters (AA2 x 10A3) for ias069. 	u(eq) is defined 
as one third of the trace of the orthogonalized uij tensor. 
x y z u(eq) 
N(1) 1653(2) 2364(1) 10807(1) 24(1) 
C(1 1 ) 2706(2) 2223(1) 9597(1) 23(1) 
C(2) 2499(2) 2764(1) 10311(1) 24(1) 
C(2') 1606(2) 2510(1) 9040(1) 23(1) 
N(3) 3046(2) 3611(1) 10368(1) 26(1) 
C(3') 1655(2) 1907(1) 8339(1) 24(1) 
C(3A) 2634(2) 4189(2) 10968(1) 28(1) 
C(4) 3040(3) 5135(2) 11015(l) 38(1) 
C(4') 1842(2) 834 1) 8496(1) 24(1) 
C(5) 2607(3) 5707(2) 11614(2) 46(1) 
C(5') 2931(2) 678(1) 9085(1) 24(1) 
C(6) 1814(3) 5344(2) 12159(2) 44(1) 
0(6') 2585(1) 1218(1) 9733(1) 24(1) 
C(6') 3135(2) -353(2) 9312(1) 29(1) 
C(6A) 1354(2) 4376(2) 12137(1) 35(1) 
 527(2) 3943(2) 12679(1) 43(1) 
 93(3) 3015(2) 12603(1) 42(1) 
 452(2) 2456(2) 11980(1) 34(1) 
C(9A) 1277(2) 2854(2) 11450(1) 27(1) 
C(9B) 1761(2) 3807(2) 11520(1) 27(1) 
0(21) 1813(2) 3494(1) 8822(1) 27(1) 
 1120(2) 4177(2) 9205(1) 28(1) 
0(23) 273(2) 3986(1) 9657(1) 34(1) 
 1573(3) 5164(2) 8989(1) 40(1) 
0(31) 373(2) 2084(1) 7985(1) 28(1) 
 336(3) 2149(1) 7237(1) 31(1) 
0(33) 1283(2) 2004(1) 6843(1) 41(1) 
 -1040(3) 2441(2) 6984(2) 46(1) 
0(41) 2351(2) 376(1) 7836(1) 30(1) 
 1467(2) -37(2) 7364(1) 30(1) 
0(43) 293(2) -115(1) 7500(1) 43(1) 
 2143(3) -346(2) 6669(2) 45(1) 
0(61) 1912(2) -697(1) 9660(1) 34(1) 
 1918(3) -1642(2) 9844(1) 37(1) 
0(63) 2829(2) -2164(1) 9691(1) 56(1) 
 654(4) -1940(2) 10217(2) 69(1) 
0(15) 72(2) 647(1) 10594(1) 32(1) 
















































-H 2 3A) 
-H 23B) 






































































































































































































































c(9A)-c(9B)-c(3A) 119. 57(18) 






















c(42) -0(41) -c(4') 118.61(16) 
0(43)-c(42)-0(41) 122.9(2) 
0(43)-c(42)-c(43) 126.0(2) 







c(62) -0(61) -c(6') 114.96(18) 
0(63)-c(62)-0(61) 122.3(2) 









Symmetry transformations used to generate equivalent atoms: 
Table 4. 	Anisotropic displacement parameters (AA2 x 10A3) for ias069. 
The anisotropic displacement factor exponent takes the form: 
-2 piA2 [ hA2 a*A2 ull + ... + 2 h k a* b* u12 ] 
ull u22 u33 u23 u13 u12 
N(1) 27(1) 23(1) 23(1) -3(1) -1(1) -2(1) 
c(1 1 ) 21(1) 23(1) 24(1) -4(1) 0(1) -1(1) 
C(2) 23(1) 24(1) 24(1) -1(1) -4(1) 2(1) 
C(2') 24(1) 22(1) 22(1) -1(1) 2(1) -1(1) 
N(3) 26(1) 25(1) 26(1) -2(1) -3(1) -2(1) 
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C(3') 24(1) 27(1) 21(1) -3(1) 1(1) -3(1) 
C(3A) 24(1) 29(1) 30(1) -6(1) -7(1) 2(1) 
C(4) 37(1) 32(1) 45(1) -9(1) -6(1) -2(1) 
C(4') 22(1) 25(1) 24(1) -6(1) 1(1) -2(1) 
 44(1) 33(1) 61(2) -19(1) -15(1) 0(1) 
c(S') 20(1) 25(1) 28(1) -5(1) 1(1) -1(1) 
 38(1) 44(1) 50(1) -26(1) -11(1) 14(1) 
0(6') 26(1) 22(1) 24(1) -3(1) -1(1) 1(1) 
C(6') 27(1) 27(1) 34(1) -6(1) -1(1) 1(1) 
C(6A) 29(1) 43(1) 34(1) -15(1) -9(1) 11(1) 
 33(1) 63(2) 32(1) -20(1) -1(1) 14(1) 
 33(1) 64(2) 28(1) -5(1) 6(1) 5(1) 
 31(1) 44(1) 28(1) -1(1) 1(1) 0(1) 
C(9A) 24(1) 33(1) 23(1) -2(1) -5(1) 3(1) 
C(9B) 24(1) 32(1) 27(1) -5(1) -6(1) 6(1) 
0(21) 32(1) 23(1) 24(1) 0(1) 3(1) -1(1) 
 30(1) 27(1) 25(1) -2(1) -5(1) 2(1) 
0(23) 30(1) 33(1) 41(1) -4(1) 5(1) 4(1) 
 51(2) 27(1) 41(1) 1(1) -2(1) 1(1) 
0(31) 28(1) 33(1) 24(1) -1(1) -3(1) -1(1) 
 49(1) 21(1) 24(1) 2(1) -5(1) -6(1) 
0(33) 59(1) 40(1) 25(1) 1(1) 6(1) -8(1) 
 61(2) 39(1) 38(1) -2(1) -17(1) 2(1) 
0(41) 27(1) 34(1) 29(1) -12(1) 4(1) -1(1) 
C(42) 35(1) 27(1) 29(1) -6(1) -2(1) -1(1) 
0(43) 36(1) 54(1) 40(1) -11(1) -1(1) -15(1) 
c(43) 43(1) 52(1) 41(1) -22(1) -1(1) 6(1) 
0(61) 36(1) 25(1) 41(1) 0(1) 7(1) 1(1) 
 50(1) 27(1) 36(1) -1(1) -4(1) 0(1) 
0(63) 54(1) 32(1) 82(2) 7(1) 2(1) 9(1) 
 85(2) 41(2) 81(2) 13(2) 36(2) -5(2) 
o(ls) 28(1) 31(1) 38(1) -3(1) -1(1) 1(1) 
Table 5. Hydrogen coordinates ( x 10A4) and isotropic 
displacement parameters (AA2 x 10A3) for ias069. 
x y z u(eq) 
H(1) 1300(20) 1784(13) 10704(14) 33(7) 
H(1') 3613 2371 9389 27 
H(2') 704 2442 9278 27 
H(3') 2398 2141 8013 29 
H(4) 3609 5401 10645 46 
H(4) 975 533 8654 28 
t-i(5) 2876 6362 11637 SS 
H(5') 3800 931 8887 29 
 1563 5745 12561 52 
H(6'1) 3346 -752 8873 35 
H(6'2) 3894 -400 9664 35 
 269 4303 13103 51 
 -460 2740 12975 50 
 129 1816 11928 41 
H(23A) 1072 5644 9275 59 
H(23B) 1408 5263 8459 59 
H(230 2535 5231 9091 59 
H(33A) -1120 3144 7002 69 
H(33B) -1716 2151 7309 69 
H(330 -1183 2219 6475 69 
H(43A) 1645 -884 6449 68 
H(43B) 3062 -552 6780 68 
H(43C) 2166 193 6319 68 
H(63A) -31 -2082 9843 104 
H(63B) 339 -1417 10538 104 
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Synthesis of pyranosyl amidoximes by addition of amines to 
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Abstract—Addition of amines to pyranosyl nitrile oxides, generated by base-induced dehydrochlorination of the corresponding 
hydroximoyl chloride, affords pyranosyl N-alkyl/aryl-formamide oximes (41-90%). Reaction with amino acid esters yields the cor-
responding amidoximes and/or 3-pyranosyl- I ,2,4-oxadiazin-6-ones. The structure of N-phenyl-C-(2,3,4-tri-O-acetyl--o-xylopyrano-
syl)formamide oxime was established by X-ray crystallography. 
© 2004 Elsevier Ltd. All rights reserved. 
We have recently reported a short and efficient synthetic 
route from monosaccharides to pyranosyl hydroximoyl 
chlorides.' -3 The approach, which is illustrated in 
Scheme. 1 for the D-glucose-derived compound 1, in-
volves addition of nitromethane to D-glucose and acetyl-
ation to afford the pyranosylnitromethane 2, followed 
by reduction to oxime 3, and finally reaction with chlo-
rine. The hydroximoyl chorides were then used as a 
source of the corresponding nitrile oxide, for example, 
4, from which a variety of novel C-glycosides were pre-
pared by cycloaddition to dipolarophiles XY. 
We now report that dehydrochlorination of these 
hydroximoyl chlorides in the presence of a primary or 
secondary amine provides easy access to a range of no-
vel pyranosyl amidoximes (Scheme 2). 1,3-Addition of 
amines to arene nitrite oxides has been known for many 
years 4,5  and the resulting amidoximes have been shown 
to have a variety of useful properties. These include 
metal ligation 6-8  and biological activity, for example, 
as nitric oxide donors  and amidine prodrugs.'° Less 
attention, however, has been paid to carbohydrate ana-
logues; rare examples include cyclic amidoximes as 
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glycosidase and glycosyl transferase inhibitors 11,12  and 
amidoxime-linked 11ucleosides) 3 
In the present work the pyranosyl nitrite oxides were 
generated by dehydrochiorination of the corresponding 
hydroxinioyl chlorides in situ in order to minimise dime-
risation to I ,2,5-oxadiazole N-oxides (furoxans), which 
are often formed as by-products in reactions involving 
nitrile oxides. 34 In it typical experiment a solution of 
the glucopyranosyl-hydroximoyl chloride I (0A4 mmol) 
in dry chloroform (40m1) was added dropwise over 3h 
to a cooled (0°C) vigorously stirred solution of benzyl-
amine (1.32mmol) and dry triethylamine (7.1mmol) in 
dry chloroform (5 ml) under nitrogen. Removal of the 
solvent and chromatography of the residue (silica, hex-
ane-EtOAc) afforded the N-benzyl amidoxime 5 
(R 2 = Bn. R 3 = H) in 80% yield. The furoxan dimer 9 
was not detected. D-Xylopyranosyl nitrite oxide 6, gen-
erated from the hydroximoyl chloride 7. reacted simi-
larly to yield amidoxime 8 (R 2 = Bn. R 3 = I-I) (67Vo). 
The structures of the products were assigned on the ba-
sis of their spectroscopic properties; for example, in the 
NMR spectrum of D-xylose-derived aniidoxime 8 
(R 2 = Bn, R 3 = H) there are, in addition to the expected 
signals for the carbons and protons of the pyranosyl and 
benzene rings, distinctive peaks for the oxime unit [ó 
148.9 ppm (CN)] and the attached NHCH group [5F1 
4.38 (CH 1 ). 4.39ppm (CH I,), 5.22 (NH): JNII ,i 5.5, 
iNtl (Al,, 6.8, J(11 14.61 ­1z; - 46.4 ppm (CH)]. 
Nitrite oxide 6 also reacted readily with 1-aminobutane. 
morpholine and allylamine to afford the corresponding 
adducts (8 R 2 = Bu, R' = I-I; 637)), (8 R 2 R 3 
CH,CHOCH2CH; 677) and (8 R2 = CU7CH=CH,, 
R 3 = H; 41Vo). It is noteworthy that in the latter case 
the isolated product results from addition of the nitrite 
oxide to the amine moiety in allytamine rather than 
cycloaddition to the alkene. 
More forcing conditions were used for the correspond- 
ing reactions with aniline. Heating a 2:1 mixture of ani- 
line and i)-glucopyranosyl-hydroximoyl chloride I in 
ethanol at reflux for 5h afforded amidoxirne 5 
0 (R = Ph. R 	H) in 80/a yield. The corresponding 
reaction with n-xylop'ranosyl nitrile oxide 6 gave amid-
oxime 8 (R = Ph, R = H) (907). In neither case was 
there any evidence for the formation of the furoxan di-
met- (9,10). However, reaction with aniline in the pres-
ence of triethylamine as dehydrochlorinating agent 
afforded a mixture (-..'1:3) of the amidoxime and the 
f'uroxan. 
The structure of the adduct 8 (R 2 = Ph. R 3 = H) formed 
by 1,3-addition of aniline to nitrite oxide 6 was estab-
lished by X-ray crystallography (Fig. 1)) Of particular 
note are the 2-configuration of the oxime moiety and 
the s-trans conformation about the amidic nitrogen with 
the 1-I of the NHR facing the oxime OH. These results 
are in accord with previous studies indicating that such 
additions occur in a concerted, but rion synch ronous 
manner. 17  The near planarity of the NH-C=N-O unit 
[torsion angle 2.6(3)1 and the short nonbonded distance 
between the amidic N and the oxime 0 [N to 
0 = 2.508(3)  (A)1 are consistent with the existence of 
an intramolecular H-bond between these atoms. 17,111 
1. X-ray crystal structure 01 uniidoximc 8 (11 2 = Ph. R = II) 
showing the Z-s-trans arrangement. 
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Having established that simple amines such as aniline 
and benzylamine add readily to the pyranosyl nitrile oxi-
des, the corresponding reactions with amino acid esters 
were examined. The resulting adducts were considered 
of interest as they would contain an unusual amidoxime 
sugar/amino acid linkage, and extension of the reaction 
to oligopeptides might provide access to novel glycopep-
tide analogues. 
Reaction of hydroximoyl chloride 7 with glycine ethyl 
ester hydrochloride and triethylamine (1:1.5:15 molar 
ratio) at 0°C afforded a mixture of three products, two 
of which were isolated and characterised (Scheme 3). 
The first (40%) proved to be the amidoxime 11 
(R' = H, R2 = E0' 9 resulting from the expected addition 
of glycine ethyl ester to nitrile oxide 6; the other major 
product was identified from its spectroscopic proper-
ties20 as the 1,2,4-oxadiazin-6-one 12 (R' = H) PH  3.95 
(CH 2), 5.61 ppm (NH); bc 40.2 (CH2), 150.4 (C=N), 
164.6ppm (C0)], and the third was provisionally as-
signed structure 13 (R' = H, R 2 = Et) on the basis of 
its NMR and mass spectra. In contrast, when the 
reaction was repeated under the same conditions with 
glcine t-butyl ester the amidoxime 11 (R' = Pr', 
R = But) (881/6) was the only isolated product. The cor-
responding reaction with L-leucine ethyl ester afforded 
53% of amidoxime 11 (R' = CH 2CHMe2, R2 = Et) 
(53%) as the main product, which readily cyclised to 
oxadiazinone 12 (R' = CH 2CHMe2) (71%). Reaction 
with -alanine ethyl ester, for which cyclisation would re-
sult in a seven-membered ring, afforded only the expected 
amidoxime 8 (R 2 = CH 2CH2CO2Et, R3 = H) (50%). 
These results are consistent with nucleophilic addition of 
the amino acid ester to nitrile oxide 6 forming adduct 11, 
followed by intramolecular cyclisation with expulsion of 
ethanol to afford oxadiazinone 12, and finally nucleo-
philic ring opening to form dipeptide amidoxime 13 
(Scheme 3). Similar facile cyclisations of amino acid 
amidoximes have been reported previously for adducts 
from benzonitrile oxide, 2 ' and for oligopeptides incor-
porating amidoxime links. 22 
Support for the pathway shown in Scheme 3 was the 
observation that, in the presence of silica, amidoxime 
11 (R' = H, R2 = Et) was smoothly converted to oxadi-
azinone 12 (R' = H) (-.6h in CHC1 3 at reflux, 2-3 days 
at room temperature). Furthermore, reaction of nitrile 
oxide 6 with glycylglycine ethyl ester afforded the dipep-
tide amidoxime 13 (R' = H, R 2 = Et) directly (43 0/6), 
thus confirming the identity of the 2:1 adduct in the gly-
cine ethyl ester reaction described above. 
In conclusion, an efficient route to pyranosyl amid-
oximes has been established based on 1,3-addition of 
amines to pyranosyl nitrile oxides, which were generated 
from readily accessible hydroximoyl chlorides. The ad-
ducts resulting from the addition of amino acid esters 
cyclised to afford 3-pyranosyl- 1 ,2,4-oxadiazin-6-ones; 
the feasibility of using the oxadiazinones as precursors 
for pyranosyl oligopeptides is currently under 
investigation. 
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